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1. Summary 
 
In organisms oxidative stress is generated, when the concentration of free radicals and other 
reactive oxygen species (ROS) exceeds the capacity of the antioxidant defense system. This 
may result in biological damage which is characteristic for arteriosclerosis and other diseases 
associated with chronic inflammation, e.g. cancer. There is strong evidence, that proteins are 
the main targets of oxidative stress and free radical action, and therefore proteome analysis 
represents a suitable method to investigate biological effects of oxidative stress. 
In the first part of this study, human peripheral blood mononuclear cells (PBMCs) were 
exposed to hydrogen peroxide in autologous plasma, imitating in vivo conditions. The 
metabolically labeled cells were fractionated and the isolated cytosolic protein fractions were 
separated by 2-dimensional polyacrylamid gel electrophoresis (2D-PAGE). Protein spots were 
quantified by fluorography and autoradiography in order to reveal protein amounts and 
synthesis rates. Peptides from tryptic digestion of isolated proteins were separated by nano-
liquid-chromatography and identified by peptide fragmentation analysis with a nano-
electrospray ion trap mass spectrometer. Further, proteins were identified by shotgun analysis 
(1D-PAGE). As a result cells displayed a distinct stress response compared to control and 
down-regulated manganese superoxide dismutase. Additionally, PBMCs were isolated from 
cancer patients to analyze primary cells exposed to chronic oxidative stress. Plasma 
peroxidation levels of the patients were significantly higher than those of age and sex-
matched controls. The corresponding cells displayed significant proteome alterations 
compared to control which appear to be related to inflammation and apoptosis regulation. 
In the second part, the main aim was the identification of proteome maps of the different cell 
types of PBMCs (T-cells, monocytes, platelets, granulocytes, erythrocytes) and plasma. By 
means of these proteome maps, further evaluation of the impact of oxidative stress on the 
different cell types and plasma is performed in ongoing studies. 
With this PhD-thesis, proteome reference maps of several cell types have been established 
and the identification of putative biomarkers for oxidative stress became possible. 
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1. Zusammenfassung 
Oxidativer Stress entsteht, wenn die Konzentration von freien Sauerstoff-Radikalen oder 
anderer Radikale die Kapazität der körpereigenen Abwehrmechanismen übersteigt. Daraus 
kann eine biologische Schädigung des Organismus erfolgen, was wiederum zu Erkrankungen 
wie Arteriosklerose oder anderen mit chronischer Entzündung verbundenen Krankheiten, wie 
z.B. Krebs, führen kann. Proteine gelten als Hauptziele von oxidativem Stress, weshalb 
Proteom-Analysen passende Methoden zur Untersuchung von biologischen Effekten sind, die 
durch oxidativen Stress ausgelöst werden. 
Im ersten Teil dieser Arbeit wurden menschliche periphere mononukleare Blutzellen 
Wasserstoffperoxid ausgesetzt. Durch diese Behandlung im eigenen Plasma wurden in vivo 
Konditionen nachgeahmt. Die Zellen wurden metabolisch markiert und die isolierten 
zytosolischen Proteine mit Hilfe von zwei-dimensionaler Polyacrylamid-Gelelektrophorese 
aufgetrennt. Die Quantifizierung von Proteinspots erfolgte mit Hilfe von Flurographie und 
Autoradiographie wodurch Proteinmengen und Syntheseraten ermittelt wurde. Die durch den 
tryptischen Verdau der isolierten Proteine erhaltenen Peptide wurden mit Hilfe der nano-
Hochdruck-Flüssigchromatographie getrennt und durch Peptidfragmentations-Analysen mit 
einem Elektrospray-Ionenfallen-Massenspektrometer identifiziert. Zusätzlich wurden die 
Proteine noch durch „Shotgun“-Proteomics (ein-dimensionale Polyacrylamid-
Gelelektrophorese) identifiziert. Die Zellen zeigten eine deutliche Antwort auf den oxidativen 
Stress und die Synthese von Mangan-Superoxid Dismutase wurde vermindert. Weiters 
wurden Blutzellen von Krebspatienten isoliert und analysiert. Dies geschah in der Annahme, 
dass diese Zellen durch die Krebserkrankung einem internen, chronischen oxidativen Stress 
ausgesetzt sind. Die ermittelte Plasmaperoxidation der Krebspatienten war im Gegensatz zu 
der Kontrollgruppe gleichen Geschlechts und Alters erhöht. Die korrespondierenden 
Blutzellen zeigten Proteomveränderungen, die mit Entzüngungsparametern und Apoptose in 
Zusammenhang gebracht werden können. 
Im zweiten Teil der Arbeit wurden Proteom-Profile der verschiedenen im Blut vorhandenen 
Zelltypen (T-Zellen, Monozyten, Blutplättchen, Granulozyten und Erythrozyten) und des 
Blutplasmas erstellt. Mit Hilfe dieser Profile soll es ermöglicht werden die Auswirkungen von 
oxidativem Stress auf die einzelnen Zelltypen zu evaluieren. 
Im Zuge dieser Arbeit war es möglich, Referenz-Proteom-Profile von mehreren 
verschiedenen Zelltypen zu erstellen, und potentielle Biomarker für oxidativen Stress 
aufzuzeigen. 
VERENA HAUDEK     PhD-thesis 6
2. List of Abbreviations 
 
1/2D-PAGE: 1/2dimensional polyacrylamide gel-electrophoresis 
CPL/MUW: Clinical Proteomics Laboratories at the Medical University of Vienna 
Cu/Zn-SOD: copper/zinc superoxide dismutase 
ESI: electrospray ionization 
GPX: glutathione peroxidase 
Hsp70: heat shock protein 70 kDa 
LC-MS/MS: liquid chromatography tandem mass spectrometry 
m/z: mass-to-charge ratio 
MALDI: matrix assisted laser desorption/ionization 
Mn-SOD: manganese superoxide dismutase 
PBMC: peripheral blood mononuclear cells 
pI: isoelectric point 
PRIDE: Proteomics Identification Database (http://www.ebi.ac.uk/pride) 
ROS: reactive oxygen species 
RuBPS: Ruthenium II tris (bathophenanthrolin disulfonate) 
SDS: sodium dodecyl sulphate 
SQL: Structured Query Language 
TBA: thiobarbituric acid 
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3. Introduction 
 
3.1. General scope and background 
 
Ecotoxicology is the branch of toxicology that particularly focuses on the toxic effects of 
constituents of an ecosystem. Both natural and synthetic pollutants contribute to these toxic 
effects. Environmental toxicology is considered as a part of ecotoxicology which studies the 
effects on individuals, especially on human species. 
 
Generation of oxidative stress 
In the physiological context, reactive oxygen species (ROS) are generated endogenously by 
the respiratory chain of mitochondria or by peroxisomes. Yet, the exposure to xenobiotics, 
radiation, ultrasound, pollution, infections, drugs or smoking is considered as exogenous 
source for the production of ROS in an organism. If the concentration of free radicals or other 
ROS overrides the capacity of the antioxidant defense system of an organism, this can lead to 
the generation of oxidative stress [1]. ROS induce oxidative damage in lipids, DNA and 
proteins [2], which may result in biological damage leading to arteriosclerosis and other 
diseases associated with chronic inflammation, such as e.g. cancer [3] (cf. Figure 1).  
Several studies dealing with environmental exposures to for example lead [4] or polycyclic 
aromatic hydrocarbons (PAHs) in urban environment [5], revealed that the production of ROS 
and the following oxidative stress increases the risk for elevated DNA damage or cancer. 
 
Consequences of oxidative stress 
As mentioned above, persistent oxidative stress leads to DNA damage, mutations and 
consequently to the activation of signal transduction pathways which stimulate the 
proliferation of cells [6]. This aberrant DNA synthesis and cell growth are important steps in 
carcinogenesis and belong to the hallmarks of cancer [7] (cf. Figure 2, 3). Carcinogenesis is a 
multistage process, in which at least three distinct steps can be recognized: initiation phase, 
promotion phase and progression phase [2]. 
In this regard, inflammatory events represent the main source of radicals and oxidative stress, 
which most frequently correlate with the pathogenesis of solid tumors [6, 8, 9]. In particular, 
elevated ROS generation and persistent oxidative stress have been recognized as characteristic 
features of carcinoma cells both in vitro and in vivo [3, 10].  
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Figure 1: Scheme of the generation of oxidative stress in a eukaryotic cell (modified 
after IMD, Berlin). Endogenous and exogenous factors may lead to the generation of 
superoxide (O2
.-). Superoxide is decomposed by superoxide dismutase to hydrogen 
peroxide (H2O2), which is further processed through catalase and glutathione peroxidase 
to water and oxygen. Yet, the generation of hydroxyl radical (OH.) is possible and may 
lead further to protein damage, DNA damage and lipid peroxidation. 
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Figure 2: Multistage process of carcinogenesis [2]. After one round of DNA synthesis, 
the DNA mutation is determined and leads to an initiated cell (initiation). By induction 
of cell proliferation or inhibition of apoptosis, the initiated cell clonally expands to a 
focal lesion (promotion). By further DNA damage and genetic instability, the malignant 
stage may be reached (progression). 
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Figure 3: Oxidative stress and cancer [2]. Oxidative stress involves all three stages of the 
cancer process. During initiation it may contribute to DNA damage and chemical modifications 
of the DNA. This may result in a heritable mutation. During promotion, oxidative stress can 
contribute to abnormal gene expression, disturbance of cell-to-cell communication, and 
modification of second messenger systems. This could result in an increase in cell proliferation 
or a decrease in apoptosis in the initiated cell population which may further lead to clonal 
expansion of the initiated cells to preneoplastic focal lesions. During progression, oxidative 
stress facilitates additional DNA alterations in the initiated cell population. These may result in 
changes of enzymatic activities and provide resistance to normal growth regulation (e.g. 
apoptosis). GJIC = gap junctional intercellular communication 
VERENA HAUDEK     PhD-thesis 11
Chemoprotective properties of vegetables 
It has been reported that several types of vegetables contain a large number of potentially 
anticarcinogenic agents [11]. These include allicin in garlic [12], isoflavones in soybean [13], 
lycopene in tomatoes [14], flavonoids in tea [15], carotinoids in carrots [16], lignans in flax 
seed [17], sulforaphane and other glucosinolates in cruciferous plants [18]. Although these 
plant ingredients have toxic effects when ingested in large amounts, as it was shown in animal 
experiments, smaller subtoxic doses facilitate their role as chemoprotective agents [19].  
Numerous epidemiological studies indicated that consumption of cruciferous vegetables 
appears to protect against the incidence of various forms of cancer, such as e.g. colorectal, 
lung, prostate and breast cancer [16, 20-22]. The chemoprotective properties of cruciferous 
vegetables were attributed to breakdown products of glucosinolates (e.g. indoles, nitriles and 
isothiocyantes) [23].  
Foreign compounds, such as toxic materials or carcinogens, enter the body and are 
metabolized by endogenous Phase I and Phase II enzymes for further excretion. In some cases 
these electrophils which are directly acting on macromolecules, can lead to the formation of 
cancer. However, the ability of carcinogens to exert their effects depends on the balance 
between the different activating enzymes. It is suggested that the anticarcinogenic mechanism 
of glucosinulates and their metabolites is triggered by induction of Phase I and Phase II 
enzymes, selective inhibition of enzyme activation and scavenging of electrophils and thus 
protecting against oxidative damage [19] (cf. Figure 4). By inducing Phase I and Phase II 
enzymes they facilitate detoxification of carcinogens. Some enzymes of Phase I reactions are 
known to activate xenobiotics to carcinogens, but it is further suggested that they are inhibited 
selectively by glucosinolate metabolites [24]. Additionally, the induction of cell cycle arrest 
and apoptosis  may play a role in the cancer protective properties of cruciferous vegetables 
[20].  
In a study it was shown, that the consumption of cruciferous vegetables, in this case Brussels 
sprouts, leads to inhibition of sulfotransferases in humans which finally protects against the 
heterocyclic amine 2-amino-1-methyl-6-phenyl-imidazo-[4,5-b]pyridine (PhIP) and oxidative 
DNA-damage [25].  
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Figure 4: Common mechanism of carcinogen metabolism with the chemopreventive effects of 
glucosinulates [19]. Foreign compounds such as toxic materials or carcinogens enter the body 
and are metabolized by endogenous Phase I and Phase II enzymes for further excretion. Phase I 
enzymes contribute by means of oxidation, reduction and hydroloysis to the functionalization of 
substances, which means that they are transformed from lipophilic to more hydrophilic 
molecules. Phase II enzymes conjugate substances to larger molecules for further detoxification 
and excretion.  
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Methods for the detection of oxidative stress 
The detection of oxidative stress can be performed on three basic levels: (1) the direct 
measurement of free radicals, (2) the detection and measurement of the resulting biological 
effects on macromolecules, and (3) the response of cells to oxidative stress.  
The short half-life and the high reactivity of ROS limit the direct detection of free radicals 
in vivo [26]. The ex vivo measurement in cultured cells and preparations from isolated organs 
or tissues allows a better direct determination of oxygen-derived free radicals. There are 
several methods to measure free radicals such as e.g. by general fluorescent assays [27], 
spectrophotometric methods [28], the dichlorofluorescein assay [29], fluorescence-activated 
cell staining [30] or with flow cytometry [31]. The basic principle of all these assays is the 
reaction between the radical and the tracer, generating a measurable product. Radicals possess 
an unpaired electron and because of this another suitable method is the electron spin 
resonance technique [26]. 
The biological effect of radicals on macromolecules has been studied for many years and due 
to this investigation certain molecules which are prone to react with ROS and therefore might 
be used as indicators for oxidative stress have been identified [26]. These are for example the 
oxidative modification of proteins, which can be detected by carbonyl- or 3-nitrotyrosine-
formation [32] or the generation of peroxides measured by means of lipid peroxide assays [33, 
34].  
The response of cells to radical mediated oxidative stress can be detected on different levels: 
on DNA-, mRNA- and protein-level. Proteins present the translational output of a cell and are 
considered as the main targets of oxidative stress and free radical action [35]. The term 
proteome describes the protein pool of a cell expressed at a given time [36], so its 
investigation provides an insight into biological processes, allowing the comparison of 
physiological and pathological states of a cell. Comprehensive studies investigating ROS and 
their effects on the proteome of organisms have already been performed on various systems as 
rice [37], yeast [38, 39] and cultured human cells [40-42]. 
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Introduction of a model for measuring the response of cells to oxidative stress 
In this PhD thesis the main focus laid on the investigation of the effect of oxidative stress on 
the proteome of human peripheral blood mononuclear cells (PBMCs). Different biological 
sources are accessible to proteome analysis, such as e.g. body fluids, blood plasma and urine, 
or primary cells such as PBMCs. PBMCs are known to present an optimal source for the 
investigation of primary human cells [43]. In this regard, PBMCs represent an accurate model 
for detecting the consequences of oxidative stress on the proteome since these cells (1) show a 
response to ROS generated in the body, (2) can be efficiently prepared within a short time 
which minimizes an experimental delay that could generate artifacts, and (3) are primary cells 
and therefore not subjected to drawbacks arising from long-term cell culturing, 
immortalization or even processes of malignant transformation [44].  
PBMCs consist of lymphocytes and monocytes, which are interspersed to a varying degree 
with platelets, neutrophils, erythrocytes and plasma. Lymphocytes mainly comprise T cells 
(75%), B cells and natural killer cells. T cells and B cells are the major cellular components of 
the adaptive immune response. T cells are involved in the cell-mediated immunity, whereas B 
cells are primarily responsible for the humoral immunity. Natural killer cells are part of the 
innate immune system and play a major role in the rejection of tumors and cells infected by 
viruses as by initiating cell death [45]. Monocytes are also part of the immune system. They 
can move quickly to sites of infection and there differenciate into macrophages or dentritic 
cells [46]. The main function of erythrocytes is the delivery of oxygen to body tissues via the 
blood flow and transport carbon dioxide back to the lung. They also play a role in immune 
response and can influence the vessel walls by means of dilatation [47]. Platelets are small 
cytoplasmic bodies derived from megakaryocytes and are mainly involved in hemostasis and 
wound repair [48, 49]. Neutrophils are also essential for the immune system. They follow 
inflammation derived chemical signals and migrate towards the site of inflammation into the 
tissue to defend the body against pathogens [50]. Blood plasma makes up about 55% of the 
total blood volume. It is composed mainly of water (90%) with a high protein concentration, 
and contains dissolved glucose, mineral ions and hormones [51]. 
Due to this huge number of various features of the different blood cells and plasma, an 
assignment of proteins to the different cell types may help for further evaluation of clinical 
samples. There already exist several proteome maps of the different cell types and plasma, but 
an in-depth comparison by means of the same proteomic method has not been performed until 
now. 
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3.2. Aims and study design 
 
Comparison of acute and chronic oxidative stress 
The major aim of this study was the identification of differences between acute and chronic 
oxidative stress by means of different proteome expression patterns of PBMCs.  
The further evaluation of PBMCs and their reaction towards oxidative stress are based on the 
generation of proteome maps of main blood components, such as monocytes, T cells, 
platelets, neutrophils, erythrocytes and plasma. By comparing the proteome profiles of these 
purified cell types and plasma, the assignment of a marker protein to a specific cell type or 
plasma is possible. By means of this, it should be easier to indentify indicative proteins which 
then may serve as putative marker proteins for possible contaminations of purified cell 
samples. Additionally, the information can be used for systematic comparison of tissues and 
may further help for the detection of pathologic states. Reference proteome profiles of 
different cell types, or a specific set of proteins, such as common occurring proteins in several 
different cell types, may also be helpful for quality control or for further interpretation of 
proteome profiles of other cells. With such proteome maps the in-depth analysis of PBMCs 
and the interpretations of their cellular response will be improved. 
Experiments for the investigation of acute or chronic oxidative stress were designed at 
conditions simulating the situation in vivo. Fort the acute response experiment, we imitated 
such physiological conditions by resuspending cells in autologous plasma for treatment with 
hydrogen peroxide (H2O2) at concentrations which have been reported to occur in vivo [52]. 
Hydrogen peroxide was used for the in vitro approach due to its capacity to cross cell 
membranes and diffuse through mitochondria, thereby causing many types of cellular injuries 
[3]. By using metabolic labeling and subsequent two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) analysis, we investigated the immediate response of cells to the 
oxidative challenge in vitro. This experimental strategy was combined with shotgun 
proteomics in order to achieve optimal reliability of data. Furthermore, we hypothesized that 
some oxidative stress-induced proteins may accumulate in cells and could therefore be 
useable as biomarkers. It is assumed that oxidative stress may occur in cancer patients in vivo 
and therefore primary cells from such patients represent a model for the long-term exposition 
to oxidative stress, namely a chronic physiological situation. To pursue this strategy, we 
determined the level of lipid peroxides in plasma derived from tumor patients by standard 
lipid peroxidation assays and found them elevated in comparison to plasma derived from 
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healthy age and sex-matched individuals. PBMCs were also subjected to comprehensive 
proteome profiling and compared to cells from the control persons. 
 
Brussels sprout intervention study 
In a second step, the putative protecting effects of glucosinulates, in this case in the terms of 
Brussels sprouts, against oxidative stress should be examined by means of a proteomic 
approach. 
A consumption of sprouts (300 g/per person/d) over a period of five days was performed and 
the impact of sprouts consumption on the protein expression profile of PBMCs was 
investigated. It has been frequently emphasized that proteomics is an important tool to 
improve the current knowledge of cancer prevention by dietary factors [53-57], but only few 
investigations have been published using this technique to investigate the impact of dietary 
factors on the basis of animal models [58-60] or cell cultures [21, 22, 24].  
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3.3. Proteome analysis 
 
Proteome versus Genome 
The goal of proteomics is a comprehensive and quantitative description of protein expression 
and its changes under the influence of biological dysfunctions such as disease or drug 
treatment [61]. Protein expression depends on three different levels: (1) transcription of DNA, 
(2) translation of mRNA, and (3) posttranslational modification. For investigating the 
translational output of a cell, proteins have to be analyzed, which can be achieved by different 
strategies. 
The main advantage of mRNA analysis represents its completeness of the accessibility to all 
genes which can be transcribed. A disadvantage of the use of mRNA expression profiles in 
characterizing cellular phenotypes is that the transcriptome does not effectively represent the 
proteome [61]. Just as well, mRNA abundance represents a poor indicator for the levels of 
corresponding protein [62, 63] and might vary by up to 30-fold and conversely [64]. Proteome 
analyses have the advantage to proof the expression of proteins rather than indicate that a 
given gene might become translated. The main limitation is due to the huge difference in 
protein abundance, resulting in an enormous analytical challenge [61, 65].  
However, to examine the molecular phenotype of a particular cell population, proteome 
analysis represents a proper approach to gain insight into the network of proteins expressed at 
a given time and after a specific response [66]. 
 
Proteomics 
Proteomics is a standardized technique for detection, identification and quantification of 
thousands of different proteins in various cells, tissues and body fluids. It provides the 
methodological basis for the analysis of aberrant, disease-related proteins [61]. The proteins 
of a cell represent the “molecular machinery” that reacts to altered conditions. Consequently, 
cells that are involved in diseases express different proteins compared to those under healthy 
conditions. According to the complexity of biological samples, protein analyses represent an 
enormous challenge. Proteins may alter their function depending on sub-cellular localization, 
interaction partners and amino acid modification. 
Furthermore, there may be dramatic differences in the relative amounts of proteins. Within 
one cell, cytoskeletal proteins may be million-fold more abundant compared to e.g. signaling 
proteins. Within body fluids, such as blood plasma, differences in protein abundance may 
exceed 10-15 orders of magnitude [44]. 
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To overcome the problem of high complexity of samples, it might be an advantage to analyze 
sub-cellular fractions. The protein content of a cell can be roughly divided into several 
compartments, which are the cytoplasmic, nuclear, mitochondrial, membrane and secreted 
fractions. These purified sub-cellular protein fractions represent the protein composition in a 
more detailed way [67]. Another advantage of working with cell fractions is that this strategy 
allows a better detection of low abundant proteins. 
However, proteomics represent a reliable tool for the discovery of potential biomarkers for 
cancer and other inflammatory diseases [68-74]. Biomarkers are molecular signatures that 
indicate physiological and pathological changes [75], allowing early detection of disease or 
therapy control. As mentioned above, in contrast to methods focusing on DNA or mRNA, 
approaches considering proteins as potential biomarker candidates have the advantage that 
those are more reflective for changes in biological systems [76]. There is also strong evidence 
that proteins are the main initial targets of oxidative stress and free radical action [35, 77], as 
already described for Alzheimer, asthma, atherosclerosis, Diabetes Mellitus and other diseases 
[78]. 
 
For the investigation of the proteome of a cell, we focused on a combination of established 
proteome analysis methods, as described in the following. 
 
2D-Polyacrylamide gel-electrophoresis (2D-PAGE) 
One of the most common techniques for proteome profiling is based on the separation of 
proteins by means of high resolution two-dimensional gel-electrophoresis [79] (cf. Figure 5). 
The 2D-PAGE technique consists of two steps – the separation by (1) the different isoelectric 
point (pI) and (2) the different molecular weight. In combination with liquid chromatography 
tandem mass spectrometry (LC-MS/MS) it constitutes a powerful method for quantitative 
proteome analysis. 
 
First dimension: Isoelectric focusing on an immobilized pH-gradient 
Proteins can be separated due to their different charges, whereas the state of their charge is 
determined by the amino acid composition. The pH, at which the positive and negative 
charges of amino acids are neutral, is called the isoelectric point or pI-value. At this point, a 
single polypeptide is trapped in the gel-matrix during isoelectric focusing. The proteins 
become electrically neutral and do not migrate in the electric field anymore. 
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The immobilized pH-gradients are generated by means of co-polymerisation of a mixture of 
acrylamide derivates composed of sulfonyl-, amino- and carboxyl groups and a gel matrix. 
 
Second dimension: Gel electrophoresis, separation by different molecular weight 
Proteins are treated with sodium dodecyl sulphate (SDS), which denatures the proteins and 
attaches SDS molecules to the protein proportional to its molecular weight. Due to the 
negative charge of the SDS molecules, all proteins acquire approximately the same mass-to-
charge ratio. This is important, because after isoelectric focusing the proteins are uncharged 
and thus will not move in an electric field. After application of an electric field, the proteins 
migrate to the anode according to their mass, which are slowed by frictional forces, appearing 
inversely proportional to the molecular weight.  
 
Fluorescence detection versus autoradiography 
There are different methods that enable spot quantification. The quantification may be based 
on a two-color fluorescence labeling system [80], dual metabolic labeling with stable isotopes 
[81, 82] or on post-isolation isotopic protein labeling with isotope-coded affinity tags [83, 84]. 
Here, we used the combination of fluorescence detection and autoradiography in order to 
measure the protein amount of cells and to determine protein synthesis rates (cf. Figure 6). 
Furthermore, the combination of metabolic labeling of cells, sub-cellular fragmentation and 
subsequent 2D-analysis allows the detection of alterations in protein synthesis [67], 
modification and sub-cellular localization [85]. 
 
1D-Polyacrylamide gel-electrophoresis – liquid chromatography mass spectrometry 
(1D-PAGE - shotgun) 
Another very powerful approach for proteome profiling is represented by 1D-PAGE (shotgun 
proteomics) with subsequent LC-MS/MS analysis. Although 2D-PAGE is the method of 
choice for quantitative analysis, 1D-PAGE represents a qualitative technique with high 
protein identification throughput. 
In 1D-PAGE, complex protein mixtures are separated according to their molecular weight. 
The gel is then cut into several slices and digested with trypsin. The peptides are separated by 
nano-flow liquid chromatography and subsequently identified and quantified by mass 
spectrometry. 
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Figure 5: Fluorescence detection of a 2D-gel after separation of cellular 
extracts obtained from PBMCs. First dimension – separation by different pI; 
second dimension – separation by different molecular weight (unpublished 
data) 
Figure 6: Fluorography versus autoradiography. The whole protein amount of a 
given sample can be measured by fluorescence detection, whereas autoradiography 
detects proteins that have been newly synthesized during the labeling period.  
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Figure 7: MS² spectra of one peptide. The amino acid sequence of the peptide can 
be reconstructed by sorting the peaks and assign the m/z differences to fitting amino 
acids. Y- and b-series differ in their starting points, one starts from the C-terminal 
and the other from the N-terminal end of the peptide sequence. 
Protein Identification by Mass Spectrometry (MS) 
Mass spectrometry represents the method of choice for the reliable and sensitive identification 
of proteins and peptides [86]. It is the most potent technology in proteomics and important for 
the global understanding of cellular functions [87].  
Mass spectrometry is based on three principle components: an ion source, a mass analyzer and 
an ion detector. The molecules have to be charged and transferred into the gaseous phase by 
ionization, which can be accomplished e.g. by matrix assisted laser desorption/ionization 
(MALDI) or electrospray ionization (ESI) [88]. Under atmospheric pressure, ESI is based on 
spraying an electrically generated fine mist of ions into the mass spectrometer [87, 89].  
In a second step, the ionized sample reaches the mass analyzer, where the ions are separated 
due to their different mass-to-charge (m/z) ratio. For mass analysis, we used an ion trap. The 
ions are first accumulated for several milliseconds and afterwards scanned from low to high 
m/z [87, 89]. In the detector the ions are detected by a photomultiplier, which results in a MS1 
spectrum or mass fingerprint, displaying an overview of peptide masses. The ion trap, 
however, also allows further analysis. Based on the data of MS1, ions with defined 
electrochemical properties are exclusively selected to enter the ion trap, where they get 
fragmented by collision with helium. Single peptide bounds are broken and the resulting 
peptide fragments are displayed in the MS2 spectrum [90].  
The resulting peak sequence indicates the amino acid sequence of the peptide, which can be 
read by combining the y- and the b-series. They y-series starts from the C-terminal and the b-
series from the N-terminal end of the peptide sequence. Due to the uniqueness of many amino 
acid sequences of single peptides, some proteins can already be identified from one peptide 
sequence (cf. Figure 7).  
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3.4. Significance of the study 
 
To assess the impact of oxidative stress on the proteome of a cell in an accurate fashion, we 
combined 2D-PAGE and 1D-PAGE analyses of human PBMCs. The obtained data were 
further processed and analyzed by a home made SQL-database, recently designed as database 
of the “Clinical Proteomics Laboratories at the Medical University of Vienna” (CPL/MUW-
database, Wimmer H. et al., manuscript in preparation).  
The major aim of this PhD thesis was the identification of potential oxidative stress 
biomarkers in PBMCs and the investigation of their relation to a physiologic state (hydrogen 
peroxide treated, cancer patient, intervention with Brussel sprouts) or to cellular sub-
populations (monocytes, T-cells, neutrophils, platelets, plasma) of the derived blood samples. 
In total, we detected more than 1400 different proteins in PBMCs. Out of this list we found 25 
regulated proteins, either (1) by treatment with hydrogen peroxide, or (2) by comparing 
healthy persons (controls) versus patients with cancer, or (3) as the result of the Brussels 
sprout intervention. 
One of the most important results was the distinct down-regulation of manganese superoxide 
dismutase (Mn-SOD), which has been reported to be specific for oxidative stress. One 
potential explanation might be the inactivation of this enzyme by hydrogen peroxide followed 
by proteasomal degradation as described for Cu/Zn-SOD (copper/zinc superoxide dismutase) 
in red blood cells by Salo et al. [91]. Furthermore, it might be that this down-regulation is part 
of the cells’ survival strategy. Mn-SOD decomposes superoxide to hydrogen peroxide, which 
is then processed to molecular oxygen and water by catalase, glutathione peroxidase and 
peroxiredoxin [3]. If the capacity of the hydrogen peroxide processing enzymes such as 
catalase is insufficient, the catalysis of the reverse conversion of H2O2 to superoxide by Mn-
SOD will predominate. Immediate down-regulating Mn-SOD synthesis may be a strategy to 
reduce superoxide production under acute oxidative stress [92]. In other studies the down-
regulation of Mn-SOD was also described in association with tumor suppressor activity of this 
protein [93-95]. 
Quite notably, under conditions designed to reduce oxidative stress which were introduced in 
the controlled Brussels sprouts intervention study, Mn-SOD was found to be significantly up-
regulated. This was accompanied by the down-regulation of heat shock 70 kDa protein 
(hsp70). Both proteins play a role in malignant transformation of cells. Hsp70 is involved in 
the regulation of apoptosis, which leads to elimination of cancer cells. These findings indicate 
that the alteration of the synthesis of these proteins may be involved in the anticarcinogenic 
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effects of cruciferous vegetables, which was observed in earlier laboratory studies with 
animals [19]. 
Additionally, it was possible to generate proteome reference maps of the different PBMC cell 
types and plasma. With this information it should be possible to gain more detailed 
information about the cellular origin of potential biomarkers in PBMCs and use them for 
systematic comparison of tissues. Also, common occurring proteins in several different cell 
types can be used for quality control or for further interpretation of proteome profiles of other 
cell types. 
In summary, these data suggests that the down-regulation of Mn-SOD might be a specific 
response and thus an indicator for oxidative stress. This thesis further demonstrates that the 
advanced methods of proteomics used in this study are highly suitable tools to identify 
putative markers of oxidative stress and their cellular occurrence. The reliability of those 
different regulated proteins such as Mn-SOD as potential biomarkers has to be evaluated by 
further studies.  
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 Abstract  
 
Clinical proteome analysis will almost inevitably be confronted with blood constituents. 
Purified plasma, serum, cell or tissue samples may easily be contaminated with some other 
constituents, affecting the final proteome analysis result. In order to recognize proteins which 
are potentially indicative for the presence of major blood constituents, we purified T cells, 
monocytes, neutrophils, erythrocytes, platelets and plasma and performed comparative 
proteome profiling employing 2D-PAGE in addition to shotgun proteomics. By mass 
analysis, 605 different proteins were identified in the 2D gels. Seven of those displayed a 
highly specific expression pattern. A total of 1889 proteins were identified by shotgun 
proteomics, including 34 proteins with highly specific expression patterns. Indeed, proteins 
specific for each of the constituents were successfully identified. The corresponding genes 
displayed compatible expression specificities as determined by the use of GENATLAS. The 
present protein maps of each of the constituents may serve as references for comparative 
analyses and will aid the interpretation of proteome profiles of clinical materials. 
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 Introduction 
 
Human blood represents an optimal source for discovery and analysis of biomarker. Proteins 
derived from diseased tissue compartments may leak into lymph and blood, eventually 
becoming detectable in plasma and serum. Many diseases accompanied by e.g. inflammation 
may directly affect the protein expression profile of blood compartments such as immune 
cells or platelets.1 Such characteristic alterations may as well give rise to clinical biomarkers. 
Another important approach for biomarker discovery is the comparison of tissue specimen 
derived from healthy and diseased organs.2 Differences in the finally obtained protein lists, 
however, may be due to epiphenomena accompanying disease states such as leukocyte 
invasion, platelet and fibrin deposition3 or alterations of the blood supply. It is not trivial to 
recognize such events from differential analysis of proteome profiles.4 To support data 
interpretation of clinical proteome profiling results, reference proteome maps might be very 
helpful.5 The knowledge of proteins expressed in a healthy background and the assignment of 
proteins to their potential source of origin could render comparative analyses searching for 
disease marker proteins easier to interpret.  
Much effort has already been spent on the establishment of proteome profiles of blood 
constituents. Amongst others, these include the analysis of peripheral blood mononuclear 
cells (PBMCs),6, 7 lymphocytes,8 monocytes,9 neutrophils,10 erythrocytes,5, 11 platelets,12-14 
T cells,15 and plasma.16-18 Proteome studies of blood constituents were employed to 
investigate various diseases such as atopic dermatitis,19 rheumatoid arthritis,20 or to perform in 
vivo intervention studies with soy isoflavones,21 Brussels sprouts,22 or vitamin C 
supplementation.23 Despite the large number of studies already performed, there is still a lack 
of standardization and it is hard to conclude for specificities in protein expression by 
comparing results obtained from different research teams. Therefore, systematic comparative 
studies employing different laboratories have been performed.24 Obviously, apparent 
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 differences are derived from variations in methods employed for the purification of 
constituents, for protein isolation, protein and peptide separation and protein identification. 
This may be not surprising, considering the large number of diverse molecules in biological 
samples. Thousands of different proteins occur in concentration spans up to 8-10 orders of 
magnitude,25, 26 and are mixed with metabolites, lipids, polysaccharides and nucleic acids. We 
have described recently that protein isolation strategies may be critical to obtain 
representative and reproducible results.27  
Here, we present a comparative proteome study of the most abundant blood constituents 
including plasma, lymphocytes, monocytes, platelets, neutrophils and erythrocytes. We 
purified each of those constituents and the analysis was confined to cytoplasmic proteins. The 
major aim was a reliable assignment of specific proteins to each of the different constituents. 
On one hand, we used 2D-PAGE and performed comparative pattern analysis. Spots were cut 
out and identified by mass spectrometry. On the other hand, we analyzed the same samples by 
shotgun proteomics28,29 resulting in many more protein identifications. Database-assisted 
analysis allowed us to identify several specifically expressed proteins which may serve as 
marker proteins for the respective blood constituents.  
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 Experimental section 
 
Isolation of PBMCs (peripheral blood mononuclear cells) 
PBMCs were isolated from heparinized whole blood of different healthy donors by standard 
density gradient centrifugation with Ficoll-Paque (GE Healthcare Bio-Sciences AB, Uppsala, 
Sweden).8, 30 The cells were subsequently washed with HBSS (Hanks` Buffered Salt Solution, 
1:1).  
 
Isolation of plasma 
2 ml of the heparinized whole blood were used for plasma isolation by centrifugation for 10 
min at room temperature at 8000 g. The supernatant plasma was carefully isolated and stored 
at -80°C. 
 
Monocyte and T cell separation 
T cells and monocytes were separated by magnetic sorting using the MACS technique 
(Miltenyi Biotec, Bergisch Gladbach, Germany). Purified T cells were obtained through 
negative depletion of CD11b, CD14, CD16, CD19, CD33, and MHC class II-positive cells 
with the respective monoclonal antibody. Monocytes were enriched by using the biotinylated 
CD14 mAb VIM13 (achieving a cell purity 95 %) as previously described.31 
 
Neutrophil and Erythrocyte separation 
After standard density gradient centrifugation with Ficoll-Paque the resulting soft pellet was 
put on ice. 200 µl of the pellet were resuspendened in 200 µl of sample buffer (7.5 M urea, 
1.5 M thiourea, 4% CHAPS, 0.05% SDS, 100 mM DDT) to gain the erythrocytes. The rest of 
the pellet was resuspended in haemolysis buffer (0.16 M ammonium chloride, 0.01 M 
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 potassium hydrogen carbonate, 1 µM EDTA) to destroy erythrocytes and centrifuged to pellet 
neutrophils. The procedure was repeated two times to isolate the neutrophils. 
 
Platelet separation 
Whole blood of healthy donors was collected in Acid-Citrate-Dextrose-A tubes and was 
centrifuged at 110g for 30 minutes at room temperature. The supernatant was washed with 
RPMI 0 medium by centrifugation. Prostaglandin E1 (0.1µg/ml) (98% (HPLC) Synthetic, 
Sigma, Steinheim, Germany) was added during all steps to keep the thrombocytes inactivated. 
The pellet was resuspended in RPMI 0, an aliquote was taken for control and another aliquote 
was activated by Thrombin (1µg/ml) (Sigma, Steinheim, Germany). The platelets were then 
sonicated. 
 
Sub-cellular fractionation 
The isolation of cytoplasmic proteins was performed as described by Gundacker et al. 27 Cells 
were lysed in hypotonic lysis buffer (10 mM HEPES/NaOH, pH 7.4, 0.25 M sucrose, 10 mM 
NaCl, 3 mM MgCl2, 0.5% Triton X-100) supplemented with protease inhibitors and pressed 
through a 26 g syringe to induce cell lysis. The cytoplasmic fraction was separated from 
nuclei by centrifugation and precipitated by addition of ethanol. Afterwards, all protein 
samples were dissolved in sample buffer (7.5 M urea, 1.5 M thiourea, 4% CHAPS, 0.05% 
SDS, 100 mM DDT). 
 
2D polyacrylamid gel electrophoresis (2D-PAGE) 
Proteins were loaded by passive rehydration on IPG strips pH 5–8, 17 cm (BioRad, Hercules, 
CA) at room temperature. Alternatively, IPG immobiline strips (GE) were used, which gave 
similar results (not shown). IEF was performed in a stepwise fashion (1 h 0– 500 V linear; 5 h 
500 V; 5 h 500–3500 V linear; 12 h 3500 V). After IEF, the strips were equilibrated with 100 
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 mM DTT and 2.5% iodacetamide according to the instructions of the manufacturer (BioRad). 
For SDS-PAGE using the Protean II xi electrophoresis system (BioRad), IPG strips were 
placed on top of 1.5 mm 12% polyacrylamide slab gels and overlaid with 0.5% low-melting 
agarose. The gels were stained with a 400 nM solution of Ruthenium II tris 
(bathophenanthroline disulfonate) (RuBPS) as described.32 Fluorography scanning was 
performed with the FluorImager 595 (GE Healthcare, Fairfield, CT) at a resolution of 100 
µm.33 All 2D gel data were independently reproduced two times. Gels were warped to a 
reference gel with the TT900 S2S software (version 2006.0.2389, Nonlinear dynamics, 
Carlsbad, CA) and evaluated with the Progenesis software PG200 (version 2006, Nonlinear) 
using the “same spot” algorithm.  
 
1D-PAGE for subsequent shotgun analysis 
Cytoplasmic protein fractions were loaded on 13% polyacrylamid gels, electrophoresis was 
performed until complete separation of a pre-stained molecular marker (Dual Color, Biorad, 
Hercules, CA) was visible. After fixation with 50% methanol/10% acetic acid and subsequent 
silver staining, gel lanes were cut out of the gel and digested with trypsin as described below.  
 
MS-compatible silver staining procedure 
2D gels were fixed with 50% methanol, washed and sensitized with 0.02% Na2S2O3. The gels 
were stained with 0.1% AgNO3 ice cold for 20 minutes, rinsed with bi-distilled water and 
subsequently developed with 3% Na2CO3/0.05% formaldehyde as previously described.34 
 
Tryptic digest 
Protein spots were cut out of the gel, the gel-pieces were de-stained with 15 mM 
K3Fe(CN)6/50 mM Na2S2O3 and intensively washed with 50% methanol/10% acetic acid. The 
pH was adjusted with 50 mM NH4HCO3, proteins were reduced with 10 mM DTT/50 mM 
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 NH4HCO3 for 30 minutes at 56°C and alkylated with 50 mM iodacetamide/50 mM NH4HCO3 
20 minutes in the dark. Afterwards the gel-pieces were treated with acetonitrile (ACN) and 
dried in a vacuum centrifuge. Between each step, the tubes were shaken for 5-10 minutes 
(Eppendorf Thermomixer comfort). Dry gel-spots were treated with trypsin 0.1 mg/ml 
(Trypsin sequencing grade, Roche Diagnostics, Germany)/50 mM NH4HCO3 for 20 minutes 
on ice, afterwards covered with 50 mM NH4HCO3 and subsequently incubated over night at 
37°C. The digested peptides were eluted by adding 50 mM NH4HCO3, the supernatant was 
transferred into silicon-coated tubes, and this procedure was repeated two times with 5% 
formic acid/50% ACN. Between each elution step the gel-spots were ultrasonicated for 10 
minutes. Finally the peptide solution was concentrated in a vacuum centrifuge to an 
appropriate volume. 
 
Mass spectrometry analysis 
For the identification of 2D spots, peptides were loaded on a Zorbax 300SB-C8 (5 µm, 
0.3 mm, 5 mm) column and separated by nanoflow LC (1100 Series LC system, Agilent, Palo 
Alto, CA) with a Zorbax 300SB-C18 (5 µm, 75 mm, 150 mm) column at a flow rate of 
250 nl/min using a gradient from 0.2% formic acid and 3% ACN to 0.2% formic acid and 
45% ACN over 12 minutes. In case of shotgun analysis, peptides were also separated by 
nano-flow LC (1100 Series LC system, Agilent, Palo Alto, CA) using the HPLC-Chip 
technology (Agilent) equipped with a 40 nl Zorbax 300SB-C18 trapping column and a 75 µm 
x 150 mm Zorbax 300SB-C18 separation column at a flow rate of 400 nl/min, using a 
gradient from 0.2% formic acid and 3% ACN to 0.2% formic acid and 50% ACN over 80 
minutes. Peptide identification was accomplished by MS/MS fragmentation analysis with an 
iontrap mass spectrometer (XCT-Ultra, Agilent) equipped with an orthogonal nanospray ion 
source. The MS/MS data, including peak list-generation and search engine, were interpreted 
by the Spectrum Mill MS Proteomics Workbench software (Version A.03.02, Agilent) 
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 allowing for two missed cleavages and searched against the SwissProt Database for human 
proteins (Version 20080409 containing 19038 entries or, alternatively, version 14.3 
containing 20328 entries) allowing for precursor mass deviation of 1.5 Da, a product mass 
tolerance of 0.7 Da and a minimum matched peak intensity (%SPI) of 70%. Due to previous 
chemical modification, carbamidomethylation of cysteine was set as fixed modification. No 
other modifications were considered here.  
 
Construction of proteome reference maps 
For the generation of the final protein list of all different cell types and plasma, the following 
protein selection algorithm was applied. Peptide scores were considered to select appropriate 
sequence assignments. To assess the reliability of the peptide scores, searches were performed 
against the corresponding reversed database. 5.9% positive hits were found with peptides 
scoring >9.0, while 0.21% positive hits were found with peptides scoring >13.0. Only 
peptides scoring higher than 9.0 were considered for protein identification. Identification 
details for each protein including all identified peptides, sequence coverage, peptide scores 
and MS2 spectra are fully accessible via PRIDE database (http://www.ebi.ac.uk/pride/).35, 36 
In the final protein list (see supplementary data) the sums of all peptides related to the single 
proteins from the corresponding cell type are listed. Proteins derived from obvious 
contaminants such as fetal calf serum were deleted. Proteins were selected based on the 
expression of specific peptides. Selection of protein isoforms was performed as described by 
Zhang et al.37 In case a definite assignment was not possible due to sequence homologies, the 
biologically most plausible candidate was selected. The derived data was further arranged and 
analyzed by a home made SQL-database, recently designed as database of the Clinical 
Proteomics Laboratories at the Medical University of Vienna (CPL/MUW-database, Wimmer 
H. et al, manuscript in preparation). 
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 Results 
 
2D-PAGE analysis of purified blood constituents 
In order to assess the specificity of protein expression patterns, we employed 2D-PAGE to 
analyze the cytoplasmic protein fraction of three to six individual samples each of purified T 
cells, monocytes, neutrophils, erythrocytes and platelets in addition to blood plasma (Figure 
1). Furthermore, we analyzed PBMCs which consist of lymphocytes (mainly T cells) and 
monocytes, interspersed to a varying degree with platelets, neutrophils, erythrocytes and 
plasma. Referring to previously published data, several commonly expressed proteins were 
readily identified.38 Including proteins previously identified in PBMCs,7 a total of 1445 spots 
were cut out of the gels, resulting in the identification of 605 proteins (Table S1).  
 
Shotgun analysis of purified blood constituents 
All protein fractions analyzed by 2D-PAGE were also investigated by shotgun proteomics. 
Here, proteins were pre-fractionated via SDS-PAGE and the sliced gels digested with trypsin. 
Mass analysis was similar as applied for isolated 2D gel spots. A total of 1887 proteins were 
identified. All complete data analyzed in the present study is publicly accessible via PRIDE 
database (http://www.ebi.ac.uk/pride/),35, 36 PRIDE accessions 8884-8908. The number of 
proteins identified in the purified constituents is depicted in Figure 2.  
In comparison, shotgun proteomics proved to be more sensitive than protein identification in 
2D gels. All proteins identified in 2D gel spots were independently identified by shotgun 
proteomics as indicated in Table S1. 
 
Comparative analysis searching for specifically expressed proteins 
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 In order to find specifically expressed proteins, we compared 2D gel spot patterns of the 
purified constituents. It was our aim to identify proteins occurring in one, but not in any other 
of the purified blood constituents.  
In T cells no specific protein was identified in 2D gels. Plasminogen activator inhibitor 2 
(P05120) was found to be specific for monocytes; annexin A3 (P12429) for neutrophils; 
hemoglobin subunit beta (P68871) for erythrocytes and Integrin alpha-IIb (P08514) for 
platelets (Figure 1). Erythrocytes additionally displayed other specific proteins (Table 1).  
By means of shotgun analysis, these data were confirmed and extended. In Figure 2, the 
number of proteins which were only identified in the respective constituent, but not in any 
other, are indicated in brackets. The expression pattern of each identified protein can be 
retrieved from Table S1. Comparative analysis was supported by a home-made SQL-database 
(CPL/MUW-database, Wimmer et al., manuscript in preparation). To further evaluate the 
specificity of these proteins, we referred to the gene expression databases GENATLAS 
(http://genatlas.medecine.univ-paris5.fr/). In Table 1 we listed only those 34 proteins whose 
gene expression has been described to be specific for the particular constituent.  
 
Database-assisted interpretation of cell samples: 
The presented protein specificities can be used to assess the presence or absence of blood 
constituents in any protein sample of interest. The identification of a specifically expressed 
protein may give a strong indication for the presence of the corresponding constituent. This is 
exemplified for PBMCs treated in vitro with hydrogen peroxide (Table S2). The purified 
leukocyte fraction contained integrin alpha-IIb and Hemoglobin subunit alpha and beta which 
indicate contamination with platelets and erythrocytes.  
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 Discussion 
 
Enormous effort has been spent on proteome profiling of blood constituents such as serum 
and plasma.39 The value of that effort is not doubted, as it holds great promise for biomarker 
discovery. The proteome profile of plasma or other body fluids, however, may be affected by 
a large variety of contaminants, which may occur at varying degrees. Within serum or plasma, 
lysed erythrocytes or platelets may be considered as contaminants which may significantly 
affect the final proteome profile. Otherwise, plasma and other blood constituents may be 
considered as potential contaminants when analyzing primary cells or tissue specimen. 
According to our own experience, it is not trivial to recognize potential contaminants, which 
may render subsequent data interpretation inappropriate. Although a large number of 
proteome profiling studies have been performed on blood constituents, as mentioned above, 
clear specificities of protein expression can hardly be derived from these data. This is mainly 
due to the heterogeneity of study designs and methods.  
Here, we performed a comprehensive comparative proteome profiling study of the purified 
blood constituents T cells, monocytes, neutrophils, erythrocytes and platelets in addition to 
blood plasma and PBMCs. We employed both 2D-PAGE and shotgun proteomics in order to 
make the final data applicable to a broad variety of proteome studies. 
As expected, a large number of proteins were found to be expressed by more than one 
constituent (Table S1). Specific proteins of each of the purified constituents, however, were 
successfully identified (Table 1).  
We have applied the same identification methodology to all constituents, ensuring optimal 
compatibility for comparative analysis. This allows as well comparison to other published 
data as follows. 
 
PBMCs 
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 Of the 174 different proteins identified in 2D gels of PBMCs by Vergara et al.,6 we also 
identified 156 proteins by shotgun analysis, representing 90% of these recently published 
results. In a formerly published reference 2D gel,7 we were able to detect 519 different 
proteins. 138 of these listed proteins correspond to the published data of Vergara et al..6 
T cells 
Till now, no proteome map of purified T cells has been published. We were able to detect 934 
different proteins in primary human T cells by means of shotgun analysis. 95 of them were 
only found in this cell type. In Table 1, two specific T cell proteins are listed.  
Monocytes 
In a study using 2D gels for the investigation of the monocyte proteome, 231 protein spots 
have been identified, which corresponded to 164 different proteins.9 In 2D-gels we detected 
391 different proteins, 108 overlap with the published data. By means of shotgun analysis, we 
were able to identify 837 different proteins, 85% of the 164 proteins were found in this data 
set. We listed three proteins as specific for monocytes (Table 1).  
Platelets 
2D gel platelet proteome profiles were established in several studies, 12, 13 identifying about 
800 different proteins. We detected 632 proteins by means of shotgun analysis and 328 
proteins in 2D gels. In a further study, 10 potential biomarkers of platelet contaminations in 
PBMCs were presented.24 Nine of these 10 proteins have been also found in our dataset not 
displaying the claimed specificity. Furthermore, their specificity for platelets could not be 
confirmed by means of the database GENATLAS. We listed nine other proteins as putative 
markers for platelet contamination (Table 1).  
Erythrocytes 
In an in-depth analysis of red blood cells, 587 different membrane and soluble proteins have 
been identified.11 By shotgun analysis, we were able to identify 212 different proteins. The 
data overlap is about 15%. This may be mainly due to the fact that Pasini et al.11 spent more 
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 effort on pre-fractionation and focused on membrane and cytoplasmic proteins, whereas we 
focussed only cytoplasmic proteins.  
Neutrophils 
In a 2D gel based study, 102 different spots were reproducibly detected in neutrophils, 22 of 
them were successfully identified.10 We were able to identify 326 in 2D gels and 542 different 
proteins by means of shotgun proteomics. Eleven of them were found specific for neutrophils 
(Table 1). 
Plasma 
We detected 203 different proteins in plasma. A recent manually validated human blood 
plasma protein reference set listed 679 proteins.16 The overlap was 167 different proteins 
representing about 24%.  
VERENA HAUDEK     PhD-thesis 47
 Conclusion 
 
By means of 2D-PAGE and shotgun analysis we were able to define a set of specifically 
expressed proteins, which may serve as markers for one of the main blood constituents 
T cells, monocytes, neutrophils, erythrocytes, platelets and blood plasma. Some proteins were 
detectable in 2D gels, but many more were identified by shotgun proteomics. The present data 
may serve as reference for proteome profiling studies dealing with materials potentially 
contaminated with blood constituents. Furthermore, pathologic events such as tissue invasion 
by lymphocytes, monocytes and neutrophils or platelet aggregation may be detected in tissue 
samples by the use of the presently identified marker proteins. 
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 Supporting Information Available 
Table S1: List of all detected proteins in PBMCs and purified constituents. 
This table represents the total list of identified proteins in PBMCs, T cells, monocytes, 
neutrophils, platelets, erythrocytes and plasma. Proteins are sorted according to protein names 
and identified by their SwissProt Accession numbers. The numbers listed in rows indicate the 
number of distinct peptides identified by mass spectrometry corresponding to each 
constituent. Proteins which were also identified in 2D gels are marked (X)  
Table S2: Example of database-assisted interpretation of a single sample. The table lists all 
proteins identified in a sample of PBMCs treated in vitro with 100 µM hydrogen peroxide. It 
was chosen to show the use of database-assisted interpretation of cell samples. It is 
immediately possible to read the potential origins of each of the identified proteins with 
respect to the single constituents. This information may be used for the interpretation of 
differently regulated proteins in any kind of clinical sample.  
This information is available free of charge via the internet at http://pubs.arc.org. 
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 Legend to the figures/tables 
Figure 1:  
Specific proteins indicated in 2D gel sections of PBMCs, monocytes, platelets, neutrophils, 
plasma and erythrocytes. For each constituent except T cells, one potential marker protein 
was exemplified to demonstrate specific expression. For orientation on the gels, actin 
(P60709) was marked with a pentagon. The following proteins, detected by fluorescence 
staining, were depicted on the 2D gel sections: plasminogen activator inhibitor 2, P05120 
(monocytes), annexin A3, P12429 (neutrophils), hemoglobin subunit alpha, P69905 
(erythrocytes), integrin alpha-IIb, P08514 (platelets) and serum albumin, P02768 (plasma). 
Full circles indicate expressed proteins, whereas dashed circles indicate the localization of the 
absent proteins.  
Figure 2:  
Number of proteins in PBMCs, T cells, monocytes, platelets, neutrophils, erythrocytes and 
plasma identified by shotgun proteomics. In total, 1887 proteins have been identified. In the 
figure the total number of identified proteins for each constituent is listed, the X-axis 
represents the corresponding percentage with respect to the total number of proteins. The dark 
gray bar represents ubiquitous proteins, the dashed bar represents the numbers of proteins 
which were only identified in the respective constituent, but not in any others. The 
corresponding number for each constituent is also indicated in brackets. 
Table 1:  
Proteins specifically occurring in the purified constituents as indicated. Proteins were 
identified by shotgun proteomics, the observed specificity was also found to apply to the 
corresponding genes according to gene expression data. Proteins which were also detectable 
on 2D gels are listed under “2D”. 
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 Synopsis: 
Blood mainly consists of lymphocytes, monocytes, neutrophils, erythrocytes, platelets and 
plasma. We purified these constituents and applied 2D-PAGE in addition to shotgun 
proteomics, resulting in the identification of 1887 proteins. For each constituent we present 
specifically expressed marker proteins. These data provide validated reference proteome maps 
of each constituent and may aid the interpretation of clinical proteome data.  
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percantage of total sum of proteins (1887)
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
plasma
erythrocytes
neutrophils
platelets
monoytes
T cells
PBMCs 1231 (199)
934 (95)
873 (73)
632 (82)
542 (113)
212 (17)
203 (127)
Figure 2
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cell-specific proteins (without plasma)  
    
cell type AccNr Protein 2D
monocytes P05120 Plasminogen activator inhibitor 2 precursor  x 
 Q9Y336 Sialic acid-binding Ig-like lectin 9 precursor  
 O60603 Toll-like receptor 2 precursor  
    
T cells P23743 Diacylglycerol kinase alpha  
 P14151 L-selectin precursor   
    
platelets P08514 Integrin alpha-IIb precursor x 
 P22064 Latent-transforming growth factor beta-binding protein, isoform 1S precursor  
 Q14766 Latent-transforming growth factor beta-binding protein, isoform 1L precursor   
 Q13201 Multimerin-1 precursor  
 P02776 Platelet factor 4 precursor  
 P10720 Platelet factor 4 variant precursor   
 P07359 Platelet glycoprotein Ib alpha chain precursor   
 P40197 Platelet glycoprotein V precursor   
 P16109 P-selectin precursor   
    
neutrophils P49913 Cathelicidin antimicrobial peptide precursor   
 P20061 Transcobalamin-1 precursor  
 P12429 Annexin A3 x 
 P17213 Bactericidal permeability-increasing protein precursor   
 P59665 Neutrophil defensin 1 precursor   
 Q08477 Cytochrome P450 4F3  
 P22894 Neutrophil collagenase precursor  
 P11678 Eosinophil peroxidase precursor  
 O15389 Sialic acid-binding Ig-like lectin 5   
 O75015 Low affinity immunoglobulin gamma Fc region receptor III-B precursor   
 Q8N6Q3 CD177 antigen   
    
erythrocytes P02730 Band 3 anion transport protein x 
 P16452 Erythrocyte membrane protein band 4.2  
 P69905 Hemoglobin subunit alpha (Alpha-globin) x 
 P68871 Hemoglobin subunit beta (Beta-globin)   
 P02042 Hemoglobin subunit delta (Delta-globin)   
 P69891 Hemoglobin subunit gamma-1 x 
 P11171 Protein 4.1   
 P02549 Spectrin alpha chain, erythrocyte   
 P11277 Spectrin beta chain, erythrocyte x 
 
Table 1 
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AccNr Protein pl
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1 Q04446 1,4-alpha-glucan branching enzyme (EC 2,4,1,18) (Gly -  -  - 3  -  -  -  - 
2 P61604 10 kDa heat shock protein, mitochondrial (Hsp10) (10  -  - 2 2 2 5 6 X
3 P42704 130 kDa leucine-rich protein (LRP 130) (GP130) (Leuc -  -  - 1  - 1 16 X
4 Q9NRX4 14 kDa phosphohistidine phosphatase (EC 3.1.3.-) (Ph -  -  -  - 2  -  -  - 
5 P31946 14-3-3 protein beta/alpha (Protein kinase C inhibitor pr  -  - 8 4 10 9 13  - 
6 P62258 14-3-3 protein epsilon (14-3-3E)  - 3 13 3 10 10 12  - 
7 Q04917 14-3-3 protein eta (Protein AS1)  -  - 10 6 11 4 7  - 
8 P61981 14-3-3 protein gamma (Protein kinase C inhibitor prote -  - 9  - 10 9 9 X
9 P27348 14-3-3 protein theta (14-3-3 protein tau) (14-3-3 protein -  - 8 2 12 8 12  - 
10 P63104 14-3-3 protein zeta/delta (Protein kinase C inhibitor pro -  - 19 7 23 14 17 X
11 O60613 15 kDa selenoprotein precursor  -  -  -  -  -  - 2  - 
12 Q9Y4L1 150 kDa oxygen-regulated protein precursor (Orp150)  -  -  -  - 1  - 4 X
13 Q99943 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha -  -  -  -  -  -  - 1  - 
14 P09543 2*,3*-cyclic-nucleotide 3*-phosphodiesterase (EC 3,1,4 -  -  - 1  -  -  -  - 
15 Q16698 2,4-dienoyl-CoA reductase, mitochondrial precursor (E -  -  -  - 3 1 3  - 
16 P62191 26S protease regulatory subunit 4 (P26s4) (Proteasom - 1  -  -  -  -  - X
17 P17980 26S protease regulatory subunit 6A (TAT-binding prote -  -  -  - 2  - 3 X
18 P43686 26S protease regulatory subunit 6B (MIP224) (MB67-in -  -  -  -  - 3 2 X
19 P62195 26S protease regulatory subunit 8 (Proteasome subun  -  -  -  - 1 1 2 X
20 P62333 26S protease regulatory subunit S10B (Proteasome su - 1  -  - 3 1 5 X
21 Q99460 26S proteasome non-ATPase regulatory subunit 1 (26  - 1  -  -  - 1 3  - 
22 O75832 26S proteasome non-ATPase regulatory subunit 10 (2  -  -  -  -  -  - 2  - 
23 O00231 26S proteasome non-ATPase regulatory subunit 11 (2  -  - 1  - 1 1 1 X
24 O00232 26S proteasome non-ATPase regulatory subunit 12 (2  - 1  -  - 1 1 2  - 
25 Q9UNM6 26S proteasome non-ATPase regulatory subunit 13 (2  -  - 1  - 2 1 1 X
26 O00487 26S proteasome non-ATPase regulatory subunit 14 (2  -  -  -  - 1  - 1 X
27 Q13200 26S proteasome non-ATPase regulatory subunit 2 (26  - 1  -  - 3 3 4  - 
28 O43242 26S proteasome non-ATPase regulatory subunit 3 (26  -  -  -  - 2 10 3  - 
29 Q15008 26S proteasome non-ATPase regulatory subunit 6 (26  -  -  -  -  - 2  -  - 
30 P51665 26S proteasome non-ATPase regulatory subunit 7 (26  -  -  -  - 2 1 1 X
31 P48556 26S proteasome non-ATPase regulatory subunit 8 (26  -  -  -  - 1 2 1 X
32 Q13442 28 kDa heat- and acid-stable phosphoprotein (PDGF-a -  -  -  -  -  - 2  - 
33 Q02218 2-oxoglutarate dehydrogenase E1 component, mitocho -  -  -  - 6  - 5 X
34 P42126 3,2-trans-enoyl-CoA isomerase, mitochondrial precurso -  -  -  - 4 1  - X
35 Q9Y3B7 39S ribosomal protein L11, mitochondrial precursor (L1 -  -  -  -  -  - 2  - 
36 P52815 39S ribosomal protein L12, mitochondrial precursor (L1 -  -  -  - 1 1  - X
37 Q7Z2W9 39S ribosomal protein L21, mitochondrial precursor (L2 -  -  -  -  -  - 1  - 
38 Q99714 3-hydroxyacyl-CoA dehydrogenase type II (EC 1.1.1.3  -  - 8 1 11 8 12 X
39 Q9BUT1 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.30  -  -  -  -  -  - 1  - 
40 P31937 3-hydroxyisobutyrate dehydrogenase, mitochondrial pr  -  -  -  - 2 1 4 X
41 P42765 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (B -  -  -  - 2  - 1  - 
42 P09110 3-ketoacyl-CoA thiolase, peroxisomal precursor (EC 2.  -  -  - 1  -  -  -  - 
43 P25325 3-mercaptopyruvate sulfurtransferase (EC 2.8.1.2) (MS -  - 1 1 1  -  - X
44 P46783 40S ribosomal protein S10  -  -  -  - 6 1 5  - 
45 P62280 40S ribosomal protein S11 - Homo sapiens (Human)  -  -  -  - 8  - 7  - 
46 P25398 40S ribosomal protein S12 - Homo sapiens (Human)  -  -  -  - 1  - 4 X
47 P62277 40S ribosomal protein S13  -  -  -  - 5  - 6  - 
48 P62263 40S ribosomal protein S14  -  -  -  - 7 1 9  - 
49 P62841 40S ribosomal protein S15 (RIG protein) - Homo sapie  -  -  -  - 1  - 2  - 
50 P62244 40S ribosomal protein S15a  -  -  -  - 3 2 7  - 
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51 P62249 40S ribosomal protein S16  -  -  -  - 7 1 8  - 
52 P08708 40S ribosomal protein S17 - Homo sapiens (Human)  -  -  -  - 3  - 5  - 
53 P62269 40S ribosomal protein S18 (Ke-3) (Ke3)  -  -  -  - 10 1 8  - 
54 P39019 40S ribosomal protein S19  -  -  -  - 3  - 7  - 
55 P15880 40S ribosomal protein S2 (S4) (LLRep3 protein) - Hom -  -  -  - 3 1 5  - 
56 P60866 40S ribosomal protein S20 - Homo sapiens (Human)  -  -  -  - 2  - 5  - 
57 P63220 40S ribosomal protein S21  -  -  -  - 1  -  -  - 
58 P62266 40S ribosomal protein S23 - Homo sapiens (Human)  -  -  -  - 1  -  -  - 
59 P62847 40S ribosomal protein S24 - Homo sapiens (Human)  -  -  -  - 3  - 2  - 
60 P62851 40S ribosomal protein S25  -  -  -  - 2  - 2  - 
61 P62854 40S ribosomal protein S26  -  -  -  - 3 1 3  - 
62 P62857 40S ribosomal protein S28  -  -  -  - 1 3 1  - 
63 P23396 40S ribosomal protein S3 - Homo sapiens (Human)  - 2  -  - 9 1 12  - 
64 P61247 40S ribosomal protein S3a - Homo sapiens (Human)  -  -  -  - 6  - 10  - 
65 P62701 40S ribosomal protein S4, X isoform (Single copy abun -  -  -  - 6  - 8  - 
66 P46782 40S ribosomal protein S5  -  -  -  - 5 1 2  - 
67 P62753 40S ribosomal protein S6 (Phosphoprotein NP33)  -  -  -  - 4  - 5  - 
68 P62081 40S ribosomal protein S7  -  -  -  - 8 2 6  - 
69 P62241 40S ribosomal protein S8  -  -  -  - 6 1 7  - 
70 P46781 40S ribosomal protein S9 - Homo sapiens (Human)  -  -  -  - 4  - 3  - 
71 P08865 40S ribosomal protein SA (p40) (34/67 kDa laminin rec -  -  -  - 8 2 5 X
72 P08195 4F2 cell-surface antigen heavy chain (4F2hc) (Lympho -  -  -  -  - 1 1  - 
73 P49189 4-trimethylaminobutyraldehyde dehydrogenase (EC 1.2 - 1  -  - 8  - 8 X
74 Q8TCD5 5*(3*)-deoxyribonucleotidase, cytosolic type (EC 3.1.3  -  -  -  - 1  - 1  - 
75 Q00013 55 kDa erythrocyte membrane protein (p55) (Membran -  - 2  -  -  -  -  - 
76 P10809 60 kDa heat shock protein, mitochondrial precursor (Hs -  - 15 1 26 15 21 X
77 P05388 60S acidic ribosomal protein P0 (L10E)  -  -  -  - 7 1 7 X
78 P05386 60S acidic ribosomal protein P1  -  -  -  -  - 1 1  - 
79 P05387 60S acidic ribosomal protein P2  -  -  -  - 5 2 4  - 
80 P27635 60S ribosomal protein L10 (QM protein) (Tumor suppre -  -  -  - 1  - 5  - 
81 P62906 60S ribosomal protein L10a (CSA-19) - Homo sapiens  -  -  -  - 1  - 1  - 
82 P62913 60S ribosomal protein L11 (CLL-associated antigen KW -  -  -  - 6 1 5  - 
83 P30050 60S ribosomal protein L12  -  -  -  - 6 3 5  - 
84 P26373 60S ribosomal protein L13 (Breast basic conserved pro -  -  -  - 3  - 5  - 
85 P50914 60S ribosomal protein L14 (CAG-ISL 7) - Homo sapien -  -  -  - 2 1 3  - 
86 P61313 60S ribosomal protein L15 - Homo sapiens (Human)  -  -  -  - 2  - 2  - 
87 P18621 60S ribosomal protein L17 (L23) - Homo sapiens (Hum -  -  -  - 6  - 2  - 
88 Q07020 60S ribosomal protein L18  -  -  -  - 1  - 3  - 
89 Q02543 60S ribosomal protein L18a - Homo sapiens (Human)  -  -  -  - 4  - 3  - 
90 P46778 60S ribosomal protein L21 - Homo sapiens (Human)  -  -  -  - 3  - 1  - 
91 P35268 60S ribosomal protein L22 (Epstein-Barr virus small RN -  -  -  - 1 1 5  - 
92 P62829 60S ribosomal protein L23 (Ribosomal protein L17)  -  -  -  - 2 1 6  - 
93 P62750 60S ribosomal protein L23a - Homo sapiens (Human)  -  -  -  - 5 1 2  - 
94 P83731 60S ribosomal protein L24 (Ribosomal protein L30) - H -  -  -  - 2  -  -  - 
95 P61254 60S ribosomal protein L26  -  -  -  - 4  -  -  - 
96 P61353 60S ribosomal protein L27 - Homo sapiens (Human)  -  -  -  - 3  -  -  - 
97 P46776 60S ribosomal protein L27a - Homo sapiens (Human)  -  -  -  - 5  - 2  - 
98 P46779 60S ribosomal protein L28 - Homo sapiens (Human)  -  -  -  - 3  - 2  - 
99 P47914 60S ribosomal protein L29 (Cell surface heparin-bindin -  -  -  - 2  - 1  - 
100 P39023 60S ribosomal protein L3 (HIV-1 TAR RNA-binding pro -  -  -  - 4  - 7  - 
101 P62888 60S ribosomal protein L30  -  -  -  - 3 1 3  - 
102 P62910 60S ribosomal protein L32 - Homo sapiens (Human)  -  -  -  - 3  -  -  - 
103 P42766 60S ribosomal protein L35 - Homo sapiens (Human)  -  -  -  - 3 1  -  - 
104 P61513 60S ribosomal protein L37a - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
105 P63173 60S ribosomal protein L38 - Homo sapiens (Human)  -  -  -  - 2 2 4  - 
106 P36578 60S ribosomal protein L4 (L1) - Homo sapiens (Human -  -  -  - 5  - 4  - 
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107 P46777 60S ribosomal protein L5 - Homo sapiens (Human)  - 1  -  - 2  - 5  - 
108 Q02878 60S ribosomal protein L6 (TAX-responsive enhancer e -  -  -  - 4 1 5  - 
109 P18124 60S ribosomal protein L7 - Homo sapiens (Human)  -  -  -  - 2  - 5  - 
110 P62424 60S ribosomal protein L7a (Surfeit locus protein 3) (PL -  -  -  - 2  - 5  - 
111 P62917 60S ribosomal protein L8 - Homo sapiens (Human)  -  -  -  - 4  - 2  - 
112 P32969 60S ribosomal protein L9 - Homo sapiens (Human)  -  -  -  - 4  - 3  - 
113 Q01813 6-phosphofructokinase type C (EC 2.7.1.11) (Phospho  - 3 3  -  -  - 1  - 
114 P17858 6-phosphofructokinase, liver type (EC 2.7.1.11) (Phosp -  -  -  -  - 4 5  - 
115 P52209 6-phosphogluconate dehydrogenase, decarboxylating  -  - 1 17 5 12 7 X
116 O95336 6-phosphogluconolactonase (EC 3.1.1.31) (6PGL)  -  - 4 8 7 10 9 X
117 P11021 78 kDa glucose-regulated protein precursor (GRP 78)  -  - 25 2 22 22 23 X
118 Q9NUJ1 Abhydrolase domain-containing protein 10, mitochondr -  -  -  - 1  -  -  - 
119 Q8NFV4 Abhydrolase domain-containing protein 11 - Homo sap -  - 3 1  - 1 1  - 
120 Q96IU4 Abhydrolase domain-containing protein 14B (CCG1-int -  - 2 2 6 5 6 X
121 P24752 Acetyl-CoA acetyltransferase, mitochondrial precursor  -  -  - 4 5 4 3 X
122 O00400 Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA tr  -  -  -  -  -  - 1  - 
123 Q13510 Acid ceramidase precursor (EC 3.5.1.23) (Acylsphingo -  -  - 5 2 5 5 X
124 P39687 Acidic leucine-rich nuclear phosphoprotein 32 family m -  -  - 1 5 5 7 X
125 Q92688 Acidic leucine-rich nuclear phosphoprotein 32 family m -  -  - 1 3 5 3  - 
126 O43423 Acidic leucine-rich nuclear phosphoprotein 32 family m -  -  -  -  -  - 2  - 
127 Q9BTT0 Acidic leucine-rich nuclear phosphoprotein 32 family m -  -  -  - 4 5 5  - 
128 Q99798 Aconitate hydratase, mitochondrial precursor (EC 4.2.1 -  -  -  - 6  - 13 X
129 P60709 Actin, cytoplasmic 1 (Beta-actin)  - 3 31 22 34 23 26 X
130 P63261 Actin, cytoplasmic 2 (Gamma-actin)  - 3 31 22 34 23 26 X
131 P61160 Actin-like protein 2 (Actin-related protein 2)  - 1 10 11 10 6 12 X
132 P61158 Actin-like protein 3 (Actin-related protein 3)  -  - 15 9 12 8 16 X
133 O15143 Actin-related protein 2/3 complex subunit 1B (ARP2/3  -  - 5 6 7 5 11  - 
134 O15144 Actin-related protein 2/3 complex subunit 2 (ARP2/3 co - 1 9 11 11 6 19 X
135 O15145 Actin-related protein 2/3 complex subunit 3 (ARP2/3 co -  - 6 3 6 4 7  - 
136 P59998 Actin-related protein 2/3 complex subunit 4 (ARP2/3 co -  - 4 4 6 3 6  - 
137 O15511 Actin-related protein 2/3 complex subunit 5 (ARP2/3 co -  - 4 1 4 3 4 X
138 Q9BPX5 Actin-related protein 2/3 complex subunit 5-like protein -  -  -  -  -  - 2 X
139 Q9P1U1 Actin-related protein 3B OS=Homo sapiens GN=ACTR -  -  - 2  -  -  -  - 
140 P53999 Activated RNA polymerase II transcriptional coactivato  -  -  -  - 3 4 5  - 
141 O95433 Activator of 90 kDa heat shock protein ATPase homolo -  - 1  -  - 1  - X
142 P13798 Acylamino-acid-releasing enzyme (EC 3.4.19.1) (AARE - 5 1  - 2 1 2 X
143 P45954 Acyl-CoA dehydrogenase, short/branched chain specif  -  -  -  - 2  -  - X
144 P16219 Acyl-CoA dehydrogenase, short-chain specific, mitoch  -  - 1  - 3 1  - X
145 P49748 Acyl-CoA dehydrogenase, very-long-chain specific, mit -  -  -  -  - 8 2 X
146 P07108 Acyl-CoA-binding protein (ACBP) (Diazepam-binding in -  -  - 2 2 2 4  - 
147 O75608 Acyl-protein thioesterase 1 (EC 3.1.2.-) (Lysophosphol  -  - 4 4 2 4 5 X
148 O95372 Acyl-protein thioesterase 2 (EC 3.1.2.-) (Lysophosphol  -  -  -  - 2  - 4 X
149 Q7L5N7 Acyltransferase-like 1 (EC 2,3,1,-) - Homo sapiens (Hu -  -  - 1  -  -  -  - 
150 O14672 ADAM 10 precursor (EC 3.4.24.81) (A disintegrin and m -  - 3  -  -  -  -  - 
151 O43184 ADAM 12 precursor - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
152 P07741 Adenine phosphoribosyltransferase (EC 2.4.2.7) (APR  - 2 7 7 10 9 10 X
153 P55263 Adenosine kinase (EC 2.7.1.20) (AK) (Adenosine 5*-ph - 1  -  - 2  - 2 X
154 P23526 Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-h - 1  - 3 2 1 4 X
155 P00568 Adenylate kinase isoenzyme 1 (EC 2.7.4.3) (ATP-AMP - 6 5  - 4  - 1  - 
156 P54819 Adenylate kinase isoenzyme 2, mitochondrial (EC 2.7.4 -  - 7 4 9 11 11 X
157 P30566 Adenylosuccinate lyase (EC 4.3.2.2) (Adenylosuccinas - 2  -  - 2  - 4 X
158 P30520 Adenylosuccinate synthetase isozyme 2 (EC 6.3.4.4) (  -  -  - 6  -  - 2 X
159 Q01518 Adenylyl cyclase-associated protein 1 (CAP 1)  -  - 12 17 17 15 22 X
160 Q9HDC9 Adipocyte plasma membrane-associated protein (BSC  -  -  - 7 1  - 5 X
161 Q9NZ08 Adipocyte-derived leucine aminopeptidase precursor (E -  -  - 2 3 7 8  - 
162 Q15848 Adiponectin precursor (Adipocyte, C1q and collagen do 2  -  -  -  -  -  -  - 
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163 P12235 ADP/ATP translocase 1 (Adenine nucleotide translocat -  -  -  -  - 1  -  - 
164 P05141 ADP/ATP translocase 2 (Adenine nucleotide translocat -  - 2  - 2 4 8  - 
165 P12236 ADP/ATP translocase 3 (Adenine nucleotide translocat -  -  -  -  - 5  -  - 
166 Q9BRR6 ADP-dependent glucokinase (EC 2.7.1.147) (ADPGK)  -  - 1 1  - 1 1  - 
167 Q10588 ADP-ribosyl cyclase 2 precursor (EC 3,2,2,5) (Cyclic A -  -  - 1  -  -  -  - 
168 P84077 ADP-ribosylation factor 1  - 3 12  - 12 9 11  - 
169 P61204 ADP-ribosylation factor 3  -  -  -  -  -  - 10  - 
170 P18085 ADP-ribosylation factor 4  -  - 7  - 6 4 5  - 
171 P84085 ADP-ribosylation factor 5  -  -  -  - 7 4  -  - 
172 P62330 ADP-ribosylation factor 6 - Homo sapiens (Human)  -  -  -  - 2 2 7  - 
173 P40616 ADP-ribosylation factor-like protein 1  -  -  - 2  -  -  -  - 
174 Q96BM9 ADP-ribosylation factor-like protein 8A (ADP-ribosylatio -  -  -  - 1 3 2  - 
175 Q9NVJ2 ADP-ribosylation factor-like protein 8B (ADP-ribosylatio -  -  - 4  -  -  -  - 
176 Q9UKK9 ADP-sugar pyrophosphatase (EC 3.6.1.13) (EC 3.6.1.- -  -  -  - 2  - 2 X
177 P43652 Afamin precursor (Alpha-albumin) (Alpha-Alb) - Homo 6  -  -  -  -  -  -  - 
178 O43488 Aflatoxin B1 aldehyde reductase member 2 (EC 1.-.-.-)  - 1 5  - 4  - 2 X
179 O00170 AH receptor-interacting protein (AIP) (Aryl-hydrocarbon -  -  -  - 2  - 3 X
180 P49588 Alanyl-tRNA synthetase (EC 6.1.1.7) (Alanine--tRNA lig - 1  -  - 2  - 4 X
181 P14550 Alcohol dehydrogenase [NADP+] (EC 1.1.1.2) (Aldehy  -  -  -  - 5  - 3 X
182 P11766 Alcohol dehydrogenase class 3 chi chain (EC 1.1.1.1)  -  -  -  - 3  - 3 X
183 Q8IZ83 Aldehyde dehydrogenase family 16 member A1 - Hom  -  - 1 1 1 2 4  - 
184 P05091 Aldehyde dehydrogenase, mitochondrial precursor (EC -  -  -  -  - 6 4 X
185 P15121 Aldose reductase (EC 1.1.1.21) (AR) (Aldehyde reduct  - 1 1  - 8 2 6 X
186 P55008 Allograft inflammatory factor 1 (AIF-1) (Ionized calcium -  -  - 1 1 1  - X
187 P02763 Alpha-1-acid glycoprotein 1 precursor (AGP 1) (Orosom 5  -  - 2  -  - 1  - 
188 P19652 Alpha-1-acid glycoprotein 2 precursor (AGP 2) (Orosom 3  -  -  -  -  -  -  - 
189 P04217 Alpha-1B-glycoprotein precursor (Alpha-1-B glycoprote 11  -  -  -  -  - 1  - 
190 P08697 Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibit 3  -  -  -  -  -  -  - 
191 P02765 Alpha-2-HS-glycoprotein precursor (Fetuin-A) (Alpha-2 1  -  -  -  -  - 1  - 
192 P01023 Alpha-2-macroglobulin precursor (Alpha-2-M) 61  - 24  -  -  - 42  - 
193 P12814 Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (No - 13 56 7 18 21 41 X
194 P35609 Alpha-actinin-2 (Alpha actinin skeletal muscle isoform 2 -  -  -  -  -  - 4  - 
195 O43707 Alpha-actinin-4 (Non-muscle alpha-actinin 4) (F-actin c - 15 23  - 14 24 33 X
196 P35611 Alpha-adducin (Erythrocyte adducin subunit alpha) - H  -  -  -  - 3  - 1  - 
197 P61163 Alpha-centractin (Centractin) (Centrosome-associated  -  - 4  -  - 1 1 X
198 P06733 Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate h - 4 17 16 30 25 27 X
199 P02771 Alpha-fetoprotein precursor (Alpha-fetoglobulin) (Alpha -  -  - 1  - 2 1 X
200 P54920 Alpha-soluble NSF attachment protein (SNAP-alpha) (  -  - 6  - 5 2 7 X
201 P37840 Alpha-synuclein (Non-A beta component of AD amyloid - 6 6  - 6  - 1 X
202 Q8TCU4 Alstrom syndrome protein 1 - Homo sapiens (Human)  -  -  -  - 1  -  -  - 
203 P02760 AMBP protein precursor [Contains: Alpha-1-microglobu 10  -  -  -  -  - 2  - 
204 Q9H4A4 Aminopeptidase B (EC 3.4.11.6) (Ap-B) (Arginyl amino -  -  - 1  - 3  - X
205 P15144 Aminopeptidase N (EC 3.4.11.2) (hAPN) (Alanyl amino - 4  -  -  -  -  -  - 
206 Q01432 AMP deaminase 3 (EC 3,5,4,6) (AMP deaminase isofo -  -  - 2  -  -  -  - 
207 Q7Z5R6 Amyloid beta A4 precursor protein-binding family B me -  -  -  -  -  - 2  - 
208 P03950 Angiogenin precursor (EC 3,1,27,-) (Ribonuclease 5) ( 7  -  -  -  -  -  -  - 
209 P01019 Angiotensinogen precursor [Contains: Angiotensin-1 (A 3  -  -  - 1  - 4 X
210 P16157 Ankyrin-1 (Erythrocyte ankyrin) (Ankyrin-R) - Homo sa  - 29 6  - 9  -  -  - 
211 P04083 Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chr -  -  - 23 22 19 27 X
212 P50995 Annexin A11 (Annexin XI) (Calcyclin-associated annex -  - 1 4 11 4 8 X
213 P07355 Annexin A2 (Annexin II) (Lipocortin II) (Calpactin I heav - 5  -  - 18 19 27 X
214 P12429 Annexin A3 (Annexin III) (Lipocortin III) (Placental antic -  - 4 24  - 5  - X
215 P09525 Annexin A4 (Annexin IV) (Lipocortin IV) (Endonexin  -  - 1 10 4 4 7 X
216 P08758 Annexin A5 (Annexin V) (Lipocortin V) (Endonexin II) (  -  - 8 11 16 17 20 X
217 P08133 Annexin A6 (Annexin VI) (Lipocortin VI) (P68) (P70) (P -  - 1 22 39 32 37 X
218 P20073 Annexin A7 (Annexin VII) (Synexin)  - 1  -  - 7 1 6 X
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219 Q03518 Antigen peptide transporter 1 (APT1) (Peptide transpo  -  -  -  -  - 2 1  - 
220 Q03519 Antigen peptide transporter 2 (APT2) (ATP-binding cas -  -  -  -  -  - 2  - 
221 P01008 Antithrombin-III precursor (ATIII) - Homo sapiens (Hum 8  -  -  -  -  - 1  - 
222 Q10567 AP-1 complex subunit beta-1 (Adapter-related protein  -  - 3  -  - 2 4  - 
223 O43747 AP-1 complex subunit gamma-1 (Adapter-related prote -  -  -  -  -  - 1  - 
224 P63010 AP-2 complex subunit beta-1 (Adapter-related protein  -  -  -  - 3  - 4  - 
225 P02647 Apolipoprotein A-I precursor (Apo-AI) (ApoA-I) [Contain31  -  -  -  - 1 27 X
226 Q8NCW5 Apolipoprotein A-I-binding protein precursor - Homo sa -  -  -  -  -  - 2  - 
227 P02652 Apolipoprotein A-II precursor (Apo-AII) (ApoA-II) [Cont 2  -  -  -  -  -  -  - 
228 P06727 Apolipoprotein A-IV precursor (Apo-AIV) (ApoA-IV) 24  -  -  -  -  - 8 X
229 P04114 Apolipoprotein B-100 precursor (Apo B-100) [Contains 77  -  -  -  -  - 3  - 
230 Q0VD83 Apolipoprotein B-100 receptor - Homo sapiens (Human - 1  - 2  - 2 4  - 
231 P02656 Apolipoprotein C-III precursor (Apo-CIII) (ApoC-III) - Ho 1  -  -  -  - 2 3  - 
232 P55056 Apolipoprotein C-IV precursor (Apo-CIV) (ApoC-IV) - H 3  -  -  -  -  -  -  - 
233 P05090 Apolipoprotein D precursor (Apo-D) (ApoD) - Homo sa 5  -  -  -  -  -  - X
234 P02649 Apolipoprotein E precursor (Apo-E) - Homo sapiens (H 16  -  -  -  -  - 5  - 
235 Q13790 Apolipoprotein F precursor (Apo-F) (Lipid transfer inhib 2  -  -  -  -  -  -  - 
236 O95445 Apolipoprotein M (Apo-M) (ApoM) (Protein G3a) - Hom 3  -  -  -  -  -  -  - 
237 O14791 Apolipoprotein-L1 precursor (Apolipoprotein L-I) (Apoli 4  -  -  -  -  -  -  - 
238 Q07812 Apoptosis regulator BAX, membrane isoform alpha  -  -  - 2 1 2 3  - 
239 Q9ULZ3 Apoptosis-associated speck-like protein containing a C -  -  - 7 4 12 9 X
240 O14727 Apoptotic protease-activating factor 1 (Apaf-1)  -  -  -  -  - 1 2  - 
241 P18054 Arachidonate 12-lipoxygenase, 12S-type (EC 1.13.11.3 -  - 2  -  -  -  -  - 
242 P16050 Arachidonate 15-lipoxygenase (EC 1.13.11.33) (Arach  -  -  - 8  -  -  - X
243 P09917 Arachidonate 5-lipoxygenase (EC 1.13.11.34) (5-lipoxy -  -  -  -  - 2  -  - 
244 P05089 Arginase-1 (EC 3.5.3.1) (Type I arginase) (Liver-type a -  -  - 8  -  -  - X
245 P55145 ARMET protein precursor (Arginine-rich protein) - Hom -  - 3  - 1 4 4  - 
246 O43681 Arsenical pump-driving ATPase (EC 3.6.3.16) (Arsenit  -  - 1  - 1 1  - X
247 P17174 Aspartate aminotransferase, cytoplasmic (EC 2.6.1.1)  - 1  - 1  -  -  - X
248 P00505 Aspartate aminotransferase, mitochondrial precursor (E -  - 1 1 4 2 8  - 
249 Q9ULA0 Aspartyl aminopeptidase (EC 3.4.11.21) - Homo sapie  -  -  -  -  -  - 4 X
250 P14868 Aspartyl-tRNA synthetase (EC 6.1.1.12) (Aspartate--tR -  - 2  - 3  -  - X
251 Q6DD88 Atlastin-3 - Homo sapiens (Human)  -  -  -  -  - 5 1  - 
252 P00846 ATP synthase a chain (EC 3.6.3.14) (ATPase protein 6 -  -  -  -  - 1  -  - 
253 P25705 ATP synthase alpha chain, mitochondrial precursor (EC -  - 16 8 22 17 23 X
254 P24539 ATP synthase B chain, mitochondrial precursor (EC 3.  -  - 1  - 2 2 6  - 
255 P06576 ATP synthase beta chain, mitochondrial precursor (EC -  - 17 6 21 18 20 X
256 O75947 ATP synthase D chain, mitochondrial (EC 3.6.3.14)  -  - 3  - 9 7 9 X
257 P30049 ATP synthase delta chain, mitochondrial precursor (EC -  - 2 1 1 2 1 X
258 P56385 ATP synthase e chain, mitochondrial (EC 3.6.3.14) - H  -  -  -  - 1 2  -  - 
259 P56134 ATP synthase f chain, mitochondrial (EC 3.6.3.14)  -  -  -  - 1 2 2  - 
260 P36542 ATP synthase gamma chain, mitochondrial precursor (  -  - 2 1 7 1 5  - 
261 P48047 ATP synthase O subunit, mitochondrial precursor (EC  -  - 5 2 8 7 11  - 
262 O75964 ATP synthase subunit g, mitochondrial (EC 3.6.3.14) (A -  - 3  - 1 5 4  - 
263 Q8N139 ATP-binding cassette sub-family A member 6 - Homo s -  -  - 1  -  -  -  - 
264 Q8NE71 ATP-binding cassette sub-family F member 1 (ATP-bin -  -  -  - 1  -  -  - 
265 P53396 ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-  - 2  - 1 1 4 8  - 
266 P12956 ATP-dependent DNA helicase 2 subunit 1 (EC 3.6.1.-)  -  -  -  - 19 1 23 X
267 P13010 ATP-dependent DNA helicase 2 subunit 2 (EC 3.6.1.-)  -  -  -  - 16 5 17  - 
268 Q08211 ATP-dependent RNA helicase A (EC 3.6.1.-) (Nuclear  -  -  -  -  -  - 1  - 
269 Q9NUU7 ATP-dependent RNA helicase DDX19A (EC 3,6,1,-) (D -  -  -  -  - 1  - X
270 O00148 ATP-dependent RNA helicase DDX39 (EC 3.6.1.-) (DE -  -  -  -  -  - 2  - 
271 O14497 AT-rich interactive domain-containing protein 1A (ARID -  -  - 1  -  -  -  - 
272 O75882 Attractin precursor (Mahogany homolog) (DPPT-L) - H 7  -  -  -  -  -  -  - 
273 Q9NT62 Autophagy-related protein 3 (APG3-like) (hApg3) (Prot  -  -  -  -  - 4  -  - 
274 O95352 Autophagy-related protein 7 (APG7-like) (Ubiquitin-act  -  -  -  -  -  - 1  - 
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275 P20160 Azurocidin precursor (Cationic antimicrobial protein CA -  -  - 3  - 2 1  - 
276 P17213 Bactericidal permeability-increasing protein precursor ( -  -  - 6  -  -  -  - 
277 P02730 Band 3 anion transport protein (Anion exchange protei  - 12  -  - 12  -  -  - 
278 O75531 Barrier-to-autointegration factor (Breakpoint cluster reg -  -  -  - 2 3 2  - 
279 P51572 B-cell receptor-associated protein 31 (BCR-associated -  -  - 2 1 1 4  - 
280 Q13884 Beta-1-syntrophin (59 kDa dystrophin-associated prote -  -  -  -  -  - 1  - 
281 P02749 Beta-2-glycoprotein 1 precursor (Beta-2-glycoprotein I) 6  -  -  -  -  - 3  - 
282 P61769 Beta-2-microglobulin precursor [Contains: Beta-2-micro 1  - 3 1  - 2 3 X
283 P25098 Beta-adrenergic receptor kinase 1 - Homo sapiens (Hu -  -  -  -  -  - 1  - 
284 Q96KN2 Beta-Ala-His dipeptidase precursor (EC 3,4,13,20) (Ca 4  -  -  -  -  -  -  - 
285 P49407 Beta-arrestin-1 (Arrestin, beta 1)  -  - 1  -  -  - 1  - 
286 P32121 Beta-arrestin-2 (Arrestin beta 2) - Homo sapiens (Hum  -  -  -  - 1  -  -  - 
287 P42025 Beta-centractin (Actin-related protein 1B) (ARP1B)  -  - 3  -  -  -  - X
288 P13929 Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hy - 2 5 4  -  - 5  - 
289 P16278 Beta-galactosidase precursor (EC 3.2.1.23) (Lactase)  -  -  -  -  - 3 1  - 
290 P06865 Beta-hexosaminidase alpha chain precursor (EC 3.2.1  -  -  -  -  - 1  -  - 
291 P07686 Beta-hexosaminidase beta chain precursor (EC 3.2.1.5 -  -  -  -  - 4 1 X
292 Q9HBI1 Beta-parvin (Affixin)  -  - 15  - 1  - 4  - 
293 P55957 BH3 interacting domain death agonist (BID)  - 2 4 2 2 4 3 X
294 P07814 Bifunctional aminoacyl-tRNA synthetase [Includes: Glu -  -  -  - 5  - 1  - 
295 P31939 Bifunctional purine biosynthesis protein PURH [Include - 3  -  - 5  - 4 X
296 P19835 Bile salt-activated lipase precursor - Homo sapiens (Hu -  -  -  -  -  - 1  - 
297 P53004 Biliverdin reductase A precursor (EC 1.3.1.24) (Biliverd -  - 1 1 4 3 1 X
298 P50583 Bis(5*-nucleosyl)-tetraphosphatase [asymmetrical] (EC -  -  -  - 2  - 1  - 
299 P07738 Bisphosphoglycerate mutase (EC 5.4.2.4) (2,3-bisphos - 3  -  - 6  -  -  - 
300 Q13867 Bleomycin hydrolase (EC 3.4.22.40) (BLM hydrolase) ( - 1  -  -  -  - 1 X
301 Q9H3K6 BolA-like protein 2  -  -  -  - 2 3 2 X
302 P13727 Bone-marrow proteoglycan precursor (BMPG) (Proteog -  -  - 5  - 1  -  - 
303 P80723 Brain acid soluble protein 1 (BASP1 protein) (Neurona  -  -  - 1  -  - 1  - 
304 Q9UBW5 Bridging integrator 2 (Breast cancer-associated protein -  - 9 1  -  - 3  - 
305 P11586 C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF sy - 1  - 2  -  - 3  - 
306 P04003 C4b-binding protein alpha chain precursor (C4bp) (Pro 9  -  -  -  -  -  -  - 
307 P21730 C5a anaphylatoxin chemotactic receptor - Homo sapie  -  -  - 1  -  -  -  - 
308 P49593 Ca(2+)/calmodulin-dependent protein kinase phosphat  -  - 2  - 1 1 1  - 
309 P27708 CAD protein [Includes: Glutamine-dependent carbamo  -  -  -  -  - 1  -  - 
310 P63098 Calcineurin subunit B isoform 1 (Protein phosphatase 2 -  -  -  - 1  -  -  - 
311 O75746 Calcium-binding mitochondrial carrier protein Aralar1 (  -  -  -  - 2  -  -  - 
312 Q6NUK1 Calcium-binding mitochondrial carrier protein SCaMC-  -  -  - 1  - 2 3  - 
313 Q9Y376 Calcium-binding protein 39 (Protein Mo25) - Homo sap -  -  - 2  -  -  - X
314 Q9ULU8 Calcium-dependent secretion activator 1 (Calcium-dep -  -  -  -  -  - 1  - 
315 Q9Y2V2 Calcium-regulated heat stable protein 1 (Calcium-regu  -  -  - 1 2  - 1  - 
316 P06703 Calcyclin (Prolactin receptor-associated protein) (PRA) -  -  -  - 2 6  - X
317 Q9HB71 Calcyclin-binding protein (CacyBP) (hCacyBP) (Siah-in -  - 1  - 3 2 1  - 
318 Q05682 Caldesmon (CDM)  - 1 7  -  -  -  - X
319 P31949 Calgizzarin (S100 calcium-binding protein A11) (S100C -  -  - 3 2 6 3  - 
320 P05109 Calgranulin A (Migration inhibitory factor-related protei  - 1 1 13 3 15 12 X
321 P06702 Calgranulin B (Migration inhibitory factor-related protei  -  -  - 14 5 16 11 X
322 P62158 Calmodulin (CaM)  - 1 3 1 3 5 4  - 
323 P27824 Calnexin precursor (Major histocompatibility complex c -  - 5  - 2 8 10  - 
324 P60903 Calpactin I light chain (S100 calcium-binding protein A  -  -  -  -  - 4 2 X
325 P04632 Calpain small subunit 1 (CSS1) (Calcium-dependent p  - 1 7 4 10 4 7 X
326 P07384 Calpain-1 catalytic subunit (EC 3.4.22.52) (Calpain-1 la - 2 6 3 3 4 11  - 
327 P17655 Calpain-2 catalytic subunit precursor (EC 3.4.22.53) (C -  -  -  - 2 2 7  - 
328 P20810 Calpastatin (Calpain inhibitor) (Sperm BS-17 compone -  -  -  -  - 2 7  - 
329 Q99439 Calponin-2 (Calponin H2, smooth muscle) (Neutral cal  -  - 10 6 10 1 8 X
330 P27797 Calreticulin precursor (CRP55) (Calregulin) (HACBP) (  -  - 7 3 4 7 5 X
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331 P10644 cAMP-dependent protein kinase type I-alpha regulatory -  - 3  - 1 2 2 X
332 P31323 cAMP-dependent protein kinase type II-beta regulatory -  - 2  -  -  -  -  - 
333 P17612 cAMP-dependent protein kinase, alpha-catalytic subun -  -  -  -  -  - 1  - 
334 P22694 cAMP-dependent protein kinase, beta-catalytic subunit -  -  -  -  -  - 1  - 
335 Q6JBY9 Capz-interacting protein - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
336 P00915 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonic anhydras - 11 6  - 16 5 1 X
337 P00918 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonic anhydras - 7 9  - 12 2 4 X
338 P16152 Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (NADP  - 1 5  - 8 2 9 X
339 O75828 Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADP  -  -  -  -  -  - 3 X
340 Q96IY4 Carboxypeptidase B2 precursor (EC 3,4,17,20) (Carbo 2  -  -  -  -  -  -  - 
341 P22792 Carboxypeptidase N subunit 2 precursor (Carboxypept 8  -  -  -  -  -  - X
342 P13688 Carcinoembryonic antigen-related cell adhesion molec  -  -  - 2  -  -  -  - 
343 P40199 Carcinoembryonic antigen-related cell adhesion molec  -  -  - 2  -  -  -  - 
344 P31997 Carcinoembryonic antigen-related cell adhesion molec  -  -  - 2  -  -  -  - 
345 Q8N3K9 Cardiomyopathy-associated protein 5 - Homo sapiens  -  -  -  -  -  - 2  - 
346 P67870 Casein kinase II subunit beta (CK II beta) (Phosvitin) (G -  - 1  -  -  -  -  - 
347 P29466 Caspase-1 precursor (EC 3.4.22.36) (CASP-1) (Interle  -  -  -  - 2 1  - X
348 P42574 Caspase-3 precursor (EC 3.4.22.-) (CASP-3) (Apopain -  - 2  -  -  - 1 X
349 Q9BXW7 Cat eye syndrome critical region protein 5 precursor - H -  -  -  -  -  - 1  - 
350 P04040 Catalase (EC 1.11.1.6)  - 17 4 9 21 13 11 X
351 P21964 Catechol O-methyltransferase (EC 2.1.1.6)  -  -  -  - 2 6 3 X
352 P49913 Cathelicidin antimicrobial peptide precursor (18 kDa ca -  -  - 5  - 1  -  - 
353 P07858 Cathepsin B precursor (EC 3.4.22.1) (Cathepsin B1) (A -  -  -  - 4 4 4 X
354 P07339 Cathepsin D precursor (EC 3.4.23.5) [Contains: Cathe  -  - 1 2 4 8 6 X
355 P08311 Cathepsin G precursor (EC 3.4.21.20) (CG) - Homo sa -  -  - 6  - 1  -  - 
356 P09668 Cathepsin H precursor (EC 3.4.22.16) [Contains: Cath  -  -  -  - 1 1 2  - 
357 P25774 Cathepsin S precursor (EC 3.4.22.27)  -  -  - 3 3 7 6 X
358 Q9UBR2 Cathepsin Z precursor (EC 3.4.22.-) (Cathepsin X) (Ca -  -  - 1  - 2 2 X
359 Q8N6Q3 CD177 antigen OS=Homo sapiens GN=CD177 PE=1 S -  -  - 1  -  -  -  - 
360 Q15762 CD226 antigen precursor (DNAX accessory molecule  -  - 1  -  -  -  -  - 
361 P16070 CD44 antigen precursor (Phagocytic glycoprotein I) (P  - 1  -  - 1 3 3  - 
362 O43866 CD5 antigen-like precursor (SP-alpha) (CT-2) (IgM-ass 1  -  -  -  -  -  -  - 
363 P08962 CD63 antigen (Melanoma-associated antigen ME491)  -  -  - 2  -  -  -  - 
364 P21926 CD9 antigen (p24) (Leukocyte antigen MIC3) (Motility-  -  - 2  -  -  - 2  - 
365 P48960 CD97 antigen precursor (Leukocyte antigen CD97) - H -  -  -  -  - 2 2  - 
366 P14209 CD99 antigen precursor (T-cell surface glycoprotein E2 -  - 1  - 1  -  -  - 
367 Q9NV96 Cell cycle control protein 50A (Transmembrane protein -  -  - 1  -  -  -  - 
368 P60953 Cell division control protein 42 homolog precursor (G25 -  - 3 1 5 4 5 X
369 Q99741 Cell division control protein 6 homolog (CDC6-related p 1  -  -  -  -  -  -  - 
370 P62633 Cellular nucleic acid-binding protein (CNBP) (Zinc finge -  -  -  - 2 4 5  - 
371 Q15027 Centaurin-beta 1 (Cnt-b1) - Homo sapiens (Human)  - 1 2  - 4  - 1  - 
372 Q96P48 Centaurin-delta 2 (Cnt-d2) (Arf-GAP, Rho-GAP, ankyri  -  -  -  -  - 2 4  - 
373 P00450 Ceruloplasmin precursor (EC 1.16.3.1) (Ferroxidase) 39  -  -  -  -  - 13 X
374 O76074 cGMP-specific 3*,5*-cyclic phosphodiesterase (EC 3.1  -  - 1  -  -  -  -  - 
375 Q9BY43 Charged multivesicular body protein 4a (Chromatin-mo -  -  -  - 1 1  -  - 
376 Q9H444 Charged multivesicular body protein 4b (Chromatin-mo -  -  -  - 1  - 1  - 
377 Q96FZ7 Charged multivesicular body protein 6 (Chromatin-mod -  - 1  -  -  -  -  - 
378 P36222 Chitinase-3-like protein 1 precursor (Cartilage glycopro -  -  - 11  -  -  -  - 
379 Q13231 Chitotriosidase-1 precursor (EC 3.2.1.14) (Chitinase-1) -  -  - 4  -  -  -  - 
380 O00299 Chloride intracellular channel protein 1 (Nuclear chlorid - 2 6 4 8 6 7 X
381 Q9Y696 Chloride intracellular channel protein 4 (Intracellular ch -  - 6  -  -  - 1 X
382 Q9NZA1 Chloride intracellular channel protein 5 - Homo sapiens -  -  -  -  - 1  -  - 
383 Q8WWI5 Choline transporter-like protein 1 (Solute carrier family  -  -  -  -  - 1 1  - 
384 Q8IWA5 Choline transporter-like protein 2 (Solute carrier family  -  -  - 3  -  -  -  - 
385 P83916 Chromobox protein homolog 1 (Heterochromatin prote  -  -  -  - 1  -  -  - 
386 Q13185 Chromobox protein homolog 3 (Heterochromatin prote  -  -  -  - 3 3 4 X
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387 O75390 Citrate synthase, mitochondrial precursor (EC 2.3.3.1)  -  - 1 2 5 3 5  - 
388 Q00610 Clathrin heavy chain 1 (CLH-17)  - 4 10  - 13 25 45  - 
389 P53675 Clathrin heavy chain 2 (CLH-22)  -  -  -  -  -  - 11  - 
390 Q14677 Clathrin interactor 1 (Epsin-4) (Epsin-related protein) (E -  -  -  - 1  - 1  - 
391 O43809 Cleavage and polyadenylation specificity factor 5 (Clea -  -  -  - 1  - 3  - 
392 Q16630 Cleavage and polyadenylation specificity factor 6 (Clea -  -  -  - 1  -  -  - 
393 P10909 Clusterin precursor (Complement-associated protein S 17  - 7  -  -  - 7 X
394 Q99417 C-Myc-binding protein (Associate of Myc 1) (AMY-1)  -  -  -  -  - 1 1  - 
395 O43598 c-Myc-responsive protein Rcl  -  -  -  - 3 1 1 X
396 Q14019 Coactosin-like protein  -  - 6 6 6 9 10 X
397 P00740 Coagulation factor IX precursor (EC 3,4,21,22) (Christm 4  -  -  -  -  -  -  - 
398 P12259 Coagulation factor V precursor (Activated protein C cof 3  - 7  -  -  -  -  - 
399 P00742 Coagulation factor X precursor (EC 3,4,21,6) (Stuart fa 1  -  -  -  -  -  -  - 
400 P00748 Coagulation factor XII precursor (EC 3,4,21,38) (Hagem 4  -  -  -  -  -  -  - 
401 P00488 Coagulation factor XIII A chain precursor (EC 2.3.2.13) -  - 29  - 4 6 14 X
402 P05160 Coagulation factor XIII B chain precursor (Protein-gluta 2  -  -  -  -  -  -  - 
403 P53621 Coatomer subunit alpha (Alpha-coat protein) (Alpha-CO -  -  -  -  -  - 8  - 
404 P53618 Coatomer subunit beta (Beta-coat protein) (Beta-COP) -  -  -  - 3 4 5  - 
405 O14579 Coatomer subunit epsilon (Epsilon-coat protein) (Epsilo -  -  -  -  -  - 1 X
406 Q9Y678 Coatomer subunit gamma (Gamma-coat protein) (Gam -  -  - 1 1 1 5  - 
407 Q9UBF2 Coatomer subunit gamma-2 (Gamma-2 coat protein) (G -  -  -  -  -  - 2  - 
408 P61923 Coatomer subunit zeta-1 (Zeta-1 coat protein) (Zeta-1  -  -  -  - 1 2 1  - 
409 P23528 Cofilin-1 (Cofilin, non-muscle isoform) (18 kDa phosph 1 4 14 11 16 17 18 X
410 Q9Y281 Cofilin-2 (Cofilin, muscle isoform)  -  -  -  -  -  - 7 X
411 Q96CT7 Coiled-coil domain-containing protein 124 - Homo sapi  -  -  -  - 1  -  -  - 
412 Q9Y6H1 Coiled-coil-helix-coiled-coil-helix domain-containing pro -  -  -  -  - 1 1  - 
413 Q9BWP8 Collectin-11 precursor - Homo sapiens (Human) 1  -  -  -  -  -  -  - 
414 Q8N668 COMM domain-containing protein 1 (Protein Murr1) - H -  -  -  -  - 1  -  - 
415 Q9UBI1 COMM domain-containing protein 3 (Bup protein) (PIL  -  -  -  -  - 2 1 X
416 Q9P000 COMM domain-containing protein 9  -  -  -  - 1 1 1  - 
417 P02745 Complement C1q subcomponent subunit A precursor 1  -  -  -  -  -  -  - 
418 P02746 Complement C1q subcomponent subunit B precursor - 7  - 1  -  -  -  -  - 
419 P02747 Complement C1q subcomponent subunit C precursor - 4  -  -  -  -  -  -  - 
420 P00736 Complement C1r subcomponent precursor (EC 3,4,21 3  -  -  -  -  -  - X
421 P09871 Complement C1s subcomponent precursor (EC 3,4,21 2  -  -  -  -  -  - X
422 P06681 Complement C2 precursor (EC 3,4,21,43) (C3/C5 conv 3  -  -  -  -  -  -  - 
423 P01024 Complement C3 precursor [Contains: Complement C3 89  - 5  -  -  - 27 X
424 P0C0L4 Complement C4-A precursor (Acidic complement C4) [ 48  -  -  -  -  - 5 X
425 P0C0L5 Complement C4-B precursor (Basic complement C4) [ 50  -  -  -  -  -  - X
426 P01031 Complement C5 precursor [Contains: Complement C5 16  -  -  -  -  -  -  - 
427 Q07021 Complement component 1 Q subcomponent-binding p  -  - 1  - 2  - 1  - 
428 P13671 Complement component C6 precursor - Homo sapiens 8  -  -  -  -  -  -  - 
429 P10643 Complement component C7 precursor - Homo sapiens 2  -  -  -  -  -  -  - 
430 P07357 Complement component C8 alpha chain precursor (Co 2  -  -  -  -  -  -  - 
431 P07358 Complement component C8 beta chain precursor (Com 2  -  -  -  -  -  -  - 
432 P07360 Complement component C8 gamma chain precursor - 7  -  -  -  -  -  -  - 
433 P02748 Complement component C9 precursor [Contains: Com 7  -  -  -  -  -  -  - 
434 P00751 Complement factor B precursor (EC 3.4.21.47) (C3/C5 18  -  -  -  -  - 1 X
435 P00746 Complement factor D precursor (EC 3,4,21,46) (C3 co 5  -  -  -  -  -  -  - 
436 P08603 Complement factor H precursor (H factor 1) - Homo sa 36  - 1  -  -  - 3  - 
437 Q03591 Complement factor H-related protein 1 precursor (FHR 5  -  -  -  -  -  -  - 
438 P36980 Complement factor H-related protein 2 precursor (FHR 3  -  -  -  -  -  -  - 
439 Q9BXR6 Complement factor H-related protein 5 precursor (FHR 2  -  -  -  -  -  -  - 
440 P05156 Complement factor I precursor (EC 3.4.21.45) (C3B/C4 9  -  -  -  -  -  - X
441 P78357 Contactin-associated protein 1 precursor (Caspr) (Cas  -  -  - 1  -  -  -  - 
442 P61201 COP9 signalosome complex subunit 2 (Signalosome s -  -  -  - 2  -  -  - 
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443 Q9BT78 COP9 signalosome complex subunit 4 (Signalosome s - 1  -  - 2  -  - X
444 Q7L5N1 COP9 signalosome complex subunit 6 (Signalosome s -  - 1  - 1  -  - X
445 Q99627 COP9 signalosome complex subunit 8 (Signalosome s -  - 1  - 2 2  - X
446 Q99829 Copine-1 (Copine I)  -  - 1 2 4 4 5 X
447 Q96FN4 Copine-2 (Copine II) - Homo sapiens (Human)  -  -  - 2  -  -  -  - 
448 O75131 Copine-3 (Copine III)  -  -  - 5 3 3 2  - 
449 Q96A23 Copine-4 (Copine IV) (Copine-8) - Homo sapiens (Hum -  -  - 1  -  -  -  - 
450 Q9NTM9 Copper homeostasis protein cutC homolog - Homo sap -  -  -  - 1  -  -  - 
451 O75367 Core histone macro-H2A.1 (Histone macroH2A1) (mH2 -  -  - 1  -  - 1  - 
452 Q13951 Core-binding factor subunit beta (CBF-beta) (Polyomav -  -  -  - 2 1  - X
453 P31146 Coronin-1A (Coronin-like protein p57) (Coronin-like pro -  - 3 9 14 3 12 X
454 Q9ULV4 Coronin-1C (Coronin-3) (hCRNN4)  -  - 8  -  -  -  - X
455 P57737 Coronin-7 (70 kDa WD repeat tumor rejection antigen  -  -  - 2 2 2 3 X
456 P08185 Corticosteroid-binding globulin precursor (CBG) (Trans 4  -  -  -  -  -  -  - 
457 P02741 C-reactive protein precursor [Contains: C-reactive prot 1  -  -  -  -  -  -  - 
458 P46109 Crk-like protein  -  - 4  -  -  - 1 X
459 Q13363 C-terminal-binding protein 1 (EC 1.1.1.-) (CtBP1) - Hom -  -  -  - 2  -  -  - 
460 Q9Y240 C-type lectin domain family 11 member A precursor (S  -  - 1  -  -  -  -  - 
461 Q13620 Cullin-4B - Homo sapiens (Human)  -  -  -  - 1  - 1  - 
462 Q86VP6 Cullin-associated NEDD8-dissociated protein 1 (Cullin- - 7  -  - 7 3 16  - 
463 P55273 Cyclin-dependent kinase 4 inhibitor D (p19-INK4d) - Ho -  - 1  -  -  -  -  - 
464 P01040 Cystatin A (Stefin A) (Cystatin AS)  -  -  - 2 1 3 1  - 
465 P04080 Cystatin B (Liver thiol proteinase inhibitor) (CPI-B) (Ste -  -  - 2 3 5 4 X
466 P01034 Cystatin C precursor (Neuroendocrine basic polypeptid 4  -  -  -  -  -  -  - 
467 Q15828 Cystatin M precursor (Cystatin E) - Homo sapiens (Hum 1  -  -  -  -  -  -  - 
468 P21291 Cysteine and glycine-rich protein 1 (Cysteine-rich prote -  - 8  - 2  - 1 X
469 P49589 Cysteinyl-tRNA synthetase, cytoplasmic (EC 6.1.1.16)  -  -  -  -  -  - 2  - 
470 P32320 Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydro -  -  - 2  - 2 1  - 
471 P04839 Cytochrome b-245 heavy chain (p22 phagocyte B-cyto -  -  - 5 1 12 7  - 
472 P13498 Cytochrome b-245 light chain (p22 phagocyte B-cytoch -  -  - 1  - 1  -  - 
473 O43169 Cytochrome b5 outer mitochondrial membrane isoform -  - 1  - 3 2 2  - 
474 P99999 Cytochrome c  -  - 1  - 1 2 7  - 
475 P20674 Cytochrome c oxidase polypeptide Va, mitochondrial p -  -  -  - 2 3 3 X
476 P10606 Cytochrome c oxidase polypeptide Vb, mitochondrial p -  -  -  - 1 3 2  - 
477 P12074 Cytochrome c oxidase polypeptide VIa-liver, mitochond -  -  -  -  - 2  -  - 
478 P14406 Cytochrome c oxidase polypeptide VIIa-liver/heart, mit  -  -  -  -  - 2  -  - 
479 P00403 Cytochrome c oxidase subunit 2 (EC 1.9.3.1) (Cytochro -  -  -  - 4 3 5  - 
480 P13073 Cytochrome c oxidase subunit IV isoform 1, mitochond -  -  -  - 3 3 2  - 
481 P14854 Cytochrome c oxidase subunit VIb isoform 1 (EC 1.9.3  -  -  -  - 1 3  -  - 
482 P08574 Cytochrome c1, heme protein, mitochondrial precursor  -  -  -  -  - 1 4  - 
483 Q9HBI6 Cytochrome P450 4F11 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
484 P78329 Cytochrome P450 4F2 (EC 1.14.13.30) (CYPIVF2) (Le -  -  - 1  -  -  -  - 
485 Q08477 Cytochrome P450 4F3 - Homo sapiens (Human)  -  -  - 5  -  -  -  - 
486 P98187 Cytochrome P450 4F8 OS=Homo sapiens GN=CYP4F -  -  - 2  -  -  -  - 
487 Q8IUI8 Cytokine receptor-like factor 3 - Homo sapiens (Human -  - 5  - 4 1  -  - 
488 P50453 Cytoplasmic antiproteinase 3 (CAP3) (CAP-3) (Proteas -  - 1  - 7 4 11 X
489 O14576 Cytoplasmic dynein 1 intermediate chain 1 - Homo sap - 1  -  -  -  -  -  - 
490 Q13409 Cytoplasmic dynein 1 intermediate chain 2 (Dynein inte - 1  -  -  -  - 2 X
491 Q8NCM8 Cytoplasmic dynein 2 heavy chain 1 - Homo sapiens (H -  -  -  - 1  -  -  - 
492 Q7L576 Cytoplasmic FMR1-interacting protein 1 - Homo sapien -  -  -  -  - 3 1  - 
493 Q96F07 Cytoplasmic FMR1-interacting protein 2 - Homo sapien -  -  -  -  -  - 1  - 
494 P28838 Cytosol aminopeptidase (EC 3.4.11.1) (Leucine amino  -  - 1  - 1 1 3 X
495 Q96KP4 Cytosolic nonspecific dipeptidase (Glutamate carbo  -  -  -  - 5 4 8 X
496 P47712 Cytosolic phospholipase A2 (cPLA2) (Phospholipase A -  -  -  - 1  -  -  - 
497 P49902 Cytosolic purine 5*-nucleotidase - Homo sapiens (Hum -  -  - 1  -  -  -  - 
498 Q8N465 D-2-hydroxyglutarate dehydrogenase, mitochondrial pr -  - 1  - 1  -  -  - 
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499 O43175 D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95) (3 -  -  -  -  - 1  - X
500 Q96EP5 DAZ-associated protein 1 (Deleted in azoospermia-ass -  -  -  - 2  - 1  - 
501 Q5TDH0 DDI1 homolog 2 - Homo sapiens (Human)  - 1  -  -  -  -  -  - 
502 P30046 D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopac  -  -  - 3 2 3 3 X
503 Q92608 Dedicator of cytokinesis protein 2  -  -  -  -  - 1 2  - 
504 Q9BTZ2 Dehydrogenase/reductase SDR family member 4 (EC  -  -  -  -  -  - 2  - 
505 Q9Y394 Dehydrogenase/reductase SDR family member 7 prec  -  -  -  -  - 1  -  - 
506 Q8NBQ5 Dehydrogenase/reductase SDR family member 8 prec  -  -  - 1  - 1  -  - 
507 P54886 Delta 1-pyrroline-5-carboxylate synthetase (P5CS) (Ald -  -  -  -  -  - 1  - 
508 Q13011 Delta3,5-delta2,4-dienoyl-CoA isomerase, mitochondri 1  - 6 1 10 8 8 X
509 P13716 Delta-aminolevulinic acid dehydratase (EC 4.2.1.24) (P - 4 10  - 9  -  - X
510 P27707 Deoxycytidine kinase (EC 2.7.1.74) (dCK) - Homo sap  -  -  -  -  - 1 1  - 
511 P32321 Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deam -  - 2  -  - 1 1 X
512 P33316 Deoxyuridine 5*-triphosphate nucleotidohydrolase, mit  -  -  -  - 3 1 1 X
513 Q07507 Dermatopontin precursor - Homo sapiens (Human) 3  -  -  -  -  -  -  - 
514 P60981 Destrin (Actin-depolymerizing factor) (ADF)  -  - 5  - 2  - 7 X
515 Q9Y295 Developmentally-regulated GTP-binding protein 1 (DR  -  -  -  -  - 1 1  - 
516 Q9NR28 Diablo homolog, mitochondrial precursor (Second mito -  - 2  - 2 2 3  - 
517 P23743 Diacylglycerol kinase alpha (EC 2.7.1.107) (Diglyceride -  -  -  - 3  - 4  - 
518 P49619 Diacylglycerol kinase gamma - Homo sapiens (Human  -  - 1  -  -  -  -  - 
519 Q9H4E7 Differentially expressed in FDCP 6 - Homo sapiens (Hu -  -  -  - 1  - 1  - 
520 P09622 Dihydrolipoyl dehydrogenase, mitochondrial precursor  -  -  - 1 1 1 2 X
521 P36957 Dihydrolipoyllysine-residue succinyltransferase compo  -  -  -  - 3  -  - X
522 P09417 Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Q  -  -  -  - 1  - 1 X
523 Q16555 Dihydropyrimidinase-related protein 2 (DRP-2) (Collap  -  - 2  - 2 2 3 X
524 Q3LXA3 Dihydroxyacetone kinase (EC 2.7.1.29) (Glycerone kin -  -  -  - 1  -  - X
525 Q01459 Di-N-acetylchitobiase precursor - Homo sapiens (Hum  -  -  - 1  -  -  -  - 
526 P53634 Dipeptidyl-peptidase 1 precursor (EC 3.4.14.1) (Dipept  -  - 1 4 1 2 4  - 
527 Q9UHL4 Dipeptidyl-peptidase 2 precursor (EC 3.4.14.2) (Dipept  -  - 1 2  - 1 2  - 
528 Q9NY33 Dipeptidyl-peptidase 3 (EC 3.4.14.4) (Dipeptidyl-peptid -  -  -  -  - 1 2  - 
529 O95989 Diphosphoinositol polyphosphate phosphohydrolase 1  -  -  - 2  -  -  -  - 
530 Q8NFP7 Diphosphoinositol polyphosphate phosphohydrolase 3  -  -  -  -  -  - 1  - 
531 Q14689 Disco-interacting protein 2 homolog A - Homo sapiens  -  -  -  -  - 1  -  - 
532 P26358 DNA (cytosine-5)-methyltransferase 1 (EC 2.1.1.37) (D -  - 1  -  -  -  -  - 
533 Q16531 DNA damage-binding protein 1 (Damage-specific DNA -  -  -  - 1 2 3  - 
534 Q9UBZ9 DNA repair protein REV1 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
535 Q13472 DNA topoisomerase 3-alpha (EC 5.99.1.2) (DNA topois -  -  -  - 1  -  -  - 
536 P27695 DNA-(apurinic or apyrimidinic site) lyase (EC 4.2.99.18 -  -  - 3 7 1 9  - 
537 Q9UBS4 DnaJ homolog subfamily B member 11 precursor (ER-  -  - 1  -  - 1  - X
538 P59910 DnaJ homolog subfamily B member 13 - Homo sapien  -  -  -  -  - 1  -  - 
539 Q9NVM6 DnaJ homolog subfamily C member 17 - Homo sapien  -  -  -  -  - 1  -  - 
540 Q9H3Z4 DnaJ homolog subfamily C member 5 (Cysteine string  -  -  - 2  - 1 1  - 
541 O75937 DnaJ homolog subfamily C member 8 (Splicing protein -  -  -  - 3  - 6  - 
542 O60496 Docking protein 2 (Downstream of tyrosine kinase 2) (p -  - 3  -  -  - 1 X
543 Q7L591 Docking protein 3 (Downstream of tyrosine kinase 3) -  -  - 2 1  -  -  -  - 
544 O60762 Dolichol-phosphate mannosyltransferase (EC 2.4.1.83  -  -  -  -  -  - 2  - 
545 P39656 Dolichyl-diphosphooligosaccharide--protein glycosyltra -  -  - 1  - 4 3  - 
546 P04844 Dolichyl-diphosphooligosaccharide--protein glycosyltra -  - 1 1 1 10  - X
547 P04843 Dolichyl-diphosphooligosaccharide--protein glycosyltra -  -  - 1 5 17 10 X
548 Q9C005 Dpy-30-like protein - Homo sapiens (Human)  -  -  -  -  - 1 1  - 
549 Q16643 Drebrin (Developmentally-regulated brain protein) - Ho -  - 2  -  -  -  -  - 
550 Q9UJU6 Drebrin-like protein (SH3 domain-containing protein 7)  -  - 4 2  -  - 2 X
551 Q02750 Dual specificity mitogen-activated protein kinase kinas  -  -  -  -  -  - 2  - 
552 P46734 Dual specificity mitogen-activated protein kinase kinas  -  -  - 1 2  -  -  - 
553 P51452 Dual specificity protein phosphatase 3 (EC 3.1.3.48) (E -  - 7  -  - 3 2 X
554 Q13561 Dynactin subunit 2 (Dynactin complex 50 kDa subunit)  -  - 3  -  -  - 1 X
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555 Q14203 Dynactin-1 (150 kDa dynein-associated polypeptide) (D -  - 1  -  -  - 2  - 
556 O00429 Dynamin-1-like protein (EC 3.6.5.5) (Dynamin-like prot  -  - 10  -  - 1 4  - 
557 P50570 Dynamin-2 (EC 3,6,5,5)  -  -  -  -  - 2  -  - 
558 Q14204 Dynein heavy chain, cytosolic (DYHC) (Cytoplasmic dy -  -  -  -  - 6  -  - 
559 Q96FJ2 Dynein light chain 2, cytoplasmic (Dynein light chain LC -  -  -  -  - 2  -  - 
560 Q9NP97 Dynein light chain 2A, cytoplasmic (Dynein-associated  -  -  -  - 1 2  -  - 
561 Q96C19 EF-hand domain-containing protein 2 (Swiprosin-1)  -  - 1 4 8 12 12 X
562 Q8N3D4 EH domain-binding protein 1-like protein 1 - Homo sap -  -  -  -  - 1  -  - 
563 Q9H4M9 EH-domain-containing protein 1 (Testilin) (hPAST1)  -  - 10 9 5  - 11 X
564 Q9NZN3 EH-domain-containing protein 3  -  - 14  -  -  -  -  - 
565 Q15717 ELAV-like protein 1 (Hu-antigen R) (HuR) - Homo sapi  -  -  -  -  - 1  -  - 
566 P13804 Electron transfer flavoprotein alpha-subunit, mitochond -  - 7  - 8 4 13 X
567 P38117 Electron transfer flavoprotein beta-subunit (Beta-ETF)  -  - 1  - 8 5 5  - 
568 P68104 Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation  - 2 2 7 18 13 18 X
569 P24534 Elongation factor 1-beta (EF-1-beta)  -  - 2  - 2 3 3  - 
570 P29692 Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO- -  - 2  - 7 3 4 X
571 P26641 Elongation factor 1-gamma (EF-1-gamma) (eEF-1B ga -  - 1 2 2 2 5 X
572 P13639 Elongation factor 2 (EF-2)  - 10  - 3 21 15 28 X
573 P49411 Elongation factor Tu, mitochondrial precursor (EF-Tu)  -  - 1  - 16 5 7 X
574 Q9Y6C2 EMILIN-1 precursor (Elastin microfibril interface-locate  -  - 3  -  -  -  -  - 
575 Q9UI08 Ena/VASP-like protein (Ena/vasodilator-stimulated pho -  -  -  - 1  - 2  - 
576 O94919 Endonuclease domain-containing 1 protein precursor (  -  - 1  -  -  -  -  - 
577 Q6P179 Endoplasmic reticulum aminopeptidase 2 - Homo sapie -  -  -  -  -  - 1  - 
578 P30040 Endoplasmic reticulum protein ERp29 precursor (ERp3 -  - 6 2 6 8 8 X
579 P14625 Endoplasmin precursor (94 kDa glucose-regulated pro  - 3 14  - 14 19 23 X
580 Q96AP7 Endothelial cell-selective adhesion molecule precursor  -  - 2  -  -  -  -  - 
581 O60869 Endothelial differentiation-related factor 1 (EDF-1) (Mu  -  -  -  -  - 1 2  - 
582 Q9UHY7 Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-m -  - 1  - 1 1  -  - 
583 Q9NTX5 Enoyl-CoA hydratase domain-containing protein 1 - Ho -  -  -  -  -  - 2  - 
584 P30084 Enoyl-CoA hydratase, mitochondrial precursor (EC 4.2 -  - 1  - 8 4 8 X
585 P12724 Eosinophil cationic protein precursor (EC 3.1.27.-) (EC -  -  - 2  - 1  -  - 
586 Q05315 Eosinophil lysophospholipase (EC 3.1.1.5) (Charcot-Le -  -  - 6 2 4 1  - 
587 P11678 Eosinophil peroxidase precursor (EC 1.11.1.7) (EPO) [  -  -  - 6  -  -  -  - 
588 P61916 Epididymal secretory protein E1 precursor (Niemann-P -  -  -  - 1 3 1 X
589 P12830 Epithelial-cadherin precursor (E-cadherin) (Uvomorulin 3  -  -  -  -  -  -  - 
590 P07099 Epoxide hydrolase 1 (EC 3.3.2.9) (Microsomal epoxide -  -  -  -  - 1  -  - 
591 Q96HE7 ERO1-like protein alpha precursor (EC 1.8.4.-) (ERO1- -  -  -  - 2 4 1  - 
592 P27105 Erythrocyte band 7 integral membrane protein (Stomat - 5 13 2 6 1 8  - 
593 P16452 Erythrocyte membrane protein band 4.2 (Erythrocyte p - 14  -  - 1  -  -  - 
594 P30042 ES1 protein homolog, mitochondrial precursor (Protein -  - 2  - 4  - 4 X
595 P10768 Esterase D (EC 3.1.1.1)  - 1 4 2 4 3 6 X
596 Q92506 Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-b -  -  -  - 1  -  - X
597 O95571 ETHE1 protein, mitochondrial precursor (EC 3.-.-.-) (Et  -  - 3 3 7 5 5 X
598 P60842 Eukaryotic initiation factor 4A-I (EC 3.6.1.-) (ATP-depe  - 1 3  - 8 4 7 X
599 Q14240 Eukaryotic initiation factor 4A-II (EC 3.6.1.-) (ATP-depe -  -  -  - 5  - 5 X
600 O43324 Eukaryotic translation elongation factor 1 epsilon-1 (Mu -  -  -  -  - 1 1  - 
601 P41567 Eukaryotic translation initiation factor 1 (eIF1) (Protein  -  -  -  -  - 1 3 X
602 P47813 Eukaryotic translation initiation factor 1A, X-chromosom -  -  -  - 3  -  - X
603 P05198 Eukaryotic translation initiation factor 2 subunit 1 (Euka -  - 1  - 2  - 2 X
604 O75822 Eukaryotic translation initiation factor 3 subunit 1 (eIF-3 -  -  -  - 1  -  -  - 
605 Q14152 Eukaryotic translation initiation factor 3 subunit 10 (eIF  -  -  -  - 3  - 14  - 
606 Q9UBQ5 Eukaryotic translation initiation factor 3 subunit 12 (eIF  -  - 1  - 1  - 3  - 
607 O15372 Eukaryotic translation initiation factor 3 subunit 3 (eIF-3 -  -  -  -  -  - 1 X
608 O00303 Eukaryotic translation initiation factor 3 subunit 5 (eIF-3 -  -  -  - 3 1 1 X
609 Q9Y262 Eukaryotic translation initiation factor 3 subunit 6-intera -  -  -  -  - 4 1  - 
610 P55884 Eukaryotic translation initiation factor 3 subunit 9 (eIF-3 -  -  -  - 1  - 4  - 
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611 Q04637 Eukaryotic translation initiation factor 4 gamma 1 (eIF-4 -  -  -  - 2  -  -  - 
612 O43432 Eukaryotic translation initiation factor 4 gamma 3 (eIF-4 -  -  -  -  -  - 1  - 
613 P23588 Eukaryotic translation initiation factor 4B (eIF-4B)  -  -  -  - 1  -  - X
614 P06730 Eukaryotic translation initiation factor 4E (eIF4E) (eIF-4 -  - 2  - 1 1 2 X
615 Q8N5X7 Eukaryotic translation initiation factor 4E type 3 - Homo -  -  - 1  -  -  -  - 
616 Q15056 Eukaryotic translation initiation factor 4H (eIF-4H) (Will  -  - 1  - 3 1 2 X
617 P55010 Eukaryotic translation initiation factor 5 (eIF-5)  -  - 1  -  -  -  - X
618 P63241 Eukaryotic translation initiation factor 5A (eIF-5A) (eIF-  - 3 6  - 7 6 6 X
619 P56537 Eukaryotic translation initiation factor 6 (eIF-6) (B4 inte -  -  - 1 1 1 3  - 
620 P34910 EVI2B protein precursor (Ecotropic viral integration site -  -  -  -  - 3 1  - 
621 Q16394 Exostosin-1 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
622 O14980 Exportin-1 (Chromosome region maintenance 1 protein -  -  -  -  - 3 3  - 
623 Q9UIA9 Exportin-7 (Exp7) (Ran-binding protein 16) - Homo sap -  -  -  - 1 1  -  - 
624 P15311 Ezrin (p81) (Cytovillin) (Villin-2)  -  - 3 7 12 9 14 X
625 O14745 Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP5 -  - 4 2 6 1 3  - 
626 P52907 F-actin capping protein alpha-1 subunit (CapZ alpha-1  - 2 7 7 8 6 9 X
627 P47755 F-actin capping protein alpha-2 subunit (CapZ alpha-2  - 2 8 1 5 7 5 X
628 P47756 F-actin capping protein beta subunit (CapZ beta).  -  - 12 8 10 9 14 X
629 Q13158 FADD protein (FAS-associating death domain-containi  -  -  -  -  -  - 1  - 
630 Q96AE4 Far upstream element-binding protein 1 (FUSE-binding -  -  -  - 4 2 9 X
631 Q92945 Far upstream element-binding protein 2 (FUSE-binding - 1  -  - 5 7 11 X
632 Q96I24 Far upstream element-binding protein 3 (FUSE-binding -  -  -  - 2  -  -  - 
633 P14324 Farnesyl pyrophosphate synthetase (FPP synthetase)  -  - 1 1  -  - 1  - 
634 P49327 Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carri  -  - 4  - 1 1 7  - 
635 Q01469 Fatty acid-binding protein, epidermal (E-FABP) (Psoria -  -  - 1 1 4 4 X
636 P02794 Ferritin heavy chain (EC 1.16.3.1) (Ferritin H subunit) (  -  -  -  - 3 2 6 X
637 P02792 Ferritin light chain (Ferritin L subunit)  -  -  - 7 4 6 7 X
638 P02671 Fibrinogen alpha chain precursor [Contains: Fibrinopep 9  - 15  -  -  - 15 X
639 P02675 Fibrinogen beta chain precursor [Contains: Fibrinopept 16 1 27  - 1  - 23 X
640 P02679 Fibrinogen gamma chain precursor 11  - 12  -  -  - 15 X
641 P02751 Fibronectin precursor (FN) (Cold-insoluble globulin) (C 33 2 6  -  -  - 4  - 
642 P23142 Fibulin-1 precursor 2  -  -  -  -  -  -  - 
643 O00602 Ficolin-1 precursor (Collagen/fibrinogen domain-contai  -  -  -  -  - 3  - X
644 Q15485 Ficolin-2 precursor (Ficolin-B) (Ficolin-beta) (L-ficolin) ( 3  -  -  -  -  -  -  - 
645 O75636 Ficolin-3 precursor (Collagen/fibrinogen domain-contai 7  -  -  -  -  -  -  - 
646 P20930 Filaggrin - Homo sapiens (Human)  -  -  -  -  -  - 2  - 
647 P21333 Filamin-A (Alpha-filamin) (Filamin-1) (Endothelial actin- 1 17 94 12 56 65 103 X
648 O75369 Filamin-B (FLN-B) (Beta-filamin) (Actin-binding-like pro - 23  -  - 1 3 9  - 
649 Q14315 Filamin-C (Gamma-filamin) (Filamin-2) (Protein FLNc)  - 8  -  -  -  - 4  - 
650 P62942 FK506-binding protein 1A (EC 5.2.1.8) (Peptidyl-prolyl  -  - 1  -  - 2 2  - 
651 P26885 FK506-binding protein 2 precursor (EC 5.2.1.8) (Peptid -  - 1  -  - 2 2 X
652 Q00688 FK506-binding protein 3 (EC 5.2.1.8) (Peptidyl-prolyl c  -  -  -  - 1  - 2  - 
653 Q02790 FK506-binding protein 4 (EC 5.2.1.8) (Peptidyl-prolyl c  -  -  -  - 1  - 1 X
654 Q13451 FK506-binding protein 5 (EC 5.2.1.8) (Peptidyl-prolyl c  -  -  -  - 4  - 2 X
655 P30043 Flavin reductase (EC 1.5.1.30) (FR) (NADPH-depende - 11 2  - 8 6 7 X
656 O75955 Flotillin-1 - Homo sapiens (Human)  - 3 1  -  -  -  -  - 
657 Q14254 Flotillin-2 - Homo sapiens (Human)  - 1 1  -  -  -  -  - 
658 P41439 Folate receptor gamma precursor (FR-gamma) (Folate -  -  - 3  -  -  -  - 
659 Q96RU3 Formin-binding protein 1 (Formin-binding protein 17) (h -  -  -  - 4  -  -  - 
660 O95466 Formin-like 1 protein (Formin-like protein) (Leukocyte f  -  -  -  - 2 4 9  - 
661 Q13642 Four and a half LIM domains protein 1 (FHL-1) (Skelet  -  - 2  - 1  - 2  - 
662 P09467 Fructose-1,6-bisphosphatase 1 (EC 3.1.3.11) (D-fructo -  -  - 1 2 2 5 X
663 P04075 Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Musc - 7 14 10 19 14 16 X
664 P09972 Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain -  - 3 3 6 2 5  - 
665 P07954 Fumarate hydratase, mitochondrial precursor (EC 4.2.  -  - 1 1 2 1 2 X
666 P16930 Fumarylacetoacetase (EC 3.7.1.2) (Fumarylacetoaceta -  - 2 2  - 2  - X
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667 Q6P587 Fumarylacetoacetate hydrolase domain-containing pro -  -  -  - 1 1 2 X
668 O15117 FYN-binding protein (FYN-T-binding protein) (FYB-120 -  - 3  -  -  -  -  - 
669 O95866 G6b protein precursor - Homo sapiens (Human)  -  - 3  -  -  -  -  - 
670 P09382 Galectin-1 (Beta-galactoside-binding lectin L-14-I) (Lac -  -  -  - 3 6 5 X
671 P17931 Galectin-3 (Galactose-specific lectin 3) (Mac-2 antigen  -  -  - 4  - 4 2  - 
672 Q08380 Galectin-3-binding protein precursor (Lectin galactosid  -  - 2  -  -  -  -  - 
673 Q3ZCW2 Galectin-related protein - Homo sapiens (Human)  -  - 6  -  -  -  -  - 
674 O95166 Gamma-aminobutyric acid receptor-associated protein  -  -  - 1  - 2  -  - 
675 P09104 Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate -  -  -  - 6  -  - X
676 Q92820 Gamma-glutamyl hydrolase precursor (EC 3.4.19.9) (G 2  -  - 1  - 1 1  - 
677 P13284 Gamma-interferon-inducible lysosomal thiol reductase  -  -  -  -  - 1 1  - 
678 Q9HBI0 Gamma-parvin - Homo sapiens (Human)  -  -  - 2  - 1 1  - 
679 P17900 Ganglioside GM2 activator precursor (GM2-AP) (Cereb -  -  -  -  - 1  -  - 
680 Q9NS71 Gastrokine-1 precursor - Homo sapiens (Human) 1  -  -  -  -  -  -  - 
681 O95479 GDH/6PGL endoplasmic bifunctional protein precursor  -  -  - 1  -  - 1  - 
682 Q13630 GDP-L-fucose synthetase (EC 1.1.1.271) (Protein FX)  - 2  -  -  -  -  - X
683 P06396 Gelsolin precursor (Actin-depolymerizing factor) (ADF) 9 4 18 14 5 6 16 X
684 Q9P107 GEM-interacting protein (GMIP)  -  -  -  -  - 1 1  - 
685 O60763 General vesicular transport factor p115 (Transcytosis-a -  -  -  -  - 3 1  - 
686 P60983 Glia maturation factor beta (GMF-beta)  -  - 2  - 3 2 2 X
687 O60234 Glia maturation factor gamma (GMF-gamma)  -  - 2 1 6 3 5 X
688 P46926 Glucosamine-6-phosphate isomerase (EC 3.5.99.6) (G -  -  -  - 2 1 2 X
689 P11413 Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49)  -  - 4 11 3 9 5 X
690 P06744 Glucose-6-phosphate isomerase (EC 5.3.1.9) (GPI) (P  - 1 4 12 8 12 9 X
691 P14314 Glucosidase II beta subunit precursor (Protein kinase C -  -  - 1 1  - 6  - 
692 P00367 Glutamate dehydrogenase 1, mitochondrial precursor ( -  -  -  - 8 2 10 X
693 P48506 Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.  - 3  -  -  -  -  -  - 
694 P48507 Glutamate--cysteine ligase regulatory subunit (EC 6.3.  -  - 3  - 1  -  - X
695 O94925 Glutaminase kidney isoform, mitochondrial precursor (  -  -  -  - 1  - 1 X
696 P35754 Glutaredoxin-1 (Thioltransferase-1) (TTase-1)  -  -  - 2  - 3  -  - 
697 P07203 Glutathione peroxidase 1 (EC 1.11.1.9) (GSHPx-1) (GP - 1 11  - 6 11 10 X
698 P22352 Glutathione peroxidase 3 precursor (EC 1,11,1,9) (GSH 4  -  -  -  -  -  - X
699 P00390 Glutathione reductase, mitochondrial precursor (EC 1.8 - 1 2 3 9 2 5  - 
700 Q9Y2Q3 Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST -  - 5  - 8 4 11  - 
701 P09488 Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GSTM1 -  -  -  - 5 4 7  - 
702 P28161 Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GSTM2 -  - 1  - 5  - 4  - 
703 P21266 Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GSTM3 -  -  -  - 3  - 1 X
704 Q03013 Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GSTM4 -  - 2  - 5 4 7  - 
705 P09211 Glutathione S-transferase P (EC 2.5.1.18) (GST class-  -  - 8 8 6 9 8 X
706 P48637 Glutathione synthetase (EC 6.3.2.3) (Glutathione s  -  -  -  -  - 2 1 X
707 P78417 Glutathione transferase omega-1 (EC 2.5.1.18) (GSTO -  - 9 5 5 4 6 X
708 P04406 Glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.  - 7 22 25 25 14 21 X
709 Q8N335 Glycerol-3-phosphate dehydrogenase 1-like protein - H -  -  - 1  -  -  -  - 
710 P43304 Glycerol-3-phosphate dehydrogenase, mitochondrial p  -  - 2  - 1 2 3 X
711 P35573 Glycogen debranching enzyme (Glycogen debrancher  -  -  - 1  -  - 2  - 
712 P11216 Glycogen phosphorylase, brain form (EC 2.4.1.1)  -  - 2  - 5  - 9 X
713 P06737 Glycogen phosphorylase, liver form (EC 2.4.1.1) - Hom -  -  - 28  - 4 4  - 
714 P46976 Glycogenin-1 (EC 2.4.1.186) - Homo sapiens (Human) -  -  - 1  -  -  -  - 
715 P04921 Glycophorin C (PAS-2*) (Glycoprotein beta) (GLPC) (G - 1  -  -  -  -  -  - 
716 P30419 Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.  -  -  -  -  -  - 1  - 
717 P41250 Glycyl-tRNA synthetase (EC 6.1.1.14) (Glycine--tRNA  -  -  -  - 1  - 1 X
718 Q9HC38 Glyoxalase domain-containing protein 4 - Homo sapien -  - 1 2 4  - 10  - 
719 Q9UBQ7 Glyoxylate reductase/hydroxypyruvate reductase (EC  -  -  -  -  -  - 2 X
720 P36959 GMP reductase 1 (EC 1.7.1.7) (Guanosine 5*-monoph  -  - 1  - 1  -  -  - 
721 Q9H4A6 Golgi phosphoprotein 3 (Coat-protein GPP34)  - 1  -  -  -  - 1 X
722 Q9H3P7 Golgi resident protein GCP60 (Acyl-CoA-binding doma -  -  - 1  - 2  -  - 
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723 Q9H4G4 Golgi-associated plant pathogenesis-related protein 1 1  - 1 2 2 2 3  - 
724 P28676 Grancalcin  -  - 1 4 3 5 3 X
725 P10144 Granzyme B precursor - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
726 O75791 GRB2-related adapter protein 2 (GADS protein) (Grow  -  - 1  - 1  -  -  - 
727 Q12849 G-rich sequence factor 1 (GRSF-1)  -  -  -  - 1 1 1 X
728 Q4V328 GRIP1-associated protein 1 (GRASP-1) - Homo sapien -  -  -  -  -  - 1  - 
729 P62993 Growth factor receptor-bound protein 2 (Adapter protei  -  - 2 3 2 4 10 X
730 Q9UIJ7 GTP:AMP phosphotransferase mitochondrial (EC 2.7.4 -  - 2  - 2 1 1  - 
731 P01112 GTPase HRas precursor (Transforming protein p21) (p -  - 2  -  - 2  -  - 
732 P01111 GTPase NRas precursor (Transforming protein N-Ras) -  - 2  - 1  -  -  - 
733 Q8WWP7 GTPase, IMAP family member 1 (Immunity-associated -  -  -  - 3 1 4  - 
734 Q9NUV9 GTPase, IMAP family member 4 (Immunity-associated -  -  -  - 7 1 5  - 
735 P62826 GTP-binding nuclear protein Ran (GTPase Ran) (Ras-  - 4 4 4 10 10 12 X
736 P36406 GTP-binding protein ARD-1 (ADP-ribosylation factor do -  -  -  - 1  -  -  - 
737 Q15382 GTP-binding protein Rheb (Ras homolog enriched in b -  - 2  -  -  -  -  - 
738 Q9NR31 GTP-binding protein SAR1a (COPII-associated small G -  - 8 3 2 2 4 X
739 Q9Y6B6 GTP-binding protein SAR1b (GTBPB)  -  -  -  -  -  - 2 X
740 Q03113 Guanine nucleotide-binding protein alpha-12 subunit (G -  -  - 1  -  -  - X
741 Q14344 Guanine nucleotide-binding protein alpha-13 subunit (G -  -  -  -  -  - 2  - 
742 P63244 Guanine nucleotide-binding protein beta subunit 2-like  - 1  -  - 11 3 13 X
743 P63096 Guanine nucleotide-binding protein G(i), alpha-1 subun -  -  -  - 2  -  -  - 
744 P04899 Guanine nucleotide-binding protein G(i), alpha-2 subun -  - 8 8 7 8 9 X
745 P59768 Guanine nucleotide-binding protein G(I)/G(S)/G(O) sub -  -  - 1  -  -  -  - 
746 P62873 Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta -  - 6  - 5 2  - X
747 P62879 Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta -  - 6 3 5  - 7 X
748 P09471 Guanine nucleotide-binding protein G(o) subunit alpha  -  -  - 2  -  -  -  - 
749 P50148 Guanine nucleotide-binding protein G(q) subunit alpha  -  - 4 2  -  - 1  - 
750 P19086 Guanine nucleotide-binding protein G(z) subunit alpha  -  - 3  -  -  -  -  - 
751 Q16774 Guanylate kinase (EC 2.7.4.8) (GMP kinase)  -  -  -  - 2  - 2 X
752 Q9H0R5 Guanylate-binding protein 3 (GTP-binding protein 3) (G -  -  -  - 2  -  -  - 
753 Q96PP8 Guanylate-binding protein 5 (GTP-binding protein 5) (G -  -  -  -  -  - 1  - 
754 Q9H0R4 Haloacid dehalogenase-like hydrolase domain-contain  -  - 4  - 1  -  -  - 
755 Q9BSH5 Haloacid dehalogenase-like hydrolase domain-contain  -  -  -  -  -  - 1  - 
756 P00738 Haptoglobin precursor [Contains: Haptoglobin alpha ch 25  -  - 3  - 8 10 X
757 P00739 Haptoglobin-related protein precursor - Homo sapiens 18 1  -  -  - 5  -  - 
758 Q7Z4H3 HD domain-containing protein 2 - Homo sapiens (Hum  -  -  -  - 1  - 1  - 
759 Q8N4P3 HD domain-containing protein 3 - Homo sapiens (Hum  -  -  -  - 1  -  -  - 
760 Q86WZ0 HEAT repeat-containing protein 4 - Homo sapiens (Hu  -  -  -  - 1  - 2  - 
761 P08107 Heat shock 70 kDa protein 1 (HSP70.1) (HSP70-1/HSP - 1 8 16 12 13 16 X
762 P34931 Heat shock 70 kDa protein 1L (Heat shock 70 kDa prot -  -  - 9  -  - 6 X
763 P34932 Heat shock 70 kDa protein 4 (Heat shock 70-related pr - 4 2  - 4 4 6 X
764 P17066 Heat shock 70 kDa protein 6 (Heat shock 70 kDa prote -  -  - 5  - 2 4 X
765 P11142 Heat shock cognate 71 kDa protein (Heat shock 70 kD - 7 16 8 24 15 25 X
766 Q12931 Heat shock protein 75 kDa, mitochondrial precursor (H -  - 1  - 1 2 1 X
767 P07900 Heat shock protein HSP 90-alpha (HSP 86)  - 5 17 5 24 23 30 X
768 P08238 Heat shock protein HSP 90-beta (HSP 84) (HSP 90)  - 3 9 5 18 21 29 X
769 P54652 Heat shock-related 70 kDa protein 2 (Heat shock 70 kD -  -  -  -  -  - 6 X
770 Q92598 Heat-shock protein 105 kDa (Heat shock 110 kDa prot  - 1  -  -  -  -  - X
771 P04792 Heat-shock protein beta-1 (HspB1) (Heat shock 27 kD  -  - 6  - 1  - 4 X
772 Q9NQ75 HEF-like protein - Homo sapiens (Human)  -  - 4  -  -  -  -  - 
773 P14317 Hematopoietic lineage cell-specific protein (Hematopoi  - 1  -  - 8 2 3 X
774 Q9NRV9 Heme-binding protein 1 (p22HBP)  - 1  - 1 2 2 1 X
775 Q9Y5Z4 Heme-binding protein 2 (Protein SOUL) (Placental prot -  - 1 3 1 3  -  - 
776 P69905 Hemoglobin subunit alpha (Hemoglobin alpha chain) (A 4 19  - 6  - 11 9  - 
777 P68871 Hemoglobin subunit beta (Hemoglobin beta chain) (Be 6 21  - 11  - 17 15 X
778 P02042 Hemoglobin subunit delta (Hemoglobin delta chain) (D  - 15  - 4  - 12 12  - 
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779 P69891 Hemoglobin subunit gamma-1 (Hemoglobin gamma-1  - 7  -  -  -  -  -  - 
780 P69892 Hemoglobin subunit gamma-2 (Hemoglobin gamma-2 4  -  -  -  -  -  -  - 
781 P02790 Hemopexin precursor (Beta-1B-glycoprotein) 13  -  -  -  -  - 5  - 
782 Q9Y251 Heparanase precursor (EC 3.2.-.-) (Heparanase-1) (Hp -  - 1  -  -  -  -  - 
783 P05546 Heparin cofactor 2 precursor (Heparin cofactor II) (HC- 9  -  -  -  -  -  -  - 
784 Q04756 Hepatocyte growth factor activator precursor (EC 3,4,2 1  -  -  -  -  -  -  - 
785 P26927 Hepatocyte growth factor-like protein precursor (Macro 1  -  -  -  -  -  -  - 
786 P51858 Hepatoma-derived growth factor (HDGF) (High-mobility -  -  - 1 2  - 5  - 
787 Q13151 Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A -  -  -  -  - 1 1  - 
788 P09651 Heterogeneous nuclear ribonucleoprotein A1 (Helix-de -  -  - 3 6 2 7  - 
789 Q32P51 Heterogeneous nuclear ribonucleoprotein A1-like prote -  -  -  -  -  - 8  - 
790 P51991 Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A -  -  -  - 1  - 2  - 
791 O60812 Heterogeneous nuclear ribonucleoprotein C-like 1 (hnR -  -  -  -  - 3 2  - 
792 Q14103 Heterogeneous nuclear ribonucleoprotein D0 (hnRNP  -  -  - 1 6 4 8 X
793 P52597 Heterogeneous nuclear ribonucleoprotein F (hnRNP F  -  -  -  - 6 2 5 X
794 P38159 Heterogeneous nuclear ribonucleoprotein G (hnRNP G -  -  -  - 1 2  -  - 
795 P31943 Heterogeneous nuclear ribonucleoprotein H (hnRNP H -  -  -  - 6 2 4 X
796 P31942 Heterogeneous nuclear ribonucleoprotein H3 (hnRNP  -  -  -  - 1 1  - X
797 P61978 Heterogeneous nuclear ribonucleoprotein K (hnRNP K  -  - 3 2 12 14 11 X
798 O60506 Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q -  -  -  - 3 2 2  - 
799 O43390 Heterogeneous nuclear ribonucleoprotein R (hnRNP R -  -  -  - 1  - 2  - 
800 Q9BUJ2 Heterogeneous nuclear ribonucleoprotein U-like protei  -  -  -  - 1  -  -  - 
801 Q1KMD3 Heterogeneous nuclear ribonucleoprotein U-like protei  -  -  -  -  -  - 1  - 
802 P22626 Heterogeneous nuclear ribonucleoproteins A2/B1 (hnR - 2  - 3 6 6 10 X
803 P07910 Heterogeneous nuclear ribonucleoproteins C1/C2 (hnR -  -  -  - 2 4 3 X
804 Q00839 Heterogenous nuclear ribonucleoprotein U (hnRNP U)  -  -  -  - 9 2 8  - 
805 P19367 Hexokinase-1 (EC 2.7.1.1) (Hexokinase type I) (HK I) ( - 3 3  - 4  - 6  - 
806 P52790 Hexokinase-3 (EC 2.7.1.1) (Hexokinase type III) (HK II  -  -  - 13  - 10 10  - 
807 P30273 High affinity immunoglobulin epsilon receptor gamma-s -  - 1 1  - 3 1  - 
808 P09429 High mobility group protein 1 (HMG-1) (High mobility g  -  -  -  - 16 11 19  - 
809 Q9UGV6 High mobility group protein 1-like 10 (HMG-1L10)  -  -  -  -  -  - 7  - 
810 P26583 High mobility group protein 2 (HMG-2)  -  -  - 1 7 8 16  - 
811 O15347 High mobility group protein B3 (High mobility group pro -  -  -  -  - 2  -  - 
812 P37235 Hippocalcin-like protein 1 (Visinin-like protein 3) (VILIP -  -  -  - 4  -  - X
813 P49773 Histidine triad nucleotide-binding protein 1 (Adenosine  -  - 2  - 3 4 4 X
814 P04196 Histidine-rich glycoprotein precursor (Histidine-proline- 10  -  -  -  -  -  -  - 
815 P12081 Histidyl-tRNA synthetase (EC 6.1.1.21) (Histidine--tRN -  -  -  - 2  -  - X
816 Q96QV6 Histone H2A type 1-A - Homo sapiens (Human)  -  -  -  -  -  - 3  - 
817 P33778 Histone H2B type 1-B (H2B,f) (H2B/f) (H2B,1) - Homo  -  -  -  -  -  - 2  - 
818 P62805 Histone H4  -  - 3  - 4 1 11  - 
819 P30443 HLA class I histocompatibility antigen, A-1 alpha chain  - 1 4  - 2  - 5  - 
820 P13746 HLA class I histocompatibility antigen, A-11 alpha chai  -  -  -  -  -  - 4  - 
821 P01892 HLA class I histocompatibility antigen, A-2 alpha chain  -  - 5  -  -  - 6  - 
822 P18462 HLA class I histocompatibility antigen, A-25 alpha chai  -  -  -  -  -  - 4  - 
823 P16188 HLA class I histocompatibility antigen, A-30 alpha chai  -  -  -  -  -  - 6  - 
824 P30455 HLA class I histocompatibility antigen, A-36 alpha chai  -  -  -  -  -  - 5  - 
825 P30464 HLA class I histocompatibility antigen, B-15 alpha chai  -  -  -  -  -  - 8  - 
826 P30685 HLA class I histocompatibility antigen, B-35 alpha chai  -  -  -  -  -  - 6  - 
827 P30481 HLA class I histocompatibility antigen, B-44 alpha chai  -  -  -  -  -  - 3  - 
828 P30491 HLA class I histocompatibility antigen, B-53 alpha chai  -  -  -  -  -  - 5  - 
829 P01889 HLA class I histocompatibility antigen, B-7 alpha chain  -  -  - 3  -  -  -  - 
830 P30460 HLA class I histocompatibility antigen, B-8 alpha chain  -  -  -  -  -  - 5  - 
831 P30499 HLA class I histocompatibility antigen, Cw-1 alpha cha  -  -  -  -  -  - 1  - 
832 Q07000 HLA class I histocompatibility antigen, Cw-15 alpha ch  -  -  -  -  -  - 2  - 
833 P30501 HLA class I histocompatibility antigen, Cw-2 alpha cha  -  -  -  -  -  - 1  - 
834 P04233 HLA class II histocompatibility antigen gamma chain (H -  -  -  -  - 2 2  - 
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835 P28068 HLA class II histocompatibility antigen, DM beta chain  -  -  -  -  -  - 1  - 
836 P01908 HLA class II histocompatibility antigen, DQ(1) alpha ch -  -  -  -  -  - 1 X
837 P01903 HLA class II histocompatibility antigen, DR alpha chain -  -  -  -  - 3  -  - 
838 P01912 HLA class II histocompatibility antigen, DR-1 beta chai  -  -  -  -  - 2  -  - 
839 P13761 HLA class II histocompatibility antigen, DRB1-7 beta ch -  -  -  -  -  - 4 X
840 P50502 Hsc70-interacting protein (Hip) (Putative tumor suppres - 1 4  - 2  - 3 X
841 Q16543 Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein - 1 1  - 2 2 3  - 
842 Q16775 Hydroxyacylglutathione hydrolase (EC 3.1.2.6) (Glyoxa -  -  -  - 1  -  - X
843 P35914 Hydroxymethylglutaryl-CoA lyase, mitochondrial precu  -  -  - 1  -  -  -  - 
844 Q6YN16 Hydroxysteroid dehydrogenase-like protein 2 - Homo s -  -  - 2  -  -  -  - 
845 P00492 Hypoxanthine-guanine phosphoribosyltransferase (EC  - 1 5 3 3 6 4 X
846 P01876 Ig alpha-1 chain C region - Homo sapiens (Human) 11  -  -  -  -  - 8 X
847 P01877 Ig alpha-2 chain C region - Homo sapiens (Human) 7  -  -  -  -  - 5  - 
848 P01857 Ig gamma-1 chain C region - Homo sapiens (Human) 14  -  -  -  -  - 14  - 
849 P01859 Ig gamma-2 chain C region - Homo sapiens (Human) 10  -  -  -  -  - 7  - 
850 P01860 Ig gamma-3 chain C region (Heavy chain disease prote 9  -  -  -  -  - 4  - 
851 P01861 Ig gamma-4 chain C region - Homo sapiens (Human) 8  -  -  -  -  -  -  - 
852 P01742 Ig heavy chain V-I region EU - Homo sapiens (Human) -  -  -  -  -  - 1  - 
853 P01743 Ig heavy chain V-I region HG3 precursor - Homo sapie 2  -  -  -  -  -  -  - 
854 P06331 Ig heavy chain V-II region ARH-77 precursor - Homo s 2  -  -  -  -  -  -  - 
855 P01825 Ig heavy chain V-II region NEWM - Homo sapiens (Hu 1  -  -  -  -  -  -  - 
856 P01824 Ig heavy chain V-II region WAH - Homo sapiens (Hum 1  -  -  -  -  -  -  - 
857 P01766 Ig heavy chain V-III region BRO - Homo sapiens (Hum 3  -  -  -  -  -  -  - 
858 P01767 Ig heavy chain V-III region BUT - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
859 P01781 Ig heavy chain V-III region GAL - Homo sapiens (Huma 4  -  -  -  -  -  -  - 
860 P01771 Ig heavy chain V-III region HIL - Homo sapiens (Huma 2  -  -  -  -  -  -  - 
861 P01777 Ig heavy chain V-III region TEI - Homo sapiens (Huma  -  -  -  -  -  - 1  - 
862 P01779 Ig heavy chain V-III region TUR - Homo sapiens (Hum 2  -  -  -  -  -  -  - 
863 P01764 Ig heavy chain V-III region VH26 precursor - Homo sap 4  -  -  -  -  -  -  - 
864 P01834 Ig kappa chain C region - Homo sapiens (Human) 7 6  - 2  -  - 7  - 
865 P01593 Ig kappa chain V-I region AG 2  -  -  -  -  -  - X
866 P04430 Ig kappa chain V-I region BAN - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
867 P01596 Ig kappa chain V-I region CAR - Homo sapiens (Huma 2  -  -  -  -  -  -  - 
868 P01602 Ig kappa chain V-I region HK102 precursor (Fragment) 1  -  -  -  -  -  -  - 
869 P01613 Ig kappa chain V-I region Ni - Homo sapiens (Human) 1  -  -  -  -  -  -  - 
870 P01609 Ig kappa chain V-I region Scw - Homo sapiens (Human 2  -  -  -  -  -  -  - 
871 P01611 Ig kappa chain V-I region Wes - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
872 P01614 Ig kappa chain V-II region Cum - Homo sapiens (Huma 2  -  -  -  -  -  -  - 
873 P04206 Ig kappa chain V-III region GOL (Rheumatoid factor) -  -  -  -  -  -  - 4  - 
874 P18135 Ig kappa chain V-III region HAH precursor 4  -  -  -  -  -  -  - 
875 P01622 Ig kappa chain V-III region Ti - Homo sapiens (Human) 3  -  -  -  -  -  -  - 
876 P04433 Ig kappa chain V-III region VG precursor (Fragment) -  -  -  -  -  -  - 1  - 
877 P01625 Ig kappa chain V-IV region Len - Homo sapiens (Huma 3  -  -  -  -  - 2  - 
878 P01842 Ig lambda chain C regions - Homo sapiens (Human) 5  -  -  - 2  - 4  - 
879 P04208 Ig lambda chain V-I region WAH - Homo sapiens (Hum -  -  -  -  -  - 2  - 
880 P80748 Ig lambda chain V-III region LOI - Homo sapiens (Hum 1  -  -  -  -  -  - X
881 P01714 Ig lambda chain V-III region SH - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
882 P01717 Ig lambda chain V-IV region Hil - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
883 P01871 Ig mu chain C region - Homo sapiens (Human) 8  -  -  -  -  - 9  - 
884 P04220 Ig mu heavy chain disease protein (BOT) - Homo sapie -  -  -  -  -  - 4  - 
885 P01591 Immunoglobulin J chain - Homo sapiens (Human) 3  -  -  -  -  -  -  - 
886 O00629 Importin alpha-4 subunit (Karyopherin alpha-4 subunit) -  -  -  - 1 1 1  - 
887 Q14974 Importin beta-1 subunit (Karyopherin beta-1 subunit) (N -  - 3 4 4 4 10  - 
888 O00410 Importin beta-3 (Karyopherin beta-3) (Ran-binding prot -  -  -  - 3  - 6  - 
889 Q8TEX9 Importin-4 (Importin 4b) (Imp4b) (Ran-binding protein 4 -  -  -  - 1  -  -  - 
890 Q96P70 Importin-9 (Imp9) (Ran-binding protein 9) (RanbP9) - H -  -  -  -  - 1  -  - 
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891 P55060 Importin-alpha re-exporter (Chromosome segregation  -  -  -  -  - 6 2  - 
892 Q5TEJ8 Induced by contact to basement membrane 1 protein (  -  -  - 1  - 1 1  - 
893 O14920 Inhibitor of nuclear factor kappa-B kinase subunit beta  -  - 1  -  - 1  -  - 
894 Q15181 Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophospha -  -  - 2 6 1 5 X
895 Q9H2U2 Inorganic pyrophosphatase 2, mitochondrial precursor  -  - 1 1 4  - 5 X
896 Q9BY32 Inosine triphosphate pyrophosphatase (EC 3.6.1.19) (I  -  -  -  - 2 2 2 X
897 P20839 Inosine-5*-monophosphate dehydrogenase 1 (EC 1.1.  -  -  -  - 1 1  - X
898 P12268 Inosine-5*-monophosphate dehydrogenase 2 (EC 1.1.  -  -  -  - 1 1 2 X
899 P29218 Inositol monophosphatase (EC 3.1.3.25) (IMPase) (IM  -  - 2  - 2 1 4 X
900 O14732 Inositol monophosphatase 2 (EC 3.1.3.25) (IMPase 2)  -  -  -  -  - 1  -  - 
901 P17936 Insulin-like growth factor-binding protein 3 precursor (IG 1  -  -  -  -  -  -  - 
902 P24593 Insulin-like growth factor-binding protein 5 precursor (IG 1  -  -  -  -  -  -  - 
903 P35858 Insulin-like growth factor-binding protein complex acid 7  -  -  -  -  -  -  - 
904 P17301 Integrin alpha-2 precursor (Platelet membrane glycopr  -  - 1  -  -  -  -  - 
905 P23229 Integrin alpha-6 precursor (VLA-6) (CD49f antigen) [Co -  - 8  -  -  -  -  - 
906 P08514 Integrin alpha-IIb precursor (Platelet membrane glycop -  - 31 3  -  - 21 X
907 P20701 Integrin alpha-L precursor (Leukocyte adhesion glycop -  -  -  - 2 3 4  - 
908 P11215 Integrin alpha-M precursor (Cell surface glycoprotein M -  -  - 33 9 32 22  - 
909 P20702 Integrin alpha-X precursor (Leukocyte adhesion glycop -  -  - 3  - 3  -  - 
910 P05556 Integrin beta-1 precursor (Fibronectin receptor beta su  - 4 4  -  -  - 1  - 
911 P05107 Integrin beta-2 precursor (Cell surface adhesion glycop -  -  - 13 2 14 11  - 
912 P05106 Integrin beta-3 precursor (Platelet membrane glycopro  -  - 23 1  -  - 9  - 
913 P18084 Integrin beta-5 precursor - Homo sapiens (Human)  -  -  - 1  - 1  -  - 
914 Q13418 Integrin-linked protein kinase (EC 2.7.11.1) (ILK-1) (ILK -  - 8  - 1  - 7 X
915 P05362 Intercellular adhesion molecule 1 precursor (ICAM-1) (  - 1  -  -  - 1  -  - 
916 P13598 Intercellular adhesion molecule 2 precursor (ICAM-2) (  -  - 2  -  -  -  -  - 
917 P32942 Intercellular adhesion molecule 3 precursor (ICAM-3) (  -  -  -  -  - 1 2  - 
918 P48551 Interferon-alpha/beta receptor beta chain precursor - H -  -  -  -  -  - 1  - 
919 P05161 Interferon-induced 17 kDa protein precursor [Contains  -  -  -  -  -  - 1  - 
920 P80217 Interferon-induced 35 kDa protein (IFP 35)  -  -  -  -  -  - 1 X
921 P20591 Interferon-induced GTP-binding protein Mx1 (Interferon -  -  -  - 2  - 3 X
922 P32455 Interferon-induced guanylate-binding protein 1 (GTP-b  -  -  -  - 1  -  -  - 
923 P32456 Interferon-induced guanylate-binding protein 2 (GTP-b  -  -  -  - 2  - 1 X
924 P09914 Interferon-induced protein with tetratricopeptide repeat  -  -  -  - 2  -  -  - 
925 P13164 Interferon-induced transmembrane protein 1 (Interferon -  -  - 1 1  - 1  - 
926 Q96AZ6 Interferon-stimulated gene 20 kDa protein (EC 3.1.13.1 -  -  -  - 3  - 2  - 
927 Q12905 Interleukin enhancer-binding factor 2 (Nuclear factor of -  -  -  -  -  - 1 X
928 P01584 Interleukin-1 beta precursor (IL-1 beta) (Catabolin)  -  -  -  -  -  - 3  - 
929 P18510 Interleukin-1 receptor antagonist protein precursor (IL-  -  -  -  -  -  - 1 X
930 Q14005 Interleukin-16 precursor (IL-16) (Lymphocyte chemoatt -  -  -  - 6  - 9  - 
931 Q27J81 Inverted formin-2 - Homo sapiens (Human)  -  - 4  -  -  - 1  - 
932 Q96CN7 Isochorismatase domain-containing protein 1 - Homo s -  - 3  -  -  - 2  - 
933 Q96AB3 Isochorismatase domain-containing protein 2, mitocho  -  - 1  - 2 1 2  - 
934 P50213 Isocitrate dehydrogenase [NAD] subunit alpha, mitocho 1  - 1  - 3 2 4 X
935 O43837 Isocitrate dehydrogenase [NAD] subunit beta, mitocho  -  -  -  -  -  - 1  - 
936 O75874 Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1  -  - 1 7  - 7 2 X
937 P48735 Isocitrate dehydrogenase [NADP], mitochondrial precu -  - 6 5 7 6 8  - 
938 P41252 Isoleucyl-tRNA synthetase, cytoplasmic (EC 6.1.1.5) (I  -  -  -  -  - 2 1  - 
939 Q9NSE4 Isoleucyl-tRNA synthetase, mitochondrial precursor (E  -  -  -  - 4 1 1  - 
940 Q13907 Isopentenyl-diphosphate delta-isomerase 1 (EC 5.3.3.2 -  -  - 1  -  -  - X
941 P26440 Isovaleryl-CoA dehydrogenase, mitochondrial precurso -  - 1  - 1  - 1 X
942 Q9Y624 Junctional adhesion molecule A precursor (JAM-A) (Ju -  - 3  -  -  -  -  - 
943 O60229 Kalirin RhoGEF - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
944 P29622 Kallistatin precursor (Serpin A4) (Kallikrein inhibitor) (P 2  -  -  -  -  -  -  - 
945 P33176 Kinesin heavy chain (Ubiquitous kinesin heavy chain) ( - 1  -  -  -  -  -  - 
946 Q86VH2 Kinesin-like protein KIF27 - Homo sapiens (Human) 1  - 1  -  -  - 1  - 
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947 P01042 Kininogen-1 precursor (Alpha-2-thiol proteinase inhibito 5  -  -  -  -  -  - X
948 Q14657 L antigen family member 3 (ITBA2 protein) (ESO-3 pro -  -  -  -  - 1 2  - 
949 P02788 Lactotransferrin precursor (EC 3.4.21.-) (Lactoferrin) (T -  -  - 45 12 19  -  - 
950 Q04760 Lactoylglutathione lyase (EC 4.4.1.5) (Methylglyoxalas  -  - 3 1 6 4 6 X
951 Q6P4A8 LAMA-like protein 1 precursor - Homo sapiens (Human -  -  - 8  - 4 2  - 
952 Q8NHP8 LAMA-like protein 2 precursor - Homo sapiens (Human -  -  -  -  -  - 1  - 
953 P42166 Lamina-associated polypeptide 2 isoform alpha (Thym  -  -  -  -  -  - 2  - 
954 P42167 Lamina-associated polypeptide 2, isoforms beta/gamm -  -  -  -  -  - 2  - 
955 Q14739 Lamin-B receptor (Integral nuclear envelope inner mem -  -  - 1  -  -  -  - 
956 P24043 Laminin alpha-2 chain precursor (Laminin M chain) (M  -  -  -  -  - 1  -  - 
957 P46379 Large proline-rich protein BAT3 (HLA-B-associated tra  -  -  -  -  - 1 1 X
958 Q14766 Latent-transforming growth factor beta-binding protein,  -  - 11  -  -  - 1  - 
959 P22064 Latent-transforming growth factor beta-binding protein,  -  - 12  -  -  -  -  - 
960 Q9BS40 Latexin (Endogenous carboxypeptidase inhibitor) (ECI  - 1  - 1  -  -  -  - 
961 Q6P5Q4 Leiomodin-2 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
962 P02750 Leucine-rich alpha-2-glycoprotein precursor (LRG) - Ho 5  -  -  -  -  -  -  - 
963 Q32MZ4 Leucine-rich repeat flightless-interacting protein 1 (LRR -  - 2  - 4 4 9  - 
964 Q8N1G4 Leucine-rich repeat-containing protein 47 - Homo sapie -  -  -  -  -  - 1  - 
965 Q8N9N7 Leucine-rich repeat-containing protein 57 - Homo sapie -  -  - 1  -  - 2  - 
966 Q96AG4 Leucine-rich repeat-containing protein 59 - Homo sapie -  - 1  -  -  - 1  - 
967 Q9P2J5 Leucyl-tRNA synthetase, cytoplasmic (EC 6.1.1.4) (Leu -  -  -  -  -  - 1  - 
968 P08575 Leukocyte common antigen precursor (EC 3.1.3.48) (L -  -  - 9 22 27 27 X
969 P30740 Leukocyte elastase inhibitor (LEI) (Serpin B1) (Monocy - 1 10 16 10 14 11 X
970 P08246 Leukocyte elastase precursor (EC 3.4.21.37) (Elastase -  -  - 6  - 1 2  - 
971 Q8N6C8 Leukocyte immunoglobulin-like receptor subfamily A m -  -  - 2  -  -  -  - 
972 Q8NHL6 Leukocyte immunoglobulin-like receptor subfamily B m -  -  -  -  - 1  -  - 
973 P09960 Leukotriene A-4 hydrolase (EC 3.3.2.6) (LTA-4 hydrola -  -  - 14 8 15 11 X
974 Q15722 Leukotriene B4 receptor 1 (LTB4-R 1) (P2Y purinocept -  -  - 1  -  -  -  - 
975 O60711 Leupaxin - Homo sapiens (Human)  -  -  -  - 1  -  - X
976 P48059 LIM and senescent cell antigen-like-containing domain  -  - 10  -  -  - 8  - 
977 Q14847 LIM and SH3 domain protein 1 (LASP-1) (MLN 50)  -  - 4 1 4 2 6 X
978 P18428 Lipopolysaccharide-binding protein precursor (LBP) - H 1  -  -  -  -  -  -  - 
979 P05451 Lithostathine 1 alpha precursor - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
980 P48304 Lithostathine 1 beta precursor - Homo sapiens (Human 1  -  -  -  -  -  -  - 
981 P23141 Liver carboxylesterase 1 precursor (EC 3.1.1.1) (Acyl c -  -  -  -  - 5 7 X
982 P00338 L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A - 1 14 14 18 9 20  - 
983 Q9BYZ2 L-lactate dehydrogenase A-like 6B (EC 1,1,1,27) - Hom -  -  -  -  - 1 1  - 
984 P07195 L-lactate dehydrogenase B chain (EC 1.1.1.27) (LDH-B 2 6 14 5 22 9 19 X
985 P36776 Lon protease homolog, mitochondrial precursor (EC 3.  -  -  -  -  -  - 3 X
986 P33121 Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long -  -  - 1  -  -  -  - 
987 P08637 Low affinity immunoglobulin gamma Fc region recepto  -  -  -  -  -  - 1  - 
988 O75015 Low affinity immunoglobulin gamma Fc region recepto  -  -  - 1  -  -  -  - 
989 P24666 Low molecular weight phosphotyrosine protein phosph - 3 4  - 5 5 4 X
990 Q07954 Low-density lipoprotein receptor-related protein 1 prec  -  -  -  -  - 3  -  - 
991 P14151 L-selectin precursor (Lymph node homing receptor) (Le -  -  -  - 1  -  -  - 
992 P51884 Lumican precursor (Keratan sulfate proteoglycan lumic 1  -  -  -  -  -  -  - 
993 P05455 Lupus La protein (Sjogren syndrome type B antigen) (S -  -  -  - 6  - 3 X
994 Q7Z4W1 L-xylulose reductase (EC 1.1.1.10) (XR) (Dicarbonyl/L- -  - 2  - 4  - 3  - 
995 Q13094 Lymphocyte cytosolic protein 2 (SH2 domain-containin -  - 1  - 2 4 2  - 
996 P33241 Lymphocyte-specific protein 1 (Protein pp52) (52 kDa p -  -  - 2 3 2  -  - 
997 P10253 Lysosomal alpha-glucosidase precursor (EC 3.2.1.20)  -  -  -  -  - 5 1 X
998 O00754 Lysosomal alpha-mannosidase precursor (EC 3.2.1.24 -  -  -  - 1 3 2  - 
999 P10619 Lysosomal protective protein precursor (EC 3.4.16.5) (  -  - 1 3  - 2 3  - 
1000 P42785 Lysosomal Pro-X carboxypeptidase precursor (EC 3.4  -  -  - 2  - 2  -  - 
1001 P11279 Lysosome-associated membrane glycoprotein 1 precu  -  -  - 4 1 4 4  - 
1002 P13473 Lysosome-associated membrane glycoprotein 2 precu  -  -  -  -  - 2  - X
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1003 P61626 Lysozyme C precursor (EC 3.2.1.17) (1,4-beta-N-acety 1  -  - 5 2 10 8  - 
1004 Q15046 Lysyl-tRNA synthetase (EC 6.1.1.6) (Lysine--tRNA liga -  -  -  -  -  - 1  - 
1005 P40121 Macrophage capping protein (Actin-regulatory protein C - 1  - 8 4 8 4 X
1006 P14174 Macrophage migration inhibitory factor (MIF) (Phenylpy -  - 1 1 1 1 1 X
1007 P34810 Macrosialin precursor (GP110) (CD68 antigen)  -  - 1  -  -  - 1  - 
1008 Q86V88 Magnesium-dependent phosphatase 1 (EC 3,1,3,-) (EC -  -  - 2  -  -  -  - 
1009 Q14728 Major facilitator superfamily domain-containing protein  -  -  - 1  - 1 1  - 
1010 P04156 Major prion protein precursor (PrP) (PrP27-30) (PrP33  -  - 1  -  -  -  -  - 
1011 Q14764 Major vault protein (MVP) (Lung resistance-related pro - 11  -  - 10 3 7 X
1012 P40925 Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cy  - 3 6 5 12 3 10 X
1013 P40926 Malate dehydrogenase, mitochondrial precursor (EC 1  -  - 11 6 16 10 16  - 
1014 Q9ULC4 Malignant T cell amplified sequence 1 OS=Homo sapie -  -  - 1  -  -  -  - 
1015 O43451 Maltase-glucoamylase, intestinal [Includes: Maltase (E  -  -  - 5  -  -  -  - 
1016 Q8NFP4 MAM domain-containing glycosylphosphatidylinositol a -  -  -  -  - 1  -  - 
1017 O00187 Mannan-binding lectin serine protease 2 precursor (EC 3  -  -  -  -  -  -  - 
1018 Q9Y5P6 Mannose-1-phosphate guanyltransferase subunit beta  -  -  -  -  -  - 1  - 
1019 O60664 Mannose-6-phosphate receptor-binding protein 1 (Carg -  - 1 3 1 4 5 X
1020 P11226 Mannose-binding protein C precursor (MBP-C) (MBP1 1  -  -  -  -  -  -  - 
1021 Q96L34 MAP/microtubule affinity-regulating kinase 4 (EC 2.7.1  -  - 1  -  - 1  -  - 
1022 Q8IX19 Mast cell-expressed membrane protein 1 - Homo sapie -  -  - 1  - 1  -  - 
1023 P43243 Matrin-3  -  -  -  -  -  - 3  - 
1024 P08493 Matrix Gla-protein precursor (MGP) (Cell growth-inhibit 1  -  -  -  -  -  -  - 
1025 P14780 Matrix metalloproteinase-9 precursor (EC 3.4.24.35) (M -  -  - 21 3 14  -  - 
1026 Q9NVC6 Mediator of RNA polymerase II transcription subunit 17 -  -  - 2  -  -  -  - 
1027 O00264 Membrane-associated progesterone receptor compone -  - 3  -  -  - 1  - 
1028 O15173 Membrane-associated progesterone receptor compone -  -  -  -  -  - 1  - 
1029 Q96N66 Membrane-bound O-acyltransferase domain-containin  -  -  -  -  - 3  -  - 
1030 Q13255 Metabotropic glutamate receptor 1 precursor (mGluR1  -  -  - 1  -  -  -  - 
1031 P01033 Metalloproteinase inhibitor 1 precursor (TIMP-1) (Eryth 1  - 5  -  -  -  -  - 
1032 P16035 Metalloproteinase inhibitor 2 precursor (TIMP-2) (Tissu 3  -  -  -  -  -  -  - 
1033 Q2M296 Methenyltetrahydrofolate synthetase domain-containin  - 1  -  -  -  -  -  - 
1034 Q9NZL9 Methionine adenosyltransferase 2 subunit beta - Homo - 1  -  - 3  -  -  - 
1035 P50579 Methionine aminopeptidase 2 (EC 3.4.11.18) (MetAP 2 -  -  -  - 1  - 2  - 
1036 Q9NZV6 Methionine-R-sulfoxide reductase B1 - Homo sapiens  -  -  - 1  -  -  -  - 
1037 Q9H8H3 Methyltransferase-like protein 7A precursor (EC 2.1.1.- -  -  -  -  - 3 1  - 
1038 O14880 Microsomal glutathione S-transferase 3 (EC 2,5,1,18) ( -  -  - 1  -  -  -  - 
1039 P67812 Microsomal signal peptidase 18 kDa subunit (EC 3.4.-.  -  -  -  -  - 2 2  - 
1040 Q9UPN3 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/ - 1  -  -  -  -  -  - 
1041 Q66K74 Microtubule-associated protein 1S - Homo sapiens (Hu -  -  -  -  -  - 1  - 
1042 P27816 Microtubule-associated protein 4 (MAP 4)  - 1  -  -  -  -  -  - 
1043 Q15691 Microtubule-associated protein RP/EB family member  -  - 6  - 6 4 4 X
1044 Q15555 Microtubule-associated protein RP/EB family member  -  - 9  -  -  -  -  - 
1045 Q8TCT9 Minor histocompatibility antigen H13 (EC 3.4.99.-) (Sig -  -  -  -  - 1  -  - 
1046 Q9Y2B0 MIR-interacting saposin-like protein precursor (Transm -  -  -  - 3 2 1 X
1047 Q02978 Mitochondrial 2-oxoglutarate/malate carrier protein (OG -  -  -  -  -  - 2  - 
1048 Q16540 Mitochondrial 39S ribosomal protein L23 (L23mt) (MRP -  -  -  -  -  - 1  - 
1049 Q9Y6C9 Mitochondrial carrier homolog 2 (Met-induced mitochon -  -  -  - 1 1 1  - 
1050 Q9Y5J7 Mitochondrial import inner membrane translocase subu -  -  -  - 2  -  -  - 
1051 Q9NS69 Mitochondrial import receptor subunit TOM22 homolog -  - 1  - 1 1 2  - 
1052 P28482 Mitogen-activated protein kinase 1 (EC 2.7.1.37) (Extra -  -  - 3 2 1 1 X
1053 Q16539 Mitogen-activated protein kinase 14 (EC 2.7.11.24) (M  -  -  - 1 1  -  -  - 
1054 Q9UHA4 Mitogen-activated protein kinase kinase 1-interacting p -  -  - 1 1 2 2 X
1055 Q9Y2Q5 Mitogen-activated protein-binding protein-interacting pr -  -  -  -  - 1 1  - 
1056 Q96T76 MMS19-like protein (hMMS19) (MET18 homolog) - Ho  -  -  -  - 1  -  -  - 
1057 P26038 Moesin (Membrane-organizing extension spike protein  - 1 10 19 24 21 30 X
1058 O95396 Molybdenum cofactor synthesis protein 3 (Molybdopte  -  - 1 1 1  - 1  - 
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1059 P50224 Monoamine-sulfating phenol sulfotransferase (EC 2.8.2 -  - 4  -  -  - 1 X
1060 O15427 Monocarboxylate transporter 4 (MCT 4) (MCT 3) (Solu  -  -  -  -  - 2 2  - 
1061 P08571 Monocyte differentiation antigen CD14 precursor (Mye  -  -  -  -  - 1  -  - 
1062 Q99685 Monoglyceride lipase (EC 3.1.1.23) (MGL) (HU-K5) (Ly -  - 10 1  -  -  -  - 
1063 Q7L9L4 Mps one binder kinase activator-like 1A (Mob1 homolo -  - 2 1 2 1 3 X
1064 Q9H8S9 Mps one binder kinase activator-like 1B (Mob1 homolo -  -  -  -  -  - 4  - 
1065 Q96BX8 Mps one binder kinase activator-like 2A (Mob1 homolo -  -  -  - 1  - 1  - 
1066 P22234 Multifunctional protein ADE2 [Includes: Phosphoribosy  -  - 1  - 3  - 2 X
1067 Q13201 Multimerin-1 precursor (Endothelial cell multimerin 1) (  -  - 15  -  -  - 5  - 
1068 Q9H8L6 Multimerin-2 precursor (EMILIN-3) (Elastin microfibril in 5  -  -  -  -  -  -  - 
1069 O00499 Myc box-dependent-interacting protein 1 (Bridging inte  -  -  -  - 1  - 1  - 
1070 P24158 Myeloblastin precursor (EC 3.4.21.76) (Leukocyte prot  -  -  - 4 4 4 2  - 
1071 P41218 Myeloid cell nuclear differentiation antigen  -  -  - 5  - 1 3  - 
1072 P05164 Myeloperoxidase precursor (EC 1.11.1.7) (MPO) [Cont -  -  - 33 8 20 20  - 
1073 Q9NZM1 Myoferlin (Fer-1-like protein 3) - Homo sapiens (Huma 1  -  -  -  -  -  -  - 
1074 Q12965 Myosin Ie (Myosin Ic)  -  -  - 1  - 1  -  - 
1075 O00160 Myosin If (Myosin-IE)  -  -  - 5 2 6 6  - 
1076 P05976 Myosin light chain 1, skeletal muscle isoform (MLC1F)  -  -  -  -  -  - 1  - 
1077 Q15746 Myosin light chain kinase, smooth muscle (EC 2.7.11.1 -  - 2  -  -  -  -  - 
1078 P60660 Myosin light polypeptide 6 (Myosin light chain alkali 3)  -  - 10 1 8 8 8  - 
1079 P19105 Myosin regulatory light chain 2, nonsarcomeric (Myosin -  - 7 2 7 5 8 X
1080 P35580 Myosin-10 (Myosin heavy chain, nonmuscle IIb) (Nonm -  -  -  - 8  - 20  - 
1081 Q7Z406 Myosin-14 (Myosin heavy chain, nonmuscle IIc) (Nonm - 1  - 3 5 3  -  - 
1082 P35579 Myosin-9 (Myosin heavy chain, nonmuscle IIa) (Nonmu - 25 76 28 71 63 156  - 
1083 P58546 Myotrophin (V-1 protein)  -  - 5 3 3 5 5 X
1084 P29966 Myristoylated alanine-rich C-kinase substrate (MARCK -  -  -  -  -  - 3  - 
1085 P20933 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase prec -  -  -  -  -  - 1  - 
1086 Q9UJ70 N-acetylglucosamine kinase (EC 2.7.1.59) (GlcNAc kin - 1  - 2 2 7 7 X
1087 P15586 N-acetylglucosamine-6-sulfatase precursor (EC 3.1.6.1 - 1  -  -  - 1  -  - 
1088 Q96PD5 N-acetylmuramoyl-L-alanine amidase precursor (EC 3 4  -  -  -  -  -  -  - 
1089 Q9GZZ1 N-acetyltransferase 13 - Homo sapiens (Human)  -  -  -  - 2 1 2  - 
1090 Q02083 N-acylethanolamine-hydrolyzing acid amidase precurs  -  -  -  -  -  - 1  - 
1091 Q13423 NAD(P) transhydrogenase, mitochondrial precursor (E  -  -  -  -  - 6 3  - 
1092 P23368 NAD-dependent malic enzyme, mitochondrial precurso -  - 1  - 2  - 4 X
1093 Q86Y39 NADH dehydrogenase [ubiquinone] 1 alpha subcomple -  -  -  -  -  - 2  - 
1094 O00483 NADH dehydrogenase [ubiquinone] 1 alpha subcomple -  -  -  - 2 2 1  - 
1095 O95182 NADH dehydrogenase [ubiquinone] 1 alpha subcomple -  -  -  -  - 1 2  - 
1096 Q16795 NADH dehydrogenase [ubiquinone] 1 alpha subcomple -  -  -  - 2 2 2  - 
1097 O96000 NADH dehydrogenase [ubiquinone] 1 beta subcomplex -  -  -  - 1 4 2  - 
1098 O95168 NADH dehydrogenase [ubiquinone] 1 beta subcomplex -  -  -  -  -  - 3  - 
1099 O43920 NADH dehydrogenase [ubiquinone] iron-sulfur protein  -  -  -  -  -  - 2  - 
1100 O75251 NADH dehydrogenase [ubiquinone] iron-sulfur protein  -  -  -  - 1  - 3  - 
1101 P00387 NADH-cytochrome b5 reductase (EC 1.6.2.2) (B5R) (D -  - 6  - 2  - 1  - 
1102 O75380 NADH-ubiquinone oxidoreductase 13 kDa-A subunit, m -  -  -  -  -  - 1  - 
1103 Q16718 NADH-ubiquinone oxidoreductase 13 kDa-B subunit (E -  - 1  - 1 1 1 X
1104 O00217 NADH-ubiquinone oxidoreductase 23 kDa subunit, mit  -  -  -  - 2 1 2  - 
1105 P19404 NADH-ubiquinone oxidoreductase 24 kDa subunit, mit  -  -  -  - 1 1  - X
1106 O75489 NADH-ubiquinone oxidoreductase 30 kDa subunit, mit  -  -  -  - 5 3 7 X
1107 O95299 NADH-ubiquinone oxidoreductase 42 kDa subunit, mit  -  -  -  - 2 1 1  - 
1108 P28331 NADH-ubiquinone oxidoreductase 75 kDa subunit, mit  -  -  -  - 3 1 3 X
1109 P56556 NADH-ubiquinone oxidoreductase B14 subunit (EC 1.6 -  -  -  -  -  - 2  - 
1110 Q9P0J0 NADH-ubiquinone oxidoreductase B16.6 subunit (EC 1 -  -  -  -  - 1 3  - 
1111 Q9Y5S8 NADPH oxidase homolog 1 (NOX-1) (NOH-1) (NADH/  -  -  -  -  - 1 1  - 
1112 Q13765 Nascent polypeptide-associated complex alpha subuni  -  - 1  - 6 2 4 X
1113 P49279 Natural resistance-associated macrophage protein 1 (N -  -  -  -  - 1  -  - 
1114 P55160 Nck-associated protein 1-like (Membrane-associated p -  -  -  - 1  - 1  - 
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1115 Q92597 NDRG1 protein (N-myc downstream-regulated gene 1  -  -  -  - 2  - 2 X
1116 Q15843 NEDD8 precursor (Ubiquitin-like protein Nedd8) (Nedd -  -  - 1 1 2  -  - 
1117 P61081 NEDD8-conjugating enzyme Ubc12 (EC 6.3.2.-) (Ubiqu -  - 2  -  - 4 2 X
1118 P08473 Neprilysin (EC 3.4.24.11) (Neutral endopeptidase) (NE -  -  - 1  -  -  -  - 
1119 Q8WXH0 Nesprin-2 (Nuclear envelope spectrin repeat protein 2)  -  -  -  -  - 1  -  - 
1120 Q09666 Neuroblast differentiation-associated protein AHNAK (D -  -  -  -  - 16 13  - 
1121 Q14697 Neutral alpha-glucosidase AB precursor (EC 3.2.1.84)  - 7 10 4 13 19 21 X
1122 P22894 Neutrophil collagenase precursor (EC 3.4.24.34) (Matr  -  -  - 9  - 4  -  - 
1123 P14598 Neutrophil cytosol factor 1 (NCF-1) (Neutrophil NADPH -  -  - 6  - 3 1  - 
1124 P19878 Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH -  -  - 4  - 3  -  - 
1125 Q15080 Neutrophil cytosol factor 4 (NCF-4) (Neutrophil NADPH -  -  - 4  - 3  -  - 
1126 P59665 Neutrophil defensin 1 precursor (HNP-1) (HP-1) (HP1)  -  -  - 3  -  -  -  - 
1127 P80188 Neutrophil gelatinase-associated lipocalin precursor (N 3  -  - 13 5 6  -  - 
1128 Q0ZGT2 Nexilin - Homo sapiens (Human)  -  - 3  -  -  -  -  - 
1129 O95865 NG,NG-dimethylarginine dimethylaminohydrolase 2 (E  -  -  -  - 2  -  - X
1130 P55769 NHP2-like protein 1 (High mobility group-like nuclear p  -  -  -  -  -  - 2  - 
1131 Q9BZQ8 Niban protein  -  -  -  -  -  - 1  - 
1132 Q96TA1 Niban-like protein (Meg-3)  - 4  -  -  - 2  -  - 
1133 P43490 Nicotinamide phosphoribosyltransferase (EC 2.4.2.12)  -  -  - 11 1  -  - X
1134 Q6XQN6 Nicotinate phosphoribosyltransferase - Homo sapiens  - 1 1 2  - 1 2  - 
1135 P14543 Nidogen-1 precursor (Entactin) - Homo sapiens (Huma -  - 6  -  -  -  -  - 
1136 Q86X76 Nitrilase homolog 1 (EC 3,5,-,-) - Homo sapiens (Huma -  -  - 1  -  -  - X
1137 Q9NQR4 Nitrilase homolog 2 - Homo sapiens (Human)  -  -  - 1  - 4 3  - 
1138 P05204 Nonhistone chromosomal protein HMG-17 (High-mobil  -  -  -  -  -  - 1  - 
1139 P10153 Nonsecretory ribonuclease precursor (EC 3.1.27.5) (R  -  -  - 5 1 3  -  - 
1140 P22307 Nonspecific lipid-transfer protein, mitochondrial precurs -  -  - 1  -  - 2 X
1141 Q9UNZ2 NSFL1 cofactor p47 (p97 cofactor p47)  - 1  -  - 4  - 2 X
1142 P41227 N-terminal acetyltransferase complex ARD1 subunit ho -  -  -  - 1  -  -  - 
1143 P49321 Nuclear autoantigenic sperm protein (NASP) - Homo s  -  -  -  - 1 1 1  - 
1144 P82979 Nuclear protein Hcc-1 (Proliferation-associated cytokin -  -  -  -  -  - 1  - 
1145 P61970 Nuclear transport factor 2 (NTF-2) (Placental protein 1  -  -  -  - 3 3 4 X
1146 P67809 Nuclease sensitive element-binding protein 1 (Y-box-b  -  -  -  - 1  - 1  - 
1147 P19338 Nucleolin (Protein C23)  -  -  - 1 10  - 4  - 
1148 P06748 Nucleophosmin (NPM) (Nucleolar phosphoprotein B23 -  -  -  - 2 1 4 X
1149 P52594 Nucleoporin-like protein RIP (HIV-1 Rev-binding protei  -  - 1  -  -  -  -  - 
1150 P15531 Nucleoside diphosphate kinase A (EC 2.7.4.6) (NDK A - 4 8 5 7 8 7 X
1151 P22392 Nucleoside diphosphate kinase B (EC 2.7.4.6) (NDK B -  - 9 7 10 9 8  - 
1152 Q96DE0 Nucleoside diphosphate-linked moiety X motif 16 (EC 3 -  -  -  -  - 3 1 X
1153 P55209 Nucleosome assembly protein 1-like 1 (NAP-1-related  -  - 5  -  - 2  -  - 
1154 Q99733 Nucleosome assembly protein 1-like 4 (Nucleosome as -  -  -  - 2  - 3  - 
1155 Q9Y5Y2 Nucleotide-binding protein 2 (NBP 2)  -  -  -  - 1  - 1 X
1156 Q8WVJ2 NudC domain-containing protein 2 - Homo sapiens (Hu -  -  -  - 1 1  -  - 
1157 Q56VL3 OCIA domain-containing protein 2 - Homo sapiens (Hu -  -  -  -  -  - 2  - 
1158 Q6UX06 Olfactomedin-4 precursor - Homo sapiens (Human)  -  -  - 6  -  -  -  - 
1159 Q9NZT2 Opioid growth factor receptor (OGFr) (Zeta-type opioid -  -  -  -  -  - 1  - 
1160 Q92882 Osteoclast-stimulating factor 1  -  - 2 4 4 5 5 X
1161 P78380 Oxidized low-density lipoprotein receptor 1 - Homo sap -  -  - 1  -  -  -  - 
1162 P50897 Palmitoyl-protein thioesterase 1 precursor (EC 3.1.2.22 -  -  -  -  -  - 1  - 
1163 O95497 Pantetheinase precursor (EC 3.5.1.92) (Pantetheine hy -  -  - 1  -  -  -  - 
1164 P20962 Parathymosin - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
1165 P49023 Paxillin  -  -  -  -  -  - 3  - 
1166 O00151 PDZ and LIM domain protein 1 (Elfin) (LIM domain pro  -  - 21  - 2  - 6 X
1167 Q9UBV8 Peflin (PEF protein with a long N-terminal hydrophobic  -  -  - 2  -  -  -  - 
1168 Q9UJ68 Peptide methionine sulfoxide reductase (EC 1.8.4.11)  -  -  - 2  -  -  -  - 
1169 O75594 Peptidoglycan recognition protein precursor (PGRP-S)  -  -  - 4  - 2  -  - 
1170 P62937 Peptidyl-prolyl cis-trans isomerase A (EC 5.2.1.8) (PPI 2 5 10 6 14 12 12 X
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1171 P23284 Peptidyl-prolyl cis-trans isomerase B precursor (EC 5.2 1  - 14 5 7 10 14 X
1172 Q9UNP9 Peptidyl-prolyl cis-trans isomerase E (EC 5.2.1.8) (PPI  -  -  -  -  -  - 1 X
1173 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1  -  -  -  - 1  -  - X
1174 Q9Y237 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4  -  -  -  -  -  - 2  - 
1175 P30405 Peptidyl-prolyl cis-trans isomerase, mitochondrial prec  -  - 5  -  - 1  -  - 
1176 Q9Y3C6 Peptidyl-prolyl cis-trans isomerase-like 1 (EC 5.2.1.8) ( - 1  -  -  -  - 2  - 
1177 Q9H2H8 Peptidyl-prolyl cis-trans isomerase-like 3 (EC 5.2.1.8) ( -  -  - 1 2 2 1  - 
1178 Q9Y3E5 Peptidyl-tRNA hydrolase 2, mitochondrial precursor (E  -  -  -  -  - 1  - X
1179 P14222 Perforin-1 precursor (P1) (Lymphocyte pore forming pr  -  -  -  - 1  - 6  - 
1180 Q06830 Peroxiredoxin-1 (EC 1.11.1.15) (Thioredoxin peroxidas - 5 7 2 17 15 19 X
1181 P32119 Peroxiredoxin-2 (EC 1.11.1.15) (Thioredoxin peroxidas - 16 5 5 15 12 11 X
1182 Q13162 Peroxiredoxin-4 (EC 1.11.1.15) (Prx-IV) (Thioredoxin p -  - 6  - 3 2 3 X
1183 P30044 Peroxiredoxin-5, mitochondrial precursor (EC 1.11.1.15 -  - 7 10 10 11 9 X
1184 P30041 Peroxiredoxin-6 (EC 1.11.1.15) (Antioxidant protein 2)  - 5 20 11 14 8 14 X
1185 P51659 Peroxisomal multifunctional enzyme type 2 (MFE-2) (D -  - 2  -  - 1 1  - 
1186 Q8WW12 PEST proteolytic signal-containing nuclear protein (PE  -  -  -  -  -  - 2  - 
1187 Q00325 Phosphate carrier protein, mitochondrial precursor (PT -  -  -  - 1 2 6  - 
1188 P30086 Phosphatidylethanolamine-binding protein (PEBP) (Pro - 6 5 5 13 10 14 X
1189 Q9NTJ5 Phosphatidylinositide phosphatase SAC1 - Homo sapi  -  - 1  -  -  -  -  - 
1190 Q8TCU6 Phosphatidylinositol 3,4,5-trisphosphate-dependent Ra -  -  -  -  - 1 1  - 
1191 P27986 Phosphatidylinositol 3-kinase regulatory subunit alpha  -  -  -  -  -  - 1  - 
1192 Q00169 Phosphatidylinositol transfer protein alpha isoform (Ptd - 1  -  - 1 1 1 X
1193 P48739 Phosphatidylinositol transfer protein beta isoform (PtdI  -  -  -  - 1  - 1 X
1194 P48426 Phosphatidylinositol-4-phosphate 5-kinase type-2 alph  -  - 2  - 3  - 3  - 
1195 P80108 Phosphatidylinositol-glycan-specific phospholipase D 1 5  -  -  -  -  -  -  - 
1196 Q16822 Phosphoenolpyruvate carboxykinase [GTP], mitochond -  -  -  -  - 1 1 X
1197 P36871 Phosphoglucomutase-1 (EC 5.4.2.2) (Glucose phosph  -  - 5 6 5  - 4 X
1198 Q96G03 Phosphoglucomutase-2 (EC 5.4.2.2) (Glucose phosph  -  -  - 1 6 1 7  - 
1199 P00558 Phosphoglycerate kinase 1 (EC 2.7.2.3) (Primer recog  - 8 16 20 21 15 23 X
1200 P18669 Phosphoglycerate mutase 1 (EC 5.4.2.1) (EC 5.4.2.4)  -  - 7 9 15 12 15 X
1201 P36969 Phospholipid hydroperoxide glutathione peroxidase, m  -  - 2  - 4 2 3  - 
1202 P55058 Phospholipid transfer protein precursor (Lipid transfer p 1  -  -  -  -  -  -  - 
1203 Q9H008 Phospholysine phosphohistidine inorganic pyrophosph -  -  - 1 2  - 3  - 
1204 Q15126 Phosphomevalonate kinase (EC 2.7.4.2) (PMKase)  -  - 2  - 1 1  - X
1205 O60256 Phosphoribosyl pyrophosphate synthetase-associated  -  -  -  - 1  -  -  - 
1206 O15067 Phosphoribosylformylglycinamidine synthase (EC 6.3.5 -  -  -  -  -  - 2 X
1207 Q96BW5 Phosphotriesterase-related protein (Parathion hydrolas -  -  -  - 2  -  - X
1208 P36955 Pigment epithelium-derived factor precursor (PEDF) (S 4  -  -  -  -  -  -  - 
1209 P35237 Placental thrombin inhibitor (Cytoplasmic antiproteinas -  - 3 2 2 6 3 X
1210 P03952 Plasma kallikrein precursor (EC 3,4,21,34) (Plasma pre 5  -  -  -  -  -  -  - 
1211 P23634 Plasma membrane calcium-transporting ATPase 4 - Ho -  -  -  -  - 4  -  - 
1212 P05155 Plasma protease C1 inhibitor precursor (C1 Inh) (C1In 15  -  -  -  -  - 2 X
1213 P02753 Plasma retinol-binding protein precursor (PRBP) (RBP 7  -  -  - 1  - 1 X
1214 P05121 Plasminogen activator inhibitor 1 precursor (PAI-1) (En -  - 2  -  -  -  - X
1215 Q8NC51 Plasminogen activator inhibitor 1 RNA-binding protein  -  -  -  - 1  - 1  - 
1216 P05120 Plasminogen activator inhibitor 2 precursor (PAI-2) (Pla -  -  -  -  - 1 1 X
1217 P00747 Plasminogen precursor (EC 3.4.21.7) [Contains: Plasm 10  - 2  -  -  - 3  - 
1218 Q02325 Plasminogen-related protein B precursor - Homo sapie 1  -  -  -  -  -  -  - 
1219 P13796 Plastin-2 (L-plastin) (Lymphocyte cytosolic protein 1) (L -  -  - 31 47 39 45 X
1220 P02775 Platelet basic protein precursor (PBP) (Small inducible 2  - 9 2  -  - 6  - 
1221 P16284 Platelet endothelial cell adhesion molecule precursor (  - 5 5  -  - 1 2  - 
1222 P02776 Platelet factor 4 precursor (PF-4) (CXCL4) (Oncostatin 1  - 6  -  -  - 6  - 
1223 P10720 Platelet factor 4 variant precursor (PF4var1) (PF4alt) (C -  - 3  -  -  -  -  - 
1224 P16671 Platelet glycoprotein 4 (Platelet glycoprotein IV) (GPIV  -  - 5  -  - 1 1  - 
1225 P07359 Platelet glycoprotein Ib alpha chain precursor (Glycopr  -  - 8  -  -  -  -  - 
1226 P13224 Platelet glycoprotein Ib beta chain precursor (GP-Ib be -  - 4  -  -  - 2  - 
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1227 P14770 Platelet glycoprotein IX precursor (GPIX) (CD42a antig -  - 5  -  -  - 2  - 
1228 P40197 Platelet glycoprotein V precursor (GPV) (CD42D antige -  - 7  -  -  - 1  - 
1229 Q9HCN6 Platelet glycoprotein VI precursor - Homo sapiens (Hum -  - 1  -  -  -  -  - 
1230 Q9H7M9 Platelet receptor Gi24 precursor - Homo sapiens (Hum -  - 1  -  - 1 1  - 
1231 P43034 Platelet-activating factor acetylhydrolase IB alpha subu - 1 1  - 4 2 2  - 
1232 P68402 Platelet-activating factor acetylhydrolase IB beta subun -  - 4  - 2 2 2 X
1233 Q15102 Platelet-activating factor acetylhydrolase IB gamma su  -  -  -  - 3 1 2 X
1234 P08567 Pleckstrin (Platelet p47 protein)  -  - 16 3 2  - 11  - 
1235 Q96S99 Pleckstrin homology domain-containing family F memb -  -  -  -  -  - 1  - 
1236 O15031 Plexin-B2 precursor (MM1) - Homo sapiens (Human)  -  -  -  -  - 1  -  - 
1237 Q9UKK3 Poly [ADP-ribose] polymerase 4 (EC 2.4.2.30) (PARP-  -  -  -  -  - 1  -  - 
1238 Q9NX46 Poly(ADP-ribose) glycohydrolase ARH3 - Homo sapien - 1  -  - 1  - 1  - 
1239 Q15365 Poly(rC)-binding protein 1 (Alpha-CP1) (hnRNP-E1) (N -  - 5 3 9 5 7 X
1240 Q15366 Poly(rC)-binding protein 2 (Alpha-CP2) (hnRNP-E2)  -  - 1  - 5 6 6 X
1241 P11940 Polyadenylate-binding protein 1 (Poly(A)-binding prote  -  - 1  - 3 1 2  - 
1242 P26599 Polypyrimidine tract-binding protein 1 (PTB) (Heteroge  -  - 1  - 3 5 7  - 
1243 P08397 Porphobilinogen deaminase (EC 2.5.1.61) (Hydroxyme -  -  -  - 2  -  -  - 
1244 Q96CX2 Potassium channel tetramerisation domain-containing  -  -  - 2  - 12 6 X
1245 O75915 PRA1 family protein 3 (ARL-6-interacting protein 5) (AD -  -  -  - 2 1 4  - 
1246 Q9UHV9 Prefoldin subunit 2  -  - 1  - 4 2 1 X
1247 P61758 Prefoldin subunit 3 (Von Hippel-Lindau-binding protein  -  - 1  - 1  - 1 X
1248 Q9NQP4 Prefoldin subunit 4 (Protein C-1) - Homo sapiens (Hum -  -  -  - 1  -  -  - 
1249 Q99471 Prefoldin subunit 5 (C-myc-binding protein Mm-1) (Myc -  -  -  - 2 1 1 X
1250 P20742 Pregnancy zone protein precursor 10  -  -  -  - 3 14  - 
1251 Q5JRX3 Presequence protease, mitochondrial precursor (EC 3  - 1  -  - 1  -  -  - 
1252 P07602 Proactivator polypeptide precursor [Contains: Saposin  -  -  - 4  - 6 2 X
1253 P38919 Probable ATP-dependent RNA helicase DDX48 (EC 3  -  -  -  - 4 1 2 X
1254 Q9HA77 Probable cysteinyl-tRNA synthetase, mitochondrial pre -  -  - 1  -  -  -  - 
1255 Q8TEA8 Probable D-tyrosyl-tRNA(Tyr) deacylase 1 (EC 3.1.-.-)  -  - 1  -  -  -  -  - 
1256 Q86Y34 Probable G-protein coupled receptor 97 precursor (G-p -  -  - 2  -  -  -  - 
1257 O96008 Probable mitochondrial import receptor subunit TOM40 -  -  -  - 1  - 1 X
1258 Q8N0Y7 Probable phosphoglycerate mutase 4 (EC 5,4,2,1) (EC -  -  -  -  - 1  -  - 
1259 P98196 Probable phospholipid-transporting ATPase IH (EC 3.6 -  -  -  -  - 1  -  - 
1260 Q86YV0 Probable Ras GTPase-activating protein FLJ00412 - H -  -  -  -  -  - 1  - 
1261 P07737 Profilin-1 (Profilin I) 3  - 17 11 12 15 14 X
1262 Q8WUM4 Programmed cell death 6-interacting protein (PDCD6-i  - 1 1  - 8 8 10 X
1263 Q9BUL8 Programmed cell death protein 10 (TF-1 cell apoptosis  -  - 5  - 3  - 3  - 
1264 Q53EL6 Programmed cell death protein 4 (Nuclear antigen H73 -  -  -  - 2  - 1  - 
1265 O75340 Programmed cell death protein 6 (Probable calcium-bin -  - 2 2 4 5 5 X
1266 P35232 Prohibitin  -  - 7 1 7 7 8 X
1267 Q99623 Prohibitin-2 (B-cell receptor-associated protein BAP37  -  - 7  - 8 2 11  - 
1268 Q9HCU5 Prolactin regulatory element-binding protein (Mammali  -  -  - 1  -  -  -  - 
1269 P12273 Prolactin-inducible protein precursor (Secretory actin-b 2  -  -  -  -  -  - X
1270 P12004 Proliferating cell nuclear antigen (PCNA) (Cyclin) - Hom -  -  -  - 1  -  -  - 
1271 Q9UQ80 Proliferation-associated protein 2G4 (Cell cycle protein -  - 1  - 2  - 2 X
1272 O94903 Proline synthetase co-transcribed bacterial homolog pr -  - 1 1 5 1 4  - 
1273 Q9H939 Proline-serine-threonine phosphatase-interacting prote -  - 5  - 1  -  -  - 
1274 P48147 Prolyl endopeptidase (EC 3.4.21.26) (Post-proline clea -  - 1  - 1  - 1 X
1275 P27918 Properdin precursor (Factor P) - Homo sapiens (Huma -  -  - 1  -  -  -  - 
1276 Q8NBP7 Proprotein convertase subtilisin/kexin type 9 precursor 2  -  -  -  -  -  -  - 
1277 Q15185 Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic pr -  - 2 1 5 4 5 X
1278 P41222 Prostaglandin-H2 D-isomerase precursor (EC 5,3,99,2 1  -  -  -  -  -  -  - 
1279 Q6S8J3 Prostate, ovary, testis-expressed protein on chromoso  -  -  - 8  -  - 9  - 
1280 Q06323 Proteasome activator complex subunit 1 (Proteasome  -  - 7 6 16 11 16 X
1281 Q9UL46 Proteasome activator complex subunit 2 (Proteasome  - 1 6 5 12 9 11 X
1282 P61289 Proteasome activator complex subunit 3 (Proteasome  -  -  -  - 1  -  - X
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1283 Q92530 Proteasome inhibitor PI31 subunit (hPI31) - Homo sap  -  -  -  - 2  -  -  - 
1284 P25786 Proteasome subunit alpha type 1 (EC 3.4.25.1) (Protea -  - 2 1 7 3 9 X
1285 P25787 Proteasome subunit alpha type 2 (EC 3.4.25.1) (Protea - 1 4 2 6 6 5 X
1286 P25788 Proteasome subunit alpha type 3 (EC 3.4.25.1) (Protea - 1 3  - 8 4 8 X
1287 P25789 Proteasome subunit alpha type 4 (EC 3.4.25.1) (Protea -  - 2  - 7 4 6 X
1288 P28066 Proteasome subunit alpha type 5 (EC 3.4.25.1) (Protea -  - 2  - 3 3 7  - 
1289 P60900 Proteasome subunit alpha type 6 (EC 3.4.25.1) (Protea - 1 2  - 6 5 10 X
1290 O14818 Proteasome subunit alpha type 7 (EC 3.4.25.1) (Protea -  - 3 1 10 6 8 X
1291 Q8TAA3 Proteasome subunit alpha type 7-like (EC 3,4,25,1)  -  -  -  -  -  - 4  - 
1292 P20618 Proteasome subunit beta type 1 (EC 3.4.25.1) (Proteas -  - 5 1 9 8 10  - 
1293 P40306 Proteasome subunit beta type 10 precursor (EC 3.4.25 -  -  -  - 4 1 3 X
1294 P49721 Proteasome subunit beta type 2 (EC 3.4.25.1) (Proteas -  - 3  - 6 5 8 X
1295 P49720 Proteasome subunit beta type 3 (EC 3.4.25.1) (Proteas -  - 4 1 6 5 8 X
1296 P28070 Proteasome subunit beta type 4 precursor (EC 3.4.25.  -  - 1  - 1 2 4 X
1297 P28074 Proteasome subunit beta type 5 precursor (EC 3.4.25.  - 3  -  - 1  -  -  - 
1298 P28062 Proteasome subunit beta type 8 precursor (EC 3.4.25.  -  - 5 1 8 7 6  - 
1299 P28065 Proteasome subunit beta type 9 precursor (EC 3.4.25.  -  - 1  - 7 5 6 X
1300 Q5VYK3 Proteasome-associated protein ECM29 homolog (Ecm -  -  -  -  -  - 2  - 
1301 P11171 Protein 4.1 (Band 4.1) (P4.1) (EPB4.1) (4.1R) - Homo  - 11 1  -  -  - 1  - 
1302 Q99873 Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (In  -  -  -  - 1  -  -  - 
1303 Q562R1 Protein beta-actin-like - Homo sapiens (Human)  -  - 10 6 9 7 8  - 
1304 Q9NQ88 Protein C12orf5  -  -  -  -  - 1 2  - 
1305 Q9Y224 Protein C14orf166  -  -  -  - 5  - 1 X
1306 Q969H8 Protein C19orf10 precursor (Stromal cell-derived growt -  -  -  - 3 4 3 X
1307 Q9NQG5 Protein C20orf77  -  -  -  -  -  - 3 X
1308 Q9P1F3 Protein C6orf115  -  -  - 2 1 1 2 X
1309 O75223 Protein C7orf24  -  -  - 1 1 1 2 X
1310 Q9NZB2 Protein C9orf10  -  -  -  - 1  -  -  - 
1311 Q9UKY7 Protein CDV3 homolog - Homo sapiens (Human)  -  -  -  - 2  - 1  - 
1312 Q8WUX9 Protein CHMP7 - Homo sapiens (Human)  -  -  -  - 2 1  -  - 
1313 Q2KHT3 Protein CLEC16A - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
1314 O75629 Protein CREG1 precursor (Cellular repressor of E1A-s  -  -  - 1 1 2  -  - 
1315 O60888 Protein CutA precursor (Brain acetylcholinesterase put  -  -  -  - 1 1 1  - 
1316 O60610 Protein diaphanous homolog 1 (Diaphanous-related fo  -  - 13  - 12 5 24  - 
1317 Q9NSV4 Protein diaphanous homolog 3 (Diaphanous-related fo  -  - 1  -  -  -  -  - 
1318 P30101 Protein disulfide-isomerase A3 precursor (EC 5.3.4.1)  -  - 12 5 16 17 20 X
1319 P13667 Protein disulfide-isomerase A4 precursor (EC 5.3.4.1)  -  -  -  - 2 3 8 X
1320 Q15084 Protein disulfide-isomerase A6 precursor (EC 5.3.4.1)  -  - 11  - 7 7 6 X
1321 P07237 Protein disulfide-isomerase precursor (EC 5.3.4.1) (PD -  - 13 10 5 14 16 X
1322 Q99497 Protein DJ-1 (Oncogene DJ1)  - 3 7 6 7 7 12 X
1323 Q9H098 Protein FAM107B - Homo sapiens (Human)  -  -  -  - 3  -  -  - 
1324 Q8IZP2 Protein FAM10A4  -  - 3  -  -  - 3  - 
1325 Q9BUR5 Protein FAM121B precursor - Homo sapiens (Human)  -  -  -  -  - 1 2  - 
1326 Q9H0Q0 Protein FAM49A  -  -  -  -  -  - 2  - 
1327 Q9NUQ9 Protein FAM49B (L1)  -  -  - 10 4 8 12  - 
1328 Q9BSJ8 Protein FAM62A (Membrane-bound C2 domain-contai  - 1 2  - 10 6 18  - 
1329 P49354 Protein farnesyltransferase/geranylgeranyltransferase  -  -  - 1  -  -  - X
1330 Q13045 Protein flightless-1 homolog  -  -  -  -  -  - 6  - 
1331 Q6NYC8 Protein KIAA1949 - Homo sapiens (Human)  -  -  -  - 1  - 2  - 
1332 Q8N163 Protein KIAA1967 (Deleted in breast cancer gene 1 pro -  -  -  -  -  - 6  - 
1333 P17252 Protein kinase C alpha type (EC 2.7.11.13) (PKC-alpha -  - 1  - 1 2  -  - 
1334 P05771 Protein kinase C beta type (EC 2.7.11.13) (PKC-beta)  -  -  -  -  -  - 3  - 
1335 Q05655 Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta -  -  - 1  - 1 1  - 
1336 Q86UE4 Protein LYRIC (Lysine-rich CEACAM1 co-isolated prot  -  -  -  - 1  -  -  - 
1337 P61326 Protein mago nashi homolog  -  -  -  -  - 2 3  - 
1338 Q96A72 Protein mago nashi homolog 2  -  -  -  -  -  - 4 X
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1339 Q9BPW8 Protein NipSnap1 - Homo sapiens (Human)  -  -  -  -  -  - 5  - 
1340 O75323 Protein NipSnap2 (Glioblastoma amplified sequence) -  -  -  -  -  - 1 2  - 
1341 Q9UFN0 Protein NipSnap3A (NipSnap4) (Target for Salmonella  -  - 3 2 2 3 6  - 
1342 Q96FA3 Protein pellino homolog 1 - Homo sapiens (Human)  -  - 1  -  -  - 1  - 
1343 O14974 Protein phosphatase 1 regulatory subunit 12A (Myosin  -  -  -  -  -  - 1  - 
1344 Q15435 Protein phosphatase 1 regulatory subunit 7 (Protein ph -  -  -  - 1  - 2 X
1345 P35813 Protein phosphatase 2C isoform alpha (EC 3.1.3.16) (P -  - 1  - 1  -  -  - 
1346 O75688 Protein phosphatase 2C isoform beta (EC 3,1,3,16) (P  -  -  - 1  -  -  - X
1347 Q96M27 Protein PPRC1 - Homo sapiens (Human)  -  -  -  - 1  -  -  - 
1348 Q9P258 Protein RCC2 (Telophase disk protein of 60 kDa) (RCC -  -  -  - 1  - 1  - 
1349 P80511 Protein S100-A12 (S100 calcium-binding protein A12)  -  -  - 3  - 3  - X
1350 P25815 Protein S100-P (S100 calcium-binding protein P) - Hom -  -  - 4  - 1  -  - 
1351 Q01105 Protein SET (Phosphatase 2A inhibitor I2PP2A) (I-2PP -  -  -  - 3 2 1 X
1352 Q15436 Protein transport protein Sec23A (SEC23-related prote -  -  -  - 1  - 2 X
1353 O95486 Protein transport protein Sec24A (SEC24-related prote -  -  -  -  - 1  -  - 
1354 P53992 Protein transport protein Sec24C (SEC24-related prote -  -  -  -  -  - 2  - 
1355 O94979 Protein transport protein Sec31A - Homo sapiens (Hum -  - 1  - 2 2 2  - 
1356 P61619 Protein transport protein Sec61 subunit alpha isoform  -  -  -  - 1 1  -  - 
1357 Q14761 Protein tyrosine phosphatase receptor type C-associat  -  -  -  - 1  - 3  - 
1358 Q12974 Protein tyrosine phosphatase type IVA protein 2 (EC 3  -  - 1  - 1  - 2  - 
1359 Q9BRP8 Protein wibg homolog - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
1360 Q9UK55 Protein Z-dependent protease inhibitor precursor (PZ-d 2  -  -  -  -  -  -  - 
1361 Q9ULC6 Protein-arginine deiminase type-1 (EC 3.5.3.15) (Prote -  - 1  - 1 1 1  - 
1362 Q9Y2J8 Protein-arginine deiminase type-2 (EC 3.5.3.15) (Prote -  -  - 1  - 1  -  - 
1363 P21980 Protein-glutamine gamma-glutamyltransferase 2 (EC 2 - 5  -  -  -  -  - X
1364 P22061 Protein-L-isoaspartate(D-aspartate) O-methyltransfera  - 1 3 2 6 3 9 X
1365 Q9Y2Y8 Proteoglycan 3 precursor (Eosinophil major basic prote -  -  - 4  -  -  -  - 
1366 Q92954 Proteoglycan-4 precursor (Lubricin) (Megakaryocyte-st 3  -  -  -  -  -  -  - 
1367 Q04941 Proteolipid protein 2 (Intestinal membrane A4 protein)  -  - 2 1 1 2 1  - 
1368 P00734 Prothrombin precursor (EC 3.4.21.5) (Coagulation fact 22  -  -  -  -  - 1  - 
1369 P06454 Prothymosin alpha [Contains: Thymosin alpha-1]  -  -  -  -  - 1  -  - 
1370 P01100 Proto-oncogene protein c-fos - Homo sapiens (Human  -  -  -  -  - 1  -  - 
1371 P09769 Proto-oncogene tyrosine-protein kinase FGR (EC 2.7.1 -  -  - 3  -  -  -  - 
1372 P06241 Proto-oncogene tyrosine-protein kinase Fyn (EC 2.7.10 -  - 2  -  -  - 3  - 
1373 P06239 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.1 -  -  -  - 1  - 2  - 
1374 P12931 Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10 -  - 7  -  -  - 5  - 
1375 P15498 Proto-oncogene vav  -  -  -  -  -  - 1  - 
1376 P16109 P-selectin precursor (Granule membrane protein 140)  -  - 6  -  - 1 1  - 
1377 P61457 Pterin-4-alpha-carbinolamine dehydratase (EC 4.2.1.9  -  -  - 1  -  -  -  - 
1378 P00491 Purine nucleoside phosphorylase (EC 2.4.2.1) (Inosine - 4 17 14 16 11 16 X
1379 P55786 Puromycin-sensitive aminopeptidase (EC 3.4.11.-) (PS - 1  -  - 1 3 5  - 
1380 Q9NTK5 Putative GTP-binding protein PTD004  -  -  -  -  -  - 1  - 
1381 Q14568 Putative heat shock protein HSP 90-alpha A2 - Homo s -  -  -  -  - 3  -  - 
1382 Q6ZN80 Putative maltase-glucoamylase-like protein FLJ16351  -  -  - 3  -  -  -  - 
1383 A6NI72 Putative neutrophil cytosol factor 1B OS=Homo sapien -  -  - 2  -  -  -  - 
1384 A8MVU1 Putative neutrophil cytosol factor 1C OS=Homo sapien -  -  - 3  -  -  -  - 
1385 O43143 Putative pre-mRNA-splicing factor ATP-dependent RN  -  -  -  -  -  - 3  - 
1386 Q53FA7 Putative quinone oxidoreductase (EC 1,-,-,-) (Tumor pr -  -  - 2  -  -  -  - 
1387 P98179 Putative RNA-binding protein 3 (RNA-binding motif pro -  -  -  - 1  - 2  - 
1388 Q9Y383 Putative RNA-binding protein Luc7-like 2 - Homo sapie -  -  -  - 2 1  -  - 
1389 Q8NFU3 Putative thiosulfate sulfurtransferase KAT (EC 2.8.1.1)  -  -  -  -  -  - 1  - 
1390 Q9Y448 Putative TRAF4-associated factor 1 - Homo sapiens (H -  -  -  -  -  - 1  - 
1391 Q5T440 Putative transferase C1orf69, mitochondrial precursor  -  -  -  -  -  - 1  - 
1392 Q9NTT1 Putative ubiquitin-conjugating enzyme E2 D3-like prote -  - 2  -  - 2 2  - 
1393 O00764 Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)  -  -  - 3 3 2 3 X
1394 P08559 Pyruvate dehydrogenase E1 component alpha subunit  -  -  -  -  -  - 3 X
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1395 P11177 Pyruvate dehydrogenase E1 component beta subunit,  -  - 2  - 5  - 9 X
1396 Q8NCN5 Pyruvate dehydrogenase phosphatase regulatory subu -  -  -  - 1  -  -  - 
1397 P14618 Pyruvate kinase isozymes M1/M2 (EC 2.7.1.40) (Pyruv - 6 29 30 32 38 35 X
1398 Q08257 Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone - 1  -  - 2  - 2  - 
1399 P31150 Rab GDP dissociation inhibitor alpha (Rab GDI alpha)  -  - 7 5 5 5 9 X
1400 P50395 Rab GDP dissociation inhibitor beta (Rab GDI beta) (G - 4 10 11 13 13 21 X
1401 Q6WKZ4 Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-  -  -  - 1  -  -  -  - 
1402 O60518 Ran-binding protein 6 (RanBP6)  -  -  -  -  -  - 1  - 
1403 P43487 Ran-specific GTPase-activating protein (Ran-binding p -  - 2 1 2 1 3 X
1404 P52306 Rap1 GTPase-GDP dissociation stimulator 1 (SMG P2 -  - 2  -  -  -  - X
1405 Q8TB24 Ras and Rab interactor 3 (Ras interaction/interference  -  -  -  - 1  -  -  - 
1406 Q14644 Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P -  - 2  -  -  - 1  - 
1407 P46940 Ras GTPase-activating-like protein IQGAP1 (p195)  - 1  - 4 23 30 39  - 
1408 Q13576 Ras GTPase-activating-like protein IQGAP2  -  - 3  - 7 2 19  - 
1409 Q7LDG7 RAS guanyl-releasing protein 2 - Homo sapiens (Huma -  -  -  -  -  - 1  - 
1410 Q15404 Ras suppressor protein 1 (Rsu-1) (RSP-1)  -  - 13 2 3  - 10  - 
1411 P63000 Ras-related C3 botulinum toxin substrate 1 precursor (  -  - 6  - 5 7 6  - 
1412 P15153 Ras-related C3 botulinum toxin substrate 2 precursor (  -  - 7 4 10 7 10 X
1413 P61026 Ras-related protein Rab-10  -  - 4 2 5 5 4  - 
1414 P62491 Ras-related protein Rab-11A (Rab-11) (YL8)  -  - 7 7 7 5 7  - 
1415 Q15907 Ras-related protein Rab-11B (GTP-binding protein YPT -  -  -  - 8 5 8  - 
1416 P61106 Ras-related protein Rab-14  -  - 10 3 4 8 9  - 
1417 P59190 Ras-related protein Rab-15  -  - 2  - 2 2 2  - 
1418 Q9NP72 Ras-related protein Rab-18 - Homo sapiens (Human)  -  -  - 3  - 5 3  - 
1419 P62820 Ras-related protein Rab-1A (YPT1-related protein)  -  - 8  -  - 9 7 X
1420 Q9H0U4 Ras-related protein Rab-1B  -  - 10 5 7 10 9  - 
1421 Q9UL25 Ras-related protein Rab-21 - Homo sapiens (Human)  -  -  - 3 1 2 3  - 
1422 Q969Q5 Ras-related protein Rab-24 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
1423 P51159 Ras-related protein Rab-27A (Rab-27) (GTP-binding p  -  -  - 6 2 5 3  - 
1424 O00194 Ras-related protein Rab-27B (C25KG)  -  - 9 2  -  - 5  - 
1425 P61019 Ras-related protein Rab-2A  -  - 2 5 5 9 6  - 
1426 Q13636 Ras-related protein Rab-31 (Rab-22B)  -  -  - 5  - 4  -  - 
1427 Q13637 Ras-related protein Rab-32 - Homo sapiens (Human)  -  - 1 2  - 3  -  - 
1428 Q9H082 Ras-related protein Rab-33B  -  - 1  - 2 2 2  - 
1429 Q15286 Ras-related protein Rab-35 (Rab-1C) (GTP-binding pro -  - 2 1 2 2 2  - 
1430 Q96AX2 Ras-related protein Rab-37  -  - 2  -  - 1  -  - 
1431 Q14964 Ras-related protein Rab-39A (Rab-39)  -  -  -  - 2 2 2  - 
1432 P20336 Ras-related protein Rab-3A  -  -  - 2  - 3 5  - 
1433 P20337 Ras-related protein Rab-3B  -  -  - 1  -  -  -  - 
1434 O95716 Ras-related protein Rab-3D  -  -  - 4  - 5 6  - 
1435 P61018 Ras-related protein Rab-4B  -  -  -  -  -  - 2  - 
1436 P20339 Ras-related protein Rab-5A  -  - 3 4  - 4 4  - 
1437 P61020 Ras-related protein Rab-5B  -  - 3 4 2  -  -  - 
1438 P51148 Ras-related protein Rab-5C (RAB5L) (L1880)  -  -  - 7 6 5 6  - 
1439 P20340 Ras-related protein Rab-6A (Rab-6)  -  -  - 2 5 2 4  - 
1440 Q9NRW1 Ras-related protein Rab-6B  -  - 9  -  -  -  -  - 
1441 P51149 Ras-related protein Rab-7  -  - 11 10 10 10 10 X
1442 P61006 Ras-related protein Rab-8A (Oncogene c-mel)  -  - 5 3 6 6 6  - 
1443 Q92930 Ras-related protein Rab-8B  -  -  - 3 4 4 7  - 
1444 Q9NP90 Ras-related protein Rab-9B (Rab-9L) (RAB9-like prote  -  -  - 1  -  -  -  - 
1445 P11233 Ras-related protein Ral-A - Homo sapiens (Human)  -  -  -  -  -  - 2  - 
1446 P11234 Ras-related protein Ral-B - Homo sapiens (Human)  -  - 3 3  -  - 3  - 
1447 P62834 Ras-related protein Rap-1A precursor (GTP-binding pr  -  -  -  - 8 8 11  - 
1448 P61224 Ras-related protein Rap-1b precursor (GTP-binding pr  -  - 16 8 12 9 14 X
1449 A6NIZ1 Ras-related protein Rap-1b-like protein OS=Homo sap  -  -  - 9  -  -  -  - 
1450 P61225 Ras-related protein Rap-2b precursor  -  - 2  - 2 2  -  - 
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1451 Q9Y3L5 Ras-related protein Rap-2c precursor  -  -  - 1  -  -  -  - 
1452 Q00765 Receptor expression-enhancing protein 5 (Polyposis lo -  -  - 1  -  - 1  - 
1453 Q12913 Receptor-type tyrosine-protein phosphatase eta precur -  -  - 1  - 2  -  - 
1454 O43665 Regulator of G-protein signaling 10 (RGS10)  -  - 5  - 6  - 2 X
1455 Q9NS28 Regulator of G-protein signaling 18 (RGS18) - Homo s  -  - 4  -  -  -  -  - 
1456 P49795 Regulator of G-protein signaling 19 OS=Homo sapiens -  -  - 1  -  -  -  - 
1457 P35244 Replication protein A 14 kDa subunit (RP-A) (RF-A) (R -  -  -  - 2  - 4  - 
1458 P15927 Replication protein A 32 kDa subunit (RP-A) (RF-A) (R -  -  -  - 2 1 3 X
1459 P27694 Replication protein A 70 kDa DNA-binding subunit (RP -  -  -  -  -  - 3  - 
1460 Q9HD89 Resistin precursor (Cysteine-rich secreted protein FIZZ -  -  - 3  - 2  - X
1461 P30622 Restin (Cytoplasmic linker protein 170 alpha-2) (CLIP-  -  - 1  -  -  - 1  - 
1462 O95197 Reticulon-3 (Neuroendocrine-specific protein-like 2) (N -  -  - 2  - 2  -  - 
1463 Q9NQC3 Reticulon-4 (Neurite outgrowth inhibitor) (Nogo protein  -  - 3 2 1 4 2  - 
1464 P00352 Retinal dehydrogenase 1 (EC 1.2.1.36) (RalDH1) (RAL - 6  -  -  -  -  - X
1465 Q99969 Retinoic acid receptor responder protein 2 precursor (T 3  -  -  -  -  -  -  - 
1466 Q9HB40 Retinoid-inducible serine carboxypeptidase precursor ( -  -  - 1  - 3 2  - 
1467 Q8TC12 Retinol dehydrogenase 11 (EC 1.1.1.-) (Retinal reducta -  - 4  -  -  - 1  - 
1468 P52565 Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GD -  - 4 5 6 5 7 X
1469 P52566 Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Rho-GD -  - 10 13 17 13 18 X
1470 Q68EM7 Rho GTPase-activating protein 17 - Homo sapiens (Hu -  -  -  -  -  - 1  - 
1471 Q7Z6I6 Rho GTPase-activating protein 30 - Homo sapiens (Hu -  -  -  - 1  - 2  - 
1472 Q92888 Rho guanine nucleotide exchange factor 1 (p115-RhoG -  -  -  - 7  - 5  - 
1473 Q96PE2 Rho guanine nucleotide exchange factor 17 - Homo sa -  -  -  - 2  -  -  - 
1474 Q13464 Rho-associated protein kinase 1 (EC 2.7.11.1) (Rho-as -  -  -  -  -  - 5  - 
1475 Q07960 Rho-GTPase-activating protein 1 (GTPase-activating p -  - 1 5 1 1 6 X
1476 Q8N392 Rho-GTPase-activating protein 18 (MacGAP) - Homo s -  - 1  -  -  -  -  - 
1477 P42331 Rho-GTPase-activating protein 25 - Homo sapiens (Hu -  -  -  - 1  - 1  - 
1478 P98171 Rho-GTPase-activating protein 4 (Rho-GAP hematopo -  -  -  - 5 4 4  - 
1479 O43182 Rho-GTPase-activating protein 6 (Rho-type GTPase-a  -  - 1  -  -  -  -  - 
1480 P62745 Rho-related GTP-binding protein RhoB precursor (H6)  -  -  - 3  -  -  - X
1481 P08134 Rho-related GTP-binding protein RhoC precursor (H9)  -  - 7  -  -  - 9  - 
1482 P84095 Rho-related GTP-binding protein RhoG precursor  -  - 2 7 6 8 8  - 
1483 P34096 Ribonuclease 4 precursor (EC 3,1,27,-) (RNase 4) - Ho 1  -  -  -  -  -  -  - 
1484 P13489 Ribonuclease inhibitor (Ribonuclease/angiogenin inhib  - 4 2 4 3 11 12  - 
1485 O00584 Ribonuclease T2 precursor (EC 3.1.27.-) (Ribonucleas -  -  - 1 1  - 1  - 
1486 P49247 Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phospho -  - 1 2 3  - 1 X
1487 P60891 Ribose-phosphate pyrophosphokinase I (EC 2.7.6.1) (P - 5  -  - 5  - 1 X
1488 P11908 Ribose-phosphate pyrophosphokinase II (EC 2,7,6,1) ( -  -  -  -  -  - 2 X
1489 P51812 Ribosomal protein S6 kinase alpha-3 (EC 2.7.11.1) (S6 -  -  -  - 1 2 5  - 
1490 Q9P2E9 Ribosome-binding protein 1 (Ribosome receptor protei  -  -  -  -  -  - 1  - 
1491 P16083 Ribosyldihydronicotinamide dehydrogenase [quinone]  -  -  - 2  -  -  - X
1492 Q63HN8 RING finger protein 213 - Homo sapiens (Human)  -  -  -  -  - 2  -  - 
1493 Q9Y5S9 RNA-binding protein 8A (RNA-binding motif protein 8A  -  - 1  - 2  - 1 X
1494 Q01844 RNA-binding protein EWS (EWS oncogene) (Ewing sa -  -  -  -  -  - 1  - 
1495 P35637 RNA-binding protein FUS (Oncogene FUS) (Oncogene -  -  -  -  -  - 1  - 
1496 Q96T51 RUN and FYVE domain-containing protein 1 (FYVE-fin -  - 1  - 2  -  -  - 
1497 Q9Y230 RuvB-like 2 (EC 3.6.1.-) (48-kDa TATA box-binding pro - 1  -  - 1  - 1 X
1498 P26447 S100 calcium-binding protein A4 (Metastasin) (Mts1 pr  -  -  - 3 3 6 4 X
1499 Q9UH99 Sad1/unc-84-like protein 2 (Rab5-interacting protein) (R -  -  -  - 1  - 2  - 
1500 P31153 S-adenosylmethionine synthetase isoform type-2 (EC 2 -  -  -  - 2  -  - X
1501 Q9Y3Z3 SAM domain and HD domain-containing protein 1 (Den -  -  -  - 14 15 31 X
1502 Q9UPN7 SAPS domain family member 1  -  -  -  -  -  - 1  - 
1503 P16615 Sarcoplasmic/endoplasmic reticulum calcium ATPase  -  -  -  -  - 1 6  - 
1504 Q93084 Sarcoplasmic/endoplasmic reticulum calcium ATPase  -  - 7 3 3 1 8  - 
1505 Q96C86 Scavenger mRNA decapping enzyme DcpS (EC 3.-.-.-  -  -  -  - 4 1  - X
1506 P55735 SEC13-related protein (SEC13-like protein 1)  -  - 1  -  -  - 1 X
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1507 Q13103 Secreted phosphoprotein 24 precursor (Spp-24) (Secre 3  -  -  -  -  -  -  - 
1508 Q96PL1 Secretoglobin family 3A member 2 precursor - Homo s 1  -  -  -  -  -  -  - 
1509 O15126 Secretory carrier-associated membrane protein 1 (Sec  -  -  -  -  - 1  -  - 
1510 O15127 Secretory carrier-associated membrane protein 2 (Sec  -  -  -  -  - 2  -  - 
1511 P49903 Selenide, water dikinase 1 (EC 2.7.9.3) (Selenophosph -  -  -  - 1  -  - X
1512 Q13228 Selenium-binding protein 1  - 6  -  - 6  -  - X
1513 Q8IZQ5 Selenoprotein H - Homo sapiens (Human)  -  -  -  -  -  - 1  - 
1514 P49908 Selenoprotein P precursor (SeP) - Homo sapiens (Hum 1  -  -  -  -  -  -  - 
1515 Q8WYJ6 Septin-1 (LARP) (Serologically defined breast cancer a -  -  -  -  -  - 3 X
1516 Q9NVA2 Septin-11  -  -  -  -  -  - 3 X
1517 Q15019 Septin-2 (Protein NEDD5)  -  - 4  - 2 1 3 X
1518 Q14141 Septin-6  -  - 1  - 4  - 6 X
1519 Q16181 Septin-7 (CDC10 protein homolog)  -  - 2  - 5  - 8  - 
1520 Q9UHD8 Septin-9 (MLL septin-like fusion protein) (MLL septin-li  - 1 1  - 8  - 5  - 
1521 P34897 Serine hydroxymethyltransferase, mitochondrial precur -  -  -  - 1 3  -  - 
1522 O15269 Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chai  -  -  -  -  - 2  -  - 
1523 P62140 Serine/threonine protein phosphatase PP1-beta cataly  -  - 5  - 6  - 7 X
1524 O94804 Serine/threonine-protein kinase 10 (EC 2.7.1.37) (Lym  -  -  -  - 3 1 12  - 
1525 Q9Y6E0 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (STE  -  - 4  -  -  -  -  - 
1526 O00506 Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ster  -  -  -  - 2  -  -  - 
1527 Q13043 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (STE2  -  -  - 1  -  - 2 X
1528 Q8TD19 Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (N  -  -  -  -  -  - 1  - 
1529 O95747 Serine/threonine-protein kinase OSR1 (EC 2.7.1.37) (O - 1  -  -  -  - 1  - 
1530 Q13177 Serine/threonine-protein kinase PAK 2 (EC 2.7.1.37) (p -  - 1  -  - 1 1 X
1531 Q96C45 Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (U -  -  -  -  -  - 1  - 
1532 P63151 Serine/threonine-protein phosphatase 2A 55 kDa regu  -  -  - 1  -  - 1 X
1533 P30153 Serine/threonine-protein phosphatase 2A 65 kDa regu  -  - 2 1 7 5 9 X
1534 P67775 Serine/threonine-protein phosphatase 2A catalytic sub  -  - 1  - 1  -  - X
1535 Q15257 Serine/threonine-protein phosphatase 2A regulatory su -  -  -  -  -  - 1  - 
1536 P62136 Serine/threonine-protein phosphatase PP1-alpha catal  -  - 5  - 6  - 8 X
1537 P02787 Serotransferrin precursor (Transferrin) (Siderophilin) (B 35  - 5  -  -  - 29 X
1538 P48595 Serpin B10 (Bomapin) (Protease inhibitor 10) - Homo s -  -  - 4  - 1  -  - 
1539 P50452 Serpin B8 (Cytoplasmic antiproteinase 2) (CAP2) (CAP -  -  -  -  - 5 2 X
1540 P02768 Serum albumin precursor 56 17  -  -  -  - 60 X
1541 P02735 Serum amyloid A protein precursor (SAA) [Contains: A 2  -  -  -  -  -  -  - 
1542 P35542 Serum amyloid A-4 protein precursor (Constitutively ex 8  - 1  -  -  -  -  - 
1543 P02743 Serum amyloid P-component precursor (SAP) (9.5S al 9  -  -  -  -  -  -  - 
1544 O95810 Serum deprivation-response protein (Phosphatidylserin -  - 9  - 1  - 2  - 
1545 P27169 Serum paraoxonase/arylesterase 1 (EC 3.1.1.2) (EC 3 7  -  -  -  -  -  - X
1546 Q15166 Serum paraoxonase/lactonase 3 (EC 3,1,1,-) - Homo s 1  -  -  -  -  -  -  - 
1547 P49591 Seryl-tRNA synthetase (EC 6.1.1.11) (Serine--tRNA lig -  -  -  - 4  - 5 X
1548 P04278 Sex hormone-binding globulin precursor (SHBG) (Sex 3  -  -  -  -  -  -  - 
1549 O60880 SH2 domain protein 1A (Signaling lymphocyte activatio -  -  -  - 2  - 3  - 
1550 O75368 SH3 domain-binding glutamic acid-rich-like protein  -  - 4 3 3 4 5 X
1551 Q9UJC5 SH3 domain-binding glutamic acid-rich-like protein 2 (F -  - 2  -  -  - 1  - 
1552 Q9H299 SH3 domain-binding glutamic acid-rich-like protein 3 (S -  - 4 2 2 4 4  - 
1553 Q9Y3L3 SH3 domain-binding protein 1 (3BP-1) - Homo sapiens -  -  -  - 4  -  -  - 
1554 O75995 SH3 protein expressed in lymphocytes homolog  -  -  -  - 1  -  -  - 
1555 Q16836 Short chain 3-hydroxyacyl-CoA dehydrogenase, mitoch -  - 8  - 9 1 8  - 
1556 Q9Y3A5 Shwachman-Bodian-Diamond syndrome protein - Hom -  - 1  - 1  -  -  - 
1557 Q9NR45 Sialic acid synthase (N-acetylneuraminate synthase) (E -  -  - 1 1 1 1 X
1558 O15389 Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens G -  -  - 1  -  -  -  - 
1559 Q9Y286 Sialic acid-binding Ig-like lectin 7 precursor (Siglec-7) (  -  -  -  -  - 1  -  - 
1560 Q9Y336 Sialic acid-binding Ig-like lectin 9 precursor (Siglec-9) (  -  -  -  -  - 2 1  - 
1561 Q9H9B4 Sideroflexin-1 (Tricarboxylate carrier protein) (TCC)  -  -  -  - 5  - 4  - 
1562 Q9BWM7 Sideroflexin-3 - Homo sapiens (Human)  -  -  -  - 1  - 2  - 
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1563 Q15005 Signal peptidase complex subunit 2 (EC 3.4.-.-) (Micro  -  -  -  -  - 1  -  - 
1564 P61009 Signal peptidase complex subunit 3 (EC 3.4.-.-) (Micro  -  -  -  -  - 1  -  - 
1565 P37108 Signal recognition particle 14 kDa protein (SRP14) (18  -  -  -  - 3 1 2  - 
1566 O76094 Signal recognition particle 72 kDa protein (SRP72) - H  -  -  -  - 1  -  -  - 
1567 P49458 Signal recognition particle 9 kDa protein (SRP9)  -  -  -  - 1 2 2  - 
1568 P42224 Signal transducer and activator of transcription 1-alpha -  -  -  - 4  - 10  - 
1569 P40763 Signal transducer and activator of transcription 3 (Acut  -  -  -  -  -  - 3  - 
1570 P51692 Signal transducer and activator of transcription 5B - Ho -  -  -  - 1 1 3  - 
1571 Q9Y3P8 Signaling threshold-regulating transmembrane adapter -  -  -  - 1  -  -  - 
1572 Q04837 Single-stranded DNA-binding protein, mitochondrial pr  -  - 1  - 2 1 7  - 
1573 Q9UIB8 SLAM family member 5 precursor (Signaling lymphocy -  - 1  -  -  -  -  - 
1574 O43765 Small glutamine-rich tetratricopeptide repeat-containin  -  - 1  -  -  -  -  - 
1575 P62304 Small nuclear ribonucleoprotein E (snRNP-E) (Sm prot -  -  -  - 1  - 1  - 
1576 P62314 Small nuclear ribonucleoprotein Sm D1 (snRNP core p -  -  -  -  -  - 1  - 
1577 P62316 Small nuclear ribonucleoprotein Sm D2 (snRNP core p -  -  -  - 1  -  -  - 
1578 P62318 Small nuclear ribonucleoprotein Sm D3 (snRNP core p -  -  -  - 2  -  -  - 
1579 P61956 Small ubiquitin-related modifier 2 precursor (SUMO-2)  -  -  - 1 1 1 1 X
1580 P13501 Small-inducible cytokine A5 precursor - Homo sapiens  -  - 2  -  -  -  -  - 
1581 Q13126 S-methyl-5-thioadenosine phosphorylase (EC 2.4.2.28  -  - 1 1  -  - 4 X
1582 O95295 SNARE-associated protein Snapin (Synaptosomal-ass -  -  -  - 1 2 1  - 
1583 P05023 Sodium/potassium-transporting ATPase alpha-1 chain  -  -  -  - 1 4 6  - 
1584 P54709 Sodium/potassium-transporting ATPase beta-3 chain (  -  -  -  -  - 1  -  - 
1585 P11166 Solute carrier family 2, facilitated glucose transporter m - 1  -  - 3  -  -  - 
1586 Q8TDB8 Solute carrier family 2, facilitated glucose transporter m -  -  - 2  -  -  -  - 
1587 P11169 Solute carrier family 2, facilitated glucose transporter m -  - 1 3  -  - 3  - 
1588 P01241 Somatotropin precursor - Homo sapiens (Human) 1  -  -  -  -  -  -  - 
1589 P30626 Sorcin (22 kDa protein) (CP-22) (V19)  -  - 4  - 4 4 2 X
1590 Q99523 Sortilin precursor (Neurotensin receptor 3) (NTR3) (NT -  -  -  -  - 1  -  - 
1591 O60493 Sorting nexin-3 (SDP3 protein)  -  - 1 2  - 3  -  - 
1592 P09486 SPARC precursor (Secreted protein acidic and rich in c 2  - 4  -  -  -  -  - 
1593 Q13813 Spectrin alpha chain, brain (Spectrin, non-erythroid alp - 3  -  -  - 1 2  - 
1594 P02549 Spectrin alpha chain, erythrocyte (Erythroid alpha-spec - 57 8  -  -  -  -  - 
1595 Q01082 Spectrin beta chain, brain 1 (Spectrin, non-erythroid be 1  - 1  -  -  -  -  - 
1596 P11277 Spectrin beta chain, erythrocyte (Beta-I spectrin) - Hom - 49 14  -  -  - 1  - 
1597 P63208 S-phase kinase-associated protein 1A (Cyclin A/CDK2  - 2  -  - 4 2 2  - 
1598 Q13838 Spliceosome RNA helicase BAT1 (EC 3.6.1.-) (DEAD  -  -  -  - 2  - 3 X
1599 P26368 Splicing factor U2AF 65 kDa subunit (U2 auxiliary facto -  -  -  -  -  - 1  - 
1600 P23246 Splicing factor, proline- and glutamine-rich (Polypyrimid -  -  -  -  -  - 1  - 
1601 Q15020 Squamous cell carcinoma antigen recognized by T-cel  -  -  -  -  -  - 3  - 
1602 O75563 Src kinase-associated phosphoprotein 2 - Homo sapie  -  - 1 3  - 4  -  - 
1603 Q14247 Src substrate cortactin (Amplaxin) (Oncogene EMS1)  -  - 4  -  -  -  - X
1604 Q7KZF4 Staphylococcal nuclease domain-containing protein 1 ( - 2 1  - 1  - 2  - 
1605 P16949 Stathmin (Phosphoprotein p19) (pp19) (Oncoprotein 18 -  -  -  - 4 5 4 X
1606 Q9UJZ1 Stomatin-like protein 2 (SLP-2) (EPB72-like 2)  -  -  -  -  -  - 1 X
1607 P38646 Stress-70 protein, mitochondrial precursor (75 kDa glu  -  -  -  - 4 4 9 X
1608 P31948 Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90 - 2 2  - 2 4 4 X
1609 Q9NRL3 Striatin-4 (Zinedin) - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
1610 Q9HCN8 Stromal cell-derived factor 2-like protein 1 precursor (S -  -  -  -  - 1 1  - 
1611 Q13586 Stromal interaction molecule 1 precursor - Homo sapie -  - 1  -  -  -  -  - 
1612 Q8WU79 Stromal membrane-associated protein 2 OS=Homo sa  -  -  - 2  -  -  -  - 
1613 P31040 Succinate dehydrogenase [ubiquinone] flavoprotein su  -  -  -  - 2 1 4 X
1614 P21912 Succinate dehydrogenase [ubiquinone] iron-sulfur prot  -  -  -  - 5 3 3  - 
1615 Q9P2R7 Succinyl-CoA ligase [ADP-forming] beta-chain, mitocho -  -  -  - 1  -  - X
1616 Q96I99 Succinyl-CoA ligase [GDP-forming] beta-chain, mitoch  -  -  -  - 2  -  - X
1617 P53597 Succinyl-CoA ligase [GDP-forming] subunit alpha, mito -  -  -  - 3  - 2  - 
1618 P55809 Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, m -  - 3  - 2  -  - X
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1619 P14410 Sucrase-isomaltase, intestinal OS=Homo sapiens GN= -  -  - 1  -  -  -  - 
1620 Q9Y6N5 Sulfide:quinone oxidoreductase, mitochondrial precurs  -  -  -  - 4 5 4  - 
1621 P50225 Sulfotransferase 1A1 (EC 2.8.2.1) (Aryl sulfotransferas -  - 4 1  - 2  - X
1622 P63279 SUMO-conjugating enzyme UBC9 (EC 6.3.2.-) (SUMO -  -  -  - 2 2 5  - 
1623 P00441 Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) 2 5 5 4 8 6 8 X
1624 P04179 Superoxide dismutase [Mn], mitochondrial precursor (E -  - 10 5 8 6 9 X
1625 Q9Y2Z0 Suppressor of G2 allele of SKP1 homolog (Sgt1) (Puta -  - 1  -  -  - 1 X
1626 Q8TF42 Suppressor of T-cell receptor signaling 1 (Sts-1) (Cbl-in -  - 2  -  -  -  -  - 
1627 O15260 Surfeit locus protein 4  -  -  - 1 1 1 2  - 
1628 Q99536 Synaptic vesicle membrane protein VAT-1 homolog (E  -  -  - 11 3 2 2 X
1629 O15056 Synaptojanin-2 (EC 3.1.3.36) (Synaptic inositol-1,4,5-tr - 1  -  - 1  -  -  - 
1630 O00161 Synaptosomal-associated protein 23 (SNAP-23) (Vesic -  - 3  -  -  - 1  - 
1631 O95721 Synaptosomal-associated protein 29 (SNAP-29) (Vesic -  - 2  -  -  -  - X
1632 Q96C24 Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin -  - 2  -  -  -  -  - 
1633 Q9NX95 Syntabulin - Homo sapiens (Human)  -  -  -  - 1  -  -  - 
1634 O75558 Syntaxin-11 - Homo sapiens (Human)  -  - 4  -  -  - 1  - 
1635 Q12846 Syntaxin-4 (NY-REN-31 antigen) - Homo sapiens (Hum -  - 1  -  -  -  -  - 
1636 O15400 Syntaxin-7 - Homo sapiens (Human)  -  - 2  -  - 1 1  - 
1637 Q15833 Syntaxin-binding protein 2 (Unc-18 homolog 2) (Unc-1  -  - 7 1  -  -  - X
1638 O00560 Syntenin-1 (Syndecan-binding protein 1) (Melanoma d  -  -  - 2  - 1  -  - 
1639 Q9Y490 Talin-1  - 17 135 42 75 53 136 X
1640 Q9Y4G6 Talin-2 - Homo sapiens (Human)  -  -  -  -  -  - 8  - 
1641 O15533 Tapasin precursor - Homo sapiens (Human)  -  - 1  - 1 1 1  - 
1642 Q13148 TAR DNA-binding protein 43 (TDP-43)  -  -  -  -  -  - 2 X
1643 O60784 Target of Myb protein 1 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
1644 Q6SJ96 TATA box-binding protein-like protein 2 - Homo sapien -  -  - 1  -  -  -  - 
1645 Q66K14 TBC1 domain family member 9B - Homo sapiens (Hum -  -  -  -  - 1  -  - 
1646 P56279 T-cell leukemia/lymphoma protein 1A (P14 TCL1 prote -  -  -  -  -  - 2  - 
1647 P04234 T-cell surface glycoprotein CD3 delta chain precursor ( -  -  -  - 2  - 1  - 
1648 P07766 T-cell surface glycoprotein CD3 epsilon chain precurso -  -  -  - 1  -  -  - 
1649 P20963 T-cell surface glycoprotein CD3 zeta chain precursor -  -  -  -  - 1  -  -  - 
1650 P06127 T-cell surface glycoprotein CD5 precursor (Lymphocyte -  -  -  - 1  - 1  - 
1651 P17987 T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT - 2 2  - 6 2 8 X
1652 P78371 T-complex protein 1 subunit beta (TCP-1-beta) (CCT-b -  - 6  - 12 1 6 X
1653 P50991 T-complex protein 1 subunit delta (TCP-1-delta) (CCT- - 2 2 1 6 4 5 X
1654 P48643 T-complex protein 1 subunit epsilon (TCP-1-epsilon) (C - 1 2  - 5 1 5 X
1655 Q99832 T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta  - 3 2 1 5 1 8 X
1656 P49368 T-complex protein 1 subunit gamma (TCP-1-gamma) (  - 1 4  - 8  - 8 X
1657 P50990 T-complex protein 1 subunit theta (TCP-1-theta) (CCT- - 2 6  - 8 4 10 X
1658 P40227 T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-z  - 1 4 1 10 6 11 X
1659 Q92526 T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CC -  - 2  -  -  -  -  - 
1660 Q9UGI8 Testin (TESS)  -  -  -  -  -  - 3  - 
1661 P05452 Tetranectin precursor (TN) (C-type lectin domain family 5  -  -  -  -  -  -  - 
1662 Q8NG11 Tetraspanin-14 (Tspan-14) (Transmembrane 4 superfa -  -  -  -  - 1  -  - 
1663 Q9Y3D6 Tetratricopeptide repeat protein 11 (TPR repeat protein -  -  -  - 1 2 2  - 
1664 Q9BU02 Thiamine-triphosphatase (EC 3.6.1.28) (ThTPase) - Ho -  -  -  - 1  -  -  - 
1665 Q9NPJ3 Thioesterase superfamily member 2 - Homo sapiens (H -  -  -  - 2  -  -  - 
1666 P10599 Thioredoxin (ATL-derived factor) (ADF) (Surface-assoc -  - 2 5 1 4 3 X
1667 Q9H3N1 Thioredoxin domain-containing protein 1 precursor (Tra -  -  - 1  - 2 3  - 
1668 O95881 Thioredoxin domain-containing protein 12 precursor (E -  -  - 2  -  -  -  - 
1669 Q9BS26 Thioredoxin domain-containing protein 4 precursor (En -  -  -  -  - 1  - X
1670 Q8NBS9 Thioredoxin domain-containing protein 5 precursor (Th -  -  -  - 1  -  - X
1671 Q16881 Thioredoxin reductase 1, cytoplasmic precursor (EC 1,  -  -  - 1  -  -  - X
1672 Q9NNW7 Thioredoxin reductase 2, mitochondrial precursor (EC  -  -  -  - 1  -  -  - 
1673 P30048 Thioredoxin-dependent peroxide reductase, mitochond -  - 6 2 4 8 8 X
1674 O43396 Thioredoxin-like protein 1 (32 kDa thioredoxin-related p - 1 6  -  -  -  - X
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1675 Q9BRA2 Thioredoxin-like protein 5 (14 kDa thioredoxin-related p -  -  - 2 1 3  -  - 
1676 Q16762 Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese  -  - 3  -  -  -  - X
1677 P26639 Threonyl-tRNA synthetase, cytoplasmic (EC 6.1.1.3) (T -  -  -  -  - 1 3  - 
1678 P07996 Thrombospondin-1 precursor 7  - 30  -  -  - 27  - 
1679 P35443 Thrombospondin-4 precursor - Homo sapiens (Human 3  -  -  -  -  -  -  - 
1680 P24557 Thromboxane-A synthase (EC 5.3.99.5) (TXA synthas  -  -  -  -  - 4  -  - 
1681 P19971 Thymidine phosphorylase precursor (EC 2.4.2.4) (TdR  -  - 5 2 5 5 7 X
1682 P23919 Thymidylate kinase (EC 2.7.4.9) (dTMP kinase)  -  -  -  - 2  -  -  - 
1683 P63313 Thymosin beta-10  -  -  -  -  - 1 1  - 
1684 P62328 Thymosin beta-4 (T beta 4) (Fx) [Contains: Hematopoi  -  -  - 1  - 3 2  - 
1685 P05543 Thyroxine-binding globulin precursor (T4-binding globu 3  -  -  -  -  -  -  - 
1686 Q9BVW5 TIMELESS-interacting protein - Homo sapiens (Human -  -  - 2  -  -  -  - 
1687 Q8WZ42 Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma a 2  -  -  -  -  -  -  - 
1688 Q9H0E2 Toll-interacting protein  -  - 1  -  - 3  - X
1689 O60603 Toll-like receptor 2 precursor (Toll/interleukin 1 recepto -  -  -  -  - 4  -  - 
1690 Q6ZVM7 TOM1-like protein 2 - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
1691 O14656 Torsin A precursor (Torsin family 1 member A) (Dyston -  -  - 1  -  - 1  - 
1692 Q5JTV8 Torsin-1A-interacting protein 1  -  -  - 1  - 1 2 X
1693 Q9Y3C4 TP53RK-binding protein - Homo sapiens (Human)  -  -  -  - 1  - 1  - 
1694 Q9Y228 TRAF3-interacting JNK-activating modulator (TRAF3-in -  -  -  - 1  - 3  - 
1695 O43617 Trafficking protein particle complex subunit 3 (BET3 ho -  - 1  - 4 2 3  - 
1696 P37837 Transaldolase (EC 2.2.1.2)  -  - 9 16 17 17 15 X
1697 P20061 Transcobalamin-1 precursor (Transcobalamin I) (TCI)  -  -  - 2  -  -  -  - 
1698 P23193 Transcription elongation factor A protein 1 (Transcriptio -  -  -  -  -  - 2  - 
1699 Q15369 Transcription elongation factor B polypeptide 1 (RNA p -  - 2  -  -  - 1  - 
1700 Q15370 Transcription elongation factor B polypeptide 2 (RNA p -  -  - 2  -  - 1  - 
1701 Q00059 Transcription factor A, mitochondrial precursor (mtTFA -  -  -  -  -  - 2  - 
1702 P20290 Transcription factor BTF3 (RNA polymerase B transcri  -  -  -  - 3 3 3 X
1703 Q96K17 Transcription factor BTF3 homolog 4 (Basic transcriptio -  -  -  - 1  - 1 X
1704 P17947 Transcription factor PU.1 (31 kDa transforming protein  -  -  -  -  - 1  -  - 
1705 P13984 Transcription initiation factor IIF subunit beta - Homo s  -  -  -  - 1  -  -  - 
1706 Q13263 Transcription intermediary factor 1-beta (TIF1-beta) (T  -  -  -  - 1  - 3 X
1707 P11308 Transcriptional regulator ERG (Transforming protein E  -  -  -  -  - 1 1  - 
1708 P02786 Transferrin receptor protein 1 (TfR1) (TR) (TfR) (Trfr) (  -  -  -  - 1  -  -  - 
1709 Q9Y6A5 Transforming acidic coiled-coil-containing protein 3 (ER -  -  -  -  -  - 1  - 
1710 P01137 Transforming growth factor beta-1 precursor (TGF-beta 1  - 6  -  -  -  -  - 
1711 O43294 Transforming growth factor beta-1-induced transcript 1 -  - 4  -  -  -  -  - 
1712 P61586 Transforming protein RhoA precursor (H12)  - 1 7 7 10 6 12 X
1713 Q01995 Transgelin (Smooth muscle protein 22-alpha) (SM22-a -  -  -  -  -  - 4  - 
1714 P37802 Transgelin-2 (SM22-alpha homolog) 1  - 22 9 16 15 19  - 
1715 P55072 Transitional endoplasmic reticulum ATPase (TER ATP  - 13 14  - 20 14 23 X
1716 P29401 Transketolase (EC 2.2.1.1) (TK)  - 2 2 23 16 21 23 X
1717 P13693 Translationally-controlled tumor protein (TCTP) (p23) (  -  - 3 1 4 2 4 X
1718 Q15631 Translin - Homo sapiens (Human)  -  -  -  - 4 6 2  - 
1719 Q99598 Translin-associated protein X (Translin-associated fact  -  -  - 1 3 1 3 X
1720 P51571 Translocon-associated protein delta subunit precursor  -  -  -  - 3 2 2 X
1721 Q9UM00 Transmembrane and coiled-coil domain-containing pro -  -  -  -  -  - 1  - 
1722 Q15363 Transmembrane emp24 domain trafficking protein 2 pr  -  -  -  - 3 1 2  - 
1723 P49755 Transmembrane emp24 domain-containing protein 10  -  -  -  - 4 5 5  - 
1724 Q9Y3B3 Transmembrane emp24 domain-containing protein 7 p -  - 1  -  -  -  -  - 
1725 Q9BVK6 Transmembrane emp24 domain-containing protein 9 p -  - 3  - 1 3 4  - 
1726 Q9BVC6 Transmembrane protein 109 precursor (Mitsugumin-23 -  -  -  -  - 1  -  - 
1727 Q4KMQ2 Transmembrane protein 16F - Homo sapiens (Human) -  -  -  -  -  - 1  - 
1728 Q86WV6 Transmembrane protein 173 - Homo sapiens (Human)  -  -  -  -  - 5  -  - 
1729 Q6UW68 Transmembrane protein 205 - Homo sapiens (Human)  -  -  -  -  - 1 1  - 
1730 P57088 Transmembrane protein 33 (DB83 protein) - Homo sap -  -  -  -  - 1 1  - 
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1731 Q9BTV4 Transmembrane protein 43 - Homo sapiens (Human)  -  -  -  -  - 1 1  - 
1732 Q92973 Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M -  -  -  - 1  - 2  - 
1733 P02766 Transthyretin precursor (Prealbumin) (TBPA) (TTR) (A 15 1 2  -  - 6 6  - 
1734 Q86YW5 Trem-like transcript 1 protein precursor (TLT-1) (Trigge -  - 5  - 1  - 1  - 
1735 P40939 Trifunctional enzyme alpha subunit, mitochondrial prec 6  -  -  - 2 1 17  - 
1736 P55084 Trifunctional enzyme subunit beta, mitochondrial precu -  - 1  - 2 3 5  - 
1737 P60174 Triosephosphate isomerase (EC 5.3.1.1) (TIM) (Triose  - 4 16 11 20 16 21 X
1738 P29144 Tripeptidyl-peptidase 2 (EC 3.4.14.10) (Tripeptidyl-pep -  - 2  -  -  - 2  - 
1739 O14773 Tripeptidyl-peptidase I precursor (EC 3.4.14.9) (TPP-I)  -  - 1 2 1 4 3 X
1740 Q9UI30 TRM112-like protein - Homo sapiens (Human)  -  -  -  - 1  - 1 X
1741 Q9NZR1 Tropomodulin-2 (Neuronal tropomodulin) (N-Tmod) - H -  -  - 1  -  -  -  - 
1742 Q9NYL9 Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod) -  -  - 6 3  -  -  - X
1743 P09493 Tropomyosin 1 alpha chain (Alpha-tropomyosin)  -  - 11  - 7 6 9 X
1744 P06753 Tropomyosin alpha-3 chain (Tropomyosin-3) (Tropomy -  - 14  - 16 12 16 X
1745 P67936 Tropomyosin alpha-4 chain (Tropomyosin-4) (TM30p1  -  - 25  - 14 9 19 X
1746 P07951 Tropomyosin beta chain (Tropomyosin 2) (Beta-tropom -  - 11  - 7 7 8 X
1747 P23381 Tryptophanyl-tRNA synthetase (EC 6.1.1.2) (Tryptopha -  -  - 2 1 5 5 X
1748 Q9Y3Q8 TSC22 domain family protein 4 - Homo sapiens (Huma -  - 1  -  -  -  -  - 
1749 Q8TAP9 TTD non-photosensitive 1 protein - Homo sapiens (Hu  -  -  -  -  -  - 1  - 
1750 P68366 Tubulin alpha-1 chain (Alpha-tubulin 1) (Testis-specific  -  -  -  -  - 7 16  - 
1751 Q13748 Tubulin alpha-2 chain (Alpha-tubulin 2)  -  -  -  -  - 5  -  - 
1752 Q71U36 Tubulin alpha-3 chain (Alpha-tubulin 3) (Tubulin B-alph -  -  - 10  - 9 17 X
1753 Q9BQE3 Tubulin alpha-6 chain (Alpha-tubulin 6)  -  - 17  -  -  -  - X
1754 Q9NY65 Tubulin alpha-8 chain (Alpha-tubulin 8)  -  -  -  -  -  - 10  - 
1755 P68363 Tubulin alpha-ubiquitous chain (Alpha-tubulin ubiquitou -  -  -  - 15 12 17 X
1756 Q9H4B7 Tubulin beta-1 chain - Homo sapiens (Human)  -  - 29  -  -  - 16  - 
1757 P07437 Tubulin beta-2 chain  - 2 27  - 22 16 24 X
1758 Q13885 Tubulin beta-2A chain - Homo sapiens (Human)  -  -  -  -  -  - 16  - 
1759 P68371 Tubulin beta-2C chain (Tubulin beta-2 chain)  -  -  - 14  - 7 21  - 
1760 P04350 Tubulin beta-4 chain (Tubulin 5 beta)  -  -  -  -  -  - 15  - 
1761 Q9BUF5 Tubulin beta-6 chain - Homo sapiens (Human)  -  - 7  -  -  - 6  - 
1762 O75347 Tubulin-specific chaperone A (Tubulin-folding cofactor  -  - 1 1 2 3 2 X
1763 Q99426 Tubulin-specific chaperone B (Tubulin folding cofactor  -  - 2  - 3  - 2 X
1764 Q14166 Tubulin--tyrosine ligase-like protein 12  -  -  -  -  -  - 2 X
1765 Q6EMB2 Tubulin--tyrosine ligase-like protein 5 (SRC1 and TIF2- -  -  -  -  - 1  -  - 
1766 O95379 Tumor necrosis factor, alpha-induced protein 8 - Homo -  -  -  - 1  - 3  - 
1767 Q6P589 Tumor necrosis factor, alpha-induced protein 8-like pro -  -  - 1 2 1 3  - 
1768 O43399 Tumor protein D54 (hD54) (Tumor protein D52-like 2)  -  - 2  - 2 4 3 X
1769 Q6IBS0 Twinfilin-2 (Twinfilin-1-like protein) (A6-related protein)  -  - 6 4 3 2 5 X
1770 O43914 TYRO protein tyrosine kinase-binding protein precurso -  -  -  -  - 2 1  - 
1771 P41240 Tyrosine-protein kinase CSK (EC 2.7.1.112) (C-SRC k  -  - 2  - 4 3 6 X
1772 P08631 Tyrosine-protein kinase HCK (EC 2.7.10.2) (p59-HCK/  -  -  -  -  - 1  -  - 
1773 P43405 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyr  -  -  -  -  - 4  -  - 
1774 P43403 Tyrosine-protein kinase ZAP-70 (EC 2.7.1.112) (70 kD  -  -  -  - 1  - 4  - 
1775 P18031 Tyrosine-protein phosphatase non-receptor type 1 (EC -  - 1  - 1  -  -  - 
1776 P29350 Tyrosine-protein phosphatase non-receptor type 6 (EC -  - 2 5 6 11 20  - 
1777 P35236 Tyrosine-protein phosphatase non-receptor type 7 - Ho -  -  -  - 1  -  -  - 
1778 P78324 Tyrosine-protein phosphatase non-receptor type subst  -  -  - 1  -  -  -  - 
1779 P54577 Tyrosyl-tRNA synthetase, cytoplasmic (EC 6.1.1.1) (Ty -  - 1  -  -  - 1 X
1780 Q8WWY3 U4/U6 small nuclear ribonucleoprotein Prp31 - Homo s -  -  -  - 1  -  -  - 
1781 Q9Y333 U6 snRNA-associated Sm-like protein LSm2 (SnRNP c -  -  -  - 3 3 2  - 
1782 Q9Y4Z0 U6 snRNA-associated Sm-like protein LSm4 (Glycine-  -  -  -  -  -  - 1  - 
1783 P62312 U6 snRNA-associated Sm-like protein LSm6 (Sm prote -  -  -  - 1  -  -  - 
1784 O95777 U6 snRNA-associated Sm-like protein LSm8  -  -  -  -  -  - 1  - 
1785 P14927 Ubiquinol-cytochrome c reductase complex 14 kDa pro -  -  -  - 1 1  -  - 
1786 P47985 Ubiquinol-cytochrome c reductase iron-sulfur subunit, m -  - 1  - 2  - 3 X
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1787 P22695 Ubiquinol-cytochrome-c reductase complex core prote  -  - 1  - 2 1 6  - 
1788 P31930 Ubiquinol-cytochrome-c reductase complex core prote  -  - 1  - 4 4 8 X
1789 P62988 Ubiquitin  - 1 3 5 6 7 6 X
1790 P54578 Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.1.2.15)  - 1 2  - 3 1 5 X
1791 Q9Y4E8 Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.1.2.15)  -  -  -  -  -  - 1  - 
1792 P45974 Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.1.2.15) (  - 4  -  - 6 2 9 X
1793 Q93009 Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.1.2.15) (  -  -  -  - 2 3 5  - 
1794 P15374 Ubiquitin carboxyl-terminal hydrolase isozyme L3 (EC  -  -  -  - 1  - 2 X
1795 Q96FW1 Ubiquitin thiolesterase protein OTUB1 (EC 3.4.-.-) (Otu -  - 2 2 5 1 7  - 
1796 P22314 Ubiquitin-activating enzyme E1 (A1S9 protein)  - 6 5 6 18 14 25 X
1797 P41226 Ubiquitin-activating enzyme E1 homolog (D8) - Homo s -  - 3  - 1 1  -  - 
1798 P62837 Ubiquitin-conjugating enzyme E2 D2 (EC 6.3.2.19) (Ub -  -  -  - 1  - 3  - 
1799 P62256 Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (Ubi  -  -  -  -  -  - 1  - 
1800 P68036 Ubiquitin-conjugating enzyme E2 L3 (EC 6.3.2.19) (Ub -  - 2 4 4 5 4  - 
1801 O14933 Ubiquitin-conjugating enzyme E2 L6 (EC 6.3.2.19) (Ub -  -  -  -  - 3 1  - 
1802 P61088 Ubiquitin-conjugating enzyme E2 N (EC 6.3.2.19) (Ubi  - 1 3 2 6 7 9 X
1803 Q9C0C9 Ubiquitin-conjugating enzyme E2 O - Homo sapiens (H -  - 1  - 2 1 1  - 
1804 Q13404 Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (C  - 3 5  - 5 6 6 X
1805 Q15819 Ubiquitin-conjugating enzyme E2 variant 2 (MMS2) (En - 2 3 3 5  - 4 X
1806 P61086 Ubiquitin-conjugating enzyme E2-25 kDa (EC 6.3.2.19  -  - 2  - 2  - 3 X
1807 Q9UBE0 Ubiquitin-like 1-activating enzyme E1A (SUMO-activati  -  -  -  - 2  - 1 X
1808 Q9UBT2 Ubiquitin-like 1-activating enzyme E1B (SUMO-1-activ  -  -  -  - 3 2 2  - 
1809 Q9NYU2 UDP-glucose:glycoprotein glucosyltransferase 1 precu  -  - 1  -  - 10 14 X
1810 Q9Y3C8 Ufm1-conjugating enzyme 1 (Ubiquitin-fold modifier-co -  - 2  - 2  -  -  - 
1811 P30085 UMP-CMP kinase (EC 2.7.4.14) (Cytidylate kinase) (D  -  - 6 2 5  - 5 X
1812 Q86UX7 Unc-112-related protein 2 (Kindlin-3) (MIG2-like)  -  - 25 1 6 9 21 X
1813 Q70J99 Unc-13 homolog D (Munc13-4)  -  - 2  - 2 1 2  - 
1814 Q9H1C4 UNC93 homolog B1 (UNC-93B protein) (hUNC93B1) -  -  -  -  -  - 1 1  - 
1815 Q9BRF8 Uncharacterized metallophosphoesterase CSTP1 - Ho -  -  - 1  -  -  -  - 
1816 Q8IXM2 Uncharacterized potential DNA-binding protein C17orf4 -  -  -  - 3 2 3  - 
1817 Q53FT3 Uncharacterized protein C11orf73 - Homo sapiens (Hu -  - 1  - 1  - 1  - 
1818 Q9BQ61 Uncharacterized protein C19orf43 - Homo sapiens (Hu -  -  -  - 1 3 2  - 
1819 Q6PJW8 Uncharacterized protein C1orf71 - Homo sapiens (Hum -  -  -  - 1  -  -  - 
1820 Q96HY6 Uncharacterized protein C20orf116 precursor - Homo s -  -  -  -  -  - 1  - 
1821 Q7Z570 Uncharacterized protein C2orf10 - Homo sapiens (Hum -  -  - 1  - 1  -  - 
1822 Q9GZY8 Uncharacterized protein C2orf33 - Homo sapiens (Hum -  - 1  -  -  -  -  - 
1823 Q9BU61 Uncharacterized protein C3orf60 - Homo sapiens (Hum -  -  -  - 1  -  -  - 
1824 Q5VWP3 Uncharacterized protein C6orf142 - Homo sapiens (Hu - 1  -  -  -  -  -  - 
1825 Q86YL5 Uncharacterized protein C8orf42 - Homo sapiens (Hum -  - 2  -  -  -  -  - 
1826 Q9BUH6 Uncharacterized protein C9orf142 - Homo sapiens (Hu -  -  -  - 5 2 5  - 
1827 Q9Y3I0 UPF0027 protein C22orf28 - Homo sapiens (Human)  -  -  -  - 2  -  -  - 
1828 Q9NRG7 UPF0105 protein C14orf124 - Homo sapiens (Human)  -  -  -  - 1  - 1  - 
1829 Q9BVM4 UPF0131 protein - Homo sapiens (Human)  -  - 1  -  -  -  -  - 
1830 Q9H993 UPF0364 protein C6orf211 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
1831 Q6IAA8 UPF0404 protein C11orf59 - Homo sapiens (Human)  -  - 3  - 2 3 2  - 
1832 Q9GZP4 UPF0424 protein C1orf128 - Homo sapiens (Human)  - 1  -  - 4  - 3  - 
1833 Q4G0N4 UPF0465 protein C5orf33 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
1834 Q9H1C7 UPF0467 protein C5orf32 - Homo sapiens (Human)  -  -  - 1  -  -  -  - 
1835 Q9NRP0 UPF0527 membrane protein - Homo sapiens (Human)  -  -  -  -  - 1 1  - 
1836 P06132 Uroporphyrinogen decarboxylase (EC 4.1.1.37) (URO- -  -  -  - 2  - 1 X
1837 Q96QR1 Uteroglobin-related protein 2 precursor (Cytokine HIN- 2  -  -  -  -  -  -  - 
1838 Q16851 UTP--glucose-1-phosphate uridylyltransferase 2 (EC 2  -  - 1 5 4 1 2 X
1839 P54727 UV excision repair protein RAD23 homolog B (hHR23B -  -  - 1  -  -  -  - 
1840 Q9P2Y5 UV radiation resistance-associated gene protein - Hom -  -  -  -  -  - 1  - 
1841 Q9BZF9 Uveal autoantigen with coiled-coil domains and ankyrin -  - 1  -  -  -  -  - 
1842 P38606 Vacuolar ATP synthase catalytic subunit A, ubiquitous  -  - 1  -  - 3 6 X
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1843 P21281 Vacuolar ATP synthase subunit B, brain isoform (EC 3  -  - 1  - 1 2 2 X
1844 P36543 Vacuolar ATP synthase subunit E (EC 3.6.3.14) (V-AT  -  - 1  -  - 2 2 X
1845 O75348 Vacuolar ATP synthase subunit G 1 (EC 3.6.3.14) (V-A -  -  - 1  - 1 1  - 
1846 Q9UBQ0 Vacuolar protein sorting 29 (Vesicle protein sorting 29) -  - 1  -  - 4 3 X
1847 Q96QK1 Vacuolar protein sorting 35 (Vesicle protein sorting 35) -  -  -  - 1 2 5  - 
1848 Q9BRG1 Vacuolar protein sorting-associated protein 25 (hVps25 -  -  -  -  - 2  -  - 
1849 O75436 Vacuolar protein sorting-associated protein 26A (Vesic -  -  -  -  -  - 1  - 
1850 Q9UK41 Vacuolar protein sorting-associated protein 28 homolo  -  - 1  -  -  -  -  - 
1851 O75351 Vacuolar protein sorting-associating protein 4B (Suppr  -  - 1  - 2 2 2  - 
1852 P26640 Valyl-tRNA synthetase (EC 6.1.1.9) (Valine--tRNA ligas -  -  -  - 1 2 7  - 
1853 O95498 Vascular non-inflammatory molecule 2 precursor (Vani  -  -  - 1  -  -  -  - 
1854 Q9NY84 Vascular non-inflammatory molecule 3 precursor - Hom -  -  - 1  -  -  -  - 
1855 P50552 Vasodilator-stimulated phosphoprotein (VASP) - Homo -  - 5 6 1 1  -  - 
1856 O75396 Vesicle trafficking protein SEC22b (SEC22 vesicle traff -  -  - 2  - 4 5  - 
1857 P63027 Vesicle-associated membrane protein 2 (VAMP-2) (Sy  -  - 2  -  -  -  -  - 
1858 Q15836 Vesicle-associated membrane protein 3 (VAMP-3) (Sy  -  - 3  -  -  -  -  - 
1859 Q9BV40 Vesicle-associated membrane protein 8 (VAMP-8) (En  -  - 1  -  - 2 3  - 
1860 Q9P0L0 Vesicle-associated membrane protein-associated prote -  - 1  -  -  -  -  - 
1861 P46459 Vesicle-fusing ATPase (EC 3.6.4.6) (Vesicular-fusion p -  -  -  -  -  - 1 X
1862 Q12907 Vesicular integral-membrane protein VIP36 precursor ( -  - 1  - 2  - 1  - 
1863 Q00341 Vigilin (High density lipoprotein-binding protein) (HDL-b - 1  -  -  -  -  -  - 
1864 P08670 Vimentin  -  -  - 1  - 1 14 X
1865 P18206 Vinculin (Metavinculin)  - 8 51 7 12 18 37 X
1866 P02774 Vitamin D-binding protein precursor (DBP) (Group-spe 10  - 1  -  -  - 2 X
1867 P04070 Vitamin K-dependent protein C precursor (EC 3,4,21,6 3  -  -  -  -  -  -  - 
1868 P07225 Vitamin K-dependent protein S precursor - Homo sapie 2  - 3  -  -  -  -  - 
1869 P04004 Vitronectin precursor (Serum spreading factor) (S-prote 5  - 1  -  -  - 6 X
1870 P21796 Voltage-dependent anion-selective channel protein 1 (V -  - 9  - 6 3 9  - 
1871 P45880 Voltage-dependent anion-selective channel protein 2 (V -  - 5  - 4 2 5 X
1872 Q9Y277 Voltage-dependent anion-selective channel protein 3 (V -  - 11 2  - 4 6  - 
1873 O00305 Voltage-dependent L-type calcium channel subunit bet  -  -  - 1  -  -  -  - 
1874 P04275 Von Willebrand factor precursor (vWF) [Contains: Von  -  - 34  -  -  - 5  - 
1875 Q5JSH3 WD repeat protein 44 (Rabphilin-11) - Homo sapiens (  -  - 2  -  -  -  -  - 
1876 Q9GZS3 WD repeat protein 61 (Meiotic recombination REC14 p -  -  -  - 1  -  -  - 
1877 O75083 WD-repeat protein 1 (Actin-interacting protein 1) (AIP1  - 2 15 7 15 5 12 X
1878 P42768 Wiskott-Aldrich syndrome protein (WASp)  -  -  - 1  -  - 4  - 
1879 Q92558 Wiskott-Aldrich syndrome protein family member 1 (WA -  -  - 1  -  -  -  - 
1880 O43516 Wiskott-Aldrich syndrome protein-interacting protein (W -  -  -  - 1  - 2  - 
1881 Q969T9 WW domain-binding protein 2 (WBP-2) - Homo sapien  - 1 1  - 1 1  - X
1882 Q9NQW7 Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (X-Pro amino -  -  -  -  -  - 1  - 
1883 P12955 Xaa-Pro dipeptidase (EC 3.4.13.9) (X-Pro dipeptidase) -  -  -  - 2  -  - X
1884 O15231 Zinc finger protein 185 (LIM-domain protein ZNF185) (  -  - 1  -  -  -  -  - 
1885 Q5T4S7 Zinc finger UBR1-type protein 1 - Homo sapiens (Hum  -  -  - 1  - 2  -  - 
1886 P25311 Zinc-alpha-2-glycoprotein precursor (Zn-alpha-2-glycop11  -  -  -  -  -  - X
1887 Q15942 Zyxin (Zyxin-2)  -  - 9  -  - 3 5 X
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1 P61604 10 kDa heat shock protein, mitochondrial 10800.5 8.91 3 X X X X X - -
2 P42704 130 kDa leucine-rich protein (LRP 130) (G145202.1 5.5 1 X - X - - - -
3 P31946 14-3-3 protein beta/alpha (Protein kinase 27951.3 4.76 5 X X X X X - -
4 P62258 14-3-3 protein epsilon (14-3-3E) 29174.1 4.63 6 X X X X X X -
5 Q04917 14-3-3 protein eta (Protein AS1) 28087.7 4.76 4 X X X X X - -
6 P61981 14-3-3 protein gamma (Protein kinase C 28171.5 4.8 6 X X X X X - -
7 P27348 14-3-3 protein theta (14-3-3 protein tau) ( 27764.4 4.68 8 X X X X X - -
8 P63104 14-3-3 protein zeta/delta (Protein kinase 27745.3 4.73 14 X X X X X - -
9 Q9Y4L1 150 kDa oxygen-regulated protein precur 111335.9 5.16 1 X X - - - - -
10 P62191 26S protease regulatory subunit 4 (P26s4 49184.8 5.87 1 - - - - - X -
11 P17980 26S protease regulatory subunit 6A (TAT 49203.8 5.13 1 X X - - - - -
12 P35998 26S protease regulatory subunit 7 (MSS1 48502.9 5.72 1 - - - - - - -
13 P62333 26S protease regulatory subunit S10B (P 44173.2 7.09 2 X X X - - X -
14 O75832 26S proteasome non-ATPase regulatory 24428 5.72 1 X - - - - - -
15 Q9UNM6 26S proteasome non-ATPase regulatory 42918.7 5.53 1 X X X X - - -
16 Q13200 26S proteasome non-ATPase regulatory 100200.3 5.08 1 X X X - - X -
17 O43242 26S proteasome non-ATPase regulatory 60977.9 8.47 1 X X X - - - -
18 P51665 26S proteasome non-ATPase regulatory 37025.6 6.29 1 X X X - - - -
19 Q02218 2-oxoglutarate dehydrogenase E1 compo 113476.1 6.62 1 X X - - - - -
20 P42126 3,2-trans-enoyl-CoA isomerase, mitochon 32816.2 8.8 2 - X X - X - -
21 Q9H9J2 39S ribosomal protein L44, mitochondrial 37535.6 8.65 1 X - - - - - -
22 Q99714 3-hydroxyacyl-CoA dehydrogenase type 26792 7.87 2 X X X X X - -
23 P42765 3-ketoacyl-CoA thiolase, mitochondrial (E 41924.4 8.32 6 X X - - - - -
24 P62263 40S ribosomal protein S14 16141.6 9.99 1 X X X - - - -
25 P62269 40S ribosomal protein S18 (Ke-3) (Ke3) 17718.8 9.99 2 X X X - - - -
26 P39019 40S ribosomal protein S19 15929.4 9.99 2 X X - - - - -
27 P15880 40S ribosomal protein S2 (S4) (LLRep3 p 31324.6 9.99 3 X X X - - - -
28 P60866 40S ribosomal protein S20 - Homo sapie 13372.8 9.95 4 X X - - - - -
29 P62854 40S ribosomal protein S26 12884.3 9.99 2 X X X - - - -
30 P62857 40S ribosomal protein S28 7841.1 9.99 1 X X X - - - -
31 P62701 40S ribosomal protein S4, X isoform (Sin 29466.7 9.99 2 X X - - - - -
32 P46782 40S ribosomal protein S5 22745.3 9.73 1 X X X - - - -
33 P08865 40S ribosomal protein SA (p40) (34/67 kD 32723 4.79 3 X X X - X - -
34 P10809 60 kDa heat shock protein, mitochondrial 61055 5.7 14 X X X X X - -
35 P05388 60S acidic ribosomal protein P0 (L10E) 34273.7 5.72 4 X X X - - - -
36 P05386 60S acidic ribosomal protein P1 11514 4.26 1 - X X - - - -
37 P05387 60S acidic ribosomal protein P2 11665 4.42 4 X X X - - - -
38 P62913 60S ribosomal protein L11 (CLL-associat 20121.3 9.64 2 X X X - X - -
39 P30050 60S ribosomal protein L12 17818.7 9.48 3 X X X - - - -
40 P35268 60S ribosomal protein L22 (Epstein-Barr 14655.9 9.22 1 X X X - - - -
41 P62888 60S ribosomal protein L30 12652.9 9.66 3 X X X - - - -
42 Q02878 60S ribosomal protein L6 (TAX-responsiv 32596.9 9.99 2 X X X - - - -
43 P52209 6-phosphogluconate dehydrogenase, dec 53009.1 6.88 10 X X X X X - -
44 O95336 6-phosphogluconolactonase (EC 3.1.1.31 27547 5.7 5 X X X X X - -
45 P11021 78 kDa glucose-regulated protein precurs 72333.3 5.07 6 X X X X X - -
46 Q9NUJ1 Abhydrolase domain-containing protein 1 33932.7 8.8 2 - X - - - - -
47 Q96IU4 Abhydrolase domain-containing protein 1 22345.8 5.94 3 X X X X X - -
48 P24752 Acetyl-CoA acetyltransferase, mitochond 45199.8 8.98 1 X X X - X - -
49 P39687 Acidic leucine-rich nuclear phosphoprote 28585.5 4 3 X X X - X - -
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50 Q92688 Acidic leucine-rich nuclear phosphoprote 28787.9 3.94 3 X X X - X - -
51 Q9BTT0 Acidic leucine-rich nuclear phosphoprote 30692.6 3.77 2 X X X - X - -
52 Q99798 Aconitate hydratase, mitochondrial precu 85425.9 7.36 1 X X - - - - -
53 P60709 Actin, cytoplasmic 1 (Beta-actin) 41737 5.29 24 X X X X X X X
54 P63261 Actin, cytoplasmic 2 (Gamma-actin) 41793.1 5.31 24 X X X X X X X
55 P61160 Actin-like protein 2 (Actin-related protein 44761 6.29 9 X X X X X X -
56 P61158 Actin-like protein 3 (Actin-related protein 47371.4 5.61 9 X X X X X - -
57 O15143 Actin-related protein 2/3 complex subunit 40818.8 8.69 5 X X X X X - -
58 O15144 Actin-related protein 2/3 complex subunit 34333.2 6.84 4 X X X X X X -
59 O15145 Actin-related protein 2/3 complex subunit 20415.6 8.82 3 X X X X X - -
60 P59998 Actin-related protein 2/3 complex subunit 19535.9 8.53 2 X X X X X - -
61 O15511 Actin-related protein 2/3 complex subunit 16189.3 5.47 2 X X X X X - -
62 P53999 Activated RNA polymerase II transcription 14264.2 9.6 1 X X X - - - -
63 O95433 Activator of 90 kDa heat shock protein AT 38274.5 5.41 1 - - X X - - -
64 P45954 Acyl-CoA dehydrogenase, short/branched 47485.7 6.53 1 - X - - - - -
65 P49748 Acyl-CoA dehydrogenase, very-long-chai 70390.5 8.92 4 X - X - - - -
66 P07741 Adenine phosphoribosyltransferase (EC 2 19476.7 5.79 4 X X X X X X -
67 P23526 Adenosylhomocysteinase (EC 3.3.1.1) (S 47585.2 5.92 4 X X X - X X -
68 P54819 Adenylate kinase isoenzyme 2, mitochon 26346.7 7.85 7 X X X X X - -
69 P30566 Adenylosuccinate lyase (EC 4.3.2.2) (Ade 54889.6 6.68 1 X X - - - X -
70 Q01518 Adenylyl cyclase-associated protein 1 (CA 51542.1 8.13 15 X X X X X - -
71 Q9HDC9 Adipocyte plasma membrane-associated 46480.6 5.82 2 X X - - X - -
72 P05141 ADP/ATP translocase 2 (Adenine nucleot 32764.2 9.76 5 X X X X - - -
73 P84077 ADP-ribosylation factor 1 20565.7 6.36 5 X X X X X X -
74 P61204 ADP-ribosylation factor 3 20469.7 7.03 5 - - - X - - -
75 P84085 ADP-ribosylation factor 5 20398.6 6.36 3 - X X - - - -
76 Q12802 A-kinase anchor protein 13 - Homo sapie 307552 5.12 1 - - - - - - -
77 P14550 Alcohol dehydrogenase [NADP+] (EC 1.1 36442 6.35 1 X X - - X - -
78 P15121 Aldose reductase (EC 1.1.1.21) (AR) (Ald 35722.4 6.56 2 X X X X - X -
79 P02763 Alpha-1-acid glycoprotein 1 precursor (AG 23511.7 4.93 1 X - - - X - X
80 P02765 Alpha-2-HS-glycoprotein precursor (Fetu 39324.9 5.43 2 X - - - - - X
81 P01023 Alpha-2-macroglobulin precursor (Alpha-2163278.8 6 6 X - - X - - X
82 P12814 Alpha-actinin-1 (Alpha-actinin cytoskeleta 103058.1 5.25 2 X X X X X X -
83 P06733 Alpha-enolase (EC 4.2.1.11) (2-phospho- 47038 6.99 22 X X X X X X -
84 P04083 Annexin A1 (Annexin I) (Lipocortin I) (Cal 38583.3 6.64 15 X X X - X - -
85 P50995 Annexin A11 (Annexin XI) (Calcyclin-asso 54390 7.53 4 X X X X X - -
86 P07355 Annexin A2 (Annexin II) (Lipocortin II) (Ca 38473.1 7.56 15 X X X - X X -
87 P09525 Annexin A4 (Annexin IV) (Lipocortin IV) ( 35751.7 5.85 2 X X X X X - -
88 P08758 Annexin A5 (Annexin V) (Lipocortin V) (E 35805.7 4.94 8 X X X X X - -
89 P08133 Annexin A6 (Annexin VI) (Lipocortin VI) ( 75742.5 5.42 20 X X X X X - -
90 P20073 Annexin A7 (Annexin VII) (Synexin) 52739.5 5.52 2 X X X - X X -
91 P02647 Apolipoprotein A-I precursor (Apo-AI) (Ap 30778 5.56 12 X - X - - - X
92 Q8NCW5 Apolipoprotein A-I-binding protein precurs 31674.8 7.56 3 X - - - - - -
93 P06727 Apolipoprotein A-IV precursor (Apo-AIV) 45399.3 5.28 11 X - - - - - X
94 P02656 Apolipoprotein C-III precursor (Apo-CIII) ( 10852.4 5.23 2 X - X - - - X
95 P02649 Apolipoprotein E precursor (Apo-E) - Hom 36154.3 5.65 3 X - - - - - X
96 Q07812 Apoptosis regulator BAX, membrane isof 21184.5 5.08 2 X X X - X - -
97 P10415 Apoptosis regulator Bcl-2 26266 6.75 1 - - - - - - -
98 Q9ULZ3 Apoptosis-associated speck-like protein c 21626.9 5.95 2 X X X - X - -
99 P55145 ARMET protein precursor (Arginine-rich p 20256.7 8.69 1 X X X X X - -
100 P00505 Aspartate aminotransferase, mitochondria 47475.8 9.13 6 X X X X X - -
101 P25705 ATP synthase alpha chain, mitochondrial 59750.9 9.16 21 X X X X X - -
102 P24539 ATP synthase B chain, mitochondrial pre 28908.8 9.37 4 X X X X X - -
103 P06576 ATP synthase beta chain, mitochondrial p 56560.2 5.26 17 X X X X X - -
104 O75947 ATP synthase D chain, mitochondrial (EC 18360.1 5.22 2 X X X X X - -
105 P30049 ATP synthase delta chain, mitochondrial 17490 5.38 2 X X X X X - -
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106 P56134 ATP synthase f chain, mitochondrial (EC 10786.7 9.7 2 X X X - - - -
107 P36542 ATP synthase gamma chain, mitochondr 32996.2 9.23 2 X X X X - - -
108 P48047 ATP synthase O subunit, mitochondrial p 23277.4 9.97 7 X X X X X - -
109 Q86UK0 ATP-binding cassette sub-family A memb 293252.3 7.89 1 - - - - - - -
110 P53396 ATP-citrate synthase (EC 2.3.3.8) (ATP-c 120825.9 6.95 1 X X X - X X -
111 P12956 ATP-dependent DNA helicase 2 subunit 69712.2 6.23 2 X X X - - - -
112 P13010 ATP-dependent DNA helicase 2 subunit 2 82573.8 5.55 1 X X X - - - -
113 P20160 Azurocidin precursor (Cationic antimicrob 26885.8 9.75 1 X - X - X - -
114 P51572 B-cell receptor-associated protein 31 (BC 27860.6 8.44 2 X X X - X - -
115 P61769 Beta-2-microglobulin precursor [Contains 13714.6 6.06 1 X - X X X - X
116 P13929 Beta-enolase (EC 4.2.1.11) (2-phospho-D 46855.9 7.73 4 X - - X X X -
117 P07686 Beta-hexosaminidase beta chain precurs 63111.7 6.29 1 X - X - - - -
118 P31939 Bifunctional purine biosynthesis protein P 64616.2 6.27 2 X X - - - X -
119 P53004 Biliverdin reductase A precursor (EC 1.3. 33428.7 6.06 2 X X X X X - -
120 P49593 Ca(2+)/calmodulin-dependent protein kin 49831.1 4.99 1 X X X X X - -
121 P31949 Calgizzarin (S100 calcium-binding protein 11740.5 6.56 1 X X X - X - X
122 P05109 Calgranulin A (Migration inhibitory factor- 10834.6 6.51 8 X X X X X X X
123 P06702 Calgranulin B (Migration inhibitory factor- 13242.1 5.71 7 X X X - X - X
124 P62158 Calmodulin (CaM) 16706.5 4.09 3 X X X X X X -
125 P27824 Calnexin precursor (Major histocompatibi 67568.6 4.47 6 X X X X X - -
126 P04632 Calpain small subunit 1 (CSS1) (Calcium 28315.9 5.05 4 X X X X X X -
127 Q99439 Calponin-2 (Calponin H2, smooth muscle 33566.1 6.92 1 X X X X X - -
128 P27797 Calreticulin precursor (CRP55) (Calreguli 48141.8 4.29 8 X X X X X - -
129 P10644 cAMP-dependent protein kinase type I-al 42981.9 5.27 1 X X X X X - -
130 P16152 Carbonyl reductase [NADPH] 1 (EC 1.1.1 30243.9 8.55 4 X X X X X X -
131 O75828 Carbonyl reductase [NADPH] 3 (EC 1.1.1 30719.2 5.82 2 X - - - - - -
132 P04040 Catalase (EC 1.11.1.6) 59625.3 6.95 6 X X X X X X -
133 P07339 Cathepsin D precursor (EC 3.4.23.5) [Co 44552.5 6.1 3 X X X X X - -
134 P25774 Cathepsin S precursor (EC 3.4.22.27) 37495.9 8.61 5 X X X - X - -
135 P60953 Cell division control protein 42 homolog p 21310.7 5.77 1 X X X X X - -
136 P62633 Cellular nucleic acid-binding protein (CNB 19462.9 8 1 X X X - - - -
137 O00299 Chloride intracellular channel protein 1 (N 26791.7 5.09 5 X X X X X X -
138 O75390 Citrate synthase, mitochondrial precursor 51712.7 8.45 5 X X X X X - -
139 Q00610 Clathrin heavy chain 1 (CLH-17) 191484.5 5.48 18 X X X X X X -
140 O43809 Cleavage and polyadenylation specificity 26227.4 8.85 1 X X - - - - -
141 P10909 Clusterin precursor (Complement-associa 52494.9 5.89 6 X - - X X - X
142 Q14019 Coactosin-like protein 15813.9 5.55 9 X X X X X - -
143 P23528 Cofilin-1 (Cofilin, non-muscle isoform) (18 18371.4 8.27 9 X X X X X X X
144 P01024 Complement C3 precursor [Contains: Co 187149.1 6.02 4 X - - X - - X
145 P31146 Coronin-1A (Coronin-like protein p57) (Co 51026.6 6.25 11 X X X X X - -
146 P57737 Coronin-7 (70 kDa WD repeat tumor rejec 100575.6 5.51 1 X X X - X - -
147 Q86VP6 Cullin-associated NEDD8-dissociated pro 136376.5 5.52 2 X X X - X X -
148 Q8ND76 Cyclin-Y - Homo sapiens (Human) 39336.9 6.76 1 - - - - - - -
149 P04080 Cystatin B (Liver thiol proteinase inhibitor 11139.6 6.96 1 X X X - X - -
150 P04839 Cytochrome b-245 heavy chain (p22 pha 65205.1 8.9 2 X X X - X - -
151 P13498 Cytochrome b-245 light chain (p22 phago 20827.3 9.61 1 - - X - X - -
152 P99999 Cytochrome c 11617.6 9.59 2 X X X X - - -
153 P00403 Cytochrome c oxidase subunit 2 (EC 1.9. 25565.2 4.67 5 X X X - - - -
154 P13073 Cytochrome c oxidase subunit IV isoform 19576.8 9.52 2 X X X - - - -
155 Q8IUI8 Cytokine receptor-like factor 3 - Homo sa 49766.2 5.01 1 - X X X - - -
156 P50453 Cytoplasmic antiproteinase 3 (CAP3) (CA 42403.9 5.61 4 X X X X X - -
157 Q7L576 Cytoplasmic FMR1-interacting protein 1 - 145183.3 6.46 1 X - X - - - -
158 P28838 Cytosol aminopeptidase (EC 3.4.11.1) (L 52640.4 6.28 1 X X X X - - -
159 Q96KP4 Cytosolic nonspecific dipeptidase (Glutam 52878.8 5.66 3 X X X - - - -
160 Q96EP5 DAZ-associated protein 1 (Deleted in azo 43383.6 8.73 2 X X - - - - -
161 P30046 D-dopachrome decarboxylase (EC 4.1.1. 12580.6 7.25 1 X X X - X - -
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162 Q13011 Delta3,5-delta2,4-dienoyl-CoA isomerase 35816.4 8.16 5 X X X X X - -
163 P60981 Destrin (Actin-depolymerizing factor) (AD 18374.7 8.12 1 X X - X X - -
164 P09622 Dihydrolipoyl dehydrogenase, mitochond 54150.5 7.59 1 X X X - - - -
165 Q16555 Dihydropyrimidinase-related protein 2 (DR 62294 5.95 1 X X X X X - -
166 P27695 DNA-(apurinic or apyrimidinic site) lyase 35423.5 8.42 6 X X X - X - -
167 O75937 DnaJ homolog subfamily C member 8 (S 29841.8 9.04 1 X X - - - - -
168 P39656 Dolichyl-diphosphooligosaccharide--prote 48809.7 5.43 1 X - X - X - -
169 P04844 Dolichyl-diphosphooligosaccharide--prote 69284.3 5.44 5 - X X X - - -
170 P04843 Dolichyl-diphosphooligosaccharide--prote 68569.7 5.96 4 X X X - X - -
171 Q9UJU6 Drebrin-like protein (SH3 domain-contain 48207.5 5.02 1 X - - X X - -
172 Q14203 Dynactin-1 (150 kDa dynein-associated p 141695.6 5.61 1 X - - X - - -
173 Q9HC35 Echinoderm microtubule-associated prote 108903.7 5.88 1 - - - - - - -
174 Q96C19 EF-hand domain-containing protein 2 (Sw 26697.4 5.15 1 X X X X X - -
175 Q9H4M9 EH-domain-containing protein 1 (Testilin) 60627.2 6.35 3 X X - X X - -
176 P13804 Electron transfer flavoprotein alpha-subu 35079.8 8.62 3 X X X X X - -
177 P38117 Electron transfer flavoprotein beta-subun 27843.8 8.25 3 X X X X - - -
178 P68104 Elongation factor 1-alpha 1 (EF-1-alpha-1 50141.1 9.1 13 X X X X X X -
179 P29692 Elongation factor 1-delta (EF-1-delta) (An 30990.8 4.9 3 X X X X - - -
180 P26641 Elongation factor 1-gamma (EF-1-gamma 49987.9 6.27 3 X X X X X - -
181 P13639 Elongation factor 2 (EF-2) 95207.5 6.42 8 X X X - X X -
182 P49411 Elongation factor Tu, mitochondrial precu 49541.8 7.26 7 X X X X - - -
183 P30040 Endoplasmic reticulum protein ERp29 pre 28993.6 6.77 5 X X X X X - -
184 P14625 Endoplasmin precursor (94 kDa glucose- 92469.3 4.76 2 X X X X X X -
185 P10768 Esterase D (EC 3.1.1.1) 31463 6.54 2 X X X X X X -
186 P60842 Eukaryotic initiation factor 4A-I (EC 3.6.1 46154.2 5.32 2 X X X X X X -
187 Q14240 Eukaryotic initiation factor 4A-II (EC 3.6.1 46402.5 5.33 2 X X - - - - -
188 Q14152 Eukaryotic translation initiation factor 3 su 166570.2 6.38 4 X X - - - - -
189 Q15056 Eukaryotic translation initiation factor 4H 27254 6.92 1 X X X X - - -
190 P63241 Eukaryotic translation initiation factor 5A 16701.2 5.08 3 X X X X X X -
191 O14980 Exportin-1 (Chromosome region mainten 123386.6 5.71 1 X - X - - - -
192 P15311 Ezrin (p81) (Cytovillin) (Villin-2) 69267.9 5.95 8 X X X - X - -
193 O14745 Ezrin-radixin-moesin-binding phosphopro 38737.4 5.55 2 X X X X X - -
194 P52907 F-actin capping protein alpha-1 subunit (C 32922.9 5.45 5 X X X X X X -
195 P47755 F-actin capping protein alpha-2 subunit (C 32818.1 5.58 1 X X X X X X -
196 P47756 F-actin capping protein beta subunit (Cap 31219.5 5.36 2 X X X X X - -
197 Q96AE4 Far upstream element-binding protein 1 ( 67473.6 7.18 1 X X X - - - -
198 Q01469 Fatty acid-binding protein, epidermal (E-F 15033.3 6.82 2 X X X - X - -
199 P02792 Ferritin light chain (Ferritin L subunit) 19888.6 5.51 4 X X X - X - -
200 P02671 Fibrinogen alpha chain precursor [Contai 94973.5 5.7 5 X - - X - - X
201 P02675 Fibrinogen beta chain precursor [Contain 55928.5 8.54 9 X X - X X X X
202 P02679 Fibrinogen gamma chain precursor 51511.9 5.37 6 X - - X - - X
203 P21333 Filamin-A (Alpha-filamin) (Filamin-1) (End 280631.3 5.73 47 X X X X X X -
204 P30043 Flavin reductase (EC 1.5.1.30) (FR) (NAD 21988.3 7.31 2 X X X X X X -
205 O95466 Formin-like 1 protein (Formin-like protein 121828.2 5.56 4 X X X - - - -
206 P09467 Fructose-1,6-bisphosphatase 1 (EC 3.1.3 36683.5 6.61 1 X X X - X - -
207 P04075 Fructose-bisphosphate aldolase A (EC 4. 39289 8.39 10 X X X X X X -
208 P09972 Fructose-bisphosphate aldolase C (EC 4 39324.9 6.46 1 X X X X X - -
209 P09382 Galectin-1 (Beta-galactoside-binding lect 14584.6 5.34 4 X X X - - - -
210 P17931 Galectin-3 (Galactose-specific lectin 3) (M 26057.3 8.61 1 X - X - X - -
211 P09104 Gamma-enolase (EC 4.2.1.11) (2-phosph 47137.6 4.91 4 - X - - X - -
212 Q9P107 GEM-interacting protein (GMIP) 106733.5 5.5 1 X - X - - - -
213 P60983 Glia maturation factor beta (GMF-beta) 16582.1 5.19 1 X X X X - - -
214 O60234 Glia maturation factor gamma (GMF-gam 16801.4 5.18 3 X X X X X - -
215 P11413 Glucose-6-phosphate 1-dehydrogenase ( 59134.9 6.44 4 X X X X X - -
216 P06744 Glucose-6-phosphate isomerase (EC 5.3 63016.3 8.44 8 X X X X X X -
217 P00367 Glutamate dehydrogenase 1, mitochondr 61398.2 7.66 5 X X X - - - -
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218 O94925 Glutaminase kidney isoform, mitochondri 73461.5 7.85 1 X X - - - - -
219 P07203 Glutathione peroxidase 1 (EC 1.11.1.9) (G 21899.2 6.15 5 X X X X X X -
220 P00390 Glutathione reductase, mitochondrial pre 56257.4 8.74 5 X X X X X X -
221 Q9Y2Q3 Glutathione S-transferase kappa 1 (EC 2 25365.8 8.53 4 X X X X - - -
222 P09211 Glutathione S-transferase P (EC 2.5.1.18 23224.8 5.44 4 X X X X X - -
223 P78417 Glutathione transferase omega-1 (EC 2.5 27566 6.24 2 X X X X X - -
224 P04406 Glyceraldehyde-3-phosphate dehydrogen 35922.2 8.58 17 X X X X X X X
225 Q9HC38 Glyoxalase domain-containing protein 4 - 34793.7 5.4 3 X X - X X - -
226 Q9UBQ7 Glyoxylate reductase/hydroxypyruvate re 35668.5 7.01 1 X - - - - - -
227 Q9H4G4 Golgi-associated plant pathogenesis-rela 17087.2 9.44 2 X X X X X - X
228 P28676 Grancalcin 24010.2 5.02 2 X X X X X - -
229 P62993 Growth factor receptor-bound protein 2 (A 25206.5 5.89 3 X X X X X - -
230 Q9NUV9 GTPase, IMAP family member 4 (Immun 37534 7.66 3 X X X - - - -
231 P62826 GTP-binding nuclear protein Ran (GTPas 24292 7.2 6 X X X X X X -
232 Q03113 Guanine nucleotide-binding protein alpha 44148.3 9.84 1 - - X - X - -
233 P63244 Guanine nucleotide-binding protein beta s 35076.9 7.6 8 X X X - - X -
234 P04899 Guanine nucleotide-binding protein G(i), a 40319.9 5.34 5 X X X X X - -
235 P62873 Guanine nucleotide-binding protein G(I)/G 37246 5.6 3 - X X X X - -
236 P62879 Guanine nucleotide-binding protein G(I)/G 37200.1 5.6 3 X X - X X - -
237 P08107 Heat shock 70 kDa protein 1 (HSP70.1) ( 70052.6 5.48 6 X X X X X X -
238 P11142 Heat shock cognate 71 kDa protein (Hea 70898.4 5.38 12 X X X X X X -
239 Q12931 Heat shock protein 75 kDa, mitochondria 80110.4 8.3 1 X X X X X - -
240 P07900 Heat shock protein HSP 90-alpha (HSP 8 84543 4.94 11 X X X X X X -
241 P08238 Heat shock protein HSP 90-beta (HSP 84 83133.4 4.97 10 X X X X X X -
242 P14317 Hematopoietic lineage cell-specific protei 53998.3 4.74 1 X X X - - X -
243 Q9Y5Z4 Heme-binding protein 2 (Protein SOUL) ( 22875.5 4.58 1 - X X X X - -
244 P69905 Hemoglobin subunit alpha (Hemoglobin a 15126.4 8.73 3 X - X - X X X
245 P68871 Hemoglobin subunit beta (Hemoglobin be 15867.3 6.81 9 X - X - X X X
246 P51858 Hepatoma-derived growth factor (HDGF) 26788.4 4.7 2 X X - - - - -
247 Q99729 Heterogeneous nuclear ribonucleoprotein 36612.7 9.04 1 - - - - - - -
248 P09651 Heterogeneous nuclear ribonucleoprotein 38714.8 9.26 6 X X X - X - -
249 Q14103 Heterogeneous nuclear ribonucleoprotein 38434.4 7.61 6 X X X - X - -
250 P52597 Heterogeneous nuclear ribonucleoprotein 45540.9 5.38 5 X X X - X - -
251 P31943 Heterogeneous nuclear ribonucleoprotein 49098.5 5.89 5 X X X - - - -
252 P55795 Heterogeneous nuclear ribonucleoprotein 49263.9 5.89 2 - - - - - - -
253 P61978 Heterogeneous nuclear ribonucleoprotein 50976.5 5.39 4 X X X X X - -
254 P22626 Heterogeneous nuclear ribonucleoprotein 37429.9 8.97 7 X X X - X X -
255 P07910 Heterogeneous nuclear ribonucleoprotein 33688.2 4.95 2 X X X - - - -
256 Q00839 Heterogenous nuclear ribonucleoprotein 90479.8 5.76 1 X X X - - - -
257 P09429 High mobility group protein 1 (HMG-1) (H 24762.7 5.62 7 X X X - - - -
258 P26583 High mobility group protein 2 (HMG-2) 23902.7 7.77 4 X X X - - - -
259 P49773 Histidine triad nucleotide-binding protein 13670.8 6.46 1 X X X X X - -
260 P0C0S8 Histone H2A type 1 (H2A.1) - Homo sapie 13960.3 9.99 3 - - - - - - -
261 P62805 Histone H4 11236.2 9.99 1 X X X X - - -
262 P13746 HLA class I histocompatibility antigen, A- 40937 5.77 3 - - - X - - -
263 P01892 HLA class I histocompatibility antigen, A- 40922.1 6.5 3 X - - X - - -
264 P01908 HLA class II histocompatibility antigen, D 28105.3 5.12 1 X - - - - - -
265 P50502 Hsc70-interacting protein (Hip) (Putative 41331.9 5.18 1 X X - X - X -
266 P00492 Hypoxanthine-guanine phosphoribosyltra 24448.3 6.24 2 X X X X X X -
267 P01876 Ig alpha-1 chain C region - Homo sapiens 37654.9 6.08 4 X X - - - - X
268 P01857 Ig gamma-1 chain C region - Homo sapie 36106.1 8.46 6 X - - - - X X
269 P01859 Ig gamma-2 chain C region - Homo sapie 35884.8 7.66 5 X - - - - - X
270 P01834 Ig kappa chain C region - Homo sapiens 11608.9 5.58 3 X - - - X X X
271 P01842 Ig lambda chain C regions - Homo sapien 11236.6 6.91 2 X X - - X - X
272 Q9H2U2 Inorganic pyrophosphatase 2, mitochond 37962.5 7.06 2 X X - X X - -
273 P29218 Inositol monophosphatase (EC 3.1.3.25) 30189 5.16 1 X X X X X - -
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274 Q16270 Insulin-like growth factor-binding protein 7 29130.5 8.25 2 - - - - - - -
275 P08514 Integrin alpha-IIb precursor (Platelet mem 113391.5 5.21 8 X - - X X - -
276 P20701 Integrin alpha-L precursor (Leukocyte ad 128770.3 5.4 3 X X X - - - -
277 P11215 Integrin alpha-M precursor (Cell surface g 127179.2 6.88 12 X X X - X - -
278 P13164 Interferon-induced transmembrane protei 13938.5 7.78 1 X X - - X - -
279 Q2TAA2 Isoamyl acetate-hydrolyzing esterase 1 h 27598.9 5.13 1 - - - - - - -
280 P50213 Isocitrate dehydrogenase [NAD] subunit a 39592 6.47 1 X X X X - - -
281 O43837 Isocitrate dehydrogenase [NAD] subunit b 42212 8.64 1 X - - - - - -
282 O75874 Isocitrate dehydrogenase [NADP] cytopla 46659.6 6.53 2 X - X X X - -
283 P48735 Isocitrate dehydrogenase [NADP], mitoch 50909.6 8.88 10 X X X X X - -
284 Q86Y91 Kinesin-like protein LOC146909 - Homo s 92195 8.73 1 - - - - - - -
285 Q04760 Lactoylglutathione lyase (EC 4.4.1.5) (Me 20588.6 5.25 3 X X X X X - -
286 P42166 Lamina-associated polypeptide 2 isoform 75361.2 7.8 1 - - - - - - -
287 P42167 Lamina-associated polypeptide 2, isoform 50539.3 9.39 1 X - - - - - -
288 Q32MZ4 Leucine-rich repeat flightless-interacting p 89253.5 4.59 7 X X X X - - -
289 P08575 Leukocyte common antigen precursor (E 147255 5.77 16 X X X - X - -
290 P30740 Leukocyte elastase inhibitor (LEI) (Serpin 42742 5.9 10 X X X X X X -
291 P09960 Leukotriene A-4 hydrolase (EC 3.3.2.6) (L 69154.4 5.8 5 X X X - X - -
292 Q14847 LIM and SH3 domain protein 1 (LASP-1) 29717.3 6.61 3 X X X X X - -
293 P23141 Liver carboxylesterase 1 precursor (EC 3 62521.4 6.15 3 X - X - - - -
294 P00338 L-lactate dehydrogenase A chain (EC 1.1 36557.7 8.46 10 X X X X X X X
295 Q9BYZ2 L-lactate dehydrogenase A-like 6B (EC 1 41943.2 8.88 1 - - - X - - -
296 P07195 L-lactate dehydrogenase B chain (EC 1.1 36507.5 5.72 14 X X X X X X X
297 Q9NZR2 Low-density lipoprotein receptor-related p 515501.7 5.09 1 - - - - - - -
298 P05455 Lupus La protein (Sjogren syndrome type 46837.3 6.68 6 X X - - - - -
299 Q7Z4W1 L-xylulose reductase (EC 1.1.1.10) (XR) 25913.2 8.33 1 X X - X X - -
300 Q13094 Lymphocyte cytosolic protein 2 (SH2 dom 60188.5 5.89 2 X X X X X - -
301 P42785 Lysosomal Pro-X carboxypeptidase precu 55800.1 6.76 2 - - X - X - -
302 P11279 Lysosome-associated membrane glycopr 44773.3 9.22 2 X X X - X - -
303 P61626 Lysozyme C precursor (EC 3.2.1.17) (1,4 16537.1 9.38 3 X X X - X - X
304 P40121 Macrophage capping protein (Actin-regul 38517.8 5.89 4 X X X - X X -
305 P14174 Macrophage migration inhibitory factor (M 12345.2 8.24 1 X X X X X - -
306 P40925 Malate dehydrogenase, cytoplasmic (EC 36295.1 6.89 7 X X X X X X -
307 P40926 Malate dehydrogenase, mitochondrial pre 35531.5 8.92 11 X X X X X - -
308 Q5VYJ5 MAM and LDL-receptor class A domain-c 136444.6 5.7 1 - - - - - - -
309 Q96IJ6 Mannose-1-phosphate guanyltransferase 46291.4 6.74 1 - - - - - - -
310 Q96T17 MAP7 domain-containing protein 2 - Hom 81961.8 8.95 1 X X - X - - -
311 O15173 Membrane-associated progesterone rece 23818.6 4.76 1 - X - - - - -
312 Q15691 Microtubule-associated protein RP/EB fa 29868 5.02 1 X X X X X - -
313 Q02978 Mitochondrial 2-oxoglutarate/malate carri 33930.7 9.92 1 X - - - - - -
314 Q9NS69 Mitochondrial import receptor subunit TO 15390.5 4.27 1 X X X X - - -
315 P28482 Mitogen-activated protein kinase 1 (EC 2 41258.7 6.53 3 X X X - X - -
316 Q16539 Mitogen-activated protein kinase 14 (EC 41162.3 5.48 1 - X - - X - -
317 P26038 Moesin (Membrane-organizing extension 67689.2 6.09 17 X X X X X X -
318 Q7L9L4 Mps one binder kinase activator-like 1A ( 24959.8 6.24 1 X X X X - - -
319 P22234 Multifunctional protein ADE2 [Includes: P 46948.3 7.09 2 X X - X - - -
320 O00499 Myc box-dependent-interacting protein 1 64699.7 4.97 1 X X - - - - -
321 P24158 Myeloblastin precursor (EC 3.4.21.76) (Le 27807.2 8.71 1 X X X - X - -
322 P05164 Myeloperoxidase precursor (EC 1.11.1.7) 83869.1 9.19 9 X X X - X - -
323 P60660 Myosin light polypeptide 6 (Myosin light c 16799 4.56 8 X X X X X - -
324 P19105 Myosin regulatory light chain 2, nonsarco 19663 4.67 2 X X X X X - -
325 Q7Z406 Myosin-14 (Myosin heavy chain, nonmus 228002.9 5.77 3 - X X - X X -
326 P35579 Myosin-9 (Myosin heavy chain, nonmusc 226402.2 5.5 53 X X X X X X -
327 P58546 Myotrophin (V-1 protein) 12763.7 5.28 1 X X X X X - -
328 P20933 N(4)-(beta-N-acetylglucosaminyl)-L-aspa 37194.5 5.86 1 X - - - X - -
329 Q9UJ70 N-acetylglucosamine kinase (EC 2.7.1.59 37244.7 5.82 4 X X X - X X -
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330 Q13423 NAD(P) transhydrogenase, mitochondria 113896.3 8.31 3 X - X - - - -
331 O95168 NADH dehydrogenase [ubiquinone] 1 bet 15077.5 9.85 1 X - - - - - -
332 O00217 NADH-ubiquinone oxidoreductase 23 kDa 23705.3 6 1 X X X - - - -
333 P19404 NADH-ubiquinone oxidoreductase 24 kDa 27391.7 8.21 1 - X X - - - -
334 O75489 NADH-ubiquinone oxidoreductase 30 kDa 30241.7 6.98 1 X X X - - - -
335 O95299 NADH-ubiquinone oxidoreductase 42 kDa 40750.8 8.67 1 X X X - - - -
336 Q9P0J0 NADH-ubiquinone oxidoreductase B16.6 16567.2 8.24 1 X - X - - - -
337 Q13765 Nascent polypeptide-associated complex 23384 4.52 1 X X X X - - -
338 Q14697 Neutral alpha-glucosidase AB precursor ( 106874.5 5.73 3 X X X X X X -
339 P43490 Nicotinamide phosphoribosyltransferase 55521.4 6.69 1 - X - - X - -
340 P49321 Nuclear autoantigenic sperm protein (NA 85238.1 4.26 1 X X X - - - -
341 P19338 Nucleolin (Protein C23) 76483.5 4.6 1 X X - - X - -
342 P15531 Nucleoside diphosphate kinase A (EC 2.7 17148.8 5.83 2 X X X X X X -
343 P22392 Nucleoside diphosphate kinase B (EC 2.7 17298.1 8.52 5 X X X X X - -
344 Q56VL3 OCIA domain-containing protein 2 - Hom 16953.6 9.24 1 X - - - - - -
345 Q92882 Osteoclast-stimulating factor 1 23798.9 5.19 1 X X X X X - -
346 Q9UBV8 Peflin (PEF protein with a long N-termina 30381.1 6.1 1 X - - - X - -
347 Q9UJ68 Peptide methionine sulfoxide reductase ( 26132.6 8.22 1 - - - - X - -
348 P62937 Peptidyl-prolyl cis-trans isomerase A (EC 17881.4 7.82 12 X X X X X X X
349 P23284 Peptidyl-prolyl cis-trans isomerase B prec 22742.5 9.33 5 X X X X X - X
350 Q9H2H8 Peptidyl-prolyl cis-trans isomerase-like 3 18154.6 6.29 1 X X X - X - -
351 Q06830 Peroxiredoxin-1 (EC 1.11.1.15) (Thioredo 22110.5 8.27 8 X X X X X X -
352 P32119 Peroxiredoxin-2 (EC 1.11.1.15) (Thioredo 21760.8 5.67 3 X X X X X X -
353 P30044 Peroxiredoxin-5, mitochondrial precursor 22026.5 8.85 2 X X X X X - -
354 P30041 Peroxiredoxin-6 (EC 1.11.1.15) (Antioxida 24903.9 6.03 6 X X X X X X -
355 Q00325 Phosphate carrier protein, mitochondrial 40095.1 9.45 2 X X X - - - -
356 O95674 Phosphatidate cytidylyltransferase 2 (EC 51418.3 6.64 1 - X X - - - -
357 P30086 Phosphatidylethanolamine-binding protei 20925.7 7.43 5 X X X X X X -
358 P36871 Phosphoglucomutase-1 (EC 5.4.2.2) (Glu 61318.2 6.32 1 X X - X X - -
359 Q96G03 Phosphoglucomutase-2 (EC 5.4.2.2) (Glu 68210.6 6.18 1 X X X - X - -
360 P00558 Phosphoglycerate kinase 1 (EC 2.7.2.3) ( 44483.8 8.3 19 X X X X X X -
361 P18669 Phosphoglycerate mutase 1 (EC 5.4.2.1) 28672.9 6.75 10 X X X X X - -
362 P36969 Phospholipid hydroperoxide glutathione p 22128 8.65 1 X X X X - - -
363 Q9H008 Phospholysine phosphohistidine inorgani 29165.5 5.8 1 X X - - X - -
364 P35237 Placental thrombin inhibitor (Cytoplasmic 42590.1 5.19 1 X X X X X - -
365 Q14651 Plastin-1 (I-plastin) (Intestine-specific plas 70353 5.33 5 - - - - - - -
366 P13796 Plastin-2 (L-plastin) (Lymphocyte cytosol 70289.7 5.2 44 X X X - X - -
367 P02775 Platelet basic protein precursor (PBP) (S 13894.3 9.04 1 X - - X X - X
368 P68402 Platelet-activating factor acetylhydrolase 25569.4 5.57 2 X X X X - - -
369 Q15102 Platelet-activating factor acetylhydrolase 25734.4 6.33 2 X X X - - - -
370 P08567 Pleckstrin (Platelet p47 protein) 40097.1 8.5 3 X X - X X - -
371 Q9UKK3 Poly [ADP-ribose] polymerase 4 (EC 2.4. 192589.6 5.43 1 - - X - - - -
372 Q15365 Poly(rC)-binding protein 1 (Alpha-CP1) (h 37498 6.66 5 X X X X X - -
373 Q15366 Poly(rC)-binding protein 2 (Alpha-CP2) (h 38580.3 6.33 5 X X X X - - -
374 Q3KNV8 Polycomb group RING finger protein 3 - H 28115.7 8.53 1 - - - - - - -
375 Q96CX2 Potassium channel tetramerisation doma 35701 5.51 5 X - X - X - -
376 O75915 PRA1 family protein 3 (ARL-6-interacting 21614.8 9.77 3 X X X - X - -
377 O96008 Probable mitochondrial import receptor s 37893.3 6.79 1 X X - - - - -
378 P07737 Profilin-1 (Profilin I) 14923.1 8.47 11 X X X X X - X
379 P35232 Prohibitin. 29804.2 5.57 6 X X X X X - -
380 Q99623 Prohibitin-2 (B-cell receptor-associated p 33296.5 9.83 5 X X X X - - -
381 O94903 Proline synthetase co-transcribed bacteri 30344.1 7.09 1 X X X X - - -
382 Q15185 Prostaglandin E synthase 3 (EC 5.3.99.3 18697.5 4.34 1 X X X X - - -
383 Q6S8J3 Prostate, ovary, testis-expressed protein 80753.2 5.64 10 - - - - X - -
384 Q06323 Proteasome activator complex subunit 1 28723.3 5.78 7 X X X X X - -
385 Q9UL46 Proteasome activator complex subunit 2 27230.6 5.44 8 X X X X X X -
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386 P25786 Proteasome subunit alpha type 1 (EC 3.4 29555.8 6.15 3 X X X X - - -
387 P25788 Proteasome subunit alpha type 3 (EC 3.4 28302.2 5.19 4 X X X X X X -
388 P25789 Proteasome subunit alpha type 4 (EC 3.4 29484 7.58 3 X X X X - - -
389 P28066 Proteasome subunit alpha type 5 (EC 3.4 26411.2 4.74 3 X X X X - - -
390 P60900 Proteasome subunit alpha type 6 (EC 3.4 27399.6 6.35 4 X X X X X X -
391 O14818 Proteasome subunit alpha type 7 (EC 3.4 27887 8.6 8 X X X X X - -
392 P20618 Proteasome subunit beta type 1 (EC 3.4. 26489.5 8.27 5 X X X X X - -
393 P49721 Proteasome subunit beta type 2 (EC 3.4. 22836.4 6.52 3 X X X X X - -
394 P49720 Proteasome subunit beta type 3 (EC 3.4. 22949.1 6.14 2 X X X X X - -
395 P28062 Proteasome subunit beta type 8 precurso 30354.5 7.63 3 X X X X X - -
396 P28065 Proteasome subunit beta type 9 precurso 23264.4 4.93 3 X X X X - - -
397 Q969H8 Protein C19orf10 precursor (Stromal cell- 18795.3 6.2 3 X X X - X - -
398 Q9Y426 Protein C21orf25 precursor 75533.6 6.47 1 - - - - - - -
399 O75223 Protein C7orf24 21007.8 5.07 1 X X X - X - -
400 O60888 Protein CutA precursor (Brain acetylcholi 19116.4 5.42 1 X X X - - - -
401 O60610 Protein diaphanous homolog 1 (Diaphano 138979.4 5.31 18 X X X X X - -
402 P30101 Protein disulfide-isomerase A3 precursor 56782.7 5.99 11 X X X X X - -
403 Q15084 Protein disulfide-isomerase A6 precursor 48121.6 4.95 4 X X X X X - -
404 P07237 Protein disulfide-isomerase precursor (EC 57116.6 4.76 9 X X X X X - -
405 Q99497 Protein DJ-1 (Oncogene DJ1) 19891.2 6.33 3 X X X X X X -
406 Q9H0Q0 Protein FAM49A 37313.1 5.71 2 X X - - - - -
407 Q9NUQ9 Protein FAM49B (L1) 36748.2 5.76 3 X X X - X - -
408 Q9BSJ8 Protein FAM62A (Membrane-bound C2 d 122857 5.57 7 X X X X - X -
409 Q8N163 Protein KIAA1967 (Deleted in breast can 102902.1 5.14 2 X - - - - - -
410 P61326 Protein mago nashi homolog 17163.7 5.74 1 X - X - - - -
411 Q9UFN0 Protein NipSnap3A (NipSnap4) (Target fo 28466.8 9.21 4 X X X X X - -
412 Q15435 Protein phosphatase 1 regulatory subunit 41564.4 4.84 1 X X - - - - -
413 Q9P258 Protein RCC2 (Telophase disk protein of 56084.8 9.02 1 X X - - - - -
414 Q01105 Protein SET (Phosphatase 2A inhibitor I2 33489 4.23 3 X X X - - - -
415 O94979 Protein transport protein Sec31A - Homo 133015.4 6.43 1 X X X X - - -
416 P61619 Protein transport protein Sec61 subunit a 52133.9 8.33 1 - X X - - - -
417 Q9ULC6 Protein-arginine deiminase type-1 (EC 3. 74666 6.07 1 X X X X - - -
418 P22061 Protein-L-isoaspartate(D-aspartate) O-me 24519.4 6.78 5 X X X X X X -
419 P00491 Purine nucleoside phosphorylase (EC 2.4 32148.1 6.45 3 X X X X X X -
420 Q9NTK5 Putative GTP-binding protein PTD004 44743.8 7.64 1 X X X X - - -
421 Q9NTT1 Putative ubiquitin-conjugating enzyme E2 16905.5 8.81 1 X - X X - - -
422 Q6ZWB7 Putative uncharacterized protein FLJ4135 23948.7 9.99 1 - - - - - - -
423 P08559 Pyruvate dehydrogenase E1 component 43295.9 8.35 1 X - - - - - -
424 P11177 Pyruvate dehydrogenase E1 component 39219.6 6.21 3 X X - X - - -
425 P14618 Pyruvate kinase isozymes M1/M2 (EC 2. 57806 7.95 30 X X X X X X -
426 Q08257 Quinone oxidoreductase (EC 1.6.5.5) (NA 35206.8 8.56 3 X X - - - X -
427 P31150 Rab GDP dissociation inhibitor alpha (Ra 50583 5 5 X X X X X - -
428 P50395 Rab GDP dissociation inhibitor beta (Rab 50663.5 6.11 14 X X X X X X -
429 P43487 Ran-specific GTPase-activating protein (R 23310.2 5.19 1 X X X X X - -
430 Q15404 Ras suppressor protein 1 (Rsu-1) (RSP-1 31409.3 8.57 3 X X - X X - -
431 P63000 Ras-related C3 botulinum toxin substrate 21450.2 8.77 4 X X X X X - -
432 P15153 Ras-related C3 botulinum toxin substrate 21428.9 7.52 8 X X X X X - -
433 P62491 Ras-related protein Rab-11A (Rab-11) (Y 24262.4 6.14 2 X X X X X - -
434 P61106 Ras-related protein Rab-14 23765.9 5.86 5 X X X X X - -
435 P59190 Ras-related protein Rab-15 24390.8 5.53 2 X X X X X - -
436 P62820 Ras-related protein Rab-1A (YPT1-relate 22546.7 5.93 3 X - X X X - -
437 Q9H0U4 Ras-related protein Rab-1B 22171.3 5.55 4 X X X X X - -
438 Q9UL25 Ras-related protein Rab-21 - Homo sapie 24216.5 8.16 2 X X X - X - -
439 P61019 Ras-related protein Rab-2A 23545.7 6.08 1 X X X X X - -
440 Q13637 Ras-related protein Rab-32 - Homo sapie 24866.2 6.1 1 - - X X X - -
441 Q9H082 Ras-related protein Rab-33B 25717.7 6.71 1 X X X X - - -
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442 Q15286 Ras-related protein Rab-35 (Rab-1C) (GT 23025.3 8.53 2 X X X X X - -
443 P61018 Ras-related protein Rab-4B 23586.9 5.8 2 - - - - - - -
444 P61020 Ras-related protein Rab-5B 23706.9 8.29 2 - X - X X - -
445 P51148 Ras-related protein Rab-5C (RAB5L) (L1 23482.7 8.64 4 X X X - X - -
446 P20340 Ras-related protein Rab-6A (Rab-6) 23461.7 5.42 1 X X X - X - -
447 P51149 Ras-related protein Rab-7 23489.9 6.39 7 X X X X X - -
448 P62834 Ras-related protein Rap-1A precursor (G 20987.3 6.39 3 X X X - X - -
449 P61224 Ras-related protein Rap-1b precursor (GT 20824.9 5.65 5 X X X X X - -
450 P52565 Rho GDP-dissociation inhibitor 1 (Rho GD 23207.2 5.02 4 X X X X X - -
451 P52566 Rho GDP-dissociation inhibitor 2 (Rho GD 22988.1 5.1 6 X X X X X - -
452 Q07960 Rho-GTPase-activating protein 1 (GTPas 50436 5.85 3 X X X X X - -
453 P13489 Ribonuclease inhibitor (Ribonuclease/ang 49842.6 4.71 10 X X X X X X -
454 P49247 Ribose-5-phosphate isomerase (EC 5.3.1 26091.2 6.97 1 X X - X X - -
455 P60891 Ribose-phosphate pyrophosphokinase I ( 34703.3 6.56 1 X X - - - X -
456 P35637 RNA-binding protein FUS (Oncogene FU 53426.1 9.4 1 X - - - - - -
457 P26447 S100 calcium-binding protein A4 (Metasta 11728.6 5.85 4 X X X - X - -
458 P31153 S-adenosylmethionine synthetase isoform 43660.9 6.02 1 - X - - - - -
459 Q9Y3Z3 SAM domain and HD domain-containing 72200.9 6.7 19 X X X - - - -
460 Q93084 Sarcoplasmic/endoplasmic reticulum calc 113978.1 5.42 2 X X X X X - -
461 Q96C86 Scavenger mRNA decapping enzyme Dc 38681 5.84 1 - X X - - - -
462 Q15019 Septin-2 (Protein NEDD5) 41487.7 6.15 1 X X X X - - -
463 Q14141 Septin-6 49585.7 6.25 4 X X - X - - -
464 Q16181 Septin-7 (CDC10 protein homolog) 50680.2 8.77 4 X X - X - - -
465 Q9UHD8 Septin-9 (MLL septin-like fusion protein) ( 65369.7 9.05 3 X X - X - X -
466 O94804 Serine/threonine-protein kinase 10 (EC 2 112135.9 6.52 6 X X X - - - -
467 P63151 Serine/threonine-protein phosphatase 2A 51692.4 5.82 1 - X - - X - -
468 P30153 Serine/threonine-protein phosphatase 2A 65092.7 4.97 4 X X X X X - -
469 P62136 Serine/threonine-protein phosphatase PP 37512.3 5.94 3 X X - X X - -
470 P02768 Serum albumin precursor 69367.1 5.92 54 X - - - - X X
471 P49591 Seryl-tRNA synthetase (EC 6.1.1.11) (Se 58646.4 6.06 2 X X - - - - -
472 O60880 SH2 domain protein 1A (Signaling lympho 14187.3 8.74 1 X X - - - - -
473 O75368 SH3 domain-binding glutamic acid-rich-lik 12774.3 5.22 3 X X X X X - -
474 Q9H299 SH3 domain-binding glutamic acid-rich-lik 10437.8 4.82 1 X X X X X - -
475 Q16836 Short chain 3-hydroxyacyl-CoA dehydrog 34277.7 8.88 4 X X X X X - -
476 Q9H9B4 Sideroflexin-1 (Tricarboxylate carrier prot 35488.4 9.22 2 X X - - - - -
477 Q04837 Single-stranded DNA-binding protein, mit 17259.8 9.59 3 X X X X - - -
478 P62304 Small nuclear ribonucleoprotein E (snRN 10803.7 9.46 1 X X - - - - -
479 P62316 Small nuclear ribonucleoprotein Sm D2 (s 13527 9.92 1 - X - - - - -
480 Q13126 S-methyl-5-thioadenosine phosphorylase 31250.3 6.75 1 X - - X X - -
481 Q4G0N8 Sodium/hydrogen exchanger 10 - Homo s 135206.8 6.72 2 - - - - - - -
482 P30626 Sorcin (22 kDa protein) (CP-22) (V19) 21676.5 5.32 1 X X X X X - -
483 O60493 Sorting nexin-3 (SDP3 protein) 18631.2 8.73 1 - - X X X - -
484 Q13838 Spliceosome RNA helicase BAT1 (EC 3.6 48991.6 5.44 3 X X - - - - -
485 P84103 Splicing factor, arginine/serine-rich 3 (Pre 19329.7 9.99 1 - - - - - - -
486 P31948 Stress-induced-phosphoprotein 1 (STI1) 62639.6 6.4 2 X X X X - X -
487 P21912 Succinate dehydrogenase [ubiquinone] ir 31629.9 9.03 5 X X X - - - -
488 Q96I99 Succinyl-CoA ligase [GDP-forming] beta- 46510.9 6.15 1 - X - - - - -
489 Q9Y6N5 Sulfide:quinone oxidoreductase, mitocho 49961 9.18 1 X X X - X - -
490 P63279 SUMO-conjugating enzyme UBC9 (EC 6 18006.9 8.87 2 X X X - - - -
491 P00441 Superoxide dismutase [Cu-Zn] (EC 1.15. 15804.6 5.7 1 X X X X X X X
492 P04179 Superoxide dismutase [Mn], mitochondria 24722.2 8.34 2 X X X X X - -
493 O15260 Surfeit locus protein 4 30394.2 7.64 1 X X X - X - -
494 Q15833 Syntaxin-binding protein 2 (Unc-18 homo 66438.9 6.11 1 - - - X X - -
495 Q9Y490 Talin-1 269768.5 5.78 56 X X X X X X -
496 P78371 T-complex protein 1 subunit beta (TCP-1 57357.3 6.02 9 X X X X - - -
497 P50991 T-complex protein 1 subunit delta (TCP-1 57793.4 8.13 4 X X X X X X -
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498 P48643 T-complex protein 1 subunit epsilon (TCP 59671.4 5.45 2 X X X X X X -
499 Q99832 T-complex protein 1 subunit eta (TCP-1-e 59367 7.55 2 X X X X X X -
500 P49368 T-complex protein 1 subunit gamma (TCP 60534.3 6.1 5 X X - X - X -
501 P50990 T-complex protein 1 subunit theta (TCP-1 59489.7 5.42 7 X X X X X X -
502 P40227 T-complex protein 1 subunit zeta (TCP-1- 57893.3 6.25 4 X X X X X X -
503 Q9UGI8 Testin (TESS) 47996.8 7.96 5 X - - - - - -
504 Q9Y3D6 Tetratricopeptide repeat protein 11 (TPR 16937.8 8.84 1 X X X - X - -
505 P10599 Thioredoxin (ATL-derived factor) (ADF) (S 11606.4 4.82 1 X X X X X - -
506 Q9H3N1 Thioredoxin domain-containing protein 1 31791.4 4.92 1 X - X - - - -
507 Q8NBS9 Thioredoxin domain-containing protein 5 47629.1 5.63 2 - X - - - - -
508 P30048 Thioredoxin-dependent peroxide reductas 27692.8 7.67 2 X X X X X - -
509 P19971 Thymidine phosphorylase precursor (EC 49955.8 5.36 4 X X X X X - -
510 Q5JTV8 Torsin-1A-interacting protein 1 66248.7 8.21 1 X - X - X - -
511 P37837 Transaldolase (EC 2.2.1.2) 37540.3 6.36 12 X X X X X - -
512 P61586 Transforming protein RhoA precursor (H1 21768.3 5.83 5 X X X X X X -
513 P37802 Transgelin-2 (SM22-alpha homolog) 22260.4 8.45 8 X X X X X - X
514 P29401 Transketolase (EC 2.2.1.1) (TK) 67878 7.58 18 X X X X X X -
515 P13693 Translationally-controlled tumor protein (T 19595.5 4.84 2 X X X X X - -
516 P51571 Translocon-associated protein delta subu 18998.7 5.76 2 X X X - X - -
517 P49755 Transmembrane emp24 domain-containi 24976.1 6.98 1 X X X - X - -
518 P55084 Trifunctional enzyme subunit beta, mitoch 51294.8 9.44 3 X X X X - - -
519 P60174 Triosephosphate isomerase (EC 5.3.1.1) 26538.4 6.51 13 X X X X X X -
520 P29144 Tripeptidyl-peptidase 2 (EC 3.4.14.10) (T 138219.4 5.9 2 X - - X - - -
521 O14773 Tripeptidyl-peptidase I precursor (EC 3.4 61229.2 5.97 1 X X X X X - -
522 P06753 Tropomyosin alpha-3 chain (Tropomyosin 32818.9 4.68 8 X X X X X - -
523 P67936 Tropomyosin alpha-4 chain (Tropomyosin 28390.8 4.67 7 X X X X X - -
524 P07951 Tropomyosin beta chain (Tropomyosin 2) 32850.9 4.66 4 X X X X - - -
525 P23381 Tryptophanyl-tRNA synthetase (EC 6.1.1 53165.7 5.83 3 X X X - X - -
526 P68366 Tubulin alpha-1 chain (Alpha-tubulin 1) (T 49924.7 4.95 13 X - - X - - -
527 P07437 Tubulin beta-2 chain 49671.1 4.78 19 X X X X X X -
528 P68371 Tubulin beta-2C chain (Tubulin beta-2 ch 49831.3 4.79 17 X - - - X - -
529 P04350 Tubulin beta-4 chain (Tubulin 5 beta) 49631.2 4.81 15 X - - - - - -
530 O75347 Tubulin-specific chaperone A (Tubulin-fol 12723.7 5.25 1 X X X X X - -
531 Q6IBS0 Twinfilin-2 (Twinfilin-1-like protein) (A6-re 39548.2 6.37 4 X X X X X - -
532 P41240 Tyrosine-protein kinase CSK (EC 2.7.1.1 50704.6 6.62 1 X X X X - - -
533 P29350 Tyrosine-protein phosphatase non-recept 67561.5 7.65 11 X X X X X - -
534 P22695 Ubiquinol-cytochrome-c reductase compl 48443.2 8.74 3 X X X X - - -
535 P62988 Ubiquitin 8564.9 6.56 5 X X X X X X -
536 Q93009 Ubiquitin carboxyl-terminal hydrolase 7 (E 128272.7 5.33 3 X X X - - - -
537 Q96FW1 Ubiquitin thiolesterase protein OTUB1 (E 31284.2 4.85 2 X X X X X - -
538 P22314 Ubiquitin-activating enzyme E1 (A1S9 pro 117849.6 5.49 1 X X X X X X -
539 P62837 Ubiquitin-conjugating enzyme E2 D2 (EC 16735.4 7.69 1 X X - - X - -
540 P68036 Ubiquitin-conjugating enzyme E2 L3 (EC 17861.7 8.68 2 X X X X X - -
541 P61088 Ubiquitin-conjugating enzyme E2 N (EC 6 17137.9 6.13 10 X X X X X X -
542 Q13404 Ubiquitin-conjugating enzyme E2 variant 25796.9 8.55 4 X X X X X X -
543 Q15819 Ubiquitin-conjugating enzyme E2 variant 16231.7 8.05 3 X X - X X X -
544 Q9UBE0 Ubiquitin-like 1-activating enzyme E1A (S 38450.1 5.17 1 X X - - - - -
545 Q9NYU2 UDP-glucose:glycoprotein glucosyltransfe 174977.9 5.4 7 X - X X - - -
546 Q86UX7 Unc-112-related protein 2 (Kindlin-3) (MIG 75953.2 6.52 5 X X X X X - -
547 Q9BUH6 Uncharacterized protein C9orf142 - Homo 21639.7 5.39 1 X X X - - - -
548 Q6IAA8 UPF0404 protein C11orf59 - Homo sapie 17744.9 5.01 2 X X X X - - -
549 Q16851 UTP--glucose-1-phosphate uridylyltransfe 56809.3 8.15 7 X X X X X - -
550 Q9UBQ0 Vacuolar protein sorting 29 (Vesicle prote 20505.8 6.28 2 X - X X - - -
551 O75396 Vesicle trafficking protein SEC22b (SEC2 24609.5 8.68 2 X - X - X - -
552 Q9BV40 Vesicle-associated membrane protein 8 ( 11438.3 6.73 2 X - X X - - -
553 P08670 Vimentin 53520.7 5.06 4 X - X - X - -
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554 P18206 Vinculin (Metavinculin) 123668.8 5.51 4 X X X X X X -
555 P21796 Voltage-dependent anion-selective chann 30641.5 8.63 3 X X X X X - -
556 P45880 Voltage-dependent anion-selective chann 38092.9 6.32 3 X X X X - - -
557 Q9Y277 Voltage-dependent anion-selective chann 30658.8 8.84 5 X - X X X - -
558 Q6ZS11 VPS9 domain-containing protein FLJ4590 50053.3 5.69 1 - - - - - - -
559 O75083 WD-repeat protein 1 (Actin-interacting pro 66062.7 6.18 9 X X X X X X -
560 P42768 Wiskott-Aldrich syndrome protein (WASp 52781.7 6.18 2 X - - - - - -
561 Q9H171 Z-DNA-binding protein 1 - Homo sapiens 46343.1 6.29 1 - - - - - - -
562 Q5T4S7 Zinc finger UBR1-type protein 1 - Homo s 573844.3 5.7 1 - - - - X - -
563 Q15942 Zyxin (Zyxin-2) 61277.7 6.22 3 X - X X X - -
VERENA HAUDEK     PhD-thesis 103
 VERENA HAUDEK     PhD-thesis 104
 
 
Introducing a New Parameter for Quality Control of Proteome Profiles: 
Consideration of Commonly Expressed Proteins  
 
Astrid Slany1, Verena J. Haudek1, Nina C. Gundacker1, Johannes Griss1, Thomas Mohr1, 
Helge Wimmer2, Maria Eisenbauer1, Leonilla Elbling1, Christopher Gerner1 
 
1Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, 
Austria 
2Section Biomedical Laboratory Science, University of Applied Sciences, Vienna, Austria 
 
 
 
 
 
 
 
 
 
Correspondence: Christopher Gerner, Department of Medicine I, Institute of Cancer 
Research, Medical University of Vienna, Austria 
Email: Christopher.gerner@meduniwien.ac.at 
Phone: +43-1-4277-65230 
 
Keywords: 
2D-PAGE, Shotgun Proteomics, Common Proteins, Quality Control, Proteome Profiling 
 
 
 
VERENA HAUDEK     PhD-thesis 105
 
 
Abbreviations: 
 
ACN: Acetonitrile 
CPL/MUW: Clinical Proteomics Laboratories at the Medical University of Vienna 
DC: Dendritic Cell 
DMEM: Dulbecco's Modified Eagle Medium 
HaCaT: Human keratinocyte cell line 
HUVEC: Human Umbilical Vein Endothelial Cell 
MEM: minimal essential medium 
PRIDE: Proteomics Identifications Database (http://www.ebi.ac.uk/pride) 
RuBPS: Ruthenium II tris (bathophenanthroline disulfonate) 
SPI: Scored Peak Intensity 
SQL: Structured Query Language 
SW-480: human colon adenocarcinoma cell line 
 
 
Reviewer account for PRIDE-submissions (http://www.ebi.ac.uk/pride/plainLogin.do): 
 
A: dendritic cells and HUVEC: 
Username: review35774 
Password: DAs-RfzP 
 
B: fibroblasts and HaCaT: 
Username: review89790 
Password: mDsGF$cf 
 
VERENA HAUDEK     PhD-thesis 106
 
 
Abstract 
 
Interpretation of proteome profiling experiments largely relies on comparative analyses. False 
positive identifications may cause fatal misinterpretation of data. On the other hand, proteome 
analysis may also suffer from false negatives, when proteins which are actually present are 
not detected. This circumstance may be as fatal as false positive identifications and was 
hardly considered until now. Appropriate positive controls would facilitate quality assessment 
of proteome profiling experiments. Based on cell biology knowledge, our aim was to generate 
a list of commonly expressed proteins which may serve as positive control. Following a 
pragmatic experimental strategy, we compared the cytoplasmic fractions of four largely 
differing kinds of cells, which were human dendritic cells, endothelial cells, fibroblasts and 
keratinocytes. Proteome profiling was performed by 2D-PAGE in addition to shotgun 
analysis. By shotgun analysis, 665 proteins were identified which occurred in each of the four 
cells types, 360 proteins of those were also detectable in the corresponding 2D gels. We 
consider these proteins as common proteins. All shotgun analysis data, including mass 
fragmentation spectra of the corresponding peptides, are accessible via the PRIDE database. 
As expected, most of the common proteins could be clearly assigned to at least one of the 
following functional categories: chaperones, cytoskeleton, energy metabolism, redox 
regulation, nucleic acid processing, protein turnover, membrane transport, protein synthesis 
and signaling. We suggest that the present data may proof helpful for data assessment, quality 
control and interpretation of a large variety of experiments based on proteome profiling. 
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Introduction 
 
One important ambition of proteome research is the establishment of protein profiles of 
biological systems, providing insight in the protein expression pattern of the investigated cells 
or tissues. Comparative studies of protein profiles may support the understanding of 
biological processes as well as the identification of biomarkers and novel molecular drug 
targets [1-3]. 
The comparison of protein profiles for biomedical interpretation relies on the robustness and 
sensitivity of the applied methods. Current concepts for quality control focus on the reliability 
of protein identification and the elimination of false positive results [4, 5]. Here, we introduce 
a new parameter for an improved quality assessment of proteome profiles: the positive 
identification of proteins that are ubiquitous present in any human nucleated cell type. Even 
though cells arise from different origin and exert diverse functions, they comprise essential, 
ubiquitous cell organelles and beside cell- and function-specific proteins they consist of a 
standard set of proteins. Positive identification of these commonly expressed proteins may 
serve as validation of analytical quality. Missing of such proteins indicates inadequate or 
incomplete analysis which may, as well as false positive identifications, lead to fatal 
misinterpretation of data.  
To generate a reference list of commonly expressed proteins the following strategy was used. 
Cells representative for human leukocytes, endothelial cells, epithelial cells and fibroblasts 
were chosen, comprising normal primary cells in addition to immortalized cultured cells, 
proliferating as well as non-proliferating cells. A protein list was generated selecting only 
proteins identified in each of the four different cell types.  
Due to the large number of diverse molecules present in biological samples, protein analysis 
represents a big challenge. Many thousands of proteins, occurring at highly different 
concentrations spanning up to eight orders of magnitude [6] with very different chemical 
properties are mixed with a broad variety of non-protein molecules, such as lipids, 
polysaccharides and nucleic acids, which may impede analysis. 
The most usual proteome analysis methods are based either on the separation of proteins, as 
two-dimensional polyacrylamide electrophoresis (2D-PAGE) [7], or on the separation of 
peptides by nano flow liquid chromatography (nano-LC) as employed for shotgun proteomics 
[8]. Proteins may then be identified by mass spectrometric analysis of peptides generated by 
most usually tryptic digest [9]. Using 2D-PAGE, proteins can be quantified by fluorescence 
detection according to integrated staining intensities [10]. Shotgun proteomics is based on the 
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identification of peptide sequences by fragmentation analysis via mass spectrometry [11] and 
enables the identification of a larger number of proteins compared to 2D-PAGE. We have 
achieved very high accordance combining the two techniques, 2D-PAGE and shotgun, 
supporting our concept of optimal data reliability.  
In this study, we present proteome reference maps of dendritic cells as well as of human 
umbilical vein endothelial cells (HUVEC), fibroblasts and keratinocytes. These reference 
maps will be again presented elsewhere with focus on the identification of cell type-specific 
and cell function-associated proteins. Here, we used these reference maps with another 
objective, namely to find out ubiquitous rather than specific proteins. The consideration of 
these data allowed the implementation of a new parameter which may proof useful for quality 
control for proteome profiling: the introduction of commonly expressed proteins as a kind of 
internal standard.  
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Materials and Methods 
 
Monocyte-derived DC preparation and maturation 
Peripheral blood mononuclear cells were isolated from heparinized whole blood of four 
different healthy donors by standard density gradient centrifugation with Ficoll-Paque (GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden). Subsequently, monocytes were separated by 
magnetic sorting using the MACS technique (Miltenyi Biotec, Bergisch Gladbach, Germany) 
as previously described [12]. Monocytes were enriched by using the biotinylated CD14 mAb 
VIM13 (purity 95%) as previously described [12]. Dendritic cells (DC) were generated by 
culturing purified blood monocytes for 7 days with a combination of granulocyte-macrophage 
colony-stimulating factor (GM-CSF) (50 ng/ml) and interleukin-4 (IL-4) (100 U/ml). 
 
Isolation and culture of HUVECs 
Human umbilical vein endothelial cells (HUVECs) were isolated as described by Jaffe et al. 
[13]. Obtained cells where seeded into tissue culture flasks (Corning, Corning NY) coated 
with 0.5 µg/cm² human fibronectin (HFN, Chemicon, Temecula, CA, USA) and cultivated in 
EBM-2(MV) (Cambrex) supplemented with growth factors according to the instructions of 
the manufacturer and additionally with 10% FCS and 10 µg/ml ECGS (EBM-2MV complete). 
 
Isolation and cultivation of fibroblasts 
Fibroblasts were cultured as described by Frazier et al. [14], except that cells were isolated 
from normal skin punches and were cultured in RPMI supplemented with 10% FCS at 
standard cell culture conditions. 
 
Isolation and cultivation of HaCaT 
HaCaT are a spontaneously transformed human epithelial cell line, which maintain full 
epidermal differentiation capacity, as described by Boukamp et al. [15]. Cells were cultured 
in DMEM supplemented with 10% FCS at standard cell culture conditions. 
 
Sub-cellular fractionation 
The isolation of cytoplasmic proteins was performed as described by Gundacker et al. [16]. 
Cells were lysed in hypotonic lysis buffer (10 mM HEPES/NaOH, pH 7.4, 0.25 M sucrose, 10 
mM NaCl, 3 mM MgCl2, 0.5% Triton X-100) supplemented with protease inhibitors and 
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pressed through a 26 g syringe to induce cell lysis. The cytoplasmic fraction was separated 
from nuclei by centrifugation and precipitated by the addition of ethanol. Afterwards, all 
protein samples were dissolved in sample buffer (7.5 M urea, 1.5 M thiourea, 4% CHAPS, 
0.5% SDS, 100 mM DDT). 
 
2D polyacrylamid gel electrophoresis (2D-PAGE) 
Proteins were loaded by passive rehydration on IPG strips pH 5–8, 17 cm (BioRad, Hercules, 
CA) at room temperature. Alternatively, IPG Immobiline™ strips (GE) were used and applied 
at similar conditions, which gave similar results (not shown). IEF was performed in a 
stepwise fashion (1 h 0– 500 V linear; 5 h 500 V; 5 h 500–3500 V linear; 12 h 3500 V). After 
IEF, the strips were equilibrated with 100 mM DTT and 2.5% iodacetamide according to the 
instructions of the manufacturer (BioRad). Tube gels with free ampholytes were prepared as 
described previously [17]. For SDS-PAGE using the Protean II xi electrophoresis system 
(BioRad), the IPG strips were placed on top of 1.5 mm 12% polyacrylamide slab gels and 
overlaid with 0.5% low-melting agarose. The gels were stained with a 400 nM solution of 
Ruthenium II tris (bathophenanthroline disulfonate) (RuBPS) as described [18]. Fluorography 
scanning was performed with the FluorImager 595 (GE Healthcare, Fairfield, CT) at a 
resolution of 100 µm. [19]. All 2D gel data were independently reproduced two times. Gels 
were warped to a reference gel with the TT900 S2S software (version 2006.0.2389, Nonlinear 
dynamics, Carlsbad, CA) and evaluated with the Progenesis software PG200 (version 2006, 
Nonlinear) using the “same spot” algorithm. Spot assignment, background correction, 
normalization and statistical calculations (analysis of variance, ANOVA) were performed 
using this software package. The synthetic 2D image of common proteins (Figure 3) was 
generated with the aid of the ImageMaster 2D Platinum software (Amersham). The web-page 
accessible via http://www.meduniwien.ac.at/proteomics/Bilder/common-PG200A/gel.html 
was created using the Progenesis software PG200 (version 2006, Nonlinear). 
 
1D-PAGE for subsequent shotgun analysis 
Cytoplasmic protein fractions were loaded on 12% polyacrylamid gels, electrophoresis was 
performed until complete separation of a pre-stained molecular marker (Dual Color, Biorad, 
Hercules, CA) was visible. Gels were fixed with 50% methanol/10% acetic acid and 
subsequently silver stained as described below. Gel lanes were cut out of the gel and were 
digested with trypsin as described below.  
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MS-compatible silver staining procedure 
2D gels were fixed with 50% methanol, washed and sensitized with 0.02% Na2S2O3. The gels 
were stained with 0.1% AgNO3 ice cold for 20 minutes, rinsed with bi-distilled water and 
subsequently developed with 3% Na2CO3/0.05% formaldehyde as previously described [20]. 
 
Tryptic digest 
Protein spots were cut out of the gel, the gel-pieces were de-stained with 15 mM 
K3Fe(CN)6/50 mM Na2S2O3 and intensively washed with 50% methanol/10% acetic acid. The 
pH was adjusted with 50 mM NH4HCO3, proteins were reduced with 10 mM DTT/50 mM 
NH4HCO3 for 30 minutes at 56°C and alkylated with 50 mM iodacetamide/50 mM NH4HCO3 
20 minutes in the dark. Afterwards the gel-pieces were treated with acetonitril and dried in a 
speedvac. Between each step, the tubes were shaken 5-10 minutes (Eppendorf Thermomixer 
comfort). Dry gel-spots were treated with trypsin 0.1 mg/ml (Trypsin sequencing grade, 
Roche Diagnostics, Germany)/50 mM NH4HCO3, in a ratio of 1:8 for 20 minutes on ice, 
afterwards covered with 50 mM NH4HCO3 and were subsequently incubated over night at 
37°C. The digested peptides were eluted by adding 50 mM NH4HCO3, the supernatant was 
transferred into silicon-coated tubes, and this procedure was repeated two times with 5% 
formic acid/50% acetonitril. Between each elution step the gel-spots were ultrasonicated for 
10 minutes. Finally the peptide solution was concentrated in a speedvac to an appropriate 
volume. 
 
Mass spectrometry analysis 
For the identification of 2D spots, peptides were loaded on a Zorbax 300SB-C8 (5 µm, 0.3 
mm, 5 mm) column and separated by nanoflow LC (1100 Series LC system, Agilent, Palo 
Alto, CA) with a Zorbax 300SB-C18 (5 µm, 75 mm, 150 mm) column at a flow rate of 250 
nl/min using a gradient from 0.2% formic acid and 3% acetonitrile (ACN) to 0.2% formic 
acid and 45% ACN over 12 minutes. In case of shotgun analysis, peptides were separated by 
nano-flow LC (1100 Series LC system, Agilent, Palo Alto, CA) using the HPLC-Chip 
technology (Agilent) equipped with a 40 nl Zorbax 300SB-C18 trapping column and a 75 µm 
x 150 mm Zorbax 300SB-C18 separation column at a flow rate of 400 nl/min, using a 
gradient from 0.2% formic acid and 3% ACN to 0.2% formic acid and 50% ACN over 60 
minutes. Peptide identification was accomplished by MS/MS fragmentation analysis with an 
iontrap mass spectrometer (XCT-Ultra, Agilent) equipped with an orthogonal nanospray ion 
source. The MS/MS data, including peak list-generation and search engine, were interpreted 
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by the Spectrum Mill MS Proteomics Workbench software (Version A.03.02, Agilent) 
allowing for two missed cleavages and searched against the SwissProt Database for human 
proteins (Version 20071025 containing 17 482 entries or alternatively Version 20080409 
containing 19 038 entries) allowing for precursor mass deviation of 1.5 Da, a product mass 
tolerance of 0.7 Da and a minimum matched peak intensity (%SPI) of 70%. Due to previous 
chemical modification, carbamidomethylation of cysteine was set as fixed modification. No 
other modifications were considered here.  
 
Construction of proteome reference maps 
The following protein selection algorithm was applied for the generation of the final protein 
lists. Peptides scores were considered to select appropriate sequence assignments. To assess 
the reliability of the peptide scores, we performed searches against the corresponding reversed 
database. 5.9% positive hits were found with peptides scoring >9.0, while 0.21% positive hits 
were found with peptides scoring >13.0. Only peptides scoring higher than 9.0 were 
considered for protein identification. Identification details for each protein including all 
identified peptides, sequence coverage, peptide scores and MS2 spectra are fully accessible 
via PRIDE database (http://www.ebi.ac.uk/pride/) [21, 22]. Dendritic cells: PRIDE accessions 
3381-3884; HUVEC: PRIDE accessions 3718-3721, fibroblasts: PRIDE accessions 3860-
3862; HaCat: PRIDE accessions 3863-3865. Each of the proteome reference maps listed in 
Tables S1 to S4 were generated by combining the corresponding independent shotgun 
experiments. These combinations list the sum of all peptides related to single proteins which 
were collected from all corresponding experiments. Proteins derived from obvious 
contaminants such as fetal calf serum were deleted. Proteins were selected based on the 
expression of specific peptides, identified in one protein only. Selection of protein isoforms 
was performed as described by Zhang et al. [23]. In case an unambiguous assignment was not 
possible due to sequence homologies, the biologically most plausible candidate based on gene 
expression data was selected.  
 
Identification of common proteins 
Final protein lists of dendritic cells and HUVEC, HaCaT and fibroblasts were compared and 
proteins present in each of these four cell types were determined using our own specially 
created SQL database (Clinical Proteomics Laboratories at the Medical University of Vienna, 
CPL/MUW-database, programmed by HW).  
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Results 
 
Generation of proteome reference maps for human dendritic cells, endothelial cells, 
fibroblasts and keratinocytes 
The use of sub-cellular fractions for protein profiling rather than whole cell lysates has been 
described previously to improve data reliability [16]. Therefore, the cytoplasmic protein 
fractions of four different kinds of human cells, namely dendritic cells, umbilical vein 
endothelial cells (HUVEC), cultured fibroblasts from skin punches and keratinocytes 
(HaCaT) were isolated and investigated by 2D-PAGE and shotgun analysis.  
Immature DCs of four different donors were generated by in vitro cultivation and treatment of 
peripheral blood monocytes with GM-CSF and IL-4. Cytoplasmic proteins were isolated as 
described [16] and analyzed by shotgun proteomics and 2D-PAGE. The supplementary Table 
S1 lists all 1 347 distinct proteins assembled from the four independent shotgun experiments. 
The complete data generated by these experiments is accessible via PRIDE database 
(http://www.ebi.ac.uk/pride/) [21, 22], PRIDE accessions 3381-3384. 923 spots were 
reproducibly detected in 2D gels, cut out of silver-stained gels and subsequently analyzed by 
nano-LC-MS/MS. 768 spots were identified successfully, corresponding to 537 different 
proteins.  
HUVEC were analyzed using the methods as described above. The supplementary Table S2 
lists all 1 377 distinct proteins identified and assembled from four independent shotgun 
experiments, accessible via PRIDE accessions 3718-3721. 526 proteins were identified in 2D 
gels of these cells (Table S2).  
Fibroblasts cultured from skin punches were analyzed similarly. The supplementary Table S3 
lists all 1 262 distinct proteins identified and assembled from three independent shotgun 
experiments, accessible via PRIDE accessions 3860-3862. 715 spots were cut out of 2D gels 
from fibroblast cytoplasmic protein fractions, resulting in the identification of 512 different 
proteins.  
1 460 different proteins were identified in three independent shotgun experiments with 
HaCaT keratinocyte cytoplasmic fractions (Table S4), accessible via PRIDE accessions 3381-
3384. 745 spots were cut out of 2D gels derived from the same protein fractions, resulting in 
the identification of 539 different proteins.  
 
Identification of common proteins 
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The analysis of the four reference proteome maps revealed 665 proteins to occur in all of 
these cell types (Figure 1). We designated these proteins as common proteins. 360 of those 
were also detectable in 2D gels in at least one of the four investigated cell types. 230 spots 
were detectable in each of the 2D gels of the four investigated cell types (Figure 2A-D). A 
synthetic 2D gel was created consisting only of those 230 spots, extracted from the 2D gels of 
dendritic cells. This fully annotated gel was made publicly available via 
http://www.meduniwien.ac.at/proteomics/Bilder/common-PG200A/gel.html. The identified 
spots are listed in alphabetical order at 
http://www.meduniwien.ac.at/proteomics/Bilder/common-PG200A/summary.html. Clicking 
on a spot displays the corresponding 2D gel sections of the four different kinds of cells to 
enable direct comparison of the spot environments. In addition to the presently applied IPG 
strips from BioRad we tested Immobiline™ strips from Pharmacia and tube gel-based iso-
electric focusing with free ampholytes [17], which resulted in similar spot patterns at 
corresponding pI ranges including the presently described common spots (data not shown). 
The common protein pattern may thus proof useful for the fast assignment of commonly 
expressed proteins in a broad variety of cells. 
In Figure 3 we demonstrate the feasibility of this strategy with a 2D gel generated from the 
cytoplasmic fraction of human colon carcinoma SW40 cells. The main part of the common 
proteins was clearly assigned. To verify these results, identification of each protein has been 
confirmed independently by mass-spectrometry as well (data not shown). 
 
Characterization of common proteins 
Many common proteins are represented as highly abundant spots on 2D gels, most obvious in 
case of several chaperons and cytoskeletal proteins. On average, the sum of integrated 
intensities of the spots comprising the common proteins exceeds more than 50% of the total 
integrated spot intensities of the analyzed 2D gels. We classified the identified common 
proteins into nine categories, namely: 1) chaperones 2) cytoskeleton 3) energy metabolism 4) 
redox regulation 5) nucleic acid processing 6) protein synthesis 7) protein turnover 8) 
membrane transport and 9) signaling (Table 1).  
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Discussion 
 
Numerous studies rely on the analysis of proteins derived from clinical samples [1]. Classical 
assessment of the applicability as well as of the sensitivity of analytical methods is based on 
the primary analysis of samples of known composition. Such an approach is not conceivable 
in case of proteome profiling because the nature of the analyzed samples is thus complex that 
it could not be adequately represented by an artificial mixture. Therefore, alternative 
strategies are required for quality assessment. 
Somatic cells comprise several organelles in common as for example mitochondria, 
ribosomes or proteasomes. The protein composition of organelles may vary to some extent 
but certain proteins are essential and must be present in all cell types [24]. In this study we 
chose a pragmatic approach in order to perform systematic evaluation of these proteins, which 
has not been realized in this way until now. We compared cells of quite different origin and 
function and identified their common proteins. Indeed, according to our primary concept, 
most of them could be clearly related to basic cellular functions. To systematically structure 
the data, we defined nine different functional categories. Table 1 lists all common proteins 
including the assignment to functional categories as well as the information wether these 
proteins were identified in 2D gels. More than 93% of all common proteins were assigned to 
at least one of these functional categories. The remaining 7% are related to basic cell 
functions too, but are more heterogeneous regarding potential classifications. 
The common proteins can therefore be regarded as a set of internal standard proteins as they 
are expected to occur in any kind of cell. It is obvious, however, that common proteins may 
still be expressed at quite different concentrations, depending on cell type and functional state. 
We analyzed the cytoplasmic fraction of a variety of other human cells by shotgun proteomics 
as well as by 2D-PAGE. Considering our shotgun experiments, results of considerable quality 
typically list 1 200 to 1 500 proteins per cell type. Such lists of proteins usually comprise 
about 95% of the common proteins (data not shown). 
In addition to the shotgun data, common proteins were identified on 2D gels. As the protein 
amounts vary considerably depending on the cell type, some spots were not detected in all 2D 
gels. Based on the common proteins detectable in all 2D gels, a synthetical spot pattern was 
generated. Remarkably, the total spot intensity of these common proteins was found to sum 
up to more than 50% of the total integrated spot intensity of all 2D gels analyzed. This finding 
suggested that the identification of this spot pattern may facilitate quick and reliable 
assignment of a large number of protein spots in 2D gels of cytoplasmic fractions of nearly 
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any kind of human cells. Presuming optimal protein solubilization and separation [16], the 
common spot pattern was detectable independent of the conditions applied for iso-electric 
focusing. The feasibility of this approach is demonstrated for human colon carcinoma SW-
480 cells in Figure 3. In 2D gels of cytoplasmic fractions of different human cells, we 
typically detected about 90% of the protein spots classified as common (data not shown). The 
fully annotated synthetic gel was made publicly available via 
www.meduniwien.ac.at/proteomics. Clicking on a spot on the synthetic gel provides the spot 
identification and the local spot environment of the four different cell types including 
normalized spot volumes. The same information is accessible via clicking proteins from an 
alphabetic protein list.   
As a conclusion, the detection of common proteins, whose existence is biologically evident, 
can be used in proteomic experiments as positive control. The application of two different 
proteome profiling methods supported the validity of the protein list which we generated by 
the comparison of highly differing cell types. The knowledge of identity, spot position and 
relative intensity of commonly expressed proteins will proof useful for data interpretation 
within proteome profiling experiments. 
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Legend to Figures: 
 
Figure 1: Schematic presentation of the number of proteins identified by shotgun and 2D-
PAGE. Results obtained from dendritic cells, HUVEC, HaCaT and fibroblasts were 
compared, the number of proteins shared by two different cells respectively are indicated in 
the intersection areas. 672 proteins were common to all four cell types. 364 of those were also 
identified in each of the 2D gels.  
 
Figure 2: Proteome profiling of human dendritic cells (A), HUVEC (B), HaCaT (C) and 
fibroblasts (D). Corresponding 2D gel sections of the four different cell types are shown. 
Protein detection was performed by fluorescence staining with RuBPS. Proteins were 
identified by mass spectrometric analysis of tryptic digests. Annotation: Swiss Prot accession 
numbers. 
 
Figure 3: Application of a synthetic 2D gel of commonly expressed proteins for the 
assignment of spot identities. Based on a 2D gel of dendritic cells a synthetic gel was 
generated including only common protein spots (common). A 2D gel of the cytoplasmic 
fraction of human colon carcinoma SW-480 cells was warped to the synthetic gel for easy and 
quick assignment of common proteins (common on SW-480). 
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Legend to Tables: 
 
Table 1: List of common proteins identified by shotgun analysis. Proteins were classified into 
nine categories according to their specific function. AccNo, Swiss Prot accession number. 2D, 
proteins as well identified in 2D gels (X).  
 
Supplementary Tables:  
 
Table S1: Proteome reference map of human dendritic cells. Proteins were identified by 
shotgun analysis from four independent samples. Proteins are sorted according to protein 
names and identified by their SwissProt accession numbers. Molecular weight, pI value, the 
number of distinct peptides identified per protein and the consequent sequence coverage are 
indicated. Furthermore, protein identifications which contain at least one peptide not 
identified in any other protein (row: SP; specific peptide) and proteins which were 
independently identified in 2D gels as well (row: 2D) are marked (X). 
 
Table S2: Proteome reference map of HUVEC. Annotation as in Table S1. 
 
Table S3: Proteome refence map of human fibroblasts. Annotation as in Table S1.  
 
Table S4: Proteome refence map of human HaCaT cells. Annotation as in Table S1. 
 
These lists will be available at http://www3.interscience.wiley.com/journal/10008330/home. 
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P61604 10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperon X - - - - - - - - -
P42704 130 kDa leucine-rich protein (LRP 130) (GP130) (Leucine-rich PPR - X - - - - - - - X
Q9NRX4 14 kDa phosphohistidine phosphatase (EC 3,1,3,-) (Phosphohistidin - - - - - X - - - -
P31946 14-3-3 protein beta/alpha (Protein kinase C inhibitor protein 1) (KCIP - - X - - - - - - -
P62258 14-3-3 protein epsilon (14-3-3E) - - X - - - - - - -
Q04917 14-3-3 protein eta (Protein AS1) - - X - - - - - - -
P61981 14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) - - X - - - - - - X
P27348 14-3-3 protein theta (14-3-3 protein tau) (14-3-3 protein T-cell) (HS1 - - X - - - - - - -
P63104 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP - - X - - - - - - X
Q9Y4L1 150 kDa oxygen-regulated protein precursor (Orp150) (Hypoxia up-r - - - - - - - - X X
P17980 26S protease regulatory subunit 6A (TAT-binding protein 1) (TBP-1) - - - - X - - - - X
P43686 26S protease regulatory subunit 6B (MIP224) (MB67-interacting prot - - - - X - - - - X
P62195 26S protease regulatory subunit 8 (Proteasome subunit p45) (p45/S - - - - X - - - - X
P62333 26S protease regulatory subunit S10B (Proteasome subunit p42) (P - - - - X - - - - X
O00231 26S proteasome non-ATPase regulatory subunit 11 (26S proteasom - - - - X - - - - X
O00232 26S proteasome non-ATPase regulatory subunit 12 (26S proteasom - - - - X - - - - -
Q9UNM6 26S proteasome non-ATPase regulatory subunit 13 (26S proteasom - - - - X - - - - X
O00487 26S proteasome non-ATPase regulatory subunit 14 (26S proteasom - - - - X - - - - X
Q13200 26S proteasome non-ATPase regulatory subunit 2 (26S proteasome - - - - X - - - - -
P51665 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome - - - - X - - - - X
P48556 26S proteasome non-ATPase regulatory subunit 8 (26S proteasome - - - - X - - - - X
P42126 3,2-trans-enoyl-CoA isomerase, mitochondrial precursor (EC 5,3,3,8 - X - - - - - - - X
P52815 39S ribosomal protein L12, mitochondrial precursor (L12mt) (MRP-L - X - - - - - - - X
Q96EL3 39S ribosomal protein L53, mitochondrial precursor (L53mt) (MRP-L - X - - - - - - - -
Q99714 3-hydroxyacyl-CoA dehydrogenase type II (EC 1,1,1,35) (Type II HA - X - - - - - - - X
P31937 3-hydroxyisobutyrate dehydrogenase, mitochondrial precursor (EC 1 - X - - - - - - - X
P09110 3-ketoacyl-CoA thiolase, peroxisomal precursor (EC 2,3,1,16) (Beta- - X - - - - - - - -
P46783 40S ribosomal protein S10 - - - - - - - X - -
P62280 40S ribosomal protein S11 - Homo sapiens (Human) - - - - - - - X - -
P25398 40S ribosomal protein S12 - Homo sapiens (Human) - - - - - - - X - X
P62277 40S ribosomal protein S13 - - - - - - - X - -
P62263 40S ribosomal protein S14 - - - - - - - X - -
P62244 40S ribosomal protein S15a - - - - - - - X - -
P62249 40S ribosomal protein S16 - - - - - - - X - -
P08708 40S ribosomal protein S17 - Homo sapiens (Human) - - - - - - - X - -
P62269 40S ribosomal protein S18 (Ke-3) (Ke3) - - - - - - - X - -
P39019 40S ribosomal protein S19 - - - - - - - X - -
P15880 40S ribosomal protein S2 (S4) (LLRep3 protein) - Homo sapiens (Hu - - - - - - - X - -
P60866 40S ribosomal protein S20 - Homo sapiens (Human) - - - - - - - X - -
P63220 40S ribosomal protein S21 - - - - - - - X - -
P62266 40S ribosomal protein S23 - Homo sapiens (Human) - - - - - - - X - -
P62847 40S ribosomal protein S24 - Homo sapiens (Human) - - - - - - - X - -
P62851 40S ribosomal protein S25 - - - - - - - X - -
P62854 40S ribosomal protein S26 - - - - - - - X - -
P62857 40S ribosomal protein S28 - - - - - - - X - -
P23396 40S ribosomal protein S3 - Homo sapiens (Human) - - - - - - - X - -
P61247 40S ribosomal protein S3a - Homo sapiens (Human) - - - - - - - X - -
P62701 40S ribosomal protein S4, X isoform (Single copy abundant mRNA p - - - - - - - X - -
P46782 40S ribosomal protein S5 - - - - - - - X - -
P62753 40S ribosomal protein S6 (Phosphoprotein NP33) - - - - - - - X - -
P62081 40S ribosomal protein S7 - - - - - - - X - -
P62241 40S ribosomal protein S8 - - - - - - - X - -
P46781 40S ribosomal protein S9 - Homo sapiens (Human) - - - - - - - X - -
P08865 40S ribosomal protein SA (p40) (34/67 kDa laminin receptor) (Colon - - - - - - - X - X
P49189 4-trimethylaminobutyraldehyde dehydrogenase (EC 1,2,1,47) (TMAB - - - - - - - - X X
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P10809 60 kDa heat shock protein, mitochondrial precursor (Hsp60) (60 kDa X X - - - - - - - X
P10155 60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribo - - - X - - - - - -
P05388 60S acidic ribosomal protein P0 (L10E) - - - - - - - X - X
P05387 60S acidic ribosomal protein P2 - - - - - - - X - -
P27635 60S ribosomal protein L10 (QM protein) (Tumor suppressor QM) (La - - - - - - - X - -
P62913 60S ribosomal protein L11 (CLL-associated antigen KW-12) - - - - - - - X - -
P30050 60S ribosomal protein L12 - - - - - - - X - -
P26373 60S ribosomal protein L13 (Breast basic conserved protein 1) - Hom - - - - - - - X - -
P50914 60S ribosomal protein L14 (CAG-ISL 7) - Homo sapiens (Human) - - - - - - - X - -
P61313 60S ribosomal protein L15 - Homo sapiens (Human) - - - - - - - X - -
P18621 60S ribosomal protein L17 (L23) - Homo sapiens (Human) - - - - - - - X - -
Q07020 60S ribosomal protein L18 - - - - - - - X - -
Q02543 60S ribosomal protein L18a - Homo sapiens (Human) - - - - - - - X - -
P46778 60S ribosomal protein L21 - Homo sapiens (Human) - - - - - - - X - -
P35268 60S ribosomal protein L22 (Epstein-Barr virus small RNA-associated - - - - - - - X - -
P62829 60S ribosomal protein L23 (Ribosomal protein L17) - - - - - - - X - -
P62750 60S ribosomal protein L23a - Homo sapiens (Human) - - - - - - - X - -
P83731 60S ribosomal protein L24 (Ribosomal protein L30) - Homo sapiens - - - - - - - X - -
P61353 60S ribosomal protein L27 - Homo sapiens (Human) - - - - - - - X - -
P46776 60S ribosomal protein L27a - Homo sapiens (Human) - - - - - - - X - -
P47914 60S ribosomal protein L29 (Cell surface heparin-binding protein HIP - - - - - - - X - -
P62888 60S ribosomal protein L30 - - - - - - - X - -
P42766 60S ribosomal protein L35 - Homo sapiens (Human) - - - - - - - X - -
P61513 60S ribosomal protein L37a - Homo sapiens (Human) - - - - - - - X - -
P63173 60S ribosomal protein L38 - Homo sapiens (Human) - - - - - - - X - -
Q02878 60S ribosomal protein L6 (TAX-responsive enhancer element-bindin - - - - - - - X - -
P18124 60S ribosomal protein L7 - Homo sapiens (Human) - - - - - - - X - -
P62424 60S ribosomal protein L7a (Surfeit locus protein 3) (PLA-X polypepti - - - - - - - X - -
P62917 60S ribosomal protein L8 - Homo sapiens (Human) - - - - - - - X - -
P32969 60S ribosomal protein L9 - Homo sapiens (Human) - - - - - - - X - -
P52209 6-phosphogluconate dehydrogenase, decarboxylating (EC 1,1,1,44) - - - - - - - - X X
O95336 6-phosphogluconolactonase (EC 3,1,1,31) (6PGL) - X - - - - - - - X
P11021 78 kDa glucose-regulated protein precursor (GRP 78) (Immunoglobu X - - - - - - - - X
Q96IU4 Abhydrolase domain-containing protein 14B (CCG1-interacting facto - - - - - - - - - X
P24752 Acetyl-CoA acetyltransferase, mitochondrial precursor (EC 2,3,1,9) ( - X - - - - - - - X
Q13510 Acid ceramidase precursor (EC 3,5,1,23) (Acylsphingosine deacylas - - X - - - - - - X
Q92688 Acidic leucine-rich nuclear phosphoprotein 32 family member B (PHA - - - X - - - - - -
Q99798 Aconitate hydratase, mitochondrial precursor (EC 4,2,1,3) (Citrate hy - X - - - - - - - X
P60709 Actin, cytoplasmic 1 (Beta-actin) - - - - - - X - - X
P61160 Actin-like protein 2 (Actin-related protein 2) - - - - - - X - - X
P61158 Actin-like protein 3 (Actin-related protein 3) - - - - - - X - - X
O15143 Actin-related protein 2/3 complex subunit 1B (ARP2/3 complex 41 kD - - - - - - X - - -
O15144 Actin-related protein 2/3 complex subunit 2 (ARP2/3 complex 34 kDa - - - - - - X - - X
O15145 Actin-related protein 2/3 complex subunit 3 (ARP2/3 complex 21 kDa - - - - - - X - - -
P59998 Actin-related protein 2/3 complex subunit 4 (ARP2/3 complex 20 kDa - - - - - - X - - -
O15511 Actin-related protein 2/3 complex subunit 5 (ARP2/3 complex 16 kDa - - - - - - X - - X
P53999 Activated RNA polymerase II transcriptional coactivator p15 (SUB1 h - - - X - - - - - -
O95433 Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p X - - - - - - - - X
P07108 Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) - X - - - - - - - -
P07311 Acylphosphatase-1 (EC 3,6,1,7) (Acylphosphate phosphohydrolase - - - - - - - - - -
O75608 Acyl-protein thioesterase 1 (EC 3,1,2,-) (Lysophospholipase I) - - - - - - - - - X
O95372 Acyl-protein thioesterase 2 (EC 3,1,2,-) (Lysophospholipase II) (LPL - - - - - - - - - X
P07741 Adenine phosphoribosyltransferase (EC 2,4,2,7) (APRT) - - - X - - - - - X
P55263 Adenosine kinase (EC 2,7,1,20) (AK) (Adenosine 5*-phosphotransfe - - - X - - - - - X
P23526 Adenosylhomocysteinase (EC 3,3,1,1) (S-adenosyl-L-homocysteine - - - X - - - - - X
P54819 Adenylate kinase isoenzyme 2, mitochondrial (EC 2,7,4,3) (ATP-AM - - - X - - - - - X
Q01518 Adenylyl cyclase-associated protein 1 (CAP 1) - - - X - - - - - X
P05141 ADP/ATP translocase 2 (Adenine nucleotide translocator 2) (ANT 2) - - - X - - - - - -
P84077 ADP-ribosylation factor 1 - - - X - - - - - -
P18085 ADP-ribosylation factor 4 - - - X - - - - - -
P84085 ADP-ribosylation factor 5 - - - X - - - - - -
P62330 ADP-ribosylation factor 6 - Homo sapiens (Human) - - - X - - - - - -
P36405 ADP-ribosylation factor-like protein 3 - Homo sapiens (Human) - - - X - - - - - -
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Q9UKK9 ADP-sugar pyrophosphatase (EC 3,6,1,13) (EC 3,6,1,-) (Nucleoside - - - X - - - - - X
P49588 Alanyl-tRNA synthetase (EC 6,1,1,7) (Alanine--tRNA ligase) (AlaRS) - - - - - - - X - X
P14550 Alcohol dehydrogenase [NADP+] (EC 1,1,1,2) (Aldehyde reductase) - - - - - - - - X X
P15121 Aldose reductase (EC 1,1,1,21) (AR) (Aldehyde reductase) - - - - - - - - X X
P35221 Alpha-1 catenin (Cadherin-associated protein) (Alpha E-catenin) - - - - - - X - - -
P12814 Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (Non-muscle alp - - - - - - X - - X
O43707 Alpha-actinin-4 (Non-muscle alpha-actinin 4) (F-actin cross linking p - - - - - - X - - X
P61163 Alpha-centractin (Centractin) (Centrosome-associated actin homolog - - - - - - X - - X
P06733 Alpha-enolase (EC 4,2,1,11) (2-phospho-D-glycerate hydro-lyase) (N - X - - - - - - - X
P04083 Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chromobindin-9) - - X - - X - - - X
P50995 Annexin A11 (Annexin XI) (Calcyclin-associated annexin 50) (CAP-5 - - X - - - - - - X
P07355 Annexin A2 (Annexin II) (Lipocortin II) (Calpactin I heavy chain) (Chr - - X - - - - - - X
P09525 Annexin A4 (Annexin IV) (Lipocortin IV) (Endonexin - - X - - - - - - X
P08758 Annexin A5 (Annexin V) (Lipocortin V) (Endonexin II) (Calphobindin - - X - - - - - - X
P20073 Annexin A7 (Annexin VII) (Synexin) - - X - - - - - - X
Q10567 AP-1 complex subunit beta-1 (Adapter-related protein complex 1 bet - - - - - - - - - -
Q9ULZ3 Apoptosis-associated speck-like protein containing a CARD (hASC) - - - - - X - - - X
P55145 ARMET protein precursor (Arginine-rich protein) - Homo sapiens (Hu - - - - - - - - - -
O43681 Arsenical pump-driving ATPase (EC 3,6,3,16) (Arsenite-translocating - - X - - - - - - X
P00505 Aspartate aminotransferase, mitochondrial precursor (EC 2,6,1,1) (T - X - - - - - - - -
Q15121 Astrocytic phosphoprotein PEA-15 (Phosphoprotein enriched in diab - - - - - X - - - X
P25705 ATP synthase alpha chain, mitochondrial precursor (EC 3,6,3,14) - X - - - - - - - X
P24539 ATP synthase B chain, mitochondrial precursor (EC 3,6,3,14) - X - - - - - - - -
P06576 ATP synthase beta chain, mitochondrial precursor (EC 3,6,3,14) - X - - - - - - - X
O75947 ATP synthase D chain, mitochondrial (EC 3,6,3,14) - X - - - - - - - X
P30049 ATP synthase delta chain, mitochondrial precursor (EC 3,6,3,14) - X - - - - - - - X
P56385 ATP synthase e chain, mitochondrial (EC 3,6,3,14) - Homo sapiens - X - - - - - - - -
P56134 ATP synthase f chain, mitochondrial (EC 3,6,3,14) - X - - - - - - - -
P36542 ATP synthase gamma chain, mitochondrial precursor (EC 3,6,3,14) - X - - - - - - - -
P48047 ATP synthase O subunit, mitochondrial precursor (EC 3,6,3,14) (Olig - X - - - - - - - -
O75964 ATP synthase subunit g, mitochondrial (EC 3,6,3,14) (ATPase subun - X - - - - - - - -
P53396 ATP-citrate synthase (EC 2,3,3,8) (ATP-citrate (pro-S-)-lyase) (Citra - X - - - - - - - -
P12956 ATP-dependent DNA helicase 2 subunit 1 (EC 3,6,1,-) (ATP-depend - - - X - - - - - X
P13010 ATP-dependent DNA helicase 2 subunit 2 (EC 3,6,1,-) (ATP-depend - - - X - - - - - -
O00571 ATP-dependent RNA helicase DDX3X (EC 3,6,1,-) (DEAD box prote - - - X - - - - - X
O75531 Barrier-to-autointegration factor (Breakpoint cluster region protein 1) - - - X - - - - - -
P61769 Beta-2-microglobulin precursor [Contains: Beta-2-microglobulin varia - - X - - - - - - X
P07686 Beta-hexosaminidase beta chain precursor (EC 3,2,1,52) (N-acetyl-b - - - - - - - - - X
P55957 BH3 interacting domain death agonist (BID) - - - - - X - - - X
P31939 Bifunctional purine biosynthesis protein PURH [Includes: Phosphorib - - - X - - - - - X
P53004 Biliverdin reductase A precursor (EC 1,3,1,24) (Biliverdin-IX alpha-re - - - - - - - - X X
P78537 Biogenesis of lysosome-related organelles complex-1 subunit 1 (BLO - - - - X - - - - -
P50583 Bis(5*-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3,6,1,17) (Di - - - - - X - - - -
Q9H3K6 BolA-like protein 2 - - - - - - - - - X
P11586 C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Inclu - X - - - - - - - -
P49593 Ca(2+)/calmodulin-dependent protein kinase phosphatase (EC 3,1,3 - - - - - X - - - -
Q99653 Calcium-binding protein p22 (Calcium-binding protein CHP) (Calcine - - X - - - - - - -
P06703 Calcyclin (Prolactin receptor-associated protein) (PRA) (Growth facto - - - - - X - - - X
Q9HB71 Calcyclin-binding protein (CacyBP) (hCacyBP) (Siah-interacting prot - - - - X - - - - -
P31949 Calgizzarin (S100 calcium-binding protein A11) (S100C protein) (ML - - - - - X - - - -
P62158 Calmodulin (CaM) - - - - - X - - - -
P27824 Calnexin precursor (Major histocompatibility complex class I antigen - - X - - - - - - -
P60903 Calpactin I light chain (S100 calcium-binding protein A10) (p10 prote - - X - - - - - - X
P04632 Calpain small subunit 1 (CSS1) (Calcium-dependent protease small - - - - X - - - - X
P07384 Calpain-1 catalytic subunit (EC 3,4,22,52) (Calpain-1 large subunit) - - - - X - - - - -
P17655 Calpain-2 catalytic subunit precursor (EC 3,4,22,53) (Calpain-2 large - - - - X - - - - -
Q99439 Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin) - - - - - - X - - X
P27797 Calreticulin precursor (CRP55) (Calregulin) (HACBP) (ERp60) (grp6 X - - - - - - - - -
P16152 Carbonyl reductase [NADPH] 1 (EC 1,1,1,184) (NADPH-dependent - - - - - - - - X X
P42574 Caspase-3 precursor (EC 3,4,22,-) (CASP-3) (Apopain) (Cysteine pr - - - - X - - - - X
P21964 Catechol O-methyltransferase (EC 2,1,1,6) - - X - - - - - - X
P07858 Cathepsin B precursor (EC 3,4,22,1) (Cathepsin B1) (APP secretase - - - - X - - - - X
P07339 Cathepsin D precursor (EC 3,4,23,5) [Contains: Cathepsin D light ch - - - - X - - - - X
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P16070 CD44 antigen precursor (Phagocytic glycoprotein I) (PGP-1) (HUTC - - X - - - - - - -
P13987 CD59 glycoprotein precursor (Membrane attack complex inhibition fa - - X - - - - - - -
P60953 Cell division control protein 42 homolog precursor (G25K GTP-bindin - - - - - X - - - X
P62633 Cellular nucleic acid-binding protein (CNBP) (Zinc finger protein 9) - - - - X - - - - - -
O00299 Chloride intracellular channel protein 1 (Nuclear chloride ion channe - - - - - X - - - X
Q13185 Chromobox protein homolog 3 (Heterochromatin protein 1 homolog - - - X - - - - - X
O75390 Citrate synthase, mitochondrial precursor (EC 2,3,3,1) - X - - - - - - - -
Q00610 Clathrin heavy chain 1 (CLH-17) - - - - - - X - - -
P53675 Clathrin heavy chain 2 (CLH-22) - - - - - - X - - -
Q99417 C-Myc-binding protein (Associate of Myc 1) (AMY-1) - - - - - X - - - -
O43598 c-Myc-responsive protein Rcl - - - - - X - - - X
Q14019 Coactosin-like protein - - - - - - X - - X
P53618 Coatomer subunit beta (Beta-coat protein) (Beta-COP) - - X - - - - - - -
O14579 Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP) - - X - - - - - - X
Q9Y678 Coatomer subunit gamma (Gamma-coat protein) (Gamma-COP) - - X - - - - - - -
P61923 Coatomer subunit zeta-1 (Zeta-1 coat protein) (Zeta-1 COP) - Homo - - X - - - - - - -
P23528 Cofilin-1 (Cofilin, non-muscle isoform) (18 kDa phosphoprotein) (p18 - - - - - - X - - X
Q9UBI1 COMM domain-containing protein 3 (Bup protein) (PIL protein) - - - - - - - - - X
Q9BT78 COP9 signalosome complex subunit 4 (Signalosome subunit 4) (SG - - - - X - - - - X
Q99627 COP9 signalosome complex subunit 8 (Signalosome subunit 8) (SG - - - - X - - - - X
Q99829 Copine-1 (Copine I) - - X - - - - - - X
Q86VP6 Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated an - - - - X - - - - -
P04080 Cystatin B (Liver thiol proteinase inhibitor) (CPI-B) (Stefin B) - - - - - - - - - X
P21291 Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP1) - - - - - - - - - X
P49589 Cysteinyl-tRNA synthetase, cytoplasmic (EC 6,1,1,16) (Cysteine--tR - - - - - - - X - -
O43169 Cytochrome b5 outer mitochondrial membrane isoform precursor - X - - - - - - X -
P99999 Cytochrome c - X - - - - - - X -
P20674 Cytochrome c oxidase polypeptide Va, mitochondrial precursor (EC - X - - - - - - X X
P00403 Cytochrome c oxidase subunit 2 (EC 1,9,3,1) (Cytochrome c oxidase - X - - - - - - X -
P28838 Cytosol aminopeptidase (EC 3,4,11,1) (Leucine aminopeptidase) (LA - - - - X - - - - X
O00154 Cytosolic acyl coenzyme A thioester hydrolase (EC 3,1,2,2) (Long ch - X - - - - - - - X
Q96KP4 Cytosolic nonspecific dipeptidase (Glutamate carbo - - - - X - - - - X
P30046 D-dopachrome decarboxylase (EC 4,1,1,84) (D-dopachrome tautom - - - - - - - - - X
Q13011 Delta3,5-delta2,4-dienoyl-CoA isomerase, mitochondrial precursor (E - X - - - - - - - X
P60981 Destrin (Actin-depolymerizing factor) (ADF) - - - - - - X - - X
Q9NR28 Diablo homolog, mitochondrial precursor (Second mitochondria-deriv - - - - - X - - - -
P09622 Dihydrolipoyl dehydrogenase, mitochondrial precursor (EC 1,8,1,4) ( - X - - - - - - - X
Q16555 Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response - - - - - X - - - X
P53634 Dipeptidyl-peptidase 1 precursor (EC 3,4,14,1) (Dipeptidyl-peptidase - - - - X - - - - -
P27695 DNA-(apurinic or apyrimidinic site) lyase (EC 4,2,99,18) (AP endonu - - - X - - - - - -
P04844 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 k X - - - - - - - - -
P04843 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 k X - - - - - - - - -
Q9C005 Dpy-30-like protein - Homo sapiens (Human) - - - - - - - - - -
P51452 Dual specificity protein phosphatase 3 (EC 3,1,3,48) (EC 3,1,3,16) (D - - - - - X - - - X
Q13561 Dynactin subunit 2 (Dynactin complex 50 kDa subunit) (50 kDa dyne - - - - - - X - - X
O75935 Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) - - - - - - X - - X
Q14203 Dynactin-1 (150 kDa dynein-associated polypeptide) (DP-150) (DAP - - - - - - X - - -
P63167 Dynein light chain 1, cytoplasmic (Dynein light chain LC8-type 1) (8 - - - - - - X - - -
Q9NP97 Dynein light chain 2A, cytoplasmic (Dynein-associated protein Km23 - - - - - - X - - -
Q15075 Early endosome antigen 1 (Endosome-associated protein p162) (Zin - - X - - - - - - -
Q96C19 EF-hand domain-containing protein 2 (Swiprosin-1) - - - - - X - - - X
Q9H4M9 EH-domain-containing protein 1 (Testilin) (hPAST1) - - - - - - - - - X
P13804 Electron transfer flavoprotein alpha-subunit, mitochondrial precursor - X - - - - - - - X
P38117 Electron transfer flavoprotein beta-subunit (Beta-ETF) - X - - - - - - - -
P68104 Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor 1 A-1) - - - - - - - X - X
P24534 Elongation factor 1-beta (EF-1-beta) - - - - - - - X - -
P29692 Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4) - - - - - - - X - X
P26641 Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) - - - - - - - X - X
P13639 Elongation factor 2 (EF-2) - - - - - - - X - X
P49411 Elongation factor Tu, mitochondrial precursor (EF-Tu) (P43) - - - - - - - X - X
P30040 Endoplasmic reticulum protein ERp29 precursor (ERp31) (ERp28) X - - - - - - - - X
P14625 Endoplasmin precursor (94 kDa glucose-regulated protein) (GRP94) X - - - - - - - - X
P30084 Enoyl-CoA hydratase, mitochondrial precursor (EC 4,2,1,17) (Short c - X - - - - - - - X
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P61916 Epididymal secretory protein E1 precursor (Niemann-Pick disease ty - - X - - - - - - X
Q96HE7 ERO1-like protein alpha precursor (EC 1,8,4,-) (ERO1-Lalpha) (Oxid - X - - - - - - - -
P10768 Esterase D (EC 3,1,1,1) - - X - - - - - - X
O95571 ETHE1 protein, mitochondrial precursor (EC 3,-,-,-) (Ethylmalonic en - X - - - - - - - X
P60842 Eukaryotic initiation factor 4A-I (EC 3,6,1,-) (ATP-dependent RNA he - - - - - - - X - X
Q14240 Eukaryotic initiation factor 4A-II (EC 3,6,1,-) (ATP-dependent RNA h - - - - - - - X - X
O43324 Eukaryotic translation elongation factor 1 epsilon-1 (Multisynthetase - - - - - - - X - -
P41567 Eukaryotic translation initiation factor 1 (eIF1) (Protein translation fac - - - - - - - X - X
P05198 Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic transla - - - - - - - X - X
O75822 Eukaryotic translation initiation factor 3 subunit 1 (eIF-3 alpha) (eIF3 - - - - - - - X - -
Q14152 Eukaryotic translation initiation factor 3 subunit 10 (eIF-3 theta) (eIF3 - - - - - - - X - -
O00303 Eukaryotic translation initiation factor 3 subunit 5 (eIF-3 epsilon) (eIF - - - - - - - X - X
P55884 Eukaryotic translation initiation factor 3 subunit 9 (eIF-3 eta) (eIF3 p1 - - - - - - - X - -
Q04637 Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (e - - - - - - - X - -
Q15056 Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren - - - - - - - X - X
P55010 Eukaryotic translation initiation factor 5 (eIF-5) - - - - - - - X - X
P63241 Eukaryotic translation initiation factor 5A (eIF-5A) (eIF-4D) (Rev-bind - - - - - - - X - X
P56537 Eukaryotic translation initiation factor 6 (eIF-6) (B4 integrin interactor - - - - - - - X - -
P15311 Ezrin (p81) (Cytovillin) (Villin-2) - - - - - - X - - X
P52907 F-actin capping protein alpha-1 subunit (CapZ alpha-1) - - - - - - X - - X
P47756 F-actin capping protein beta subunit (CapZ beta), - - - - - - X - - X
Q92945 Far upstream element-binding protein 2 (FUSE-binding protein 2) (K - - - X - - - - - X
P14324 Farnesyl pyrophosphate synthetase (FPP synthetase) (FPS) (Farnes - - X - - - - - - -
Q16658 Fascin (Singed-like protein) (55 kDa actin bundling protein) (p55) - - - - - - X - - X
P49327 Fatty acid synthase (EC 2,3,1,85) [Includes: [Acyl-carrier-protein] S-a - X - - - - - - - -
Q01469 Fatty acid-binding protein, epidermal (E-FABP) (Psoriasis-associated - - X - - - - - - X
P02792 Ferritin light chain (Ferritin L subunit) - - - - - - - - X X
P21333 Filamin-A (Alpha-filamin) (Filamin-1) (Endothelial actin-binding prote - - - - - - X - - X
O75369 Filamin-B (FLN-B) (Beta-filamin) (Actin-binding-like protein) (Thyroid - - - - - - X - - -
P26885 FK506-binding protein 2 precursor (EC 5,2,1,8) (Peptidyl-prolyl cis-tr X - - - - - - - - -
P30043 Flavin reductase (EC 1,5,1,30) (FR) (NADPH-dependent diaphorase - - - - - - - - X X
P04075 Fructose-bisphosphate aldolase A (EC 4,1,2,13) (Muscle-type aldola - X - - - - - - - X
P09972 Fructose-bisphosphate aldolase C (EC 4,1,2,13) (Brain-type aldolas - X - - - - - - - -
P07954 Fumarate hydratase, mitochondrial precursor (EC 4,2,1,2) (Fumaras - X - - - - - - - X
Q6P587 Fumarylacetoacetate hydrolase domain-containing protein 1 (EC 3,- X - - - - - - - - -
P09382 Galectin-1 (Beta-galactoside-binding lectin L-14-I) (Lactose-binding - - - - - X - - - X
P17931 Galectin-3 (Galactose-specific lectin 3) (Mac-2 antigen) (IgE-binding - - - - - X - - - -
P06396 Gelsolin precursor (Actin-depolymerizing factor) (ADF) (Brevin) (AGE - - - - - - X - - X
P60983 Glia maturation factor beta (GMF-beta) - - - - - X - - - X
P46926 Glucosamine-6-phosphate isomerase (EC 3,5,99,6) (Glucosamine-6 - X - - - - - - - X
P11413 Glucose-6-phosphate 1-dehydrogenase (EC 1,1,1,49) (G6PD) - X - - - - - - - X
P06744 Glucose-6-phosphate isomerase (EC 5,3,1,9) (GPI) (Phosphoglucos - X - - - - - - - X
P14314 Glucosidase II beta subunit precursor (Protein kinase C substrate, 6 - - - - - X - - - -
O94925 Glutaminase kidney isoform, mitochondrial precursor (EC 3,5,1,2) (G - X - - - - - - - X
P07203 Glutathione peroxidase 1 (EC 1,11,1,9) (GSHPx-1) (GPx-1) (Cellula - - - - - - - - X X
P00390 Glutathione reductase, mitochondrial precursor (EC 1,8,1,7) (GR) (G - - - - - - - - X -
Q9Y2Q3 Glutathione S-transferase kappa 1 (EC 2,5,1,18) (GST 13-13) (Gluta - - - - - - - - X -
P09211 Glutathione S-transferase P (EC 2,5,1,18) (GST class-pi) (GSTP1-1 - - - - - - - - X X
P30711 Glutathione S-transferase theta-1 (EC 2,5,1,18) (GST class-theta-1) - - - - - - - - X -
P78417 Glutathione transferase omega-1 (EC 2,5,1,18) (GSTO 1-1) - - - - - - - - X X
P04406 Glyceraldehyde-3-phosphate dehydrogenase (EC 1,2,1,12) (GAPDH - X - - - - - - - X
P43304 Glycerol-3-phosphate dehydrogenase, mitochondrial precursor (EC - X - - - - - - - X
P11216 Glycogen phosphorylase, brain form (EC 2,4,1,1) - X - - - - - - - X
P41250 Glycyl-tRNA synthetase (EC 6,1,1,14) (Glycine--tRNA ligase) (GlyRS - - - - - - - X - X
Q9HC38 Glyoxalase domain-containing protein 4 - Homo sapiens (Human) - X - - - - - - - -
Q9HAV7 GrpE protein homolog 1, mitochondrial precursor (Mt-GrpE#1) (HMG - X - - - - - - - X
Q9UIJ7 GTP:AMP phosphotransferase mitochondrial (EC 2,7,4,10) (Adenyla - X - - - - - - - -
P01112 GTPase HRas precursor (Transforming protein p21) (p21ras) (H-Ra - - - - - X - - - -
P01111 GTPase NRas precursor (Transforming protein N-Ras) - Homo sapie - - - - - X - - - -
P62826 GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC - - - X - - - - - X
Q9NR31 GTP-binding protein SAR1a (COPII-associated small GTPase) - - - X - - - - - X
Q9Y6B6 GTP-binding protein SAR1b (GTBPB) - - - X - - - - - X
P63244 Guanine nucleotide-binding protein beta subunit 2-like 1 (Guanine n - - - X - - - - - X
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P62873 Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 1 (T - X - X - - - - - X
P62879 Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 2 (T - X - X - - - - - X
Q16774 Guanylate kinase (EC 2,7,4,8) (GMP kinase) - - - X - - - - - X
P08107 Heat shock 70 kDa protein 1 (HSP70,1) (HSP70-1/HSP70-2) X - - - - - - - - X
P34932 Heat shock 70 kDa protein 4 (Heat shock 70-related protein APG-2) X - - - - - - - - X
P11142 Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) X - - - - - - - - X
Q12931 Heat shock protein 75 kDa, mitochondrial precursor (HSP 75) (Tumo X - - - - - - - - X
P07900 Heat shock protein HSP 90-alpha (HSP 86) X - - - - - - - - X
P08238 Heat shock protein HSP 90-beta (HSP 84) (HSP 90) X - - - - - - - - X
Q92598 Heat-shock protein 105 kDa (Heat shock 110 kDa protein) (Antigen X - - - - - - - - X
P04792 Heat-shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HS X - - - - - - - - X
Q9NRV9 Heme-binding protein 1 (p22HBP) - - - - - - - - - X
Q9Y5Z4 Heme-binding protein 2 (Protein SOUL) (Placental protein 23) (PP23 - - - - - - - - - -
Q99729 Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBE - - - X - - - - - -
Q14103 Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich e - - - X - - - - - X
P52597 Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-lik - - - X - - - - - X
P61978 Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transforma - - - X - - - - - X
O60506 Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (hnRNP-Q) - - - X - - - - - -
Q00839 Heterogenous nuclear ribonucleoprotein U (hnRNP U) (Scaffold atta - - - X - - - - - -
P19367 Hexokinase-1 (EC 2,7,1,1) (Hexokinase type I) (HK I) (Brain form he - X - - - - - - - -
P09429 High mobility group protein 1 (HMG-1) (High mobility group protein B - - - X - - - - - -
O15347 High mobility group protein B3 (High mobility group protein 4) (HMG - - - X - - - - - -
P49773 Histidine triad nucleotide-binding protein 1 (Adenosine 5*-monophos - - - X - - - - - X
Q9BX68 Histidine triad nucleotide-binding protein 2 (EC 3,-,-,-) (HINT-2) (HIN - - - X - - - - - X
P62805 Histone H4 - - - X - - - - - -
P50502 Hsc70-interacting protein (Hip) (Putative tumor suppressor ST13) (P X - - - - - - - - X
P35914 Hydroxymethylglutaryl-CoA lyase, mitochondrial precursor (EC 4,1,3 - X - - - - - - - -
P00492 Hypoxanthine-guanine phosphoribosyltransferase (EC 2,4,2,8) (HGP - - - X - - - - - X
O00629 Importin alpha-4 subunit (Karyopherin alpha-4 subunit) (Qip1 protein - - - X - - - - - -
Q14974 Importin beta-1 subunit (Karyopherin beta-1 subunit) (Nuclear factor - - - X - - - - - -
O00410 Importin beta-3 (Karyopherin beta-3) (Ran-binding protein 5) (RanBP - - - X - - - - - -
O95373 Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) - Homo sapiens - - - X - - - - - -
P55060 Importin-alpha re-exporter (Chromosome segregation 1-like protein) - - - X - - - - - -
Q15181 Inorganic pyrophosphatase (EC 3,6,1,1) (Pyrophosphate phospho-h - - - - - X - - - X
Q9H2U2 Inorganic pyrophosphatase 2, mitochondrial precursor (EC 3,6,1,1) ( - - - - - - - - - X
Q9BY32 Inosine triphosphate pyrophosphatase (EC 3,6,1,19) (ITPase) (Inosi - - - - - - - - - X
P05556 Integrin beta-1 precursor (Fibronectin receptor beta subunit) (Integrin - - X - - - - - - -
P50213 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial precur - X - - - - - - - X
O75874 Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1,1,1,42) (Oxalos - X - - - - - - - X
P33176 Kinesin heavy chain (Ubiquitous kinesin heavy chain) (UKHC) - - - - - - X - - -
Q04760 Lactoylglutathione lyase (EC 4,4,1,5) (Methylglyoxalase) (Aldoketom - - - - - - - - - X
P46379 Large proline-rich protein BAT3 (HLA-B-associated transcript 3) (Pro X - - - - - - - - -
P30740 Leukocyte elastase inhibitor (LEI) (Serpin B1) (Monocyte/neutrophil - - - - X - - - - X
P09960 Leukotriene A-4 hydrolase (EC 3,3,2,6) (LTA-4 hydrolase) (Leukotrie - - - - X - - - - X
Q14847 LIM and SH3 domain protein 1 (LASP-1) (MLN 50) - - - - - - X - - X
P00338 L-lactate dehydrogenase A chain (EC 1,1,1,27) (LDH-A) (LDH musc - X - - - - - - - -
P07195 L-lactate dehydrogenase B chain (EC 1,1,1,27) (LDH-B) (LDH heart - X - - - - - - - X
P24666 Low molecular weight phosphotyrosine protein phosphatase (EC 3,1 - - - - - - - - - X
P05455 Lupus La protein (Sjogren syndrome type B antigen) (SS-B) (La ribo - - - X - - - - - X
P10619 Lysosomal protective protein precursor (EC 3,4,16,5) (Cathepsin A) - - - - X - - - - -
P11279 Lysosome-associated membrane glycoprotein 1 precursor (LAMP-1 - - - - X - - - - -
Q15046 Lysyl-tRNA synthetase (EC 6,1,1,6) (Lysine--tRNA ligase) (LysRS) - - - - - - - - X - -
P40121 Macrophage capping protein (Actin-regulatory protein CAP-G) - - - - - - X - - X
P14174 Macrophage migration inhibitory factor (MIF) (Phenylpyruvate tautom - - - - - X - - - X
Q14764 Major vault protein (MVP) (Lung resistance-related protein) X - - - - - - - - X
P40925 Malate dehydrogenase, cytoplasmic (EC 1,1,1,37) (Cytosolic malate - X - - - - - - - X
P40926 Malate dehydrogenase, mitochondrial precursor (EC 1,1,1,37) - X - - - - - - - -
O60664 Mannose-6-phosphate receptor-binding protein 1 (Cargo selection p - - X - - - - - - X
O15173 Membrane-associated progesterone receptor component 2 (Progest - - X - - - - - - -
Q14696 Mesoderm development candidate 2 (NY-REN-61 antigen) - Homo s - - - - - - - - - -
Q9NZL9 Methionine adenosyltransferase 2 subunit beta - Homo sapiens (Hum - - - - - - - X - -
O14880 Microsomal glutathione S-transferase 3 (EC 2,5,1,18) (Microsomal G - - - - - - - - X -
P27816 Microtubule-associated protein 4 (MAP 4) - - - - - - X - - -
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Q15691 Microtubule-associated protein RP/EB family member 1 (APC-bindin - - - - - - X - - X
Q9Y2B0 MIR-interacting saposin-like protein precursor (Transmembrane prot - - X - - - - - - X
Q9NS69 Mitochondrial import receptor subunit TOM22 homolog (Translocase - - X - - - - - - -
O94826 Mitochondrial precursor proteins import receptor (Translocase of out - - X - - - - - - X
P28482 Mitogen-activated protein kinase 1 (EC 2,7,1,37) (Extracellular signa - - - - - X - - - X
P27361 Mitogen-activated protein kinase 3 (EC 2,7,1,37) (Extracellular signa - - - - - X - - - X
Q9UHA4 Mitogen-activated protein kinase kinase 1-interacting protein 1 (MEK - - - - - X - - - X
Q9Y2Q5 Mitogen-activated protein-binding protein-interacting protein (Late en - - - - - X - - - -
P26038 Moesin (Membrane-organizing extension spike protein) - - - - - - X - - X
Q7L9L4 Mps one binder kinase activator-like 1A (Mob1 homolog 1A) (Mob1A - - - - - X - - - X
P22234 Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazo - - - X - - - - - X
Q9NZM1 Myoferlin (Fer-1-like protein 3) - Homo sapiens (Human) - - X - - - - - - -
O00159 Myosin Ic (Myosin I beta) (MMI-beta) (MMIb) - Homo sapiens (Huma - - - - - - X - - -
P60660 Myosin light polypeptide 6 (Myosin light chain alkali 3) (Myosin light c - - - - - - X - - -
P19105 Myosin regulatory light chain 2, nonsarcomeric (Myosin RLC) - - - - - - X - - X
P35580 Myosin-10 (Myosin heavy chain, nonmuscle IIb) (Nonmuscle myosin - - - - - - X - - -
Q7Z406 Myosin-14 (Myosin heavy chain, nonmuscle IIc) (Nonmuscle myosin - - - - - - X - - -
P35579 Myosin-9 (Myosin heavy chain, nonmuscle IIa) (Nonmuscle myosin h - - - - - - X - - -
P58546 Myotrophin (V-1 protein) - - - - - - - X - X
Q9UJ70 N-acetylglucosamine kinase (EC 2,7,1,59) (GlcNAc kinase) - - - - - - - - - X
O43678 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (E - X - - - - - - X -
O96000 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (E - X - - - - - - X -
P00387 NADH-cytochrome b5 reductase (EC 1,6,2,2) (B5R) (Diaphorase-1) - X - - - - - - X -
Q16718 NADH-ubiquinone oxidoreductase 13 kDa-B subunit (EC 1,6,5,3) (E - X - - - - - - X X
O00217 NADH-ubiquinone oxidoreductase 23 kDa subunit, mitochondrial pre - X - - - - - - X -
O75489 NADH-ubiquinone oxidoreductase 30 kDa subunit, mitochondrial pre - X - - - - - - X X
P56556 NADH-ubiquinone oxidoreductase B14 subunit (EC 1,6,5,3) (EC 1,6 - X - - - - - - X -
Q13765 Nascent polypeptide-associated complex alpha subunit (NAC-alpha) X - - - - - - - - -
Q92597 NDRG1 protein (N-myc downstream-regulated gene 1 protein) (Diffe X - - - - - - - - X
Q15843 NEDD8 precursor (Ubiquitin-like protein Nedd8) (Neddylin) - Homo s - - - - X - - - - -
P61081 NEDD8-conjugating enzyme Ubc12 (EC 6,3,2,-) (Ubiquitin-conjugati - - - - X - - - - X
Q14697 Neutral alpha-glucosidase AB precursor (EC 3,2,1,84) (Glucosidase X - - - - - - - - X
Q96TA1 Niban-like protein (Meg-3) - - - - - - - - - -
P43490 Nicotinamide phosphoribosyltransferase (EC 2,4,2,12) (NAmPRTase - - - X - - - - - X
Q86X76 Nitrilase homolog 1 (EC 3,5,-,-) - Homo sapiens (Human) - - - - - - - - - X
P22307 Nonspecific lipid-transfer protein, mitochondrial precursor (EC 2,3,1, - - X - - - - - - X
Q9UNZ2 NSFL1 cofactor p47 (p97 cofactor p47) - - X - - - - - - X
P61970 Nuclear transport factor 2 (NTF-2) (Placental protein 15) (PP15) - - X - - - - - - X
P15531 Nucleoside diphosphate kinase A (EC 2,7,4,6) (NDK A) (NDP kinase - - - X - - - - - X
P22392 Nucleoside diphosphate kinase B (EC 2,7,4,6) (NDK B) (NDP kinase - - - X - - - - - -
P55209 Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNR - - - X - - - - - -
Q56VL3 OCIA domain-containing protein 2 - Homo sapiens (Human) - - - - X - - - - -
Q92882 Osteoclast-stimulating factor 1 - - - - - X - - - X
P20962 Parathymosin - Homo sapiens (Human) - - - X - - - - - -
Q9UBV8 Peflin (PEF protein with a long N-terminal hydrophobic domain) (Pen - - X - - - - - - -
P62937 Peptidyl-prolyl cis-trans isomerase A (EC 5,2,1,8) (PPIase) (Rotama X - - - - - - - - X
P23284 Peptidyl-prolyl cis-trans isomerase B precursor (EC 5,2,1,8) (PPIase X - - - - - - - - -
Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5,2,1,8) ( X - - - - - - - - -
Q9Y3E5 Peptidyl-tRNA hydrolase 2, mitochondrial precursor (EC 3,1,1,29) (P X - - - - - - - - -
Q06830 Peroxiredoxin-1 (EC 1,11,1,15) (Thioredoxin peroxidase 2) (Thioredo - - - - - - - - X X
P32119 Peroxiredoxin-2 (EC 1,11,1,15) (Thioredoxin peroxidase 1) (Thioredo - - - - - - - - X X
Q13162 Peroxiredoxin-4 (EC 1,11,1,15) (Prx-IV) (Thioredoxin peroxidase AO - - - - - - - - X X
P30044 Peroxiredoxin-5, mitochondrial precursor (EC 1,11,1,15) (Prx-V) (Pe - - - - - - - - X X
P30041 Peroxiredoxin-6 (EC 1,11,1,15) (Antioxidant protein 2) (1-Cys peroxi - - - - - - - - X X
Q00325 Phosphate carrier protein, mitochondrial precursor (PTP) (Solute car - - X - - - - - - -
P30086 Phosphatidylethanolamine-binding protein (PEBP) (Prostatic binding - - - - - X - - - X
P36871 Phosphoglucomutase-1 (EC 5,4,2,2) (Glucose phosphomutase 1) (P - X - - - - - - - X
Q96G03 Phosphoglucomutase-2 (EC 5,4,2,2) (Glucose phosphomutase 2) (P - X - - - - - - - -
P00558 Phosphoglycerate kinase 1 (EC 2,7,2,3) (Primer recognition protein - X - - - - - - - X
P18669 Phosphoglycerate mutase 1 (EC 5,4,2,1) (EC 5,4,2,4) (EC 3,1,3,13) - X - - - - - - - X
Q15126 Phosphomevalonate kinase (EC 2,7,4,2) (PMKase) - - - - - - - - - X
O00625 Pirin - Homo sapiens (Human) - - - X - - - - - -
P35237 Placental thrombin inhibitor (Cytoplasmic antiproteinase) (CAP) (Pro - - - - X - - - - X
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P13797 Plastin-3 (T-plastin) - - - - - - X - - X
P43034 Platelet-activating factor acetylhydrolase IB alpha subunit (PAF acet - - - - - X X - - -
P68402 Platelet-activating factor acetylhydrolase IB beta subunit (EC 3,1,1,4 - - - - - X X - - X
Q15102 Platelet-activating factor acetylhydrolase IB gamma subunit (EC 3,1, - - - - - X X - - X
Q15365 Poly(rC)-binding protein 1 (Alpha-CP1) (hnRNP-E1) (Nucleic acid-bi - - - X - - - - - X
Q15366 Poly(rC)-binding protein 2 (Alpha-CP2) (hnRNP-E2) - - - X - - - - - X
P11940 Polyadenylate-binding protein 1 (Poly(A)-binding protein 1) (PABP 1 - - - X - - - - - -
Q96CX2 Potassium channel tetramerisation domain-containing protein 12 (Pf X - - - - - - - - X
Q9UHV9 Prefoldin subunit 2 X - - - - - - - - X
P61758 Prefoldin subunit 3 (Von Hippel-Lindau-binding protein 1) (VHL-bind X - - - - - - - - X
Q99471 Prefoldin subunit 5 (C-myc-binding protein Mm-1) (Myc modulator 1) X - - - - - - - - X
P07602 Proactivator polypeptide precursor [Contains: Saposin A (Protein A); - - X - - - - - - X
Q9HA77 Probable cysteinyl-tRNA synthetase, mitochondrial precursor (EC 6, - - - - - - - X - -
O96008 Probable mitochondrial import receptor subunit TOM40 homolog (Tr - X - - - - - - - X
P07737 Profilin-1 (Profilin I) - - - - - - X - - X
Q8WUM4 Programmed cell death 6-interacting protein (PDCD6-interacting pro - - - - - X - - - X
Q9BUL8 Programmed cell death protein 10 (TF-1 cell apoptosis-related prote - - - - - X - - - -
O14737 Programmed cell death protein 5 (Protein TFAR19) (TF-1 cell apopto - - - - - X - - - X
O75340 Programmed cell death protein 6 (Probable calcium-binding protein A - - - - - X - - - X
P35232 Prohibitin, - - - X - - - - - X
Q99623 Prohibitin-2 (B-cell receptor-associated protein BAP37) (Repressor o - - - X - - - - - -
Q9UQ80 Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 hom - - - - - X - - - X
O94903 Proline synthetase co-transcribed bacterial homolog protein - - - - - - - - - -
P48147 Prolyl endopeptidase (EC 3,4,21,26) (Post-proline cleaving enzyme) - - - - X - - - - X
Q9H7Z7 Prostaglandin E synthase 2 (EC 5,3,99,3) (Microsomal prostaglandin - - - - - X - - - X
Q15185 Prostaglandin E synthase 3 (EC 5,3,99,3) (Cytosolic prostaglandin E X - - - - - - - - X
Q06323 Proteasome activator complex subunit 1 (Proteasome - - - - X - - - - X
Q9UL46 Proteasome activator complex subunit 2 (Proteasome activator 28-b - - - - X - - - - X
P25786 Proteasome subunit alpha type 1 (EC 3,4,25,1) (Proteasome compo - - - - X - - - - X
P25787 Proteasome subunit alpha type 2 (EC 3,4,25,1) (Proteasome compo - - - - X - - - - X
P25788 Proteasome subunit alpha type 3 (EC 3,4,25,1) (Proteasome compo - - - - X - - - - X
P25789 Proteasome subunit alpha type 4 (EC 3,4,25,1) (Proteasome compo - - - - X - - - - X
P28066 Proteasome subunit alpha type 5 (EC 3,4,25,1) (Proteasome zeta ch - - - - X - - - - -
P60900 Proteasome subunit alpha type 6 (EC 3,4,25,1) (Proteasome iota ch - - - - X - - - - X
O14818 Proteasome subunit alpha type 7 (EC 3,4,25,1) (Proteasome subuni - - - - X - - - - X
P20618 Proteasome subunit beta type 1 (EC 3,4,25,1) (Proteasome compon - - - - X - - - - -
P49721 Proteasome subunit beta type 2 (EC 3,4,25,1) (Proteasome compon - - - - X - - - - X
P49720 Proteasome subunit beta type 3 (EC 3,4,25,1) (Proteasome theta ch - - - - X - - - - X
P28070 Proteasome subunit beta type 4 precursor (EC 3,4,25,1) (Proteasom - - - - X - - - - X
P28072 Proteasome subunit beta type 6 precursor (EC 3,4,25,1) (Proteasom - - - - X - - - - X
P28062 Proteasome subunit beta type 8 precursor (EC 3,4,25,1) (Proteasom - - - - X - - - - -
P28065 Proteasome subunit beta type 9 precursor (EC 3,4,25,1) (Proteasom - - - - X - - - - X
Q9NQ88 Protein C12orf5 - - - - - - - - - -
Q9Y224 Protein C14orf166 - - - - - - - - - X
Q969H8 Protein C19orf10 precursor (Stromal cell-derived growth factor SF20 - - - - - - - - - X
Q9P1F3 Protein C6orf115 - - - - - - - - - X
O75223 Protein C7orf24 - - X - - - - - - X
O60888 Protein CutA precursor (Brain acetylcholinesterase putative membra - - - - - - - - - -
O60610 Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1 - - - - - - - - - -
P30101 Protein disulfide-isomerase A3 precursor (EC 5,3,4,1) (Disulfide isom X - - - - - - - - X
P13667 Protein disulfide-isomerase A4 precursor (EC 5,3,4,1) (Protein ERp- X - - - - - - - - -
Q15084 Protein disulfide-isomerase A6 precursor (EC 5,3,4,1) (Protein disulf X - - - - - - - - X
P07237 Protein disulfide-isomerase precursor (EC 5,3,4,1) (PDI) (Prolyl 4-hy X - - - - - - - - X
Q99497 Protein DJ-1 (Oncogene DJ1) X - - - - - - - X X
Q9BSJ8 Protein FAM62A (Membrane-bound C2 domain-containing protein) - - - X - - - - - - -
Q9BPW8 Protein NipSnap1 - Homo sapiens (Human) - - - - - - - - - -
Q9UFN0 Protein NipSnap3A (NipSnap4) (Target for Salmonella secreted prot - - - - - - - - - -
O94979 Protein transport protein Sec31A - Homo sapiens (Human) - - X - - - - - - -
P22061 Protein-L-isoaspartate(D-aspartate) O-methyltransferase (EC 2,1,1,7 X - - - - - - - - X
Q04941 Proteolipid protein 2 (Intestinal membrane A4 protein) (Differentiatio - - X - - - - - - -
P61457 Pterin-4-alpha-carbinolamine dehydratase (EC 4,2,1,96) (PHS) (4-al - - - X - - - - - -
P00491 Purine nucleoside phosphorylase (EC 2,4,2,1) (Inosine phosphorylas - - - X - - - - - X
P55786 Puromycin-sensitive aminopeptidase (EC 3,4,11,-) (PSA) - - - - X - - - - -
VERENA HAUDEK     PhD-thesis 135
Q9NTK5 Putative GTP-binding protein PTD004 - - - X - - - - - -
P98179 Putative RNA-binding protein 3 (RNA-binding motif protein 3) (RNPL - - - X - - - - - -
O00764 Pyridoxal kinase (EC 2,7,1,35) (Pyridoxine kinase) - - - - - - - - - X
P14618 Pyruvate kinase isozymes M1/M2 (EC 2,7,1,40) (Pyruvate kinase m - X - - - - - - - X
P31150 Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine d - - - - - X - - - X
P50395 Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diph - - - - - X - - - X
O60518 Ran-binding protein 6 (RanBP6) - - - X - - - - - -
P43487 Ran-specific GTPase-activating protein (Ran-binding protein 1) (Ran - - - X - - - - - X
P46940 Ras GTPase-activating-like protein IQGAP1 (p195) - - - - - X - - - -
Q15404 Ras suppressor protein 1 (Rsu-1) (RSP-1) - - - - - X - - - -
P63000 Ras-related C3 botulinum toxin substrate 1 precursor (p21-Rac1) (R - - - - - X - - - -
P15153 Ras-related C3 botulinum toxin substrate 2 precursor (p21-Rac2) (S - - - - - X - - - X
P61026 Ras-related protein Rab-10 - - X - - - - - - -
P62491 Ras-related protein Rab-11A (Rab-11) (YL8) - - X - - - - - - -
P61106 Ras-related protein Rab-14 - - X - - - - - - -
P59190 Ras-related protein Rab-15 - - X - - - - - - -
Q9NP72 Ras-related protein Rab-18 - Homo sapiens (Human) - - X - - - - - - -
P62820 Ras-related protein Rab-1A (YPT1-related protein) - - X - - - - - - X
Q9H0U4 Ras-related protein Rab-1B - - X - - - - - - -
Q9UL25 Ras-related protein Rab-21 - Homo sapiens (Human) - - X - - - - - - -
P61019 Ras-related protein Rab-2A - - X - - - - - - -
Q9H082 Ras-related protein Rab-33B - - X - - - - - - -
Q15286 Ras-related protein Rab-35 (Rab-1C) (GTP-binding protein RAY) - - X - - - - - - -
Q14964 Ras-related protein Rab-39A (Rab-39) - - X - - - - - - -
P20339 Ras-related protein Rab-5A - - X - - - - - - -
P61020 Ras-related protein Rab-5B - - X - - - - - - -
P51148 Ras-related protein Rab-5C (RAB5L) (L1880) - - X - - - - - - -
P20340 Ras-related protein Rab-6A (Rab-6) - - X - - - - - - -
P51149 Ras-related protein Rab-7 - - X - - - - - - X
P61006 Ras-related protein Rab-8A (Oncogene c-mel) - - X - - - - - - -
P62834 Ras-related protein Rap-1A precursor (GTP-binding protein smg-p21 - - X - - - - - - -
P61224 Ras-related protein Rap-1b precursor (GTP-binding protein smg p21 - - X - - - - - - X
P61225 Ras-related protein Rap-2b precursor - - X - - - - - - -
P35244 Replication protein A 14 kDa subunit (RP-A) (RF-A) (Replication fact - - - X - - - - - -
Q9NQC3 Reticulon-4 (Neurite outgrowth inhibitor) (Nogo protein) (Foocen) (Ne - - - - - - - - - -
P52565 Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha) - - - - - - X - - X
P52566 Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Rho-GDI beta) (Ly-G - - - - - - X - - X
P08134 Rho-related GTP-binding protein RhoC precursor (H9) - - - - - - X - - -
P84095 Rho-related GTP-binding protein RhoG precursor - - - - - - X - - -
P13489 Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1) (RAI) (P - - - X - - - - - -
P52758 Ribonuclease UK114 (EC 3,1,-,-) (14,5 kDa translational inhibitor pro - - - X - - - - - -
P11908 Ribose-phosphate pyrophosphokinase II (EC 2,7,6,1) (Phosphoribos - - - X - - - - - X
Q96AT9 Ribulose-phosphate 3-epimerase (EC 5,1,3,1) (Ribulose-5-phosphat - - - X - - - - - X
P35637 RNA-binding protein FUS (Oncogene FUS) (Oncogene TLS) (Trans - - - X - - - - - -
P55735 SEC13-related protein (SEC13-like protein 1) - - X - - - - - - X
P35270 Sepiapterin reductase (EC 1,1,1,153) (SPR) - Homo sapiens (Huma - - - - - - - - X -
Q15019 Septin-2 (Protein NEDD5) - - - - - - X - - X
P62140 Serine/threonine protein phosphatase PP1-beta catalytic subunit (EC - - - - - X - - - X
P30153 Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit - - - - - X - - - X
P62136 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (E - - - - - X - - - X
Q9Y3F4 Serine-threonine kinase receptor-associated protein (UNR-interactin - - - - - X - - - X
P49591 Seryl-tRNA synthetase (EC 6,1,1,11) (Serine--tRNA ligase) (SerRS) - - - - - - - X - X
O75368 SH3 domain-binding glutamic acid-rich-like protein - - - - - - - - - X
Q9H299 SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-b - - - - - - - - - -
Q16836 Short chain 3-hydroxyacyl-CoA dehydrogenase, mitochondrial precu - X - - - - - - - -
Q9NR45 Sialic acid synthase (N-acetylneuraminate synthase) (EC 2,5,1,56) ( - - - - - - - - - X
Q9BWM7 Sideroflexin-3 - Homo sapiens (Human) - - - - - - - - - -
P49458 Signal recognition particle 9 kDa protein (SRP9) - - - - - - - - - -
Q04837 Single-stranded DNA-binding protein, mitochondrial precursor (Mt-S - X - - - - - - - -
P62314 Small nuclear ribonucleoprotein Sm D1 (snRNP core protein D1) (Sm - - - X - - - - - -
Q13126 S-methyl-5-thioadenosine phosphorylase (EC 2,4,2,28) (5*-methylth - - - X - - - - - X
P05023 Sodium/potassium-transporting ATPase alpha-1 chain precursor (EC - - - - - - - - - -
P30626 Sorcin (22 kDa protein) (CP-22) (V19) - - - - - X - - - X
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O60493 Sorting nexin-3 (SDP3 protein) - - X - - - - - - -
Q7KZF4 Staphylococcal nuclease domain-containing protein 1 (p100 co-activ - - - X - - - - - -
P16949 Stathmin (Phosphoprotein p19) (pp19) (Oncoprotein 18) (Op18) (Leu - - - - - - X - - X
Q9UJZ1 Stomatin-like protein 2 (SLP-2) (EPB72-like 2) - - X - - - - - - X
P38646 Stress-70 protein, mitochondrial precursor (75 kDa glucose-regulate X - - - - - - - - X
P31948 Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing p X - - - - - - - - X
P31040 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitocho - X - - - - - - X X
Q9Y6N5 Sulfide:quinone oxidoreductase, mitochondrial precursor (EC 1,-,-,-) - X - - - - - - X -
P00441 Superoxide dismutase [Cu-Zn] (EC 1,15,1,1) - - - - - - - - X X
P04179 Superoxide dismutase [Mn], mitochondrial precursor (EC 1,15,1,1) - - - - - - - - X X
O15260 Surfeit locus protein 4 - - X - - - - - - -
Q9UH65 Switch-associated protein 70 (SWAP-70) - Homo sapiens (Human) - - X - - - - - - -
Q99536 Synaptic vesicle membrane protein VAT-1 homolog (EC 1,-,-,-) - - X - - - - - - X
O95721 Synaptosomal-associated protein 29 (SNAP-29) (Vesicle-membrane - - X - - - - - - X
O00560 Syntenin-1 (Syndecan-binding protein 1) (Melanoma differentiation-a - - - - - - X - - -
Q9Y490 Talin-1 - - - - - - X - - X
O14907 Tax1-binding protein 3 (Tax interaction protein 1) (TIP-1) (Glutamina - - - - - X - - - -
P17987 T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) X - - - - - - - - X
P78371 T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) X - - - - - - - - X
P50991 T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimul X - - - - - - - - -
P48643 T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) X - - - - - - - - X
Q99832 T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-in X - - - - - - - - -
P49368 T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) X - - - - - - - - X
P50990 T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) X - - - - - - - - X
P40227 T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta) (CCT-zet X - - - - - - - - X
Q9Y3D6 Tetratricopeptide repeat protein 11 (TPR repeat protein 11) (Fis1 ho - - X - - - - - - -
P10599 Thioredoxin (ATL-derived factor) (ADF) (Surface-associated sulphyd - - - - - - - - X X
O95881 Thioredoxin domain-containing protein 12 precursor (EC 1,8,4,2) (Th - - - - - - - - X -
Q9BS26 Thioredoxin domain-containing protein 4 precursor (Endoplasmic ret - - - - - - - - X X
P30048 Thioredoxin-dependent peroxide reductase, mitochondrial precursor - - - - - - - - X X
O43396 Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) - - - - - - - - X X
Q9BRA2 Thioredoxin-like protein 5 (14 kDa thioredoxin-related protein) (TRP1 - - - - - - - - X -
P62328 Thymosin beta-4 (T beta 4) (Fx) [Contains: Hematopoietic system re - - - - - - X - - -
Q9H0E2 Toll-interacting protein - - - - - X - - - X
O43617 Trafficking protein particle complex subunit 3 (BET3 homolog) - Hom - - X - - - - - - -
P37837 Transaldolase (EC 2,2,1,2) - X - - - - - - - X
Q15369 Transcription elongation factor B polypeptide 1 (RNA polymerase II t - - - X - - - X - -
P20290 Transcription factor BTF3 (RNA polymerase B transcription factor 3) - - - X - - - - - X
Q96K17 Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like - - - X - - - - - X
P61586 Transforming protein RhoA precursor (H12) - - - - - - X - - X
P37802 Transgelin-2 (SM22-alpha homolog) - - - - - - X - - -
P55072 Transitional endoplasmic reticulum ATPase (TER ATPase) (15S Mg X - - - - - - - - X
P29401 Transketolase (EC 2,2,1,1) (TK) - X - - - - - - - X
P13693 Translationally-controlled tumor protein (TCTP) (p23) (Histamine-rele - - - - - X - - - X
Q99598 Translin-associated protein X (Translin-associated factor X) - - - X - - - - - X
P51571 Translocon-associated protein delta subunit precursor (TRAP-delta) X - - - - - - - - -
Q15363 Transmembrane emp24 domain trafficking protein 2 precursor (Mem - - X - - - - - - -
Q9BVK6 Transmembrane emp24 domain-containing protein 9 precursor (Glyc - - X - - - - - - -
Q9BVC6 Transmembrane protein 109 precursor (Mitsugumin-23) (Mg23) - - X - - - - - - -
P40939 Trifunctional enzyme alpha subunit, mitochondrial precursor (TP-alp - X - - - - - - - -
P55084 Trifunctional enzyme subunit beta, mitochondrial precursor (TP-beta - X - - - - - - - -
P22102 Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phos - - - X - - - - - X
P60174 Triosephosphate isomerase (EC 5,3,1,1) (TIM) (Triose-phosphate is - X - - - - - - - X
O14773 Tripeptidyl-peptidase I precursor (EC 3,4,14,9) (TPP-I) (Tripeptidyl a - - - - X - - - - X
Q9UI30 TRM112-like protein - Homo sapiens (Human) - - - - - - - - - X
Q9NYL9 Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod) - Homo sapien - - - - - - X - - X
P09493 Tropomyosin 1 alpha chain (Alpha-tropomyosin) - - - - - - X - - X
P06753 Tropomyosin alpha-3 chain (Tropomyosin-3) (Tropomyosin gamma) - - - - - - X - - X
P67936 Tropomyosin alpha-4 chain (Tropomyosin-4) (TM30p1) - - - - - - X - - X
P23381 Tryptophanyl-tRNA synthetase (EC 6,1,1,2) (Tryptophan--tRNA ligas - - - - - - - X - X
P68363 Tubulin alpha-ubiquitous chain (Alpha-tubulin ubiquitous) (Tubulin K - - - - - - X - - X
P07437 Tubulin beta-2 chain - - - - - - X - - X
Q9BUF5 Tubulin beta-6 chain - Homo sapiens (Human) - - - - - - X - - -
VERENA HAUDEK     PhD-thesis 137
O75347 Tubulin-specific chaperone A (Tubulin-folding cofactor A) (CFA) (TC X - - - - - X - - X
Q99426 Tubulin-specific chaperone B (Tubulin folding cofactor B) (Cytoskele X - - - - - X - - X
O43399 Tumor protein D54 (hD54) (Tumor protein D52-like 2) - - - - - - - - - X
Q12792 Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9) - Homo sapiens (H - - - - - - X - - -
Q6IBS0 Twinfilin-2 (Twinfilin-1-like protein) (A6-related protein) (hA6RP) (Pro - - - - - - X - - X
P54577 Tyrosyl-tRNA synthetase, cytoplasmic (EC 6,1,1,1) (Tyrosyl--tRNA li - - - - - - - X - X
Q9Y333 U6 snRNA-associated Sm-like protein LSm2 (SnRNP core Sm-like p - - - X - - - - - -
P47985 Ubiquinol-cytochrome c reductase iron-sulfur subunit, mitochondrial - X - - - - - - - X
P22695 Ubiquinol-cytochrome-c reductase complex core protein 2, mitochon - X - - - - - - - -
P62988 Ubiquitin - - - - X - - - - X
P54578 Ubiquitin carboxyl-terminal hydrolase 14 (EC 3,1,2,15) (Ubiquitin thio - - - - X - - - - X
P45974 Ubiquitin carboxyl-terminal hydrolase 5 (EC 3,1,2,15) (Ubiquitin thiol - - - - X - - - - X
P15374 Ubiquitin carboxyl-terminal hydrolase isozyme L3 (EC 3,4,19,12) (UC - - - - X - - - - X
Q96FW1 Ubiquitin thiolesterase protein OTUB1 (EC 3,4,-,-) (Otubain 1) (OTU - - - - X - - - - -
P22314 Ubiquitin-activating enzyme E1 (A1S9 protein) - - - - X - - - - X
P62837 Ubiquitin-conjugating enzyme E2 D2 (EC 6,3,2,19) (Ubiquitin-protein - - - - X - - - - -
P68036 Ubiquitin-conjugating enzyme E2 L3 (EC 6,3,2,19) (Ubiquitin-protein - - - - X - - - - -
O14933 Ubiquitin-conjugating enzyme E2 L6 (EC 6,3,2,19) (Ubiquitin-protein - - - - X - - - - -
P61088 Ubiquitin-conjugating enzyme E2 N (EC 6,3,2,19) (Ubiquitin-protein - - - - X - - - - X
Q13404 Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (Ubiq - - - - X - - - - X
Q15819 Ubiquitin-conjugating enzyme E2 variant 2 (MMS2) (Enterocyte diffe - - - - X - - - - X
P61086 Ubiquitin-conjugating enzyme E2-25 kDa (EC 6,3,2,19) (Ubiquitin-pr - - - - X - - - - X
P61960 Ubiquitin-fold modifier 1 precursor - Homo sapiens (Human) - - - - X - - - - X
Q9UBT2 Ubiquitin-like 1-activating enzyme E1B (SUMO-1-activating enzyme - - - - X - - - - -
Q9NYU2 UDP-glucose:glycoprotein glucosyltransferase 1 precursor (EC 2,4,1 X - - - - - - - - -
P30085 UMP-CMP kinase (EC 2,7,4,14) (Cytidylate kinase) (Deoxycytidylate - - - X - - - - - X
Q6IAA8 UPF0404 protein C11orf59 - Homo sapiens (Human) - - - - - - - - - -
P54727 UV excision repair protein RAD23 homolog B (hHR23B) (XP-C repa - - - X - - - - - -
P38606 Vacuolar ATP synthase catalytic subunit A, ubiquitous isoform (EC 3 - X - - - - - - - X
P36543 Vacuolar ATP synthase subunit E (EC 3,6,3,14) (V-ATPase E subun - X - - - - - - - X
O75348 Vacuolar ATP synthase subunit G 1 (EC 3,6,3,14) (V-ATPase G sub - X - - - - - - - -
Q9UBQ0 Vacuolar protein sorting 29 (Vesicle protein sorting 29) (hVPS29) (P - - X - - - - - - X
Q96QK1 Vacuolar protein sorting 35 (Vesicle protein sorting 35) (hVPS35) (M - - X - - - - - - -
Q9BRG1 Vacuolar protein sorting-associated protein 25 (hVps25) (ELL-assoc - - X - - - - - - -
P63027 Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2 - - X - - - - - - -
P46459 Vesicle-fusing ATPase (EC 3,6,4,6) (Vesicular-fusion protein NSF) ( - - X - - - - - - X
Q00341 Vigilin (High density lipoprotein-binding protein) (HDL-binding protein - - X - - - - - - -
P18206 Vinculin (Metavinculin) - - - - - - X - - X
P21796 Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVD - - X - - - - - - -
P45880 Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVD - - X - - - - - - X
Q9Y277 Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVD - - X - - - - - - -
O75083 WD-repeat protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1) - - - - - - X - - X
Q92558 Wiskott-Aldrich syndrome protein family member 1 (WASP-family pr - - - - - - X - - -
VERENA HAUDEK     PhD-thesis 138
Paper II 
Author contribution: Verena Haudek helped with the concept design and performed 2D gels 
and 1D-PAGE. 
 
VERENA HAUDEK     PhD-thesis 139
 VERENA HAUDEK     PhD-thesis 140
Consequences of Acute and Chronic Oxidative Stress upon the
Expression Pattern of Proteins in Peripheral Blood Mononuclear
Cells
Verena J. Haudek,† Nina C. Gundacker,† Astrid Slany,† Helge Wimmer,‡ Editha Bayer,†
Karoline Pable´,§ and Christopher Gerner*,†
Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Austria, Section
Biomedical Laboratory Science, University of Applied Science, Vienna, Austria, and Austrian Research Center
Seibersdorf, Vienna, Austria
Received June 16, 2008
Oxidative stress accompanies various diseases associated with chronic inflammation, including cancer.
We exposed human peripheral blood mononuclear cells (PBMCs) to hydrogen peroxide in autologous
plasma imitating in vivo conditions. Proteome alterations of metabolically labeled cells were recorded
by means of 2D gel electrophoresis in addition to shotgun analysis. Cells displayed a distinct stress
response and down-regulated manganese superoxide dismutase, while a large number of other redox-
regulating enzymes remained unaffected. In the second part of the experiment, we isolated PBMCs
from cancer patients to analyze primary cells exposed to chronic oxidative stress. Plasma peroxidation
levels of the patients were significantly higher than those of age and sex-matched controls. The
corresponding cells displayed significant proteome alterations which appear to be related to inflam-
mation and apoptosis regulation. The present data, fully accessible via PRIDE (accessions 3844-59),
may be the first step in the design of a combined protein assay specifically indicating oxidative stress
in human PBMCs.
Keywords: oxidative stress • 2D-PAGE • shotgun proteomics • lipid peroxidation
Introduction
In organisms, oxidative stress is generated when the con-
centration of free radicals and other reactive oxygen species
(ROS) exceeds the capacity of the antioxidant defense system.1
This may result in biological damage which is characteristic
for arteriosclerosis and other diseases associated with chronic
inflammation.2 Many sources of ROS have been identified:
endogenous sources via the respiratory-chain of mitochondria
or peroxisomes and exogenous sources via exposure to xeno-
biotics, radiation, ultrasound, pollution, infections, drugs or
smoke.3-5 High ROS generation and persistent oxidative stress
have not only been associated with chronic inflammation, but
have also been identified as characteristic features of carcinoma
cells both in vitro and in vivo.2,6
There is strong evidence that proteins are the main targets
of oxidative stress and free radical action.7-9 These effects have
been described regarding aging,10 Alzheimer’s disease, asthma,
atherosclerosis, diabetes mellitus and several other diseases.11
Additionally, cell membranes containing unsaturated fatty acids
are susceptible to oxidation when reacting with ROS. Free
radical chain reactions in the poly unsaturated lipid layer of
cell membranes are characteristic of ROS-induced lipid per-
oxidation, promoting protein oxidation.2,12 Cells are equipped
with a protein machinery to defend themselves against ROS.
Particularly, superoxide dismutase (SOD) enzymes, glutathione
peroxidases (GPX) and catalase enzymes serve as such defenses.
Proteome analysis is a very suitable method to investigate
biological effects of oxidative stress.13,14 Comprehensive studies
were performed on systems as diverse as rice,15 yeast16 and
cultured human cells.17-20 Especially regarding neurodegen-
erative disorders, various proteome studies were performed
with human clinical materials.21
Proteome studies focusing on oxidative stress may contribute
to two important issues: First, comprehensive profiling might
allow the identification of marker proteins specifically indicat-
ing and indirectly quantifying the extent of oxidative stress.
Second, the investigation of the cellular response to oxidative
stress may contribute to the understanding of the complex
biochemistry of redox regulation in the context of diseases.
The present study was designed to account for both aspects.
In contrast to many other proteome studies focusing on
oxidative stress, we used primary human peripheral blood
mononuclear cells (PBMCs). These cells are exposed to oxida-
tive stress mediated via hydrogen peroxide in vivo and thus
constitute an ideal model cell system for clinical research. The
main disadvantage of these cells is the individual variation of
protein expression and the limited time available to perform
* To whom correspondence should be addressed. Christopher Gerner,
Department of Medicine I, Institute of Cancer Research, Medical University
of Vienna, Austria. E-mail, Christopher.Gerner@meduniwien.ac.at; phone,
0043-1-4277-65230.
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in vitro experiments due to the fact that these cells cannot be
maintained in culture.
We overcame some of these obstacles by designing a
short-time experiment which was performed at conditions
very much similar to in vivo conditions as the cells were kept
in autologous plasma. The required sensitivity of the pro-
teome profiling technique was achieved by metabolic label-
ing of the cells combined with autoradiographic detection
of protein synthesis. To imitate physiologic conditions, we
resuspended cells in autologous plasma for treatment with
hydrogen peroxide at concentrations which have been
reported in vivo.22 Hydrogen peroxide was used for the in
vitro approach due to its capacity to cross cell membranes
and diffuse through mitochondria, thereby causing many
types of cellular injuries.2 By the use of metabolic labeling
and subsequent two-dimensional polyacrylamide gel elec-
trophoresis (2D-PAGE) analysis, we investigated the immedi-
ate response of cells to the oxidative challenge in vitro. This
Figure 1. Fully annotated 2D-gel of the cytoplasmic protein fraction of human PBMCs. Proteins were detected by RuBPS fluorescence
staining. Spots were cut out of the gel, digested with trypsin and subjected to LC-MS/MS analysis for identification of proteins. Swiss-
Prot accession numbers are annotated.
Consequences of Acute and Chronic Oxidative Stress research articles
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experimental strategy was combined with shotgun proteom-
ics in order to achieve optimal reliability of data.
Furthermore, we hypothesized that some oxidative stress-
induced proteins accumulate in cells and could therefore be
useable as biomarkers. As indicated above, however, it is
assumed that oxidative stress may occur in cancer patients in
vivo. Cells from such patients, therefore, can serve as model
for cells which were exposed to oxidative stress for a long period
of time. To pursue this strategy, we determined the level of
oxidative stress in plasma derived from tumor patients by
standard lipid peroxidation assays. Higher levels of oxidative
stress in vivo were successfully verified. These cells were also
subjected to comprehensive proteome profiling and compared
to cells from healthy age and sex-matched individuals.
Experimental Section
Sample Collection. Twenty milliliters of heparinized blood
was collected per donor, aged between 50 and 80 years. A group
of 10 cancer patients (6 with breast cancer, 2 with colon cancer
and 2 with kidney cancer) was compared to 10 control persons,
matched in sex and age. For the in vitro approach, four more
healthy persons, aged between 28 and 40, were included. The
study design was reviewed and approved by the “Forum
O¨sterreichischer Ethikkommissionen”, EK-Nr. 360/2005. Two
milliliters of the whole blood sample was used for plasma
isolation by centrifugation for 10 min at room temperature at
8000g. The supernatant plasma was carefully isolated and
stored at -80 °C. PBMCs were isolated by standard density
gradient centrifugation as described.23,24 The cells were sub-
sequently washed with HBSS (Hanks‘ Buffered Salt Solution,
1:1).
In Vitro Treatment. Resuspended cells were treated in vitro
for 6 h with hydrogen peroxide (H2O2, 100 µM) to simulate
acute oxidative stress and the cell aliquots were labeled with
0.2 mCi/mL [35S] methionine and cysteine (Trans35label,
Biomedica, MP Biomedicals). Because of inherent catalase
activity in plasma, the active concentration of hydrogen
peroxide was immediately reduced. During the experiment, cell
viability was assayed by Trypan blue staining and was found
to be consistently higher than 95%. Cells were washed with
HBSS and harvested after 6 h of incubation at 37 °C in a 5%
humidified atmosphere.
Subcellular Fractionation. For isolation of cytoplasmic
proteins, all buffers were supplemented with protease inhibi-
tors: PMSF (1 mM), aprotinin, leupeptin and pepstatin A (each
at 1 µg/mL). Cells were lysed in hypotonic buffer (10 mM
HEPES/NaOH, pH 7.4, 0.25 M sucrose, 10 mM NaCl, 3 mM
MgCl2, 0.5% Triton X-100). Nuclei were separated from the
cytoplasm by centrifugation at 1000g for 5 min at 4 °C.
Cytoplasmic proteins were precipitated with ethanol and
dissolved in sample buffer (7.5 M urea, 1.5 M thiourea, 4%
CHAPS, 0.5% SDS, 100 mM DDT).
Figure 2. Differently expressed proteins caused by in vitro
treatment of PBMCs with hydrogen peroxide. 2D-gel autoradio-
graphs of untreated (AR-con) and hydrogen peroxide treated (AR-
H2O2) PBMCs are shown. Proteins up-regulated by hydrogen
peroxide are encircled and annotated in AR-H2O2, proteins down-
regulated are marked by hexagons and annotated in AR-con.
Several redox-regulating proteins which were not significantly
regulated are annotated in both gel sections.
Figure 3. Up-regulation of proteins by hydrogen peroxide is
highly reproducible with different donors. Corresponding 2D gel
sections of three individual donors, untreated (control) and
treated (H2O2). PBMC protein spots quantified by fluorescence
detection (FL) and [35S]-autoradiography (AR).
research articles Haudek et al.
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Table 1. Proteins Identified in the Present Study and Related to Oxidative Stressa
protein name accession no. [35S] shotgun published implications
1. In Vitro
cell stress T-complex protein 1,
beta subunit
P78371 2.3 up up-regulated upon X-ray
exposition41
Heat shock 70 kDa
protein 1
P08107 12.3 n.a. up-regulated by oxidative
stress16
Activator of 90 kDa heat
shock protein ATPase
hom. 1
O95433 9.8 n.a. down-regulated upon
X-ray exposition41
Annexin A1 P04083 4.2 n.a. up-regulated by oxidative
stress, heat42
Protein
disulfide-isomerase A3
(ERp57)
P30101 2.5 n.a. association with
immunogenicity of cell
death43
Septin-6 Q14141 2.5 n.a. DNA-damage response,44
melanoma45
Stress-induced-phosphoprotein
1
P31948 2.1 n.a. up-regulated by X-ray
exposition41
Calreticulin precursor
(Calregulin)
P27797 n.d. up association with
immunogenicity of cell
death43
Heat shock protein HSP
90-alpha (HSP 86)
P07900 n.a. down down-regulated in
cytoplasm during
apoptosis46
Heat shock protein HSP
90-beta (HSP 84) (HSP
90)
P08238 n.a. down down-regulated in
cytoplasm during
apoptosis46
Endoplasmin P14625 n.a. down
Stress-70 protein,
mitochondrial precursor
P38646 n.a. down
Heat-shock protein
beta-1 (HspB1) (Heat
shock 27 kDa protein)
P04792 n.a. n.a.
cytoskeletal Coronin-1A P31146 2.5 up rearrangement of Actin
cytoskeleton47
Tubulin alpha-1B chain P68363 3.8 n.a.
Tubulin beta chain P07437 2.9 n.a.
L-plastin (Lymphocyte
cytosolic protein 1)
P13796 2.8 n.a. rearrangement of actin
cytoskeleton48
Talin-1 Q9Y490 n.a. down adhesion to cell
membrane 149
Gelsolin precursor
(Actin-depolymerizing
factor) (ADF)
P06396 n.a. down
Tubulin alpha-ubiquitous
chain (Alpha-tubulin
ubiquitous)
P68363 n.a. n.a.
redox-regulation Superoxide dismutase
[Mn]. mitochondrial
P04179 -4,2 down tumor-suppressor
activity35-37
Cytochrome b-c1
complex subunit 1
P31930 -3.5 n.a.
Glutaredoxin-3 O76003 6.5 n.d. oxidative stress
response50
NADH-cytochrome b5
reductase
P00387 n.d. up
Ferritin heavy chain (EC
1,16,3,1) (Ferritin H
subunit)
P02794 n.a. down apoptosis resistance51
Ferritin light chain
(Ferritin L subunit)
P02792 n.a. down
Glutathione S-transferase
kappa 1
Q9Y2Q3 n.d. down resistance to oxidative
stress52
Catalase P04040 n.a. n.a. up-regulated by oxidative
stress15,16
Glutathione peroxidase 1 P07203 n.a. n.a.
Glutathione reductase,
mitochondrial precursor
P00390 n.d. n.a.
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Table 1. Continued
protein name accession no. [35S] shotgun published implications
Glutathione S-transferase
Mu 1
P09488 n.d. n.a.
Glutathione S-transferase
Mu 3
P21266 n.a. n.a.
Glutathione synthetase P48637 n.a. n.a.
Microsomal glutathione
S-transferase 3
O14880 n.d. n.a.
Peroxiredoxin-1
(Thioredoxin peroxidase
2)
Q06830 n.a. n.a.
Peroxiredoxin-2
(Thioredoxin peroxidase
1)
P32119 n.a. n.a.
Peroxiredoxin-4
(Thioredoxin peroxidase
AO372)
Q13162 n.a. n.a.
Peroxiredoxin-5,
mitochondrial precursor
P30044 n.a. n.a.
Peroxiredoxin-6
(Antioxidant protein 2)
P30041 n.a. n.a.
Phospholipid
hydroperoxide
glutathione peroxidase,
mitochondrial precursor
P36969 n.d. n.a.
Superoxide dismutase
[Cu-Zn]
P00441 n.a. n.a.
Thioredoxin-dependent
peroxide reductase
(Peroxiredoxin-3)
P30048 n.a. n.a.
inflammation Proactivator polypeptide P07602 6.5 n.a.
Ficolin-1 O00602 3.5 n.d.
Thymidine phosphorylase P19971 2.6 n.a.
Protein S100-A11
(Calgizzarin)
P31949 -4.3 down
Interleukin-1 beta
precursor (IL-1 beta)
(Catabolin)
P01584 n.d. up
Mitogen-activated
protein kinase 1
P28482 n.a. up
Interleukin-16 precursor
(IL-16) (Lymphocyte
chemoattractant factor)
(LCF)
Q14005 n.d. down
Myeloperoxidase
precursor (MPO)
P05164 n.d. down
Energy metabolism Transaldolase P37837 2.4 n.a. regulate glutathione
levels,53 up-regulated
upon X-ray exposion41
ATP synthase D chain.
mitochondrial
O75947 -12.2 down down-regulated during
aging,54 X-ray
exposion41
other Histidine triad
nucleotide-binding
protein 1
P49773 -2.4 down
Tyrosine-protein kinase
ZAP-70
P43403 -2.1 down
Purine nucleoside
phosphorylase
P00491 3.7 n.a.
Ficolin-1 O00602 3.5 n.d.
Sorcin (22 kDa protein) P30626 -6.2 n.a. apoptosis55,56
EF-hand
domain-containing
protein D2
Q96C19 -2.8 n.a.
Galectin-1 P09382 -2.2 n.a. involved in cancer
biology57
UTP--glucose-1-phosphate
uridylyltransferase 2
Q16851 n.d. up
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Photometry. Lipid peroxide formation was measured using
thiobarbituric assay (TBA-assay) and hydroperoxide assay with
ferric xylenol orange (XO) complex. For the TBA-assay, 30 µL
of plasma was suspended in 1 mL of 0.37% TBA in 0.25 M HCl,
heated for 45 min at 100 °C and afterward centrifuged for 10
min. Absorbance of the supernatant was read at 525 nm.7 For
the XO assay, 30 µL of plasma was suspended in a solution
which contained 25 mMH2SO4, 100 µMXO and 250 µM ferrous
ammonium sulfate in a volume of 1 mL. After 30 min in the
dark, the absorbance was read at 560 nm with 100 µM XO as
blank.25
2D Polyacrylamide Gel Electrophoresis (2D-PAGE). High
resolution 2D-PAGE was carried out as described previously.26
Proteins from PBMC were loaded on IPG strips pH 5-8, 17 cm
(BioRad, Hercules, CA) by passive rehydration. IEF (isolelectric
focusing) was performed in a stepwise fashion (1 h 0-500 V
linear; 5 h 500 V; 5 h 500-3500 V linear; 12 h 3500 V). After IEF
and equilibration with 100 mM DTT and 2.5% iodacetamide,
SDS-PAGE (19 cm × 18 cm × 1.5 mm, 12% polyacryamide)
was performed with the Protean II xi electrophoresis system
(BioRad). The gels were stained with a 400 nM solution of
Ruthenium II tris (bathophenanthroline disulfonate) (RuBPS)
as described by Rabilloud et al.27 Fluorography scanning was
performed with the FluorImager 595 (GE Healthcare, Fairfield,
CT) at a resolution of 100 µm. Thereafter, gels of the radioac-
tively labeled samples were dried and exposed to phosphor
screens (Molecular Dynamics). Scanning was performed with
the Phosphorimager SI (Molecular Dynamics) at a resolution
of 100 µm as previously described.28 Comparative 2D gel
analysis was performed with TT900 S2S software (Version
2006.0.2389, Nonlinear Dynamics, Carlsbad, CA) and Progenesis
software PG200 (Version 2006, Nonlinear Dynamics) using the
“same spot” algorithm. Spot assignment, background correc-
tion, normalization and statistical calculations (analysis of
Table 1. Continued
protein name accession no. [35S] shotgun published implications
ATP-dependent DNA
helicase 2 subunit 1
P12956 n.a. down
ATP-dependent DNA
helicase 2 subunit 2
P13010 n.d. down
Integrin alpha-M
precursor (Cell surface
glycoprotein MAC-1
alpha subunit)
P11215 n.d. down
Ras
GTPase-activating-like
protein IQGAP1 (p195)
P46940 n.d. down
Ras-related protein
Rab-2A
P61019 n.d. down
Serine/threonine-protein
kinase 10
(Lymphocyte-oriented
kinase)
O94804 n.d. down
Ubiquinol-cytochrome-c
reductase complex core
protein I, mitochondrial
precursor
P31930 n.a. down
2. In Vivo
S100 calcium-binding
protein A8 (Calgranulin
A isoform 1)
P05109 6.8 n.a. inflammation58,59
S100 calcium-binding
protein A8 (Calgranulin
A isoform 2)
P05109 6.4 n.a. inflammation58,59
S100 calcium-binding
protein A4 (Matastasin)
P26447 5.1 n.a. inflammation,
metastasis60,61
Myotrophin (V-1 protein) P58546 1.9 n.a.
Phosphoglycerate mutase
1
P18669 1.6 n.a. glycolysis62
Serine/threonine protein
phosphatase 2A, 65 kDa
regulatory subunit
P30153 -1.8 n.a. apoptosis63,64
Ezrin P15311 -1.7 n.a.
Caspase-3 P42574 -1.6 n.a. Apoptosis65,66
Ubiquitin-activating
enzyme E1
P22314 -1.6 n.a. removal of damaged
proteins67
a In vitro, data derived from the in vitro treatment of PBMCs with hydrogen peroxide. Proteins are classified as indicated in the text. In Vivo, protein
alterations observed when comparing PBMCs derived from cancer patients with age and sex-matched healthy controls. Proteins were assigned to
functional groups. Accessions no., Swiss-Prot protein accessions. [35S], difference factors determined from the comparison of normalized integrated
autoradiography spot intensities of corresponding protein derived from treated cells divided by those of untreated cells. All ANOVA p-values derived from
the four independent experiments are <0.05. Shotgun, alteration of protein amounts as determined by the spectral count method. Proteins reproducibly
affected are marked by “up” or “down”, respectively. Related observations are indicated with references. n.a, not affected; n.d, not determined (not
detectable with the corresponding technique).
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variance, ANOVA) were performed using this software package.
Factors indicating up- and down-regulation of proteins in 2D
gels were obtained using normalized integrated spot intensities.
1D-PAGE for Subsequent Shotgun analysis. The cytoplas-
mic protein fraction of the PBMC was loaded onto the slots of
a 13% polyacrylamid gel; electrophoresis was performed until
complete separation of the molecular marker (Dual Color, Bio-
Rad) was achieved. Gels were fixed with 50% methanol/10%
acidic acid and subsequently silver stained as described below.
The different lanes were cut out of the gel with respect to the
molecular weights shown by the molecular marker. The result-
ing thin gel-lanes were digested with trypsin as described
below.
MS-Compatible Silver Staining Procedure for Proteolytic
Digest. Gels were fixed with 50% methanol, washed and
sensitized with 0.02% Na2S2O3. They were stained with ice-
cold 0.1% AgNO3 for 20 min, rinsed with bidistilled water and
subsequently developed with 3% Na2CO3/0.05% formaldehyde
as previously described.29
Tryptic Digestion. Silver stained gel pieces were destained
with 15 mM K3Fe(CN)6/50 mMNa2S2O3 and intensively washed
with 50%methanol/10% acetic acid. The pH was adjusted with
50 mMNH4HCO3; the proteins were reduced with 10 mMDTT/
50 mM NH4HCO3 and alkylated with 50 mM iodacetamide/50
mM NH4HCO3 for 20 min in the dark. After drying, the gel
pieces were treated with 0.1 mg/mL trypsin (Trypsin sequenc-
ing grade, Roche Diagnostics, Germany)/50 mM NH4HCO3
overnight at 37 °C. Peptides were eluted with 5% formic acid/
50% acetonitrile and concentrated in the Speed-Vac to an
appropriate volume.
Mass Spectrometry Analysis. For the identification of 2D
spots, peptides were loaded on a Zorbax 300SB-C8 (5 µm, 0.3
mm, 5 mm) column and separated by nanoflow LC (1100 Series
LC system, Agilent, Palo Alto, CA) with a Zorbax 300SB-C18 (5
µm, 75 mm, 150 mm) column at a flow rate of 250 nL/min
using a gradient from 0.2% formic acid and 3% acetonitrile
(ACN) to 0.2% formic acid and 45% ACN over 12 min. In case
of shotgun analysis, peptides were separated by nanoflow LC
(1100 Series LC system, Agilent, Palo Alto, CA) using the HPLC-
Chip technology (Agilent) equipped with a 40 nL Zorbax 300SB-
C18 trapping column and a 75 µm × 150 mm Zorbax 300SB-
C18 separation column at a flow rate of 400 nL/min, using a
gradient from 0.2% formic acid and 3% ACN to 0.2% formic
acid and 50% ACN over 60 min. Peptide identification was
accomplished by MS/MS fragmentation analysis with an ion-
trap mass spectrometer (XCT-Ultra, Agilent) equipped with an
orthogonal nanospray ion source. The MS/MS data, including
peak list-generation and search engine, were interpreted by the
Spectrum Mill MS Proteomics Workbench software (Version
A.03.02, Agilent). The software was set to allow two missed
cleavages and searched against the Swiss-Prot Database for
human proteins (Version 20080409 containing 19 038 entries)
allowing for precursor mass deviation of 1.5 Da, a product mass
tolerance of 0.7 Da and a minimum matched peak intensity
(%SPI) of 70%. Because of previous chemical modification,
carbamidomethylation of cysteines was set as fixed modifica-
tion. No other modifications were considered here.
The following protein selection algorithm was applied for
the generation of the final protein lists. Peptide scores were
used to select appropriate sequence assignments. To assess the
reliability of the peptide scores, we performed searches against
the corresponding reversed database. A total of 5.9% positive
hits were found with peptides scoring >9.0, while 0.21%
positive hits were found with peptides scoring >13.0. Only
peptides scoring higher than 9.0 were considered for protein
identification. Identification details for each protein including
Figure 4. Comparison of lipid-peroxidation levels in plasma
samples of “cancer” and “control” groups. The Kruskal-Wallis
rank sum test showed a significant increase in the “cancer” group
(p-value < 0.01).
Figure 5. Differently expressed proteins detected in PBMCs of
cancer patients displaying increased oxidative stress compared
to healthy controls. 2D-gels of PBMCs of control (A) and cancer
groups (B) are shown. Proteins were detected by RuBPS fluo-
rescence staining. Proteins down-regulated in the “cancer” group
are surrounded by pentagons, up-regulated proteins are encircled.
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all identified peptides, sequence coverage, peptide scores and
MS/MS spectra are fully accessible via PRIDE database
(http://www.ebi.ac.uk/pride/),30,31 PRIDE accessions 3844-59.
Table S1 in Supporting Information was generated by com-
bining all independent shotgun experiments from the in vitro
experiments. These combinations comprise all peptides related
to single proteins which were collected from all individual
experiments. Proteins were selected based on the expression
of specific peptides (identified in one protein only, indicated
in Table S1, row “Sg” in Supporting Information). Selection of
protein isoforms was performed as described by Zhang et al.32
Semiquantitative assessment was performed using the num-
ber of distinct peptides identified per protein. This approach
is based on the fact that the number of peptides identified per
protein increases with the concentration. For comparative
analysis, we considered the difference of the number of distinct
peptides per protein in the reference maps such as control
versus treated. Furthermore, we introduced the matching
factor. The matching factor shows the average difference
between different sets of data. An increase of 6 peptides, for
example, for a protein comparing the hydrogen peroxide-
treated PBMCs to the untreated PBMCs with a matching factor
of 0.33 translates to an average increase of two () 6 × 0.33)
peptides observed in the four experiments. We considered
proteins as up-regulated when the average increase in peptide
number was more than one-third of the number of peptides
of the corresponding control. Down-regulation was calculated
vice versa.
Results and Discussion
In all 2D gels of the current study from cytoplasmic proteins
isolated from PBMCs, 1034 spots were reproducibly detected.
A total of 670 of these spots were successfully identified by mass
spectrometry, corresponding to 519 different proteins (Figure
1). These 519 proteins were accessible to quantification via
fluorescence detection as well as [35S] -autoradiography. Fur-
thermore, 1432 different proteins were independently identified
by shotgun analysis. A total of 513 of the 519 proteins identified
in the 2D gels were also independently identified by shotgun
proteomics (Table S1 in Supporting Information).
Protein Expression Alterations of Primary White Blood
Cells Induced by Oxidative Stress in Vitro. Treatment with
hydrogen peroxide induced distinct proteome alterations as
illustrated in Figure 2. We observed a general average increase
of the [35S]-incorporation of 42% ((29%). This was determined
by summarizing the corresponding [35S]-autoradiography spot
intensities of all detected 2D gel spots. To elude this bias,
quantitative assessment was corrected by normalization. Most
importantly, the observed proteome alteration pattern was
reproduced with cells derived from all donors as demonstrated
in Figure 3. Seventeen proteins were found significantly
(ANOVA p < 0.05) up-regulated and nine proteins were found
significantly down-regulated (Table 1). By shotgun analysis of
the corresponding protein samples, we found nine proteins
markedly and reproducibly up-regulated and 23 down-regu-
lated by hydrogen peroxide treatment (Table 1).
Somewhat unexpectedly, rather few redox-regulating pro-
teins were found regulated. Table 1 lists some of these proteins
which were successfully identified but did not show detectable
alterations. Proteins presently found to be affected may be
related to one of the following scenarios:
(1) Indication of Cell Stress. Up-regulation of several
chaperones, cytoskeletal proteins, redox-regulating enzymes
and proteins related to DNA-repair was observed (Table 1) and
was concordant with published data. Hydrogen peroxide may
indirectly damage proteins by the introduction of oxidative
modifications and thus functional inactivation, which may
cause the observed cell stress response. These regulatory events
may as well demonstrate the direct effort of the cells to cope
with ROS. The observed down-regulation of ATP-dependent
DNA helicase 2 subunits 1 and 2 (Ku antigens 70 and 80, Table
1) is consistent with cancelation of cell proliferation consequent
to a general stress response.
(2) Indication of Distinct Survival Strategy. The cell stress
response indicated above is a general survival strategy of cells.
It is evoked in response to very different kinds of stressors. We
also observed a distinct down-regulation of Mn-SOD which
appears to be rather specific for oxidative-stress. One potential
explanation might be the inactivation of this enzyme by
hydrogen peroxide followed by proteasomal degradation as
described for Cu/Zn-SOD (copper/zinc superoxide dismutase)
in red blood cells by Salo et al.33 Another explanation might
be that this down-regulation is part of the cells’ survival
strategy. Mn-SOD decomposes superoxide to hydrogen per-
oxide, which is then processed to molecular oxygen and water
by catalase, glutathione peroxidase and peroxiredoxin.2,10 If the
capacity of the hydrogen peroxide processing enzymes such
as catalase is insufficient, the catalysis of the reverse conversion
of H2O2 to superoxide by Mn-SOD will predominate. Immedi-
ate down-regulating Mn-SOD synthesis may be a strategy to
reduce superoxide production under acute oxidative stress.
Quite notably, under conditions designed to reduce oxidative
stress which were introduced in a controlled Brussels sprouts
intervention study, Mn-SOD was found significantly up-
regulated. This was accompanied by the down-regulation of
hsp70.34 In other studies, the down-regulation of Mn-SOD was
also described in association with tumor-suppressor activity
of this protein.35-37 We therefore suggest that down-regulation
of Mn-SOD may be a specific response and thus an indicator
for oxidative stress.
A similar interpretation applies to the observed down-
regulation of proteins involved in energy metabolism (Table
1). As ROS formation invariably accompanies oxidative phos-
phorylation, it could make sense for cells to down-regulate the
corresponding processes in order to increase the chance of
survival.
(3) Indication of Compensatory Up-Regulation of Protein
Synthesis. Several proteins, including hsp70, annexin A1, purine
nucleoside phosphorylase and tubulin alpha displayed in-
creased protein synthesis. However, shotgun analysis deter-
mined them to be decreased in protein amounts (Table 1). This
apparent discrepancy may actually suggest a oxidative stress-
induced loss of these proteins, accompanied by compensatory
up-regulation of protein synthesis. This suggests that these
proteins might be targets highly susceptible to irreversible
oxidative damage.
(4) Inflammatory Activation of Monocytes. The increased
expression of IL-1 may indicate inflammatory activation of
monocytes. Up-regulation of ficolin, an opsonin and thymidine
phosphorylase (which is also known as platelet-derived endot-
helial cell growth factor) would be in line with this interpretation.
Assessment of Plasma Peroxidation Levels. Direct assess-
ment of peroxidation was performed with plasma samples
taken from 10 patients with cancer and 10 control persons
matched in age and sex. Peroxidation of plasma samples was
measured with the TBA assay.7 Figure 4 shows the significant
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difference in the peroxidation level between the “control” and
the “cancer” group. The calculated average malondialdehyde
(MDA) value for the “control” group was 1.6 µmol/L and for
the “cancer” group 2.9 µmol/L. The absolute values obtained
by this method may be somewhat inaccurate.38 To investigate
relative alterations of lipid peroxidation, this is a well-
established method providing significant varieties.39,40 With the
use of the hydroperoxide assay with ferric XO complex, the
observed difference (although apparently more pronounced
than that obtained with the TBA assay) was not significant.
Protein Expression Alterations of Primary White Blood
Cells Related to Oxidative Stress in Vivo. PBMCs from blood
of the donors described above were isolated. Comparative
proteome analysis was performed focusing on the determina-
tion of protein amounts by 2D-PAGE for all 20 individual
samples.
Compared to the group of PBMCs derived from healthy
donors, the PBMCs isolated from cancer patients displayed
eight significantly regulated proteins (ANOVA, p < 0.05, Figure
5, Table 1).
Shotgun analysis was performed with PBMCs from four
members of each group. All proteins identified as altered by
2D-PAGE displayed a similar tendency of regulation with
shotgun analysis. As exemplified in Figure 5, we observed some
characteristic alterations. These alterations appear to be mainly
related to chronic inflammation, metabolism and apoptosis
regulation (Table 1). These data suggest that PBMCs of cancer
patients may indeed display characteristic proteome alterations.
None of these alterations, however, could be clearly related to
oxidative stress.
Conclusion
In this study, a distinct proteome response of PBMCs to in
vitro hydrogen peroxide treatment was observed. Besides
classical indicators for stress response, the observed proteome
alterations indicate cellular strategies to minimize superoxide
production in order to increase the chances of survival. No
potential single marker protein specifically induced by oxidative
stress and up-regulated in PBMCs of cancer patients was
identified. Down-regulation of Mn-SOD, however, may serve
as characteristic marker to indicate oxidative stress. The present
data suggest that the combined assessment of proteins related
to survival, redox regulation and DNA damage repair in PBMCs
may prove useful to specifically detect oxidative stress in vivo.
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Proteome alterations induced in human white blood cells
by consumption of Brussels sprouts: Results of a pilot
intervention study
Christine Hoelzl, Olga Lorenz, Verena Haudek, Nina Gundacker,
Siegfried Knasmüller and Christopher Gerner
Internal Medicine Clinic I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria
Epidemiological studies indicate a correlation of cruciferous vegetables consumption with
reduced incidence of cancer. This study was designed to investigate molecular mechanisms,
which may help to understand the beneficial effects of Brussels sprout consumption. In order to
avoid the limitations of in vitro model systems, we performed a dietary intervention study with
five participants. We investigated, whether sprout consumption affects the proteome profile of
primary white blood cells. In order to achieve maximal sensitivity in detecting specific adaptive
proteome alterations, we metabolically labelled freshly isolated cells in the presence of 35S-
methionine/cysteine and performed autoradiographic quantification of protein synthesis. Pro-
teins were separated by 2-DE and spots of interest were cut out, digested and identified by MS.
After the intervention, we found a significant up-regulation of the synthesis of manganese
superoxide dismutase (1.56-fold) and significant down-regulation of the synthesis of heat shock
70 kDa protein (hsp70; 2.27-fold). Both proteins play a role in malignant transformation of cells.
Hsp-70 is involved in the regulation of apoptosis, which leads to elimination of cancer cells, while
SOD plays a key role in protection against reactive oxygen species mediated effects. Our findings
indicate that the alteration of the synthesis of these proteins may be involved in the anti-
carcinogenic effects of cruciferous vegetables, which was observed in earlier laboratory studies
with animals.
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1 Introduction
Numerous epidemiological studies indicate that consump-
tion of cruciferous vegetables is inversely related with the
incidence of various form of cancer, in particular with colo-
rectal cancer; in some studies also inverse relations were
observed with the incidences of lung, prostate and breast
cancer [1–4]. Already in the 1970s, Wattenberg and co-work-
ers [5, 6] reported that feeding of active compounds of these
vegetables protects laboratory rodents against induction of
cancer by polycyclic aromatic hydrocarbons; subsequent
investigation confirmed these findings and showed that
Brassicas are also protective against other dietary carcino-
gens such as nitrosamines and heterocyclic aromatic amines
(for review see [7]). The chemoprotective properties of these
plants were attributed to breakdown products (indoles,
nitriles and isothiocyantes) of glucosinolates, which are con-
stituents of cruciferous plants and were explained by mod-
ulation of the activities of drug metabolising enzymes (e.g.
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GST, glucuronosyl transferase), which catalyse the activation
and detoxification of these carcinogens [8]. Subsequent
investigations showed that the glucosinolate metabolites
activate transcription factors (e.g. Nrf2), which increase the
transcription of phases I and II, as well as of antioxidant
enzymes and of a number of proteins involved in cell sig-
nalling [1, 9, 10]. Apart from alterations of the activities of
xenobiotic drug metabolising enzymes, also other mechan-
isms of cancer chemoprevention were identified. For exam-
ple, potential protective effects towards breast cancer were
explained on the basis of findings, which indicated that
indoles inhibit the transcription of estrogen responsive
genes (87R, 88R) and increase the excretion of 2-OHestrone
(87R, 98R). Also induction of cell cycle arrest and apoptosis
[1] as well as inhibition of tumour invasion and anti-inflam-
matory properties due to reduced binding of DNA to NF-kB-a
pro-inflammatory transcription factor may play a role in the
cancer protective properties of Brassica vegetables [11].
In a recent intervention trial, we found in single cell gel
electrophoresis assays that consumption of sprouts (300 g/P/
day) over a period of 5 days causes a strong reduction of en-
dogenous formation of oxidised DNA bases and reduces the
sensitivity of the cells towards exogenous DNA damage by
reactive oxygen species in peripheral lymphocytes [12].
The present article describes the results of a follow up
study using an identical design and the same sprout cultivar
as in the previous trial. Here, the impact of sprouts con-
sumption on the protein expression profile of white blood
cells was investigated. It has been emphasised repeatedly
that proteomics is an important tool to improve our current
knowledge of cancer prevention by dietary factors [13–17],
but only few investigations have been published in which
this technique was used to investigate the impact of dietary
factors in animal models [18–20] or cell cultures [21–28].
2 Materials and methods
2.1 Brussels sprouts
The study was carried out with the cultivar ‘Cyrus’. The glu-
cosinolate contents of this variety have been analysed earlier
by HPLC (for details see [21]).
2.2 Design of the intervention study
Five healthy, nonsmoking participants (age: 33 6 7 years,
b.w.: 60 6 7 kg, three males, two females) were included in
the experiment. All of them were nonvegetarians and did not
use pharmaceutical drugs 1 month before the study. Fur-
thermore, they did not consume vitamin supplements or
vitamin-enriched foods 5 days before (‘run in’-phase) and
during the intervention (5 days). The study design was iden-
tical to that of an earlier study in which the impact of Brus-
sels sprouts consumption on DNA-stability in lymphocytes
was studied [12], and similar run in-phase (5–7 days) have
been used in a number of earlier human intervention studies
[22–24]. Five days before and during the intervention period
(5 days), the volunteers were asked to consume a controlled
diet to avoid inter individual differences, which may arise
from different dietary habits. The usual food intake was
recorded by use of a standardised questionnaire [25] and all
of the participants consumed only low amounts of crucifer-
ous vegetables (200 g/month). The evaluation also showed
that all of them consumed a typical mixed (Austrian) diet
(energy intake 2000–2540 kcal/day). All of them were pro-
vided with an information sheet in which the diet before and
during the intervention was specified in detail, and were
asked to record the approximate consumption of the con-
trolled items on a daily base. The participants were not
allowed to consume additional cruciferous vegetables and
refrained from intake of more than 200 g/day of citrus fruits,
fruit juices, onions and wholemeal products. It is known
from earlier studies which were conducted with conventional
techniques that these dietary factors cause antioxidant effects
and/or induce detoxifying (phase II) enzymes [26–28]. Fur-
thermore, it has also been shown for individual constituents
such as resveratrol [18], quercetin [28], ascorbic acid [29] and
genistein [30] that they affect the protein expression patterns.
Therefore, additive or synergistic effects in combination of
these items with consumption of Brussels sprouts cannot be
excluded. Furthermore, the participants were also asked not
to consume more than 200 mL wine, beer or coffee per day.
During the intervention, the participants consumed one
portion (300 g) of Brussels sprouts per day over a period of
5 days. At lunchtime, the deep frozen vegetables were cooked
in a microwave (8 min, 950 W, Micromat 175Z, AEG Elek-
trolux, Stockholm) and were subsequently distributed to the
participants who consumed them in 2–3 portions during the
rest of the day (i.e. half of them during lunchtime and the
second portion as dinner – between 6 and 8 pm). At the
beginning and at the end of the study (after the last inter-
vention day) 40 mL blood were collected in heparinised tubes
(BN Vacutainer Systems, Plymouth, UK) in the morning (8
am). The rationale for the time schedule was designed on the
basis of the results of earlier investigations [24]. Cruciferous
vegetables (including Brussels sprouts) contain a specific
group of chemoprotective compounds, so-called glucosino-
lates (for review see [4, 32, 33]). Their breakdown products
and a number of metabolites are found transiently (up to
24 h) in the blood after consumption of Brassicas [24]. It is
known from experiments with individual model compounds
(e.g. sulphoraphane and phenethyl isothiocyanate) that they
affect the transcription of numerous genes, in particular
those controlled by the transcription factors Nrf2 and NF-kB
[9–11, 34–36].
2.3 Cell preparation
Peripheral blood mononuclear cells (PBMC) were isolated
from heparinised whole blood of healthy donors (mixed with
2 vol. HBSS) by standard density gradient centrifugation
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with Ficoll-Paque (Pharmacia Biotech). The interface cells
(PBMC, here white blood cells, WBC) were resuspended in
autologous plasma and supplemented with 0.2 mCi/mL 35S
Protein labelling Mix (Trans35label, Biomedica, MP Bio-
medicals). After 6 h at 377C in a humidified atmosphere
containing 5% CO2, cells were washed and fractionated.
Washing and fractionation was carried out at 47C.
2.4 Subcellular fractionation
All buffers were supplemented with protease inhibitors
PMSF (1 mM), aprotinin, leupeptin and pepstatin A (each at
1 mg/mL). Cells were lysed in 0.25 M sucrose, 3 mM MgCl2,
0.5% Triton X-100 in hypotonic buffer (10 mM HEPES/
NaOH, pH 7.4, 10 mM NaCl, 3 mM MgCl2). The cytoplas-
matic fraction was separated from the nuclei by centrifuga-
tion through a 30% Sucrose gradient at 3500 rpm for 5 min
at 47C. After ethanol precipitation, the pelleted cytoplasmatic
protein fraction was directly solubilised in sample buffer.
2.5 2-D PAGE
High resolution 2-DE was carried out as described previously
[37] using a slightly modified method according to Hoch-
strasser et al. [38], using the Protean II xi electrophoresis
system (BioRad, Hercules, CA). The protein samples were
dissolved in sample buffer (7.5 M urea, 1.5 M thiourea, 4%
CHAPS, 0.5% SDS, 100 mM DTT). To optimise solubilisa-
tion of proteins, we saturated the protein solution with urea
by addition of solid urea. Solubilised protein (300 mg/gel)
was diluted to 280 mL solution with sample buffer freshly
adjusted to 0.2% resolytes pH 3.5–10 (BDH, Electran), and
0.1% Bromophenol blue. After 12 h rehydration of IPG
strips pH 5–8, 17 cm (BioRad) at room temperature, IEF of
protein samples was performed in a stepwise fashion (1 h, 0–
500 V linear; 5 h, 500 V; 5 h, 500–3500 V linear; 12 h,
3500 V). After IEF the strips were equilibrated with 100 mM
DTT and 2.5% iodoacetamide according to the manu-
facturer’s instructions (BioRad). For SDS-PAGE, focussed
and equilibrated IPG strips were placed on top of 1.5 mm
12% T polyacrylamide slab gels and overlaid with 0.5% low
melting agarose. The gels were run at 157C at 150 mA for
about 4–5 h. The gels were stained with a 400 nM solution of
Ruthenium II tris (bathophenanthroline disulphonate)
(RuBPS) as described by Rabilloud et al. [39]. Fluorescence
scanning was performed with the FluorImager 595 (Amers-
ham Biosciences, Amersham, UK) at a resolution of 100 mm.
After scanning, gels were laid on Whatman 3 MM chroma-
tography paper, covered with cling film, and dried at 607C
using the slab gel dryer SE110 (Hoefer, San Francisco, CA,
USA). Exposure of storage phosphor screens (Molecular
Dynamics) occurred at room temperature for 24 h. Screens
were subsequently scanned with the Phosphorimager SI
(Molecular Dynamics) at a resolution of 100 mm.
Gels were warped to a reference gel with the TT900 S2S
software (Version 2006.0.2389, Nonlinear dynamics, Carls-
bad, CA) and evaluated with the Progenesis software PG200
(Version 2006, Nonlinear, Newcastle upon Tyne, UK) using
the ‘same spot’ algorithm. Spot assignment, background
correction, normalisation and statistical calculations were
performed with this software. Integrated intensities from
fluorescence detection and autoradiography were normal-
ised against the sum of all matched spots.
2.6 Tryptic digest
Protein spots were cut out of the gel, the gel-pieces were
destained with 15 mM K3Fe(CN)6/50 mM Na2S2O3 and
intensively washed with 50% methanol/10% acetic acid. The
pH was adjusted with 50 mM NH4HCO3, the proteins were
reduced with 10 mM DTT/50 mM NH4HCO3 for 30 min at
567C and finally alkylated with 50 mM iodoacetamide/
50 mM NH4HCO3 20 min in the dark. Afterwards the gel-
pieces were dried with ACN and accelerated dried in the
SpeedVac. Between each step, the tubes were shaken 5–
10 min (Eppendorf Thermomixer comfort).
The dried gel-spots were treated with trypsin 0.1 mg/mL
(Trypsin sequencing grade, Roche Diagnostics, Germany)/
50 mM NH4HCO3, in a ration of 1:8 for 20 min on ice, cov-
ered with 50 mM NH4HCO3 and were subsequently stored
over night at 377C.
The digested peptides were eluted adding 50 mM
NH4HCO3 to the gel spots, the supernatant was transferred
into silicon-coated tubes, and the extraction procedure re-
peated for two times with 5% formic acid/50% ACN. Between
each elution step the gel spots were sonicated. Finally the
peptide solution was concentrated to an appropriate volume.
2.7 MS analysis
Proteins were identified by mass spectrometric analysis.
Peptides were loaded on a Zorbax 300SB-C8 (5 mm,
0.3 mm65 mm) column and separated by nanoflow LC
(1100 Series LC system, Agilent, Palo Alto, CA) with a Zorbax
300SB-C18 (5 mm, 75 mm6150 mm) column at a flow-rate of
250 nL/min using a gradient from 0.2% formic acid and 3%
ACN to 0.2% formic acid and 45% ACN over 12 min. Peptide
identification was accomplished by MS/MS fragmentation
analysis with an IT mass spectrometer (XCT-Ultra, Agilent)
equipped with an orthogonal nanospray ion source. The MS/
MS data were interpreted by the Spectrum Mill MS Prote-
omics Workbench software (Version A.03.02, Agilent) and
searched against the Swiss-Prot Database version 20061207
allowing the initial search algorithm for precursor mass
deviation of 2.5 Da, a product mass tolerance of 0.7 Da and a
minimum matched peak intensity (%SPI) of 70%. Due to
previous chemical modification, carbamidomethylation of
cysteines was set as fixed modification. No other modifica-
tions were considered here. Peptide scores are essentially
calculated from sequence tag lengths, but also consider mass
deviations. To assess the reliability of the peptide scores, we
performed searches against the corresponding reverse data-
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base. Positive hits (6.3%) were found with peptides scoring
.9.0, while no positive hits were found with peptides scoring
.13.0. All spots were identified with at least two different
peptides with one scoring at least higher than 13.0. In total,
460 protein spots were identified, here we show those most
relevant to the current study.
3 Results and discussion
Mononuclear white blood cells were isolated from partici-
pants before and after a controlled dietary intervention and
incubated for 6 h in autologous plasma in the presence of
35S-methionine/cysteine for metabolic labelling. Cyto-
plasmic proteins were isolated, separated by 2-D PAGE and
quantified by fluorescence detection in addition to auto-
radiography. Gels from all samples before the intervention
were grouped and compared to the group of the samples
after the intervention. Protein spots were quantified,
matched and evaluated statistically. Spots of interest were
excised, digested with trypsin and forwarded to peptide frag-
mentation analysis by MS after separation by nanoflow LC.
Five hundred and eleven spots were consistently detected in
all gels and accessible for quantification. Fourty-eight spots
of those were identified (Fig. 1) by peptide fragmentation
analysis of tryptic digests.
The spots with the greatest difference ratios between
the two groups and additionally several redox-regulating
proteins are listed in Table 1. The reproducibility of the
protein patterns was very high (Fig. 2). When a difference
exceeding at least 50% of the control value was set as low-
est threshold, no protein spot showed a significant differ-
ence in fluorescence intensity between the two groups (not
shown). Applying the same criteria, two statistically signif-
icant alterations in 35S-autoradiograph intensities were
identified (Fig. 2). After 5 days of controlled diet with
Brussels sprout consumption, the synthesis rate of man-
ganese superoxide dismutase (Mn-SOD) was 1.56-fold up-
regulated (p,0.001) (Fig. 3, Table 1). On the other hand,
heat shock 70 kDa protein 1 (hsp70) showed a 2.27-fold
down-regulation (56% reduction of the control value,
p,0.05, Table 1). Other proteins such as 78 kDa glucose-
regulated protein were up-regulated, and elongation factor
1-delta and epidermal fatty acid-binding protein were
down-regulated, but to a lesser extent (Table 1), and may
be thus of minor relevance. As we focus on redox regula-
tion, all identified proteins potentially relevant in this con-
text are listed as well in Table 1.
Figure 1. Fluorescence detec-
tion of a 2-D gel of cytoplasmic
proteins isolated from white
blood cells. Proteins were sepa-
rated according to pI in the first
dimension (linear from 5.0 at the
left-hand side to 8.0 at the right-
hand side) and molecular
weight (about 250 kDa on top to
10 kDa at the bottom). For iden-
tification, spots of interest were
excised, digested and for-
warded to peptide fragmenta-
tion analysis by MS. Spot anno-
tations are Swiss-Prot Acces-
sion numbers (see also Table 1).
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Table 1. Protein alterations induced by a controlled dietary intervention with Brussels sprouts in human primary white blood cells
Protein Accession
no.
Norm.
vol. (CV)
Difference
(‘norm. vol.’
vs. ‘AR before’)
ANOVA (p)
26S protease regulatory subunit 6A P17980 0.077 (18%) 21.022 0.017
40S ribosomal protein SA P08865 0.053 (25%) 1.026 0.006
78 kDa glucose-regulated protein P11021 0.439 (34%) 1.504 0.286
Alcohol dehydrogenase [NADP1] P14550 0.041 (26%) 21.292 0.371
Aldehyde dehydrogenase P05091 0.208 (22%) 21.033 0.277
Catalase P04040 0.096 (30%) 21.370 0.005
Cofilin-1 P23528 0.156 (33%) 21.553 1.547e-005
Core-binding factor, beta subunit Q13951 0.060 (33%) 21.271 0.013
Cytoplasmic antiproteinase 3 P50453 0.826 (38%) 1.497 0.026
Cytosol aminopeptidase P28838 0.048 (35%) 21.231 0.037
DJ-1 protein Q99497 0.207 (30%) 21.083 2.719e-007
Dynactin subunit 2 Q13561 0.052 (37%) 1.200 0.002
EF-hand domain-containing protein 2 Q96C19 0.427 (15%) 1.235 0.045
Elongation factor 1-delta P29692 0.061 (10%) 21.872 0.023
Fatty acid-binding protein, epidermal Q01469 0.191 (40%) 21.606 0.002
Ferritin heavy chain P02794 0.062 (38%) 21.233 0.023
Ferritin light chain P02792 0.449 (32%) 21.067 2.229e-006
Glucose-6-phosphate 1-dehydrogenase P11413 0.175 (19%) 21.158 0.179
Glutamate dehydrogenase 1, mitochondrial P00367 0.032 (9%) 21.534 0.803
Glutathione peroxidase 1 P07203 0.143 (35%) 21.136 0.202
GST P P09211 0.268 (30%) 21.086 1.443e-007
Glutathione transferase omega 1 P78417 0.260 (22%) 21.124 0.188
Glyoxylate reductase/hydroxypyruvate reductase Q9UBQ7 0.067 (36%) 21.342 0.475
Hsp70 P08107 0.142 (10%) 22.277 0.039
Hematopoietic lineage cell-specific protein P14317 0.249 (18%) 1.233 9.314e-005
NADH-ubiquinone oxidoreductase 75 kDa subunit P28331 0.046 (12%) 21.020 0.036
Peroxiredoxin 2 P32119 0.096 (37%) 21.161 0.047
Peroxiredoxin 6 P30041 0.075 (30%) 21.254 0.004
Peroxiredoxin-5, mitochondrial Q9GLW9 0.050 (44%) 21.396 0.056
Phosphoglycerate kinase 1 P00558 0.043 (22%) 21.602 0.345
Proactivator polypeptide precursor P07602 0.228 (21%) 1.453 1.662e-004
Protein disulphide-isomerase A3 P30101 0.332 (14%) 1.131 0.002
Superoxide dismutase [Cu–Zn] 1 P00441 0.065 (46%) 21.393 7.126e-004
Superoxide dismutase [Mn], mitochondrial P04179 1.083 (18%) 1.563 8.254e-007
Synaptic vesicle membrane protein VAT-1 homologue Q99536 0.042 (16%) 21.173 0.075
Thioredoxin P10599 0.098 (44%) 21.342 0.001
Thioredoxin domain containing protein 4 (ERp44) Q9BS26 0.139 (21%) 1.037 0.161
Thioredoxin reductase 1, cytoplasmic Q16881 0.037 (20%) 21.319 0.062
Thioredoxin-dependent peroxide reductase, mitochondrial P30048 0.067 (33%) 21.355 1.135e-006
Thioredoxin-like protein 1 O43396 0.134 (12%) 21.075 1.578e-004
Thioredoxin-like protein 2 O76003 0.062 (18%) 21.191 0.068
Thymidine phosphorylase P19971 0.245 (21%) 21.047 0.839
Transaldolase P37837 0.098 (17%) 21.250 0.555
Triosephosphate isomerase P60174 0.257 (30%) 21.120 0.155
Ubiquinol-cytochrome c reductase complex core protein I P31930 0.478 (63%) 1.396 0.054
Spot volumes were calculated from 35S-autoradiographs and normalised to total sum of spot volumes of the gels. Values are provided for
the group of five individuals after consumption of Brussels sprouts with CV in relation to the values before consumption of Brussels
sprouts (difference factors). Proteins were identified by mass analysis. Here, the most significant alterations of all spots accessible to
quantification in the 2-D gels, in addition to redox-regulating proteins, are listed. Proteins were considered as relevant which showed
alterations exceeding 50% of the control value with p-values below 0.05 (listed in bold font).
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Figure 2. Proteome alteration
induced by Brussels sprout con-
sumption. 2-D gels of a donor
before (A, C) and after (B, D) the
dietary intervention. Fluores-
cence detection (A, B) did not
reveal significant alterations
after normalisation. In contrast,
35S-autoradiography of the
same gels (C, D) showed more
pronounced differences. The
two most significant effects are
displayed below including error
bars from five different individ-
uals. While the amount of SOD
was not altered (E, bar 2 com-
pared to bar 1), the synthesis
rate was significantly up-regu-
lated (E, bar 4 compared to bar
3, see also Table 1). Similarly,
the amount of hsp70 was only
slightly down-regulated, while
the autoradiograph showed a
significant down-regulation of
the synthesis rate (F). FL, fluo-
rescence detection; AR, auto-
radiography.
The observed effects may seem to be subtle. Quantitative
proteome analysis solely based on protein amounts is a quite
daunting challenge which may provide limited reproducibil-
ity and thus poor statistical scores [40]. Therefore, we have
applied in the present study more sensitive techniques
which are based on the measurement of protein synthesis
[37]. We demonstrated previously that the measurement of
protein synthesis is a much more sensitive technique when
compared to the measurement of protein amounts [37, 41].
Actually cells can only adjust protein amounts in two ways:
they can synthesise new proteins or degrade existing ones. A
new stimulus may elicit the need for a new protein, which
would then result in de novo synthesis. The response of a cell
to any challenge, however, can be much easier detected when
protein synthesis is compared to protein amounts. Due to a
generally low-level turn-over of proteins, the change of pro-
tein amounts can as well be considered as more inertial as
the change of protein synthesis. To double the amount of a
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Figure 3. SOD (Mn) is signifi-
cantly up-regulated upon Brus-
sels sprout consumption. (A)
2-D gel sections of correspond-
ing gel pairs from three different
donors displaying 35S auto-
radiograph intensities of super-
oxide dismutase (Mn) compared
to the neighbouring protein
triosephosphate isomerase
before and after dietary inter-
vention. (B) 3-D view of the 2-D
gel section (35S auto-
radiography) of donor 1 point-
ing out the specific up-regula-
tion of superoxide dismutase
(Mn). (C) Identification of SOD
(Mn) by peptide fragmentation
analysis. The peptide fragmen-
tation (MS2) spectra of two pep-
tides of the protein are shown.
Note that almost complete b-
and y-series were obtained,
proving unequivocal identifica-
tion. The shown peptides are
underlined in the amino acid
sequence of the total protein.
protein, it may be easily required to induce the synthesis rate
more than ten-fold over a certain time period [37]. Compara-
tive measurements detect a ten-fold increase in synthesis
much easier than a two-fold increase in protein amount. This
is why the quantification of synthesis rates is much more
sensitive in detecting specific adaptive proteome alterations
than the quantification of protein amounts.
We cannot provide reliable conclusions whether or not
other proteins are regulated by Brussels sprouts consump-
tion. This may be due to small difference ratios or poor sta-
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tistical significance (Table 1). These limitations may be over-
come by an increase in the number of participants and by an
optimisation of the intervention protocol or other parame-
ters. However, the present results clearly indicate that con-
sumption of the vegetables leads to a significant alteration of
two proteins, which are known to play a crucial role in cancer
prevention.
Mn-SOD, which was up-regulated more than 1.56-fold, is
one of the most important antioxidant defence enzymes, and
it is known that dysfunction are associated with a number of
human pathologies (for review see [42]). It has been found
that certain dietary factors associated with DNA-and cancer
protection such as EGCG ((2) epigallocatechin-3-gallate,
unpublished data), selenium, coffee consumption, as well as
phenol-rich diet cause an induction of SOD [43–46]. Fur-
thermore, in an earlier in vivo study with rats fed cruciferous
vegetables an induction of hepatic SOD has been found [47].
SOD is controlled via the transcription factor Nrf2 [48] and
there is clear evidence that glucosinolates activate the tran-
scription factor Nrf2 [1, 9, 35]. These findings support the
assumption that glucosinolates, which are contained in
higher amounts in Brussels sprouts compared with other
cruciferous vegetables [21], account for the effect we
observed.
It is not known from earlier investigations with other
dietary factors if continuous consumption of inducers is
required to maintain higher enzyme levels, but it was found
in a study with medicinal plants that daily uptake (over
120 days) led to a continuous increase of the activity [49]. It is
also notable in this context that Mn-SOD has been credited
tumour-suppressive activities, and such effects were
observed, for example, with human melanoma cells [50, 51].
Our findings may also explain the strong antioxidative
effects (prevention of endogenous formation of oxidised
purines and pyrimidines in peripheral lymphocytes) of
Brussels sprouts consumption, which we observed in a pre-
vious single cell gel electrophoresis study, in which an iden-
tical design was used [12].
Mn-SOD, however, is a double-edged sword and may,
upon overexpression and decreased expression of catalase
and peroxiredoxins, induce H2O2 formation and consequent
cell damage [52]. The accompanying observation, the de-
crease in hsp70 expression (Fig. 2), contradicts such an
interpretation. Hsp70 is an important chaperone and is
strongly up-regulated upon cell-stress and protein damage
[53]. If Mn-SOD was induced by stress caused by Brussels
sprout consumption, we would expect strong up-regulation
of hsp70. The present observation suggests that Mn-SOD
was not induced by cell stress, but rather by another, yet
unknown mechanism. Hsp70 may have oncogenic activity
due to inhibition of apoptosis [54] and has been observed up-
regulated in many forms of cancer such as hepatocellular
carcinoma [55]. Furthermore, hsp70 was found down-regu-
lated by TGF-beta-induced epithelial-mesenchymal transi-
tion [56]. Interestingly, we observed previously down-regula-
tion of hsp70 upon silencing of the oncogenic TEL/AML1
fusion gene [57], which accounts for childhood acute lym-
phoblastic leukaemia. The suppression of an oncogene
resulted in a similar down-regulation of hsp70 as observed in
the present study.
Only few studies have been published in which the
effects of cruciferous vegetables and their constituents (i.e.
glucosinolates and their breakdown products) have been
investigated with -omics technologies. Thimmulappa et al.
[9] and also Hu et al. [58] conducted comparative experiments
with normal and Nrf2 knockout mice with sulphoraphane
and isothiocyanate formed from glucobrassica which is con-
tained in Brussels sprouts in substantial amounts [21] and
found up- and down-regulation of several hundreds of genes.
Also in an experiment with rats in which the effects of two
other glucosinolate metabolites (phenethyl isothiocyanate
and indole 3-carbinol) were analysed by use of microarrays
and proteome analyses, strong effects were observed [34]. On
the contrary, Mitchell et al. [59] could identify only two sig-
nificant protein alteration in a human trial (similar to ours)
in the plasma of the participants; one of the peaks was iden-
tified as 2-HS-glycoprotein a serum glycoprotein involved in
insulin resistance and immune functions. The lack of a
strong effect on the proteasome after consumption of the
sprouts in contrast to the strong alterations seen in the
aforementioned animal studies may be due to the fact that in
the rodents experiments relatively high concentrations of
pure compounds were administered, also organ specific
effects may play a important role. Our results did also not
support the finding of Mitchell et al. [59], as we did not detect
up-regulation of the 2-HS-glycoprotein; this difference will
be due to the fact that they analysed plasma proteins, while
we studied the effects in lymphocytes.
4 Concluding remarks
Taken together the results of our study show that consump-
tion of sprouts leads to significant alteration of the levels of
two proteins, which are associated with cancer formation/
protection supporting the assumption that the vegetables
may elicit chemopreventive properties in man.
As a result, the observed proteome alterations after con-
sumption of Brussels sprouts may generate better protection
against oxidative damage and its consequences.
The authors have declared no conflict of interest.
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Paper IV 
Author contribution: Verena Haudek helped with the concept design, performed 2D gels and 
investigated the 2D gel analysis. 
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